Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AAR2	"bA234K24.2, C20orf4"	ENSG00000131043	"AAR2 splicing factor"	Q9Y312	20	36236131-36270918	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034220, HPA048645"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034220: AB_1564205, HPA048645: AB_2680475"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.54e-3)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (5.09e-2)"	"unprognostic (6.84e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.17e-2)"	22.3	26.8	14.5	14.3	15.8	22.3	21.6	15.8	15.5	19.8	19.1	27.5	15.1	25.6	25.0	17.8	23.2	16.5	18.8	14.3	14.7	20.9	23.5	19.2	17.5	15.9	15.2	22.6	18.6	25.5	10.0	17.5	15.9	19.9	17.3	7.5	18.1	21.1	23.4	25.9	18.9	27.9	15.5	18.1	23.0	16.4	15.4	26.2	17.9	20.7	19.9	25.8	16.2	17.2	26.9	30.7	28.8	33.2	48.9	32.4	22.9	25.4	33.7	58.1	45.7	69.2	35.0	18.2	35.6	36.9	44.8	36.6	46.6	48.2	35.8	17.0	28.2	57.9	19.3	43.3	36.9	39.5	27.9	39.6	68.7	41.5	31.5	29.4	36.3	36.0	36.8	34.3	32.4	32.0	56.0	48.9	25.1	39.1	49.5	30.7	48.3	42.4	33.0	19.6	33.2	36.1	37.8	100.7	32.8	26.2	57.1	42.8	26.6	54.9	34.3	33.0	32.2	31.1	42.3	34.6	39.9	26.3	29.7	60.6	46.2	41.6	43.0	49.4	43.2	32.5	40.0	41.4	49.1	35.5	50.0	43.0	8.9	58.4	58.1	39.8	50.2	57.4	14.5	15.8	15.8	15.5	14.3	14.7	15.9	15.2	15.9	15.5	15.4	17.2	11.7	6.4	12.5	4.6	10.8	5.7	10.6	11.8	6.8	4.4	10.3	9.5	6.8	11.5	8.4	9.2	8.4	21.3	10.9	7.1	11.7	19.7	2.8	6.9	8.9	11.9	11.4	14.7	6.3	21.0	14.3	12.7	6.6	6.6	15.9	10.8	11.4	11.8	15.0	15.2	7.1	10.5	12.2	15.0	2.5	3.1	11.1	8.5	10.6	3.7	12.3	6.1	14.4	5.0	9.9	17.3	7.6	15.1	7.5	11.3	8.4	8.0	11.1	3.5	6.6	9.8	13.9	17.0	14.5	9.0	7.5	18.6	7.9	15.3	8.7	8.9
AARS1	"AARS, AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase 1"	P49588	16	70251983-70289707	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 25.1;Cytotrophoblasts: 63.0;Extravillous trophoblasts: 29.9;Hofbauer cells: 27.1;Syncytiotrophoblasts: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034261, HPA040870, HPA044223"	Supported		Supported	Cytosol		NA	NA		620000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	43.7	54.7	60.1	33.4	64.3	7.9	41.4	73.3	88.6	42.1	49.2	48.9	26.0	49.8	49.6	29.5	40.4	22.3	47.9	62.8	71.7	43.6	72.0	45.3	30.0	78.6	68.6	37.3	75.8	74.9	50.1	35.6	84.9	40.0	26.2	59.3	53.3	47.2	62.4	28.8	32.7	47.8	66.3	38.3	51.8	23.8	74.8	36.4	66.6	39.7	35.5	45.9	32.8	83.9	123.7	192.8	52.9	205.7	127.3	115.0	125.7	97.7	135.3	119.7	151.8	162.5	163.2	140.4	127.2	99.3	90.8	137.2	160.5	133.1	170.7	63.2	54.7	135.6	78.0	152.2	348.0	74.4	77.2	133.9	193.8	228.1	508.4	91.4	120.3	209.3	176.0	173.4	91.3	282.0	89.4	85.0	104.3	160.0	108.5	170.4	36.1	317.0	84.7	60.3	67.9	57.3	269.5	62.3	246.1	75.8	197.7	181.3	75.2	85.2	82.9	84.9	78.8	233.8	174.2	258.2	155.4	124.9	175.9	6.5	7.8	2.7	11.9	13.2	13.0	12.8	9.7	11.7	11.9	9.1	11.2	12.2	0.1	22.7	14.1	7.0	8.0	12.6	60.1	64.3	73.3	88.6	62.8	71.7	78.6	68.6	84.9	66.3	74.8	83.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	63.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	29.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	52.0	0.2	0.0	0.0	0.0
AC007040.2		ENSG00000258881	"Novel protein"		2	70939318-70995336	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 1.2;retina: 1.4"	"Cell type enriched"	"Detected in single"	4	"Cytotrophoblasts: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.1;JURKAT: 2.4;U-2 OS: 2.1"															NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (1.86e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.36e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.53e-9)"	"unprognostic (6.54e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	0.1	0.0	0.6	0.1	0.6	0.2	0.1	1.2	1.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.3	0.1	0.0	0.0	0.1	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	1.4	0.3	0.0	0.2	0.5	0.0	0.0	0.2	0.1	0.0	0.8	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.1	0.1	0.1	0.6	0.1	0.1	0.4	0.0	0.0	0.2	0.2	0.1	0.1	1.6	0.1	0.2	3.1	0.2	0.4	0.0	0.3	1.3	1.0	1.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.6	2.4	0.1	0.4	0.2	0.3	0.1	0.1	0.1	0.2	0.1	1.3	0.4	0.0	0.3	0.1	0.1	0.1	0.2	0.2	0.5	0.0	0.3	0.0	0.4	1.2	2.1	0.3	1.0	0.1	0.0	0.0	1.3	0.5	1.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	1.2	1.0	0.6	0.3	0.5	0.4	0.6	0.2	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0
ACBD6	MGC2404	ENSG00000230124	"Acyl-CoA binding domain containing 6"	Q9BR61	1	180269653-180502954	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028179, HPA028457"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA028179: AB_10601788, HPA028457: "	"unprognostic (3.12e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-1)"	19.5	19.0	11.5	15.0	11.3	25.9	18.4	14.9	13.8	20.5	10.7	21.1	15.2	21.5	15.1	15.1	17.7	17.7	22.3	10.6	12.3	17.7	15.5	15.2	19.0	10.7	10.5	24.7	19.5	25.0	14.4	28.2	10.7	16.4	13.6	7.2	17.3	17.4	24.0	20.7	13.8	18.5	10.3	17.8	15.4	33.0	11.1	20.5	20.0	20.6	18.1	19.5	17.3	13.5	69.4	56.4	47.6	33.2	33.9	57.4	91.1	31.3	69.7	57.6	52.0	80.1	52.8	60.0	62.2	35.3	27.5	47.0	36.2	62.7	38.3	44.5	56.8	48.3	51.9	48.2	82.2	85.5	41.2	51.1	89.5	35.9	59.0	52.4	66.2	49.9	74.5	48.9	48.4	70.7	68.1	84.1	47.8	53.2	20.3	67.3	38.0	119.4	51.4	40.8	68.0	86.0	44.4	74.6	44.9	48.6	75.6	65.4	50.4	40.8	45.3	49.5	71.0	88.1	55.7	137.4	43.4	50.7	47.7	3.1	13.1	4.4	13.6	20.0	15.4	18.1	11.6	11.8	22.0	11.6	13.9	16.3	0.9	27.3	16.3	17.7	11.7	12.2	11.5	11.3	14.9	13.8	10.6	12.3	10.7	10.5	10.7	10.3	11.1	13.5	31.5	32.1	33.0	60.4	32.7	21.3	29.9	38.7	42.7	64.2	23.6	33.3	42.3	21.5	35.4	16.5	39.6	165.0	38.7	3.8	41.1	43.7	106.9	22.2	38.0	31.9	19.4	25.0	124.9	41.6	41.7	35.6	19.9	23.3	20.2	52.2	23.9	13.4	44.6	52.2	118.1	15.7	34.6	17.8	18.6	59.2	51.3	25.0	37.4	60.9	30.0	37.8	26.8	98.0	109.3	36.2	12.9	50.8	48.4	27.2	19.6	51.2	27.4	6.6	59.2	38.4	53.4	143.6	64.6	40.5	22.4	84.4	29.4	63.2	19.2	24.8
ACP3	"ACP-3, ACPP, PAP, TM-PAP"	ENSG00000014257	"Acid phosphatase 3"	P15309	3	132317369-132368298	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	76	"prostate: 3643.7"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 13.9;Hofbauer cells: 4.7;Syncytiotrophoblasts: 8.9"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 139.7"	"Lineage enhanced"	"Detected in many"		"granulocytes: 139.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.7;OE19: 22.3;RPMI-8226: 58.0;U-698: 17.2;U-87 MG: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	NA	NA	460000	480000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	3.1	5.4	0.9	7.3	1.3	17.5	3.4	0.9	0.9	6.3	1.2	3.6	3.1	1.4	17.2	47.7	2.2	1.5	0.6	1.2	1.5	28.9	1.4	4.5	1.9	1.5	1.3	1.1	2.7	3.9	0.5	10.8	1.5	3643.7	6.5	0.4	10.6	0.8	0.2	27.0	3.4	1.8	1.0	1.8	3.2	2.4	1.0	1.0	2.4	0.2	6.5	1.8	12.1	1.7	0.5	0.1	0.0	0.0	0.2	0.9	11.7	0.3	17.7	0.1	0.0	0.4	0.4	10.6	0.8	0.0	0.1	4.8	0.0	0.1	0.0	0.1	0.5	2.0	0.4	0.2	0.2	7.3	0.1	1.1	1.6	0.1	0.0	0.2	0.0	0.0	0.1	2.7	0.2	0.1	0.0	13.5	0.7	22.3	2.1	0.1	0.0	58.0	5.0	6.5	0.0	4.1	0.1	2.0	0.6	1.7	0.3	6.5	0.0	0.1	0.1	2.5	0.1	0.8	0.4	17.2	14.9	12.7	0.2	0.1	30.2	139.7	0.2	26.9	0.2	0.7	0.0	0.0	35.3	0.0	0.0	0.0	26.4	2.6	25.8	2.4	0.0	10.1	0.9	1.3	0.9	0.9	1.2	1.5	1.5	1.3	1.5	1.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0
ACSS1	"ACAS2L, AceCS2L, dJ568C11.3, MGC33843"	ENSG00000154930	"Acyl-CoA synthetase short chain family member 1"	Q9NUB1	20	25006230-25058980	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 300.4;Cytotrophoblasts: 329.7;Syncytiotrophoblasts: 419.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.3;JURKAT: 51.2;MOLT-4: 49.6;OE19: 64.6;RPMI-8226: 75.1;U-937: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041014, HPA043228"	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA041014: AB_2677251, HPA043228: AB_2678372"	"unprognostic (6.87e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.20e-3)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.58e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.60e-1)"	12.8	9.5	65.0	15.5	70.2	33.4	14.1	55.8	66.9	16.1	124.7	28.1	49.3	16.1	19.7	14.3	18.8	15.0	91.3	64.5	55.7	49.9	13.9	20.2	25.5	57.9	65.0	22.6	57.4	34.0	11.3	118.4	53.8	29.1	20.6	4.0	39.8	12.0	44.6	18.0	46.8	13.1	53.4	33.6	62.9	38.6	67.7	30.9	29.8	41.4	21.3	15.7	14.5	60.8	0.1	11.8	3.4	0.0	10.6	4.0	0.2	1.3	5.1	5.0	3.3	12.0	1.6	21.0	2.0	4.8	21.5	5.9	17.1	2.6	1.0	0.0	1.6	36.0	0.2	50.3	11.1	8.5	0.4	7.0	8.6	0.5	0.0	0.0	10.9	51.2	1.9	39.0	0.4	1.3	49.6	14.6	0.2	64.6	18.9	38.2	1.1	75.1	7.3	9.4	8.3	0.2	2.3	4.6	33.5	0.2	22.5	19.1	1.7	0.1	0.1	0.1	0.6	26.7	1.9	0.0	0.5	51.5	13.0	5.6	2.8	7.2	4.2	5.1	3.3	4.0	2.7	3.6	3.5	5.1	2.3	3.5	0.5	10.2	3.4	2.1	2.7	2.3	65.0	70.2	55.8	66.9	64.5	55.7	57.9	65.0	53.8	53.4	67.7	60.8	10.8	12.8	15.1	300.4	29.8	5.2	6.7	3.1	5.2	2.2	15.1	8.0	73.0	45.8	7.7	11.0	0.0	329.7	26.4	27.2	76.3	6.5	87.7	14.3	5.0	9.7	0.0	42.9	0.9	7.7	10.9	14.0	26.5	7.2	5.7	20.4	9.3	6.2	53.2	0.0	1.8	28.5	10.2	11.2	8.8	16.2	34.5	12.0	7.2	41.2	12.3	14.8	25.7	32.2	31.4	1.9	15.8	32.4	42.2	14.0	90.6	16.7	13.8	1.0	19.7	8.8	12.0	1.1	2.0	9.5	4.3	419.5	22.6	60.2	23.4	4.1
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 146.7;Endometrial stromal cells: 36.9;Extravillous trophoblasts: 46.4;Fibroblasts: 34.5;Hofbauer cells: 34.0;Syncytiotrophoblasts: 99.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 11.1"	"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 92.0;BEWO: 200.3;HSkMC: 43.8;K-562: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	32.0	5.1	1.1	14.9	1.0	4.2	24.7	0.8	11.1	22.9	7.9	19.3	3.6	20.0	1.6	33.3	29.2	7.7	22.3	0.8	1.4	6.4	17.3	26.1	1.8	4.4	2.8	17.1	3.0	0.5	3.0	62.9	2.9	9.0	3.8	0.6	11.8	3.4	37.7	11.8	13.7	11.4	1.2	5.4	17.2	2.4	3.6	0.8	6.1	47.9	1.2	32.8	23.3	1.5	22.0	0.6	0.3	3.9	19.1	92.0	200.3	20.8	18.0	12.1	7.0	1.8	8.5	0.2	4.3	14.4	0.2	11.0	0.8	3.2	4.9	1.7	0.4	6.2	2.6	8.9	15.3	0.3	3.0	43.8	0.9	3.0	6.8	10.3	0.1	0.0	67.7	0.7	2.2	0.5	0.0	1.1	3.5	0.6	0.7	0.0	0.0	0.1	2.1	0.8	0.1	0.6	6.7	15.9	0.1	10.0	4.5	11.5	3.8	0.7	5.5	8.6	0.3	1.9	0.6	4.5	0.8	4.0	0.5	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.3	1.1	1.0	0.8	11.1	0.8	1.4	4.4	2.8	2.9	1.2	3.6	1.5	2.8	0.0	1.5	1.0	0.5	2.4	2.3	0.2	0.6	1.7	1.3	1.8	2.2	10.0	0.6	0.0	0.0	146.7	1.0	0.2	0.0	1.7	0.6	2.6	36.9	5.3	0.0	0.0	0.3	0.6	46.4	34.5	0.0	5.4	2.5	0.9	1.8	10.6	34.0	0.0	0.1	0.2	0.0	24.0	12.5	0.7	30.1	20.0	3.6	0.0	23.1	1.4	1.0	0.0	0.0	12.3	0.1	3.4	3.2	2.2	0.0	0.2	0.9	2.2	0.0	14.3	3.8	0.1	1.6	5.5	2.8	99.5	1.7	0.5	0.3	2.5
ADGRG1	"GPR56, TM7LN4, TM7XN1"	ENSG00000205336	"Adhesion G protein-coupled receptor G1"	Q9Y653	16	57610652-57665580	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, G-protein coupled receptor, Heparin-binding, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 216.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 222.5;Exocrine glandular cells: 170.7;NK-cells: 208.1;Syncytiotrophoblasts: 186.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 160.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 160.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 218.4;SK-BR-3: 277.7;SK-MEL-30: 297.8;TIME: 241.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046065	Uncertain				"Secreted to blood"	NA	NA		32000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA046065: AB_2679521"	"unprognostic (4.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (4.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (5.52e-7)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-1)"	50.9	13.2	79.6	12.7	67.7	19.6	50.5	46.9	115.2	36.3	0.0	36.7	26.1	19.7	84.2	46.7	52.2	69.6	36.8	68.7	71.5	158.9	4.2	37.3	5.2	64.6	76.2	5.3	59.8	28.4	17.7	101.3	73.9	31.7	33.4	6.6	92.2	57.5	15.7	87.5	19.3	19.8	54.8	12.3	47.9	45.4	92.5	28.9	216.3	16.9	15.6	37.1	37.8	51.6	41.8	47.1	12.0	0.6	0.0	0.1	127.7	8.5	3.9	14.4	2.6	34.7	218.4	0.2	110.5	8.2	196.1	149.1	0.0	103.4	5.1	1.6	0.0	5.1	56.0	39.3	0.3	0.4	2.1	2.4	143.8	24.5	10.2	15.8	118.1	1.0	0.1	1.2	3.2	51.4	107.3	0.8	1.7	143.3	42.6	3.8	1.4	30.8	209.4	134.9	38.2	1.2	2.0	277.7	297.8	8.4	123.8	0.8	241.4	25.6	38.0	1.5	96.2	0.2	2.1	0.6	200.5	0.7	62.9	2.9	0.8	0.2	160.3	0.5	1.9	0.3	10.5	62.6	0.2	0.1	5.3	45.2	3.3	30.6	0.7	0.3	0.2	37.1	79.6	67.7	46.9	115.2	68.7	71.5	64.6	76.2	73.9	54.8	92.5	51.6	107.7	9.6	11.9	113.9	3.7	0.0	24.1	0.0	11.4	0.9	29.6	27.2	4.3	15.7	21.7	79.1	0.0	222.5	120.4	17.7	27.4	33.9	74.0	24.6	4.3	53.9	20.6	17.7	3.5	170.7	25.1	4.7	29.0	45.2	5.1	88.2	30.0	0.5	22.8	0.0	4.9	23.2	0.0	3.5	0.0	31.3	3.1	6.1	0.0	41.2	1.1	4.8	208.1	85.5	1.3	101.1	12.3	0.0	19.1	15.2	5.6	132.6	16.8	0.5	0.0	1.6	7.1	2.7	0.9	23.0	0.0	186.5	35.1	0.4	24.6	19.5
ADPRS	"ADPRHL2, ARH3, FLJ20446"	ENSG00000116863	"ADP-ribosylserine hydrolase"	Q9NX46	1	36088892-36093932	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 79.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 51.6;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026641, HPA027104, HPA027141"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		54000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619"	"unprognostic (3.22e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (3.71e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.74e-2)"	19.0	36.7	28.4	16.0	30.0	19.7	18.5	31.3	30.3	20.7	33.4	19.6	15.6	17.6	15.0	36.1	33.5	13.3	20.7	28.6	29.1	27.7	22.4	20.6	21.5	32.5	29.7	19.7	17.9	17.6	17.7	20.8	31.2	19.9	12.4	9.1	20.9	16.3	34.4	34.1	16.8	16.4	31.9	23.1	17.6	28.7	29.7	20.9	19.4	21.8	20.2	21.3	22.2	33.9	54.3	22.4	26.2	37.2	23.6	17.1	37.3	39.4	32.9	62.1	60.9	26.8	47.7	38.4	37.5	39.5	32.0	32.9	33.4	60.5	37.0	27.7	41.8	34.9	27.0	36.3	44.4	40.2	19.9	20.3	45.4	56.5	24.5	47.2	39.9	36.2	30.8	30.9	29.6	26.0	40.9	60.5	56.5	31.8	46.0	32.9	27.6	38.8	56.5	43.8	32.1	50.8	28.9	29.9	65.9	34.4	30.9	34.3	27.6	35.7	37.0	50.1	53.0	39.8	41.2	34.2	51.7	39.6	22.4	40.6	58.3	65.8	43.4	74.1	41.5	43.5	47.6	50.8	71.4	51.5	47.7	40.3	57.1	47.9	77.7	44.8	43.4	57.8	28.4	30.0	31.3	30.3	28.6	29.1	32.5	29.7	31.2	31.9	29.7	33.9	3.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	79.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	40.7	6.4	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	70.6	1.3	0.0	0.0	0.0
ADRB1	ADRB1R	ENSG00000043591	"Adrenoceptor beta 1"	P08588	10	114043866-114046904	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.7;lung: 13.1;placenta: 29.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 85.7;Cytotrophoblasts: 84.5;Sertoli cells: 52.6;Syncytiotrophoblasts: 38.4"	"Cancer enriched"	"Detected in many"	10	"prostate cancer: 12.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;PC-3: 2.6;THP-1: 4.5;TIME: 5.8;U-937: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067972	Enhanced					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA067972: AB_2685936"	"unprognostic (1.45e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.44e-1)"	4.0	0.2	5.5	0.3	10.3	0.5	2.3	0.7	12.0	0.1	0.2	3.1	0.9	0.1	0.1	0.9	0.1	0.1	23.7	6.8	3.3	1.1	1.4	13.1	0.2	1.8	3.1	0.0	1.3	0.8	0.8	29.1	2.4	4.4	0.6	2.1	5.4	0.1	2.3	0.4	1.9	0.1	0.9	1.5	0.7	0.5	5.0	0.1	0.6	0.0	0.3	0.7	0.1	7.8	1.4	0.8	0.1	0.8	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.3	1.0	0.2	0.2	0.0	0.4	0.3	0.1	0.1	0.1	7.1	0.4	0.3	0.1	0.1	0.0	0.2	0.4	0.0	0.7	0.0	1.3	0.1	0.1	1.0	0.0	0.1	0.1	0.8	1.1	0.9	0.3	0.2	2.6	0.2	0.2	0.1	0.0	1.1	0.1	0.2	0.0	0.5	0.0	0.3	0.2	4.5	5.8	0.2	0.1	0.1	0.1	0.0	0.0	0.3	0.0	3.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	10.3	0.7	12.0	6.8	3.3	1.8	3.1	2.4	0.9	5.0	7.8	1.1	19.2	7.8	15.0	0.5	1.0	3.9	0.8	1.2	21.8	1.0	0.5	85.7	2.8	9.8	0.0	0.0	84.5	3.0	0.1	1.9	0.1	0.1	0.4	0.6	11.3	0.0	0.0	12.8	0.2	5.2	5.3	0.0	0.3	0.0	0.0	0.4	0.2	4.4	13.5	2.5	3.3	2.0	2.2	1.6	0.2	0.0	2.8	1.8	7.5	0.6	0.7	3.1	1.0	0.3	0.1	1.4	0.4	1.2	6.1	0.8	0.0	12.1	1.7	52.6	0.4	8.2	0.5	0.2	0.1	0.0	38.4	4.8	0.0	0.6	3.9
AEBP2	MGC17922	ENSG00000139154	"AE binding protein 2"	Q6ZN18	12	19404045-19720801	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020893, HPA022282"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA020893: AB_2670528, HPA022282: AB_2670931"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	19.0	27.2	9.9	20.0	11.6	20.5	23.5	13.0	16.5	25.8	12.5	18.8	16.3	34.0	20.2	35.1	28.0	21.8	17.8	17.7	7.2	27.8	20.3	20.7	27.7	1.9	6.7	35.1	17.5	29.9	8.9	44.1	2.0	24.8	20.6	27.7	19.3	30.7	13.6	29.4	16.7	31.1	0.3	23.1	16.1	20.8	11.8	29.2	30.8	19.8	32.3	25.0	18.2	14.7	32.4	42.4	42.6	20.1	31.1	38.6	95.2	29.9	34.1	43.5	45.7	48.0	54.5	51.0	24.3	41.4	27.6	38.0	93.7	34.6	69.1	149.4	30.6	46.7	60.8	30.0	36.4	60.1	30.8	36.2	36.3	35.6	52.8	52.0	35.6	34.8	25.2	1.4	41.2	38.5	63.0	71.7	82.6	26.6	18.9	50.3	82.3	35.9	32.2	68.2	10.0	23.4	60.6	25.7	29.8	91.3	32.8	35.0	40.5	40.7	30.9	12.8	44.9	14.0	24.9	106.0	30.3	25.1	29.2	4.3	2.5	2.5	4.2	2.7	4.4	2.2	4.4	3.6	2.0	2.8	3.7	5.8	2.7	6.0	2.2	2.6	4.5	1.2	9.9	11.6	13.0	16.5	17.7	7.2	1.9	6.7	2.0	0.3	11.8	14.7	23.9	25.6	14.3	31.6	20.5	75.2	25.1	15.5	53.5	29.8	22.0	13.3	22.1	12.8	24.2	12.9	43.8	60.3	24.3	9.5	17.6	12.3	1.3	31.1	31.5	22.2	22.7	11.6	57.2	12.2	24.8	28.3	14.3	28.8	27.8	17.7	14.3	12.9	15.4	52.2	59.4	11.2	4.1	17.0	47.9	2.3	24.5	17.8	28.4	30.0	17.7	21.5	14.4	42.3	51.6	11.5	10.3	29.0	18.3	24.5	9.0	18.3	26.1	16.1	19.7	46.7	40.1	16.2	26.3	51.0	76.0	83.0	28.1	34.2	10.7	28.2
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595362	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 162.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 414.1;Proximal tubular cells: 302.1;Syncytiotrophoblasts: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 256.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		430000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	23.7	38.3	46.6	9.1	47.6	1.8	47.1	43.7	45.8	32.7	40.7	29.5	23.7	25.1	8.8	35.9	28.8	19.1	27.9	44.7	43.2	115.1	162.2	15.7	8.6	43.1	43.5	65.3	27.0	34.0	8.8	44.9	42.6	42.0	27.4	19.7	40.6	27.9	12.2	29.4	21.0	23.6	44.8	7.0	23.6	12.3	44.0	18.3	47.6	26.5	17.1	18.1	20.9	45.2	64.9	41.9	116.6	193.4	95.5	56.4	147.8	76.1	93.4	86.5	110.5	118.6	60.7	0.0	75.5	60.0	36.1	47.1	36.5	256.2	78.8	0.1	44.6	12.3	63.1	102.1	46.3	0.2	0.0	69.0	59.2	67.3	47.7	64.2	70.0	0.0	0.0	0.1	77.1	42.1	2.6	0.3	79.4	47.5	35.2	38.9	131.8	0.0	81.2	48.4	39.4	47.2	0.0	41.1	44.7	89.0	75.2	2.7	86.1	24.8	75.6	28.8	53.1	0.1	0.1	0.4	13.4	0.2	40.6	0.7	0.2	0.1	0.1	0.0	0.2	0.8	0.2	0.1	1.8	0.6	1.2	0.6	0.1	0.1	0.0	6.4	0.0	0.4	46.6	47.6	43.7	45.8	44.7	43.2	43.1	43.5	42.6	44.8	44.0	45.2	17.6	16.0	29.3	99.3	5.0	25.9	59.5	110.0	87.0	23.6	40.6	91.1	39.9	27.1	43.5	42.3	22.9	414.1	3.7	15.2	76.3	43.5	31.4	18.7	44.3	19.1	21.7	5.2	16.0	13.8	107.8	34.0	27.0	21.4	7.0	50.4	18.9	74.6	51.1	25.2	21.5	25.9	20.3	9.4	7.6	41.7	25.4	9.1	55.2	12.2	7.5	102.1	0.0	41.7	30.0	12.6	15.6	37.2	2.0	27.5	23.4	302.1	23.4	13.6	19.7	19.4	25.8	1.0	5.1	59.2	16.1	222.3	4.6	39.3	46.4	50.4
ALG6		ENSG00000088035	"ALG6 alpha-1,3-glucosyltransferase"	Q9Y672	1	63367575-63438553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062536, HPA076130"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA062536: AB_2684792, HPA076130: "	"unprognostic (1.21e-1)"	"unprognostic (5.60e-3)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (2.07e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (1.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.41e-1)"	3.5	4.5	1.1	1.1	1.3	1.4	3.4	1.9	1.4	3.7	1.0	3.8	1.1	2.9	1.4	6.1	3.0	0.8	2.1	1.1	1.2	3.0	4.6	2.7	1.9	1.1	1.2	3.2	3.3	1.4	2.0	1.0	1.1	3.1	1.2	1.2	4.3	0.6	2.8	5.1	4.4	0.6	1.1	5.2	3.2	2.2	1.1	2.0	3.1	0.1	1.6	3.1	4.2	1.4	0.5	1.3	1.3	1.2	1.8	1.3	2.6	0.9	0.2	0.3	0.3	2.0	0.6	2.7	1.4	0.7	1.5	1.0	2.0	1.0	1.4	2.4	4.2	2.2	1.5	2.4	0.6	2.8	2.4	0.9	0.6	0.9	0.6	0.7	2.0	2.3	2.2	1.3	1.0	2.5	1.7	2.4	7.6	1.3	2.3	1.8	1.6	2.1	1.6	2.2	1.5	0.8	2.3	3.2	2.3	2.9	0.9	2.1	0.9	0.6	0.6	1.8	1.5	1.7	1.7	1.7	1.2	3.3	2.4	1.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.2	0.3	0.3	0.6	0.5	0.1	0.4	0.3	0.2	0.3	0.2	1.1	1.3	1.9	1.4	1.1	1.2	1.1	1.2	1.1	1.1	1.1	1.4	9.8	9.6	4.8	9.8	12.1	11.0	8.5	24.6	15.4	6.3	8.5	5.5	3.1	12.8	22.1	3.7	4.2	42.1	10.2	6.1	1.9	12.4	2.4	11.2	7.0	8.7	4.2	9.0	19.1	8.9	28.5	8.6	11.2	10.0	8.9	12.2	8.2	11.5	15.5	6.7	19.4	7.8	22.4	7.1	8.8	2.0	6.8	9.1	16.0	4.7	4.8	5.5	13.4	19.1	16.8	6.0	3.6	4.9	11.4	4.9	8.2	7.3	11.7	5.4	6.6	4.5	6.6	16.2	15.3	18.3	11.1	26.8	15.1	10.0	11.5	7.4
AMELY	AMGL	ENSG00000099721	"Amelogenin Y-linked"	Q99218	Y	6865918-6911774	"Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"Cluster 47: Cytotrophoblasts - Unknown function"															"unprognostic (1.62e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1
AMOT	KIAA1071	ENSG00000126016	Angiomotin	Q4VCS5	X	112774503-112840889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 145.6;tongue: 53.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.5;Collecting duct cells: 29.5;Cytotrophoblasts: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 22.5;HAP1: 25.1;OE19: 21.2;SuSa: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067290, HPA067853"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Cell Junctions"	Nucleoplasm	"HPA067290: AB_2685819, HPA067853: AB_2732773"	"unprognostic (1.08e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.82e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (4.46e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (4.21e-9)"	"unprognostic (9.54e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.44e-2)"	4.3	1.6	29.0	1.3	24.7	0.3	6.5	23.4	21.9	9.2	0.6	3.5	2.9	4.9	145.6	4.0	12.2	2.8	4.0	23.7	31.6	10.4	2.1	2.7	0.8	32.8	34.4	5.7	2.3	14.3	7.2	20.7	24.1	6.3	4.3	1.7	6.9	25.7	39.0	2.3	3.7	3.2	20.6	1.5	3.0	2.3	36.4	4.4	3.8	53.5	1.0	2.8	4.1	18.2	4.3	0.0	22.5	1.0	0.5	0.5	8.8	0.7	0.0	0.0	0.0	10.5	0.8	0.5	4.7	3.5	0.0	8.4	25.1	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.2	0.0	1.1	0.2	0.0	5.1	0.6	4.9	0.2	0.4	0.0	0.0	0.6	0.4	6.8	0.3	10.5	21.2	0.1	8.4	6.6	0.1	11.2	11.0	0.0	8.0	0.1	0.0	9.8	34.9	0.8	0.2	0.1	2.9	6.8	0.0	9.4	0.7	0.0	0.0	1.0	0.1	6.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	29.0	24.7	23.4	21.9	23.7	31.6	32.8	34.4	24.1	20.6	36.4	18.2	2.2	3.2	2.0	57.5	0.9	1.8	2.7	2.5	2.8	1.1	9.7	6.9	2.0	1.5	7.2	29.5	0.0	46.2	1.1	4.9	1.9	5.1	0.2	7.2	6.3	3.7	15.8	0.4	8.9	1.9	3.8	7.2	4.1	7.1	0.0	1.5	4.2	4.0	6.2	0.0	2.0	7.2	6.1	1.6	2.1	0.5	6.8	1.0	3.6	17.8	1.7	4.9	4.1	2.0	3.5	3.2	5.6	6.4	0.0	6.6	4.7	16.8	10.1	0.5	6.6	3.9	4.0	0.4	3.2	3.0	1.1	15.9	0.9	0.8	7.3	2.5
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		770000	"Cluster 52: Eosinophils - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	50.8	34.7	50.2	87.3	60.5	137.0	71.6	62.3	59.1	54.0	33.3	81.0	70.8	59.1	50.7	65.8	75.1	59.8	127.9	48.8	57.3	75.1	76.4	71.0	156.2	60.0	56.5	57.8	53.7	61.4	27.5	101.5	65.4	75.4	89.0	106.0	54.0	66.8	62.4	36.1	76.9	57.0	62.7	85.5	78.9	20.8	54.3	203.0	73.6	64.5	141.2	76.4	43.6	71.0	196.4	234.7	303.2	263.2	104.2	90.9	200.5	101.0	134.3	193.5	161.8	195.3	358.0	629.8	184.5	114.5	114.2	279.9	709.5	206.6	230.8	286.6	241.2	478.6	192.7	247.8	64.5	380.8	247.4	72.9	143.1	106.3	210.2	126.6	285.9	300.0	354.5	239.1	168.2	136.1	386.1	311.6	270.1	192.5	118.2	531.7	280.7	375.3	170.5	304.5	399.8	247.8	153.7	170.8	282.7	301.1	227.2	491.4	129.0	199.0	313.5	139.3	275.2	143.8	433.9	733.8	132.2	632.1	186.7	12.9	26.4	44.9	16.8	30.6	14.2	18.7	13.8	17.8	30.0	17.9	16.5	14.9	27.2	28.8	27.5	26.8	17.2	16.0	50.2	60.5	62.3	59.1	48.8	57.3	60.0	56.5	65.4	62.7	54.3	71.0	100.2	109.0	118.0	20.2	98.1	64.7	67.7	147.0	91.0	92.2	57.3	70.6	80.0	60.1	105.4	69.9	35.5	258.2	119.7	57.1	107.6	112.5	6.7	61.2	67.7	91.8	78.5	144.2	16.8	96.1	172.4	57.5	69.3	70.1	92.4	63.6	78.1	81.8	194.1	65.6	17.4	92.1	114.0	150.1	112.6	6.3	34.8	111.6	78.2	37.5	158.9	103.7	84.5	15.6	55.4	79.8	57.0	29.7	92.6	59.7	99.3	148.0	113.7	87.2	26.3	49.9	75.1	8.8	18.2	86.4	34.9	232.5	99.5	82.5	94.7	52.0
AP002495.1		ENSG00000254469	"XRCC1 N-terminal domain containing 1-like"	Q6ZNB5	11	71865504-71928665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 2.2;Hofbauer cells: 2.0;Respiratory ciliated cells: 1.5;Syncytiotrophoblasts: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051121, HPA051124"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoli	"Mitotic chromosome"	"HPA051121: AB_2681349, HPA051124: "	"unprognostic (1.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.32e-3)"	"unprognostic (9.79e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.12e-3)"	1.9	2.1	1.9	2.2	2.8	4.7	3.2	4.3	2.6	2.8	2.8	2.2	2.6	3.7	5.3	2.6	2.4	2.1	2.1	1.7	2.2	2.9	2.2	1.8	4.2	2.5	1.5	4.6	3.1	2.9	2.5	2.0	2.4	3.1	3.5	7.3	2.2	2.8	1.6	4.2	2.6	2.4	0.6	2.9	2.4	3.3	2.8	3.2	3.2	1.5	3.4	2.3	2.2	5.0	2.6	6.2	4.7	4.5	1.8	1.6	3.1	2.9	2.3	3.1	3.0	6.5	6.4	5.8	2.6	2.0	3.9	8.4	4.9	3.3	3.2	8.4	4.5	9.4	7.7	4.2	1.1	4.2	3.1	2.2	1.6	5.2	3.6	2.6	4.9	8.0	6.3	7.6	3.0	4.9	4.8	3.5	4.9	9.6	4.5	3.6	16.3	4.0	3.5	3.1	6.9	6.6	4.6	4.1	9.2	3.3	5.1	2.3	4.6	2.5	4.1	4.9	1.9	5.5	8.4	7.0	4.0	4.6	3.7	2.7	1.9	1.7	2.9	3.0	1.7	2.5	5.1	3.8	2.2	3.3	4.8	4.1	2.0	1.2	1.9	4.8	4.9	1.9	1.9	2.8	4.3	2.6	1.7	2.2	2.5	1.5	2.4	0.6	2.8	5.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000363-55009057	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: AB_2680448"	"unprognostic (2.90e-2)"	"prognostic favorable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.63e-4)"	7.2	8.9	6.1	8.8	6.3	10.0	7.2	6.0	6.6	7.6	6.5	8.9	8.9	7.4	8.5	15.5	7.3	6.3	9.0	5.9	6.4	10.8	11.0	7.2	11.3	6.4	6.3	9.6	7.4	7.1	7.0	9.0	6.3	7.8	10.5	2.3	7.0	6.6	7.5	12.2	9.1	7.0	6.3	11.2	7.9	4.1	6.6	10.9	6.3	7.3	13.5	10.2	9.4	6.7	36.9	32.4	12.5	18.3	17.9	11.9	21.3	14.8	19.8	28.0	27.2	17.8	30.0	24.1	22.7	14.0	33.0	26.9	29.1	28.2	21.0	19.7	22.1	29.4	31.6	18.3	11.5	18.3	26.6	11.8	22.6	39.6	14.2	13.2	22.6	25.3	15.4	15.9	21.2	35.7	24.9	23.8	25.0	17.4	38.6	21.8	20.8	26.4	15.2	18.1	11.6	12.7	28.0	33.4	14.7	28.5	26.4	14.1	13.1	16.6	23.9	33.7	19.6	16.4	22.9	19.9	17.7	30.9	20.1	16.2	11.5	13.1	10.2	14.4	8.6	8.2	9.6	10.2	13.7	8.5	8.5	8.4	4.1	42.0	13.4	7.4	11.6	10.1	6.1	6.3	6.0	6.6	5.9	6.4	6.4	6.3	6.3	6.3	6.6	6.7	6.1	3.2	11.8	1.6	12.7	12.9	12.5	20.1	6.8	3.6	7.2	7.1	5.9	15.7	14.9	11.0	0.0	52.7	7.1	17.9	15.6	31.5	0.3	6.0	5.7	11.5	6.1	31.5	0.8	15.1	35.3	7.6	10.2	9.7	8.8	13.1	10.4	11.4	24.2	6.7	0.7	10.1	10.2	10.9	11.1	1.1	5.9	12.0	0.0	1.9	21.7	5.2	16.5	1.0	1.9	20.5	19.1	8.6	9.8	10.5	16.6	21.6	11.8	2.1	19.7	4.4	6.9	1.4	10.6	13.8	12.6	47.6	11.6	12.4	13.7	13.2
ARL6IP6	MGC33864	ENSG00000177917	"ADP ribosylation factor like GTPase 6 interacting protein 6"	Q8N6S5	2	152717893-152762396	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 214.0;eosinophil: 161.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 214.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014743	Approved		Approved	"Nuclear membrane,Cytosol"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear membrane"	Cytosol	"HPA014743: AB_1845030"	"unprognostic (4.41e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.86e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (5.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.57e-1)"	"unprognostic (7.39e-2)"	5.1	3.9	3.0	1.8	4.0	8.3	4.7	3.2	3.0	4.4	2.2	3.7	2.4	4.2	1.2	6.0	3.8	1.2	2.7	2.6	3.1	2.5	1.9	4.0	3.4	3.9	3.3	5.0	2.7	1.1	3.1	4.4	4.3	3.1	1.9	3.2	3.9	1.8	3.5	7.1	3.5	1.6	3.6	4.4	3.1	5.3	3.3	3.9	3.2	2.0	2.4	4.2	5.5	5.3	9.6	6.2	13.7	3.9	4.1	4.6	19.7	11.6	4.9	9.6	12.2	14.2	13.3	17.2	10.6	5.2	4.3	10.7	8.1	5.7	10.4	26.1	15.1	14.2	5.3	13.0	4.5	12.1	12.4	3.3	6.5	10.6	8.9	3.4	7.5	11.9	14.9	10.6	7.8	7.1	12.1	12.6	13.3	3.2	12.7	13.0	13.4	13.9	4.5	7.2	11.6	12.0	10.4	1.1	9.7	4.7	4.7	7.9	10.0	14.4	9.9	10.2	10.3	9.9	10.3	13.1	6.8	10.4	12.3	214.0	9.1	161.8	13.2	10.2	13.2	20.3	13.3	13.5	10.9	18.4	13.6	11.4	24.8	9.7	12.8	24.8	19.7	13.2	3.0	4.0	3.2	3.0	2.6	3.1	3.9	3.3	4.3	3.6	3.3	5.3	34.3	16.0	10.0	30.7	41.9	106.6	48.5	74.0	50.7	6.3	20.3	14.9	4.3	17.2	29.9	11.0	4.2	155.7	42.4	14.1	17.6	24.9	14.1	17.7	20.0	31.3	13.8	81.0	21.0	18.6	136.2	27.9	30.1	25.0	27.3	19.4	28.5	5.9	39.8	8.4	23.8	22.2	38.7	24.2	57.2	24.2	19.6	33.6	46.2	30.9	46.2	19.8	32.0	38.7	56.8	22.5	18.6	17.0	33.8	40.3	16.3	8.8	29.2	15.8	32.9	22.2	24.9	24.4	30.0	43.4	106.6	108.4	45.2	27.9	24.5	51.3
ATP5MGL	"ATP5K2, ATP5L2, dJ222E13.5"	ENSG00000249222	"ATP synthase membrane subunit g like"	Q7Z4Y8	22	42639803-42640601	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;brain: 2.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 11.6;Distal tubular cells: 5.9;Extravillous trophoblasts: 7.7;Hofbauer cells: 11.2;Syncytiotrophoblasts: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044629	Uncertain		Uncertain	Mitochondria		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA044629: AB_2679028"	"unprognostic (4.53e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-3)"	0.1	0.0	0.7	0.0	0.5	1.4	0.0	2.7	1.1	0.0	0.8	0.0	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.6	1.0	0.1	0.0	0.1	0.3	1.3	0.6	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.4	0.3	0.0	0.1	0.9	0.1	0.0	0.3	0.1	0.2	0.1	1.3	0.0	0.2	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.1	0.9	0.1	0.2	0.2	0.1	0.3	0.7	0.5	2.7	1.1	0.6	1.0	1.3	0.6	0.7	0.3	1.3	1.6	1.1	0.0	2.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	1.8	0.0	11.6	0.7	0.0	5.9	0.6	0.0	0.8	0.8	0.9	0.0	0.0	0.0	1.1	7.7	1.0	0.0	1.3	2.5	1.2	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.6	0.8	1.2	0.0	0.0
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"kidney: 63.6;salivary gland: 78.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 16.5;Cytotrophoblasts: 13.4;Distal tubular cells: 31.3;Ionocytes: 57.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 55.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018029, HPA064555"	Enhanced		Uncertain	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.2	0.0	0.3	0.0	0.4	0.0	4.7	0.1	0.5	3.7	3.1	0.0	0.1	0.1	1.2	4.9	0.0	0.0	0.0	0.6	0.2	63.6	0.0	0.4	0.0	0.3	0.2	0.0	0.1	1.6	0.1	2.5	0.2	0.9	0.0	0.0	78.4	1.5	0.0	10.2	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.4	0.0	0.0	3.7	0.1	0.2	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.6	0.6	1.8	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	5.0	1.9	0.0	0.1	0.0	0.1	0.1	0.6	0.0	4.5	0.2	0.0	0.0	0.1	55.7	1.9	2.9	0.1	0.0	0.2	0.6	1.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.5	0.6	0.2	0.3	0.2	0.2	0.2	0.3	0.3	0.0	0.0	1.1	0.3	0.0	0.0	1.1	0.9	0.0	0.0	2.5	1.4	0.5	0.0	1.7	16.5	2.1	13.4	0.3	0.0	31.3	0.0	2.2	0.9	0.1	0.1	0.0	0.0	1.4	0.0	0.7	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	57.0	0.0	0.0	2.8	0.3	0.0	7.2	1.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	4.4	0.1	0.0	0.0	0.1	0.6	0.7	0.0	0.1	5.1	0.2	0.0	0.0	1.3
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935900-70965431	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 127.4;salivary gland: 139.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	2.2	0.5	0.5	0.2	0.3	0.0	11.8	0.7	0.9	31.1	0.0	0.6	0.5	1.4	1.2	1.6	12.8	0.2	1.1	0.2	0.0	127.4	0.2	1.7	0.5	0.1	0.0	1.2	3.3	0.8	4.2	17.9	0.1	2.0	0.1	3.9	139.8	1.4	0.5	32.5	0.6	0.8	0.0	0.0	0.3	0.3	0.0	0.1	0.3	0.2	0.0	0.6	0.8	0.3	0.4	0.3	0.6	1.3	2.6	3.1	21.6	0.4	0.2	0.0	0.0	0.1	2.0	0.1	0.2	1.2	0.0	20.3	0.7	0.0	0.0	0.5	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.3	3.1	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.3	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.2	0.5	1.5	0.7	49.2	0.1	2.7	0.6	0.0	0.4	0.6	0.2	0.9	0.5	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.7	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.7	3.2	0.0	0.3	0.0	0.1	1.3	1.7	0.0	0.9	5.6	3.7	0.4	0.0	13.9	0.0	8.4	197.3	0.1	0.6	49.0	0.1	1.5	0.0	0.1	1.1	0.0	0.0	1.0	0.6	38.3	3.8	0.0	0.1	0.0	0.0	0.0	0.1	11.7	1.7	0.4	0.0	321.4	0.0	0.3	0.1	0.0	0.1	30.2	0.0	0.0	0.5	1.0	1.0	0.1	0.4	0.0	1.2	0.0	0.6	0.3	0.2	2.6	3.8	0.0	1.1	1.0	0.4	1.2	0.0	0.4	64.9	0.1	0.1	0.1	0.6
ATP6V1C2	"ATP6C2, VMA5"	ENSG00000143882	"ATPase H+ transporting V1 subunit C2"	Q8NEY4	2	10721100-10785110	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 80.3;salivary gland: 103.2;skin 1: 87.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.2;Distal tubular cells: 45.0;Enteroendocrine cells: 41.5;Glandular and luminal cells: 73.4;Ionocytes: 93.6;Syncytiotrophoblasts: 169.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"BEWO: 78.4;SK-BR-3: 27.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034734, HPA067305"	Approved		Uncertain	Mitochondria		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA034734: AB_2674305, HPA067305: AB_2732763"	"unprognostic (2.29e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.12e-11)"	"unprognostic (6.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.27e-2)"	3.4	4.0	1.4	1.7	2.1	4.3	5.7	0.7	1.4	57.5	0.9	2.4	0.9	4.7	80.3	18.3	2.9	0.9	3.0	1.8	0.8	43.3	6.0	2.8	2.0	0.7	0.8	2.9	3.8	1.2	23.5	36.7	0.6	5.1	2.5	1.6	103.2	6.8	1.0	87.6	2.7	0.2	0.6	4.0	2.4	2.0	0.9	0.5	3.8	0.0	5.0	2.0	19.0	1.6	0.6	0.9	2.4	2.7	0.0	0.0	78.4	1.1	0.0	0.0	0.0	1.5	1.9	1.9	1.3	0.0	1.2	1.2	1.3	0.1	0.1	1.1	2.6	0.9	1.4	2.7	0.0	1.8	1.0	0.0	0.3	0.0	0.0	1.8	0.0	0.6	0.9	3.6	0.0	2.1	0.7	2.9	1.8	1.1	0.8	1.6	1.4	5.5	0.0	1.7	1.9	2.3	0.7	27.2	0.8	10.0	2.4	4.0	0.4	0.9	1.8	1.1	1.1	6.2	2.5	1.1	1.1	1.5	0.8	0.0	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	1.4	2.1	0.7	1.4	1.8	0.8	0.7	0.8	0.6	0.6	0.9	1.6	13.6	0.0	2.6	0.3	1.0	0.4	3.7	2.8	1.2	0.0	1.4	1.8	0.9	0.0	6.6	7.3	0.0	147.2	0.8	0.3	45.0	0.1	0.7	31.3	13.4	1.4	41.5	0.0	2.4	0.2	33.0	2.7	1.1	73.4	2.5	0.3	0.0	0.2	13.8	0.0	1.2	0.2	93.6	0.8	0.8	0.4	0.6	0.9	0.0	2.8	0.0	0.0	0.0	0.5	1.3	0.2	0.1	0.0	4.0	1.1	0.0	1.1	4.4	0.0	0.0	0.7	1.2	0.2	1.2	0.6	2.4	169.1	1.0	0.3	0.8	0.4
BABAM1	"C19orf62, FLJ20571, HSPC142, MERIT40, NBA1"	ENSG00000105393	"BRISC and BRCA1 A complex member 1"	Q9NWV8	19	17267376-17281249	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054386, HPA068786, HPA077609"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 47: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: "	"unprognostic (5.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.74e-2)"	45.8	54.1	51.9	40.0	55.4	70.4	46.8	44.7	66.7	49.9	39.4	60.6	41.6	50.3	28.7	48.3	44.5	28.9	72.1	58.3	53.9	53.3	55.3	42.8	55.4	50.4	51.5	44.2	49.9	46.8	32.2	46.7	54.1	48.0	36.3	26.4	50.2	37.1	134.1	46.1	50.6	37.3	44.0	60.7	54.2	41.6	51.4	51.3	37.3	96.9	51.3	49.2	43.4	54.7	126.8	69.5	68.8	66.0	72.9	51.9	154.9	73.5	96.0	143.2	142.1	78.2	146.5	87.8	172.1	102.2	64.9	61.2	79.7	102.2	89.1	127.5	130.9	78.6	91.6	99.0	60.4	142.4	96.0	79.6	68.3	96.4	56.1	79.3	122.5	123.9	132.9	101.1	103.3	104.1	138.7	135.8	182.0	106.3	147.0	95.5	92.2	119.4	104.1	62.1	66.3	120.3	90.5	92.8	84.6	77.2	81.4	115.2	91.7	87.8	55.7	108.8	124.3	133.1	172.5	119.7	125.6	187.0	85.5	201.3	154.3	167.7	132.9	148.1	128.3	141.9	121.7	129.2	161.3	143.4	111.8	109.9	37.9	114.3	147.8	134.3	180.2	214.1	51.9	55.4	44.7	66.7	58.3	53.9	50.4	51.5	54.1	44.0	51.4	54.7	40.8	12.8	29.7	11.1	45.0	34.9	41.5	63.4	19.4	21.9	53.9	60.7	37.8	41.5	44.9	35.0	14.6	172.4	51.0	51.1	101.8	70.1	65.8	18.4	30.4	39.9	43.8	78.5	18.6	72.4	155.4	41.4	26.0	28.1	46.3	54.3	40.0	50.4	98.7	16.8	16.2	60.6	48.8	46.8	45.6	106.3	36.7	43.2	65.8	8.4	80.4	35.3	68.0	8.5	12.3	69.8	63.8	44.4	51.7	44.6	68.1	89.3	23.5	18.5	39.5	34.7	52.5	57.8	74.2	27.9	41.3	158.0	46.4	43.0	64.7	45.5
BCAM	"CD239, LU"	ENSG00000187244	"Basal cell adhesion molecule (Lutheran blood group)"	P50895	19	44809071-44821421	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 316.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 374.9;Basal respiratory cells: 454.1;Collecting duct cells: 548.1;Cytotrophoblasts: 705.4;Syncytiotrophoblasts: 433.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 493.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 142.7;HaCaT: 298.4;SK-BR-3: 276.8;T-47d: 157.2;U-2 OS: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005654	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		18000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli fibrillar center"		"HPA005654: AB_2667378"	"unprognostic (5.63e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.31e-4)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.94e-6)"	"unprognostic (1.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.97e-3)"	105.0	23.3	24.0	9.9	23.3	3.8	125.6	23.7	39.6	87.7	38.2	32.2	13.5	78.1	21.3	29.1	115.1	15.8	118.3	21.3	24.6	316.8	38.4	89.0	9.8	26.7	27.4	50.2	51.5	20.0	38.3	44.1	26.7	130.1	5.3	3.1	65.6	49.2	44.7	54.1	31.2	19.6	24.0	36.4	39.3	20.6	28.2	13.8	215.7	30.8	7.1	52.8	72.0	21.6	34.7	44.3	1.2	120.8	0.6	0.8	142.7	13.3	6.3	10.7	7.1	66.8	83.5	0.0	65.7	1.6	0.6	298.4	10.4	74.5	3.2	0.1	7.3	0.2	8.8	93.9	23.6	0.0	15.9	11.6	28.6	3.7	4.4	34.2	6.6	0.0	7.3	0.5	1.6	17.7	0.4	1.2	13.5	10.0	15.1	0.5	14.2	3.6	90.4	21.9	0.4	0.5	54.0	276.8	3.4	13.1	157.2	5.1	17.4	2.7	130.2	3.4	6.5	0.6	1.4	0.1	1.1	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	23.3	23.7	39.6	21.3	24.6	26.7	27.4	26.7	24.0	28.2	21.6	374.9	6.4	12.3	5.5	4.4	40.7	118.0	454.1	80.2	2.5	109.5	185.4	12.8	52.9	48.5	548.1	0.0	705.4	3.2	8.6	82.2	34.0	1.3	62.9	8.2	214.0	52.0	4.8	0.5	4.0	36.9	21.7	15.8	45.3	0.0	14.3	73.2	31.0	44.7	0.0	1.2	5.6	40.7	8.0	21.3	2.1	29.5	3.5	16.0	9.4	0.1	23.6	0.0	1.0	0.3	14.3	21.4	15.1	2.5	80.4	4.9	149.6	20.7	1.1	157.8	14.1	240.6	3.2	18.3	8.9	24.6	433.3	3.5	6.4	13.0	40.7
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724565	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		NA	NA		170000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	294.1	213.9	171.5	100.9	175.5	151.3	210.9	171.8	213.9	139.5	202.5	157.7	133.3	127.4	228.9	214.0	151.0	118.0	123.5	183.0	192.1	160.7	185.5	144.5	111.8	190.8	187.5	130.9	266.4	193.7	123.5	143.3	195.3	154.6	166.5	63.9	179.7	177.7	81.9	187.3	143.8	155.0	183.4	138.5	129.3	117.3	186.9	99.7	161.4	75.5	134.6	177.9	145.8	185.0	505.5	482.4	128.0	650.6	593.8	179.1	295.3	269.9	287.5	291.6	371.6	386.8	361.9	315.9	1068.1	412.2	373.9	506.8	337.3	518.6	221.0	152.8	436.9	198.4	350.4	323.3	276.4	335.1	373.2	233.8	454.2	282.3	330.1	298.4	372.6	172.0	268.0	528.3	332.7	535.3	187.3	402.5	145.8	704.6	431.7	207.5	152.8	693.2	459.3	546.8	173.3	241.8	111.8	520.6	350.0	200.3	196.2	320.2	380.0	248.9	234.7	338.9	495.1	518.0	1120.1	397.3	460.9	402.6	223.7	630.5	484.2	489.1	507.5	535.7	454.7	436.1	504.5	507.4	420.7	463.6	439.1	474.7	624.5	449.8	632.3	666.9	457.1	1110.8	171.5	175.5	171.8	213.9	183.0	192.1	190.8	187.5	195.3	183.4	186.9	185.0	184.9	112.2	114.1	14.7	97.5	141.9	232.2	374.0	172.4	53.0	127.3	165.7	60.3	134.4	222.8	128.8	45.9	467.5	113.5	194.1	37.2	252.4	7.8	99.7	70.1	165.5	103.2	59.3	16.9	210.0	444.8	103.6	78.5	103.9	95.6	68.5	199.6	216.0	356.2	32.0	12.8	155.1	244.1	148.4	125.6	20.6	105.3	166.2	160.1	17.8	137.5	138.2	111.2	11.6	12.9	247.1	187.4	98.9	120.8	191.8	242.8	170.9	172.6	51.8	157.8	42.9	106.5	310.3	231.3	174.0	130.4	538.1	114.6	120.4	187.0	260.4
BCAT2	"BCAM, BCT2"	ENSG00000105552	"Branched chain amino acid transaminase 2"	O15382	19	48795062-48811029	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 254.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054091	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		25000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA054091: AB_2682374"	"unprognostic (2.58e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.87e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.50e-3)"	27.2	85.4	27.5	11.4	27.8	6.1	25.2	34.6	34.5	29.7	72.3	38.8	14.8	27.0	5.3	33.7	30.2	10.7	63.4	29.0	26.5	40.5	22.1	30.4	14.0	28.2	29.7	53.3	76.7	20.1	30.7	12.4	27.8	38.4	17.4	5.6	29.1	17.0	58.7	28.0	23.7	13.5	26.1	19.7	66.4	20.2	30.8	12.0	28.9	29.4	16.5	56.6	29.0	29.2	62.9	73.3	19.3	40.6	78.1	26.3	34.2	27.3	13.8	32.7	31.7	74.5	37.4	73.3	30.2	24.3	10.1	28.8	29.8	47.4	16.5	46.0	76.0	27.0	32.7	5.0	75.3	36.9	24.2	38.5	29.8	24.2	35.0	31.8	45.5	55.3	34.9	43.8	12.2	74.8	50.4	38.9	16.9	98.5	35.7	75.2	33.1	80.8	30.8	254.3	102.6	29.4	41.0	66.7	20.7	13.3	42.3	17.9	25.9	31.5	30.3	37.6	34.3	40.8	58.4	35.8	17.2	56.7	21.0	0.0	14.4	3.0	14.3	16.1	20.1	23.5	17.5	18.8	25.6	20.3	15.7	14.1	0.6	14.8	6.2	28.9	24.9	12.3	27.5	27.8	34.6	34.5	29.0	26.5	28.2	29.7	27.8	26.1	30.8	29.2	13.1	28.9	44.8	59.7	14.1	6.0	28.3	32.3	14.2	10.4	23.5	17.9	25.5	31.5	20.6	12.9	20.9	67.6	11.0	28.8	72.4	38.6	8.0	16.2	22.4	13.5	19.9	6.3	11.2	21.3	25.2	15.3	32.6	23.8	23.5	18.3	12.8	11.2	26.2	1.7	10.6	30.4	38.7	7.9	10.5	10.2	17.4	7.5	24.9	8.4	21.6	7.3	7.2	9.0	11.2	15.8	17.7	30.1	15.1	16.1	13.9	39.4	13.2	13.4	19.7	9.9	17.3	8.0	19.5	32.6	7.1	45.8	9.5	21.9	33.9	47.7
BEX3	"Bex, DXS6984E, HGR74, NADE, NGFRAP1"	ENSG00000166681	"Brain expressed X-linked 3"	Q00994	X	103376395-103378164	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1607.8;Distal tubular cells: 1453.7;Granulosa cells: 700.3;Proximal tubular cells: 688.0;Syncytiotrophoblasts: 804.2;Theca cells: 696.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 150.9;T-reg: 137.1"	"Lineage enriched"	"Detected in all"	5	"T-cells: 150.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018886	Approved		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA018886: AB_1854453"	"unprognostic (7.74e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.15e-3)"	"prognostic unfavorable (7.23e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.28e-4)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.68e-2)"	106.8	345.8	382.4	39.6	395.3	31.1	111.0	353.0	432.9	144.6	462.7	123.4	31.2	149.1	499.4	72.8	150.9	77.1	244.7	401.5	491.6	263.6	92.8	116.8	29.3	368.8	392.1	463.7	120.0	231.1	373.7	207.0	384.1	166.7	53.0	135.9	99.5	224.9	19.8	61.6	56.3	116.5	364.9	97.3	94.6	139.9	419.3	97.0	274.6	44.5	28.4	107.8	104.6	365.7	218.5	305.3	561.5	222.3	508.5	567.3	256.6	244.7	409.8	299.5	475.0	317.9	238.1	0.3	427.8	288.7	222.0	85.3	394.1	302.5	299.4	0.8	280.6	98.7	502.9	87.4	396.2	0.8	37.4	613.4	252.2	397.3	348.0	533.6	469.5	225.0	0.1	1.0	542.2	486.1	227.2	2.7	750.5	0.1	232.3	0.4	350.3	0.5	317.9	365.3	377.3	391.4	264.7	3.2	380.3	359.8	142.4	31.8	291.5	191.6	123.3	374.6	110.0	2.2	1.0	1.6	395.3	0.3	189.1	0.3	3.7	1.1	4.1	0.9	2.2	4.6	71.8	19.1	6.4	1.2	150.9	70.8	13.9	28.9	0.8	14.5	137.1	66.5	382.4	395.3	353.0	432.9	401.5	491.6	368.8	392.1	384.1	364.9	419.3	365.7	118.5	326.9	227.7	0.0	12.6	0.0	0.0	0.0	0.0	0.0	217.4	433.2	0.0	0.0	104.0	518.6	0.0	1607.8	4.7	0.0	1453.7	201.3	0.0	187.0	284.8	132.3	0.0	0.0	0.0	70.9	471.7	189.2	0.0	144.1	16.4	700.3	0.0	0.0	172.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	2.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	1.7	0.0	0.0	688.0	23.3	0.0	0.0	0.0	117.8	0.0	0.0	0.0	0.0	804.2	12.8	696.8	0.0	0.0
BEX4	"BEXL1, FLJ10097"	ENSG00000102409	"Brain expressed X-linked 4"	Q9NWD9	X	103215108-103217246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 309.3;Syncytiotrophoblasts: 364.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 162.5;HMC-1: 188.1;K-562: 232.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045105, HPA051935"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA045105: AB_10966792, HPA051935: AB_2681667"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.03e-1)"	"unprognostic (6.33e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.54e-14)"	"unprognostic (1.62e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.33e-2)"	32.2	99.9	186.5	24.8	187.5	71.4	56.3	173.4	225.0	53.0	154.9	63.6	17.0	70.3	265.9	48.0	65.7	40.2	101.9	188.8	209.2	97.6	13.5	44.0	32.9	185.7	185.7	102.6	34.7	126.0	134.0	60.6	184.6	80.2	26.4	92.0	74.6	83.1	6.8	26.6	32.2	56.4	183.7	68.7	36.2	46.1	195.1	57.0	131.1	13.6	34.8	46.6	44.3	188.2	0.0	0.2	96.4	0.0	24.1	16.6	86.5	23.2	19.8	42.6	77.7	0.0	1.4	0.3	38.1	16.2	36.0	0.7	39.1	5.3	46.8	0.1	36.8	162.5	0.0	0.1	73.7	123.0	188.1	62.3	12.9	22.3	0.0	47.3	50.2	62.2	232.5	0.5	13.1	0.5	86.4	1.0	117.0	0.0	6.9	0.2	28.0	0.6	39.1	2.4	71.7	109.3	8.1	1.5	5.1	93.0	3.9	1.3	1.3	5.5	34.3	0.8	0.3	12.5	6.0	0.2	16.0	0.0	4.9	118.6	23.1	42.3	31.6	30.0	26.5	37.6	38.2	32.0	51.3	33.7	65.5	52.2	5.2	100.5	26.4	79.0	40.3	43.9	186.5	187.5	173.4	225.0	188.8	209.2	185.7	185.7	184.6	183.7	195.1	188.2	45.7	35.3	40.4	25.5	38.7	27.3	133.8	86.0	87.0	174.9	99.0	105.4	81.3	81.5	64.0	99.3	25.0	309.3	47.5	6.8	299.3	66.4	4.7	31.2	35.5	59.2	63.1	35.1	70.0	13.7	156.0	65.1	19.4	38.1	109.2	147.8	73.2	0.7	88.3	222.1	69.6	37.2	52.9	55.5	53.2	12.9	63.3	68.9	115.6	22.5	118.4	217.8	34.0	34.2	64.3	10.8	23.3	61.3	22.2	118.1	8.1	186.5	33.2	81.0	52.6	64.4	57.4	27.4	14.3	42.5	24.2	364.3	37.2	115.0	28.7	111.7
BMP7	OP-1	ENSG00000101144	"Bone morphogenetic protein 7"	P18075	20	57168753-57266641	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;choroid plexus: 43.8;thyroid gland: 45.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Basal squamous epithelial cells: 51.8;Cytotrophoblasts: 137.4;Oligodendrocyte precursor cells: 74.4;Squamous epithelial cells: 44.2;Syncytiotrophoblasts: 56.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 172.1;MCF7: 202.3;OE19: 94.4;RPMI-8226: 77.8;SK-BR-3: 128.4;U-698: 237.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057757			Approved	Nucleoplasm,Nucleoli,Vesicles	"Secreted to blood"	NA	NA	248000			"Cluster 27: Brain & Skin - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA057757: AB_2683518"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-3)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.59e-1)"	1.5	6.5	33.1	1.9	34.6	0.0	1.3	37.2	27.9	8.5	43.8	2.9	2.2	1.2	17.2	23.9	9.5	0.4	13.8	35.6	28.5	6.3	0.0	1.6	1.0	36.2	36.3	0.2	0.5	0.0	2.7	25.7	34.7	5.9	1.7	5.3	3.9	9.2	0.3	22.5	1.9	0.3	32.8	0.6	3.6	0.7	39.7	3.8	45.9	0.0	2.1	6.8	13.0	42.8	0.3	0.7	23.4	5.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	20.0	6.8	172.1	41.3	0.0	8.7	48.3	5.2	0.0	0.0	0.4	17.2	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	202.3	0.0	0.1	12.3	94.4	0.0	0.1	0.1	77.8	0.0	0.2	0.4	17.8	5.5	128.4	0.5	15.2	0.9	0.4	0.4	0.1	10.9	0.0	0.1	0.2	0.3	237.6	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	34.6	37.2	27.9	35.6	28.5	36.2	36.3	34.7	32.8	39.7	42.8	0.6	6.4	2.2	74.1	0.4	13.8	13.4	12.9	51.8	4.7	0.9	4.6	15.1	0.0	4.2	1.8	0.0	137.4	0.1	0.2	0.0	0.0	5.3	1.7	2.4	1.2	2.4	0.0	0.9	0.0	21.0	13.5	2.0	2.5	21.6	0.1	0.0	0.0	11.0	1.7	4.7	1.5	6.1	0.0	1.9	4.9	0.3	0.4	3.6	2.8	0.1	38.4	0.0	74.4	8.7	0.0	0.3	0.4	2.5	6.6	0.2	2.2	1.9	2.4	0.0	1.3	0.8	1.8	3.4	44.2	9.7	56.9	0.9	0.7	1.5	18.1
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CASTOR1	GATSL3	ENSG00000239282	"Cytosolic arginine sensor for mTORC1 subunit 1"	Q8WTX7	22	30285117-30289622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 48.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 71.8;Extravillous trophoblasts: 55.4;monocytes: 45.5;Syncytiotrophoblasts: 36.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073183	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA073183: "	"unprognostic (1.48e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.92e-3)"	"unprognostic (7.40e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.37e-5)"	"unprognostic (9.28e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.26e-2)"	12.7	6.4	11.5	3.3	11.3	1.5	13.3	9.9	15.8	24.7	10.1	7.3	0.6	9.1	2.5	48.0	11.1	4.3	9.3	10.6	11.0	12.3	7.5	10.9	7.2	11.0	11.8	13.8	5.5	14.5	8.6	11.0	10.4	13.5	0.6	1.2	12.0	11.9	2.7	12.3	5.9	3.3	9.9	9.3	7.8	17.2	11.5	4.8	13.1	3.1	3.4	10.3	35.2	9.9	1.5	5.9	1.8	6.2	6.6	7.3	12.6	0.5	1.5	0.9	1.0	2.1	1.4	0.5	1.9	3.5	9.4	2.9	1.8	2.4	0.1	0.9	1.4	0.4	1.1	1.7	13.5	0.5	4.5	12.9	5.4	3.0	0.5	9.4	6.1	10.8	1.3	5.2	3.5	7.6	3.4	4.0	1.0	6.2	2.8	5.0	3.2	5.0	3.5	2.0	0.4	4.2	1.8	3.8	1.4	5.5	5.8	0.7	4.8	3.6	3.8	2.3	0.4	0.4	0.4	0.3	1.7	2.2	1.3	12.2	7.6	19.5	9.8	5.1	5.9	15.6	12.9	10.4	7.6	16.3	21.4	16.0	3.0	29.2	2.6	8.2	14.8	7.5	11.5	11.3	9.9	15.8	10.6	11.0	11.0	11.8	10.4	9.9	11.5	9.9	13.6	0.0	2.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.0	5.7	0.0	0.0	1.8	7.3	0.0	71.8	2.6	0.0	9.8	6.0	0.0	1.5	1.3	2.4	0.0	0.0	0.0	2.4	55.4	3.1	0.0	4.0	2.5	2.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	45.5	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	11.6	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	36.4	1.5	2.6	0.0	0.0
CBY2	"NURIT, SPERT"	ENSG00000174015	"Chibby family member 2"	Q8NA61	13	45702320-45714559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	441	"testis: 99.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039359, HPA040046"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 36: Testis - Spermatogenesis"		"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cell Junctions"		"HPA039359: AB_10794088, HPA040046: AB_10796117"	"unprognostic (2.86e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.19e-4)"		"unprognostic (8.52e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-1)"		"unprognostic (2.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.15e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	99.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCR3	"CC-CKR-3, CD193, CKR3, CMKBR3"	ENSG00000183625	"C-C motif chemokine receptor 3"	P51677	3	46163604-46266706	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;granulocytes: 1.3;Melanocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	25	"basophil: 3389.4;eosinophil: 2509.9"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 3389.4"	"Cell line enriched"	"Detected in some"	10	"RPMI-8226: 29.6"	"Not detected"	"Not detected"							"CAB003795, HPA069514"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"		"CAB003795: AB_562259, HPA069514: "	"unprognostic (1.56e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.11e-7)"	"unprognostic (4.36e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.17e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.81e-2)"	0.1	0.0	0.2	1.6	0.3	0.4	0.0	0.1	0.5	0.1	1.7	0.8	1.3	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.2	0.1	0.1	0.6	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.7	0.4	0.0	0.7	0.0	0.0	0.1	1.7	0.8	2.6	0.9	0.0	1.5	1.2	0.2	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	2.6	0.1	0.8	0.0	0.9	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.3	0.0	29.6	0.0	2.4	0.1	0.0	0.1	0.8	0.0	0.8	0.0	0.7	0.0	0.1	0.2	0.0	0.1	3.0	2.6	0.0	0.0	0.5	0.0	3389.4	1.0	2509.9	0.5	1.5	0.8	1.2	2.6	1.4	1.1	0.7	0.3	0.9	115.8	0.5	1.4	3.5	31.1	7.6	0.2	0.3	0.1	0.5	0.1	0.2	0.4	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0
CDIPT	"PIS, PIS1"	ENSG00000103502	"CDP-diacylglycerol--inositol 3-phosphatidyltransferase"	O14735	16	29858357-29863414	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056597	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane, Plasma membrane"		"HPA056597: AB_2683182"	"unprognostic (7.81e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (1.93e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.48e-1)"	93.8	101.7	75.1	32.1	73.8	26.8	81.0	79.0	86.2	84.5	64.2	104.7	39.0	91.1	31.1	61.1	76.2	51.7	105.4	73.6	76.2	80.6	114.5	65.1	36.1	78.4	74.6	109.6	86.8	87.9	68.7	42.3	78.9	78.1	24.4	34.0	67.2	55.5	49.7	82.8	69.6	38.9	69.1	66.3	89.1	43.9	73.6	40.6	69.1	43.9	24.8	89.7	73.6	70.1	40.0	85.6	23.7	47.3	125.8	86.3	70.5	71.0	76.6	47.9	47.4	50.5	75.1	26.9	125.2	80.3	42.2	62.0	38.7	44.5	21.3	67.5	85.3	19.5	61.4	74.1	87.7	28.5	47.2	148.0	77.2	64.3	29.7	75.8	60.9	49.9	29.5	67.1	44.0	127.7	40.3	56.2	55.5	42.2	65.7	74.8	29.5	78.7	63.7	38.1	96.4	53.8	36.9	76.1	55.7	41.2	57.5	74.8	52.8	70.3	22.1	58.0	35.8	51.4	62.1	19.3	77.2	46.0	43.4	11.7	8.2	28.9	8.5	6.2	5.7	6.5	7.9	9.1	3.8	6.4	7.7	7.2	20.6	11.4	7.9	8.1	12.0	3.8	75.1	73.8	79.0	86.2	73.6	76.2	78.4	74.6	78.9	69.1	73.6	70.1	54.7	25.6	28.3	10.4	25.1	41.3	41.4	22.9	30.1	53.4	42.1	49.7	57.9	41.5	15.4	46.0	45.9	120.6	31.9	57.5	41.1	72.0	54.0	18.1	30.4	48.0	37.3	22.7	16.4	71.8	127.3	59.3	19.4	29.6	13.4	30.7	46.1	41.7	65.0	58.9	19.3	30.6	10.2	41.8	21.3	12.8	76.7	33.3	23.2	11.2	45.2	57.7	36.0	9.0	11.5	44.9	37.9	61.7	31.7	38.9	87.9	34.5	15.1	56.3	46.0	24.4	44.6	10.2	14.7	32.3	50.7	73.2	30.5	34.1	34.8	39.3
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816659	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 506.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 329.4;Hepatocytes: 149.5;Leydig cells: 91.0;Syncytiotrophoblasts: 481.9;Theca cells: 104.7"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 48.1;ASC diff: 57.9;ASC TERT1: 22.3;GAMG: 17.2;HAP1: 17.1;NTERA-2: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA036573: AB_10696658, HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	119.3	18.1	26.1	3.3	28.2	0.2	35.9	24.6	31.2	9.5	109.8	4.8	0.7	8.3	140.3	3.5	13.7	10.5	26.1	28.3	30.7	3.1	506.7	11.7	6.6	23.6	26.2	25.8	14.2	0.7	20.7	35.2	25.6	9.1	1.8	15.9	7.2	72.8	8.5	3.0	4.0	6.2	25.6	3.7	4.1	15.6	26.7	1.3	9.6	19.9	3.1	8.1	5.7	25.6	0.0	0.0	48.1	0.0	57.9	22.3	0.2	1.4	0.4	4.6	4.5	0.0	0.0	0.0	0.0	0.6	17.2	0.1	17.1	0.0	6.6	0.1	8.5	1.7	0.0	1.4	0.2	0.1	0.0	8.5	0.0	0.7	0.0	1.2	6.3	0.0	0.0	0.0	5.5	0.0	1.2	0.2	17.8	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	11.0	0.1	0.0	0.0	4.0	0.0	5.4	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	26.1	28.2	24.6	31.2	28.3	30.7	23.6	26.2	25.6	25.6	26.7	25.6	4.1	0.0	1.3	6.8	0.7	0.8	0.8	0.0	0.6	27.3	1.0	7.1	3.4	0.0	0.0	1.8	6.2	329.4	0.3	0.0	0.0	9.9	6.0	0.3	7.1	3.1	1.8	2.7	12.2	0.2	17.0	27.8	0.0	0.3	0.0	7.5	33.9	149.5	23.4	1.7	16.4	0.0	0.0	5.7	1.6	15.0	91.0	0.6	1.8	1.0	0.6	31.4	0.0	5.5	3.1	0.3	0.0	37.6	0.0	0.9	0.0	2.0	0.0	3.8	13.1	7.3	3.9	1.6	1.4	0.5	1.3	481.9	0.9	104.7	0.0	0.1
CHRNB1	CHRNB	ENSG00000170175	"Cholinergic receptor nicotinic beta 1 subunit"	P11230	17	7445061-7457710	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.4;tongue: 57.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 39.0;Skeletal myocytes: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 34.6;RH-30: 71.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005822, CAB011200"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB011200: AB_262151, HPA005822: AB_1079484"	"unprognostic (2.89e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	7.0	30.6	6.9	2.4	7.8	9.1	6.7	7.3	7.5	7.5	8.8	6.3	2.9	6.6	5.1	7.0	5.4	1.9	11.5	6.9	6.9	10.7	16.5	5.1	3.6	7.5	7.0	5.4	16.5	9.1	6.7	6.7	7.3	5.1	2.5	3.2	10.7	3.0	158.4	8.1	5.5	3.2	7.3	7.9	5.2	3.2	7.1	6.5	13.0	57.7	3.9	5.5	7.2	8.1	1.6	2.2	3.8	4.5	6.0	4.0	8.6	1.1	3.8	5.6	4.6	1.3	2.0	6.2	4.0	2.5	2.0	13.6	1.4	25.1	2.0	7.6	4.8	3.5	2.3	8.1	2.6	2.2	8.6	8.8	6.8	3.4	11.0	9.3	3.8	12.0	4.6	3.4	34.6	1.0	6.7	4.1	2.7	1.5	1.1	4.4	71.0	15.8	15.3	1.2	0.6	11.1	2.4	4.0	4.7	5.9	3.9	3.0	3.6	2.3	6.4	1.7	5.0	8.1	9.6	1.7	2.1	4.9	2.1	9.9	5.4	13.6	7.9	6.3	6.1	6.7	8.7	8.0	7.0	7.0	7.0	9.2	1.7	11.0	10.4	5.2	7.9	6.1	6.9	7.8	7.3	7.5	6.9	6.9	7.5	7.0	7.3	7.3	7.1	8.1	8.8	0.0	4.8	4.6	8.9	6.4	3.8	12.6	6.2	3.9	9.3	11.2	9.8	4.3	7.2	9.2	2.1	39.0	17.7	5.2	23.5	16.1	2.2	5.1	7.1	10.1	2.4	3.4	1.4	13.4	9.4	8.1	3.6	7.1	13.3	5.8	10.4	10.8	12.6	15.2	1.5	4.8	14.2	7.2	8.7	2.1	21.8	7.9	12.4	1.0	17.0	14.0	29.9	1.0	5.6	17.3	4.9	17.0	5.8	4.1	10.2	15.5	9.5	7.1	0.0	47.3	8.1	2.8	2.8	6.1	6.5	30.4	11.2	12.1	5.9	3.8
CHST14	"D4ST-1, D4ST1, HD4ST"	ENSG00000169105	"Carbohydrate sulfotransferase 14"	Q8NCH0	15	40470984-40473158	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.5;Extravillous trophoblasts: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057697, HPA071601"	Enhanced		Approved	"Golgi apparatus"		NA	NA		20000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"		"HPA057697: AB_2683505, HPA071601: AB_2686425"	"unprognostic (5.46e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.25e-2)"	14.2	9.6	6.8	7.7	7.5	3.4	13.7	7.0	6.5	22.0	7.3	11.8	4.5	21.6	8.0	8.7	16.5	11.3	13.8	6.2	7.0	10.1	8.8	13.0	8.5	8.0	7.1	21.1	8.1	11.3	14.4	27.0	7.2	14.6	4.6	1.6	11.0	15.4	5.0	9.1	9.9	12.6	7.5	13.6	9.4	7.9	7.0	8.6	15.8	7.4	7.5	16.1	16.1	7.3	26.2	17.1	26.4	71.6	40.4	31.0	43.0	25.2	47.3	43.5	40.9	21.2	12.8	4.3	37.6	42.7	76.7	43.7	23.7	14.2	20.3	31.5	15.0	13.4	16.9	19.8	22.5	5.7	33.4	38.3	11.6	15.4	11.6	47.8	39.2	15.1	13.6	15.0	32.6	20.1	9.6	29.8	17.0	7.9	20.1	26.2	33.4	7.6	29.5	13.3	19.7	30.2	22.2	24.4	8.4	31.9	35.7	23.9	31.9	73.0	27.1	23.3	25.5	30.3	22.6	12.2	32.8	19.6	53.7	7.6	1.1	2.2	2.2	1.1	0.6	0.3	1.1	1.9	2.0	1.1	0.9	0.8	0.1	3.3	0.6	0.7	0.8	0.7	6.8	7.5	7.0	6.5	6.2	7.0	8.0	7.1	7.2	7.5	7.0	7.3	10.6	12.8	1.1	2.0	5.8	3.4	5.4	4.1	9.1	0.6	5.8	9.7	3.2	7.2	4.6	3.7	0.0	46.5	3.5	0.5	0.0	7.7	1.8	3.2	14.5	10.2	2.4	10.7	0.1	4.9	32.4	19.3	0.0	5.6	4.5	14.9	15.4	3.7	9.3	1.7	0.1	1.4	2.0	5.6	3.3	1.3	17.7	5.6	5.4	2.8	3.4	9.8	6.2	2.0	0.5	5.2	0.3	11.7	1.9	3.6	0.2	1.1	3.0	0.8	6.6	11.8	9.2	7.5	1.3	5.6	2.6	13.5	4.9	3.9	1.9	1.3
CLCC1	MCLC	ENSG00000121940	"Chloride channel CLIC like 1"	Q96S66	1	108927361-108963504	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009087, HPA013210"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA009087: AB_1078532, HPA013210: AB_1846895"	"unprognostic (2.95e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.68e-3)"	"unprognostic (9.65e-2)"	14.6	16.5	10.1	11.4	14.3	6.1	16.3	10.6	11.7	17.0	7.8	15.4	13.2	17.0	24.3	9.9	15.1	14.0	18.3	10.7	11.5	11.0	22.2	13.0	10.5	12.8	10.9	18.6	24.8	21.3	18.3	17.7	12.1	20.2	13.2	11.8	22.3	20.0	27.2	10.3	12.7	14.9	11.0	11.5	16.1	7.6	11.8	5.2	21.9	24.8	10.8	15.2	13.4	16.0	44.2	22.3	25.1	45.8	36.7	33.9	35.6	43.8	34.2	30.1	34.2	22.6	21.0	10.8	43.7	33.3	18.5	17.1	23.9	16.1	39.4	38.0	23.2	30.4	24.7	23.5	28.9	28.7	28.2	25.2	21.9	33.2	25.7	28.3	27.1	12.1	38.6	47.7	22.1	18.9	2.3	10.1	21.5	16.6	19.8	24.5	13.1	31.2	24.3	30.5	15.9	22.7	46.9	49.6	38.9	18.9	15.9	19.7	26.7	38.3	27.7	35.1	38.4	32.1	33.3	17.1	44.7	21.8	82.5	4.1	5.6	6.1	5.6	8.4	6.1	6.1	4.5	4.4	5.6	3.2	4.9	4.5	1.4	4.7	12.4	6.4	6.8	4.4	10.1	14.3	10.6	11.7	10.7	11.5	12.8	10.9	12.1	11.0	11.8	16.0	13.3	25.6	20.9	26.8	11.8	3.7	14.0	11.7	1.8	12.3	11.8	9.1	5.9	20.0	18.0	11.0	29.2	28.7	9.0	7.1	0.0	18.6	6.7	8.1	21.3	10.9	3.6	5.9	25.0	21.1	12.8	19.5	10.7	13.5	12.0	16.3	9.7	22.3	13.1	21.9	30.3	9.0	16.2	6.7	5.1	2.8	19.9	9.3	8.8	14.0	12.0	11.4	3.1	35.7	39.3	17.7	3.8	18.8	17.7	17.7	7.2	5.0	14.9	18.9	19.7	18.6	10.7	5.5	5.4	6.4	6.3	18.5	8.4	12.5	9.8	9.9
CLN3	"BTN1, BTS, JNCL"	ENSG00000188603	"CLN3 lysosomal/endosomal transmembrane protein, battenin"	Q13286	16	28474111-28495575	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 315.9;Extravillous trophoblasts: 106.9;Syncytiotrophoblasts: 451.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 178.0;SK-BR-3: 186.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063280	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA063280: AB_2684975"	"unprognostic (2.38e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.06e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.38e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.27e-2)"	"unprognostic (5.26e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.05e-2)"	18.1	30.5	13.1	19.6	14.2	13.4	21.4	14.2	16.0	16.9	16.5	38.3	21.9	15.9	9.9	22.2	16.0	15.2	11.7	13.2	13.6	21.2	31.9	23.6	13.8	14.6	13.6	16.8	27.7	30.0	8.2	36.9	15.1	17.3	29.2	3.1	34.5	21.0	14.5	24.1	25.7	13.3	13.5	20.4	26.1	7.9	15.6	14.0	24.7	13.8	12.1	19.3	15.6	17.1	23.1	39.2	15.4	38.4	41.1	19.9	178.0	14.8	40.7	28.3	34.9	19.7	52.9	16.0	45.8	24.8	52.0	23.5	25.8	24.7	12.9	38.0	38.5	15.6	24.1	60.6	60.5	23.3	64.7	28.0	66.8	21.9	14.7	26.3	32.9	24.9	30.9	55.0	28.8	61.9	20.7	45.1	21.8	35.3	26.0	37.2	13.4	54.5	30.2	53.0	20.8	19.6	5.7	186.5	18.3	14.0	62.2	32.4	20.2	19.2	10.1	24.9	22.5	58.3	64.2	15.9	28.4	47.3	11.9	63.4	59.8	98.4	57.6	47.6	42.7	24.3	43.6	53.6	63.8	29.3	38.3	40.6	23.8	41.2	38.7	68.1	53.5	46.6	13.1	14.2	14.2	16.0	13.2	13.6	14.6	13.6	15.1	13.5	15.6	17.1	1.2	22.4	15.9	11.1	10.8	0.1	17.2	0.0	23.9	10.9	1.7	0.6	0.0	38.6	6.2	1.8	12.5	315.9	25.8	46.4	0.0	2.2	1.1	1.8	1.3	11.2	17.0	17.5	7.5	0.5	106.9	9.3	20.9	2.6	2.5	7.6	21.0	39.0	70.1	13.5	8.1	39.3	0.0	36.7	0.4	2.5	19.0	17.7	0.0	2.8	17.5	25.0	40.2	7.1	11.4	1.5	43.7	12.4	13.1	10.6	53.1	0.8	1.5	12.1	13.1	9.9	3.5	3.2	8.4	17.1	0.1	451.4	15.9	3.6	50.2	13.3
CNOT11	"C2orf29, C40"	ENSG00000158435	"CCR4-NOT transcription complex subunit 11"	Q9UKZ1	2	101252886-101270316	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069823, HPA074943"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA069823: AB_2686209, HPA074943: "	"unprognostic (1.72e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-3)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.33e-6)"	"unprognostic (4.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.72e-3)"	15.7	20.3	16.7	26.3	17.5	34.7	19.1	18.4	21.1	22.6	20.6	31.4	33.1	19.8	24.8	36.4	20.9	25.0	37.7	17.3	17.8	27.9	30.8	19.7	37.7	17.6	17.2	14.1	30.9	21.9	14.5	34.1	17.8	20.0	36.1	16.1	24.8	19.1	33.0	25.3	31.5	20.8	17.6	29.8	30.3	29.5	17.8	31.8	17.3	26.4	40.9	24.3	20.2	18.7	42.6	29.1	46.2	64.1	38.2	46.0	137.4	43.1	54.6	52.5	55.4	64.2	47.8	75.0	49.7	39.1	66.1	50.6	56.0	51.7	63.4	51.4	47.6	62.6	32.1	96.6	42.5	76.2	59.5	36.5	46.3	37.7	40.0	43.1	59.7	41.8	71.1	44.4	48.0	44.5	74.8	82.0	58.0	67.5	40.6	47.5	50.3	58.1	72.3	79.4	69.1	44.1	26.1	76.6	72.4	52.6	48.5	69.2	40.3	40.7	47.2	35.4	36.4	63.2	63.5	58.8	45.0	84.4	48.6	9.6	2.0	3.9	3.1	2.9	2.1	2.0	3.2	3.8	1.7	3.1	3.0	4.1	7.9	1.2	2.8	2.6	4.5	1.3	16.7	17.5	18.4	21.1	17.3	17.8	17.6	17.2	17.8	17.6	17.8	18.7	13.4	6.4	13.4	11.1	17.3	11.7	24.7	13.8	14.2	10.7	18.1	10.7	27.8	28.6	14.6	40.5	14.6	65.8	21.1	32.1	31.3	52.1	8.7	53.3	14.0	19.1	10.8	9.4	12.5	41.3	52.6	12.9	25.0	41.8	6.3	13.8	16.8	32.1	23.0	6.7	12.5	26.2	12.2	17.9	8.9	9.3	9.6	16.8	5.4	14.0	29.3	19.9	21.6	9.5	18.2	43.6	18.6	12.0	25.6	32.7	24.6	34.8	24.1	11.3	39.5	10.6	22.4	34.1	15.7	26.9	12.8	57.6	22.1	30.0	25.7	39.3
COG4	"COD1, DKFZP586E1519"	ENSG00000103051	"Component of oligomeric golgi complex 4"		16	70480568-70523560	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040924, HPA042539"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA040924: AB_2677203, HPA042539: AB_2678044"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.79e-1)"	17.8	22.0	25.3	12.8	27.2	14.2	15.7	27.8	27.0	20.2	29.0	20.3	10.5	17.4	11.1	30.1	19.7	12.8	25.7	25.3	26.5	16.9	16.9	18.3	15.4	26.9	26.3	18.8	10.6	27.9	19.0	19.8	26.6	14.4	16.6	14.5	17.1	16.5	67.7	23.8	16.3	19.2	25.9	17.9	17.4	19.2	27.7	22.3	15.9	49.4	17.7	18.5	20.7	28.3	37.3	59.9	47.1	31.3	62.6	43.7	53.0	41.0	53.7	51.0	43.9	48.3	66.7	25.0	57.7	64.9	35.5	53.4	60.8	65.3	70.9	21.5	36.7	23.1	59.8	47.5	36.7	15.3	15.0	51.9	41.9	66.1	40.6	59.7	51.7	31.6	55.9	18.1	57.6	75.9	25.1	23.4	45.2	50.4	30.9	46.8	31.2	57.4	42.3	31.0	43.9	45.5	80.7	30.5	24.3	48.0	77.9	26.4	49.7	46.3	29.1	35.3	29.8	19.1	26.2	78.0	50.7	15.8	46.1	20.6	26.4	23.8	19.7	28.8	14.4	11.8	19.3	17.9	32.8	14.6	16.9	15.7	13.8	14.4	34.4	15.2	24.4	25.1	25.3	27.2	27.8	27.0	25.3	26.5	26.9	26.3	26.6	25.9	27.7	28.3	13.6	16.0	16.0	21.9	11.0	9.1	12.1	22.6	11.4	24.5	9.2	8.0	23.3	2.8	21.1	3.7	14.6	47.7	13.1	20.8	9.8	23.4	3.1	11.9	13.0	16.8	12.6	12.6	10.9	16.0	26.8	16.5	18.8	13.4	8.8	28.7	16.8	17.8	24.7	8.4	13.0	18.0	24.4	14.1	8.9	6.7	14.6	11.1	8.8	7.5	14.7	29.3	12.3	19.6	19.1	17.6	21.0	19.2	12.3	6.3	21.7	13.8	18.5	29.9	32.9	14.0	18.6	37.5	25.7	13.1	10.7	39.0	12.9	37.3	19.4	8.9
COMMD7	"C20orf92, dJ1085F17.3"	ENSG00000149600	"COMM domain containing 7"	Q86VX2	20	32702699-32743467	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 225.9;Syncytiotrophoblasts: 264.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 331.1"	"Low region specificity"	"Detected in all"							HPA054119			Approved	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"HPA054119: AB_2682388"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.31e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.52e-2)"	"prognostic favorable (3.53e-4)"	34.6	38.7	60.2	23.0	62.5	40.5	36.6	59.3	87.1	27.9	58.6	41.4	18.1	29.1	49.1	27.2	27.3	25.7	61.7	62.2	59.7	52.7	44.5	29.4	29.9	59.4	62.5	24.1	36.7	40.7	17.7	38.5	59.1	35.6	30.3	24.7	31.7	31.2	66.4	37.1	26.4	33.2	58.9	36.8	36.0	11.5	61.9	25.8	49.7	54.4	34.0	38.3	28.3	58.8	69.9	45.2	43.6	30.9	32.4	58.7	80.3	59.8	96.8	96.4	66.0	88.0	44.0	55.3	51.1	71.4	80.3	30.6	38.0	49.7	72.0	22.3	25.2	154.8	25.3	65.6	83.6	63.5	84.2	45.6	61.1	73.9	43.3	76.1	95.9	30.1	55.8	26.7	62.4	51.4	55.4	133.2	37.4	68.6	43.9	51.4	4.2	19.0	103.2	46.6	26.8	41.3	59.1	81.6	101.3	47.5	48.3	101.6	65.3	97.3	54.0	61.8	61.3	29.8	25.6	18.6	119.0	331.1	39.6	116.9	105.8	162.7	76.5	144.0	67.7	63.5	61.4	70.9	122.7	61.2	67.7	64.6	10.4	99.9	165.2	82.2	75.1	166.2	60.2	62.5	59.3	87.1	62.2	59.7	59.4	62.5	59.1	58.9	61.9	58.8	71.3	22.4	17.9	10.1	43.2	16.6	31.4	44.4	23.9	56.8	58.7	50.2	48.3	47.1	32.1	36.8	68.8	225.9	70.5	33.6	88.0	102.8	3.1	27.7	25.8	54.8	33.0	36.6	19.6	118.5	116.5	36.8	31.1	31.1	53.3	49.2	44.3	39.8	124.3	67.3	25.4	44.4	59.0	46.4	30.9	4.6	37.6	69.6	56.9	16.9	92.7	81.8	123.6	4.5	10.3	118.7	47.0	47.8	35.3	32.8	27.6	124.3	23.3	74.3	46.0	27.0	49.3	13.1	19.1	36.8	28.8	264.5	75.6	36.9	45.8	37.9
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941371-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 885.9;Syncytiotrophoblasts: 648.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 818.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"		NA	NA		43000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favorable (5.67e-4)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	78.1	180.7	99.3	39.6	108.9	71.8	85.5	114.4	140.4	105.3	119.6	80.1	55.0	76.9	47.7	198.0	65.2	60.3	81.7	96.6	107.4	94.2	292.3	93.3	49.7	117.4	107.9	107.4	74.0	61.5	48.7	116.9	117.3	87.2	20.7	17.2	133.7	70.5	98.6	119.7	64.1	38.3	109.2	63.6	99.8	51.7	102.7	26.9	59.1	49.9	26.0	86.9	124.1	124.3	131.3	131.7	15.0	128.3	141.2	122.5	6.0	143.9	178.8	120.3	133.6	112.1	148.6	51.7	62.7	208.9	48.6	172.9	23.6	152.0	26.2	115.1	163.4	92.5	65.1	267.1	265.1	155.0	35.3	159.2	180.7	104.3	101.3	116.6	113.2	82.0	383.2	109.4	100.6	818.5	63.4	267.9	32.4	361.1	42.9	88.2	127.9	72.8	129.0	404.5	60.4	53.8	47.7	405.7	125.7	7.6	84.0	436.6	137.5	212.7	82.2	71.0	109.6	37.5	18.0	41.2	236.0	211.3	152.5	62.2	312.2	59.6	77.9	218.1	64.0	56.8	52.6	62.6	251.5	57.8	45.5	51.7	12.0	73.5	151.5	291.4	72.6	178.6	99.3	108.9	114.4	140.4	96.6	107.4	117.4	107.9	117.3	109.2	102.7	124.3	99.1	125.0	88.1	22.9	33.1	102.1	231.9	248.1	188.4	73.4	174.9	218.4	41.9	104.4	162.7	152.6	10.4	885.9	80.1	53.0	320.8	201.0	4.6	59.1	72.2	86.7	84.5	70.0	16.8	193.0	113.5	103.1	46.4	46.9	71.7	95.7	77.1	262.0	311.4	25.2	17.2	97.7	191.2	177.0	107.7	13.3	134.2	137.0	240.1	20.6	137.0	158.7	41.2	25.1	45.7	170.2	108.8	179.8	45.5	132.4	179.9	73.8	135.8	43.2	138.1	143.3	113.1	8.4	5.7	236.4	123.5	648.5	41.8	222.0	122.3	206.6
COPS7A	CSN7A	ENSG00000111652	"COP9 signalosome subunit 7A"	Q9UBW8	12	6724014-6731875	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026915	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		54000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA026915: AB_1847156"	"unprognostic (3.50e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	45.0	52.8	69.2	32.9	69.1	19.7	36.1	69.7	71.7	34.1	66.0	44.5	29.9	39.2	46.7	55.2	44.7	32.7	79.1	71.9	70.9	48.3	53.3	34.7	29.9	72.0	72.0	34.8	40.3	71.9	51.1	42.7	71.4	42.8	30.1	46.8	44.5	40.2	103.6	39.2	29.0	43.1	67.3	33.3	41.2	24.0	77.1	22.8	45.8	98.1	30.4	45.8	38.5	67.4	73.3	78.8	34.0	33.3	96.3	114.0	84.9	93.2	107.8	87.6	86.7	54.3	95.0	47.1	37.1	111.2	49.9	55.9	45.7	86.6	75.5	70.3	57.8	47.0	50.1	63.9	84.6	47.1	28.3	106.7	80.6	97.5	183.4	100.1	61.8	29.2	33.3	18.1	116.0	58.7	29.5	30.3	92.9	91.4	64.1	18.8	71.9	47.2	69.0	69.0	19.4	47.2	58.4	67.5	97.2	79.5	29.9	68.0	70.1	90.8	48.4	82.3	85.6	21.0	24.7	38.4	150.6	60.0	104.7	85.9	56.4	86.1	36.3	73.2	35.8	26.2	30.7	32.2	65.3	36.0	30.2	29.8	43.7	31.0	58.9	41.3	30.9	49.9	69.2	69.1	69.7	71.7	71.9	70.9	72.0	72.0	71.4	67.3	77.1	67.4	23.7	16.0	17.5	17.0	14.7	13.9	31.4	39.8	25.0	37.0	29.1	27.6	36.7	22.8	28.0	23.9	6.2	72.6	11.7	15.7	66.5	47.8	4.3	21.4	28.0	23.4	12.6	17.0	13.0	49.7	58.2	34.8	13.7	22.9	16.5	13.0	22.9	26.3	63.2	30.3	15.3	18.6	69.2	24.2	14.4	6.5	23.0	26.1	12.4	5.6	50.0	51.4	13.4	11.1	11.9	49.8	18.6	25.6	16.2	34.3	22.3	47.3	23.8	23.8	39.5	21.7	33.2	16.9	40.6	39.2	13.9	59.1	12.6	40.6	17.1	30.7
CPNE1	CPN1	ENSG00000214078	"Copine 1"	Q99829	20	35626031-35664956	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065876, HPA072634"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA065876: , HPA072634: AB_2686541"	"unprognostic (5.94e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.74e-10)"	"unprognostic (3.10e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	61.0	47.9	15.5	50.5	15.2	70.9	58.5	14.5	17.5	68.7	17.0	65.4	32.5	74.1	58.5	58.7	62.4	48.3	38.4	15.2	15.8	44.1	38.7	59.6	52.3	16.9	14.6	64.7	48.4	38.6	52.1	69.8	15.4	52.3	47.4	17.7	51.6	41.9	43.7	63.4	62.9	70.3	14.5	78.3	51.0	25.5	14.9	82.8	60.2	33.6	81.8	64.4	59.8	19.6	264.1	202.5	112.0	47.3	14.3	18.6	85.4	123.9	219.8	295.0	192.1	590.5	111.2	181.6	115.8	185.3	251.6	98.1	88.1	233.7	182.8	34.7	65.7	459.1	149.9	440.5	131.9	151.5	61.9	121.6	235.8	118.1	139.0	178.9	188.1	183.9	61.4	90.3	144.0	142.9	226.0	201.9	27.8	264.2	187.6	159.1	334.0	125.4	119.9	183.9	78.9	87.9	277.2	129.6	188.1	31.1	134.3	148.8	123.6	306.6	56.4	101.3	131.6	61.5	66.9	126.9	222.7	81.8	69.6	53.6	102.9	180.5	119.3	100.5	164.8	120.8	115.2	112.5	143.7	113.8	111.3	113.6	140.4	206.7	98.8	78.0	153.7	164.5	15.5	15.2	14.5	17.5	15.2	15.8	16.9	14.6	15.4	14.5	14.9	19.6	47.0	19.2	37.3	33.6	55.2	55.1	71.8	82.3	44.9	34.6	40.2	46.0	15.7	32.9	56.5	25.8	20.9	125.1	73.4	26.8	25.4	72.7	39.6	23.3	44.1	53.2	33.6	42.5	37.2	37.8	76.7	56.2	25.0	28.3	48.2	59.9	34.6	23.3	62.4	21.9	33.7	30.8	81.4	43.0	79.6	9.6	54.7	45.5	48.0	30.0	85.0	24.8	62.8	32.6	39.4	44.2	34.0	61.7	60.2	78.6	38.2	34.8	33.9	18.1	46.0	47.0	55.0	13.1	22.9	41.4	49.0	106.3	77.0	65.9	41.2	71.7
CPSF4	"CPSF30, NAR"	ENSG00000160917	"Cleavage and polyadenylation specific factor 4"	O95639	7	99438922-99457373	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049094, HPA066470"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Vesicles	"HPA049094: AB_2680626, HPA066470: AB_2685672"	"unprognostic (4.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.23e-2)"	20.4	19.0	31.4	13.8	30.8	20.1	19.2	29.9	35.1	18.7	23.6	16.7	14.0	16.8	11.7	20.4	15.7	11.3	17.4	30.1	30.4	17.3	20.2	15.4	23.7	35.5	31.6	18.8	29.9	8.3	18.4	16.7	32.1	19.1	10.7	7.2	19.8	12.3	36.1	20.4	16.1	11.1	30.4	22.0	20.0	32.0	32.3	16.1	13.9	18.0	19.9	16.0	17.4	30.4	40.0	33.9	55.4	44.9	22.4	25.5	66.8	25.8	31.5	38.8	50.5	56.0	52.0	56.4	34.2	25.2	48.2	34.0	39.1	40.5	35.4	41.9	41.6	27.0	41.4	54.4	117.2	49.4	33.3	46.8	34.0	40.7	60.4	28.1	35.8	40.1	70.8	64.8	36.2	95.6	99.6	88.9	51.3	53.0	47.7	40.8	37.0	66.8	24.2	36.1	43.3	50.6	29.4	60.9	61.6	58.2	25.3	51.8	20.0	36.5	50.1	64.3	50.0	59.9	68.6	83.3	28.1	48.1	44.1	1.2	3.4	2.6	3.3	3.0	4.4	8.2	5.0	6.1	4.1	8.4	6.3	5.6	1.3	4.4	2.1	5.4	8.2	3.0	31.4	30.8	29.9	35.1	30.1	30.4	35.5	31.6	32.1	30.4	32.3	30.4	11.6	6.4	8.9	6.2	11.2	8.8	16.4	10.6	9.6	4.6	11.9	10.3	10.4	14.3	8.6	1.8	10.4	55.9	17.7	8.7	15.6	15.6	3.0	4.9	9.3	11.0	7.7	15.6	10.7	17.1	33.1	12.7	5.1	5.3	12.7	27.0	8.2	8.2	21.5	6.7	14.7	10.6	14.2	10.1	13.5	7.8	27.4	8.7	8.8	5.6	18.5	10.7	14.4	6.0	8.1	13.9	6.0	17.3	14.7	28.6	10.1	20.2	4.3	6.9	19.7	23.7	16.4	20.9	19.8	9.3	9.2	45.4	10.7	25.1	12.6	14.9
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196792-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.2"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 85.1;Hepatocytes: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	12.9	14.3	6.6	9.4	8.2	5.4	13.6	7.9	7.3	10.3	16.8	35.4	32.4	6.8	10.5	14.2	10.5	9.5	19.5	6.1	7.1	35.1	91.2	11.5	10.6	8.1	7.5	10.2	21.7	27.3	6.7	18.0	8.0	12.2	32.8	7.1	14.6	11.7	17.3	6.7	24.9	11.4	7.7	8.7	18.4	12.9	9.0	10.2	12.5	33.1	13.2	11.1	4.5	8.9	16.0	8.3	17.2	17.8	14.6	11.3	17.5	9.8	13.2	17.5	17.5	8.6	14.5	28.9	14.6	9.2	20.1	19.1	35.1	25.1	15.1	17.0	16.0	21.8	9.9	6.4	25.9	15.9	19.5	23.0	23.2	13.8	11.1	18.6	15.4	26.5	20.9	9.9	13.1	12.8	10.7	13.0	29.8	38.4	20.0	13.2	16.2	34.4	22.9	22.0	25.3	14.4	22.1	30.3	39.7	36.6	32.3	32.2	8.7	8.4	6.1	16.5	8.5	26.3	19.8	16.2	11.6	20.6	12.4	5.6	14.1	14.6	7.2	20.0	8.1	5.3	6.3	8.4	17.9	7.4	10.5	7.2	5.3	6.9	20.5	8.9	9.9	10.3	6.6	8.2	7.9	7.3	6.1	7.1	8.1	7.5	8.0	7.7	9.0	8.9	5.0	12.8	24.1	4.2	7.8	1.8	5.2	20.5	5.2	6.0	7.5	7.0	18.1	15.7	11.4	11.0	14.6	85.1	4.5	49.3	25.4	12.9	1.1	10.9	8.1	5.9	14.5	9.4	1.5	10.5	20.3	7.2	18.3	10.3	2.5	12.7	8.9	88.8	26.3	15.2	2.0	26.6	16.2	15.1	7.2	2.8	6.8	10.5	7.2	1.9	20.2	11.6	6.2	2.5	4.5	10.5	25.6	5.3	9.1	4.9	38.6	41.0	7.6	11.0	6.6	7.5	8.4	49.9	31.3	13.8	2.6	54.6	6.9	25.6	29.5	5.7
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345664-87399794	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 136.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 71.7;RT4: 72.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favorable (4.02e-4)"	5.4	10.5	4.8	6.3	6.1	3.2	16.1	5.9	6.1	11.8	7.9	12.6	31.9	7.8	18.5	19.3	10.7	14.1	6.6	5.7	5.1	16.9	35.0	6.6	6.2	4.6	5.0	8.6	6.7	18.7	6.0	19.0	4.5	21.1	11.0	35.4	9.3	27.5	11.3	24.6	23.6	8.6	4.9	5.4	6.8	3.3	5.3	7.6	40.5	9.5	8.5	25.2	19.0	5.6	15.3	10.9	13.5	4.7	12.6	11.5	9.9	15.7	14.8	9.4	10.1	6.0	7.9	6.4	13.6	13.6	18.9	18.9	2.3	21.2	13.5	9.1	9.5	13.9	7.8	7.6	8.1	8.8	8.3	9.4	71.7	7.6	6.0	12.1	13.7	10.4	0.7	9.0	25.2	15.0	11.2	8.8	3.0	5.5	16.4	5.0	18.6	1.1	12.3	72.1	2.2	10.5	19.2	22.3	10.6	9.2	14.2	3.1	7.2	22.0	9.5	29.8	15.2	13.6	21.0	8.8	14.8	0.1	13.3	2.0	1.3	3.4	6.6	1.7	8.7	2.0	6.7	5.5	1.9	1.9	5.3	5.9	0.8	13.0	6.2	2.2	6.2	2.8	4.8	6.1	5.9	6.1	5.7	5.1	4.6	5.0	4.5	4.9	5.3	5.6	8.6	22.4	10.0	18.9	5.1	16.8	56.4	45.0	65.4	16.9	17.5	12.7	14.9	14.3	35.0	53.3	45.9	136.5	9.0	21.0	9.8	7.6	28.7	9.5	9.3	7.2	7.3	4.8	26.3	8.7	7.9	12.0	11.2	12.1	7.6	9.5	5.3	29.7	13.6	15.2	11.1	15.8	16.2	6.3	4.8	63.1	15.8	5.9	19.6	7.5	6.3	25.9	22.6	15.6	16.1	11.1	9.9	13.9	4.8	20.1	53.7	19.9	24.1	79.7	6.6	10.0	10.1	2.4	4.8	29.6	15.3	49.0	9.6	8.7	15.1	48.4
CYB5B	CYB5-M	ENSG00000103018	"Cytochrome b5 type B"	O43169	16	69424619-69466264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 318.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007893	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite,Cytosol"		NA	NA		99000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"	"Centriolar satellite, Cytosol"	"HPA007893: AB_1847369"	"unprognostic (1.13e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (2.87e-3)"	"unprognostic (4.35e-3)"	"unprognostic (3.87e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.30e-2)"	60.2	318.0	52.3	51.4	53.9	20.9	50.4	46.0	69.9	45.8	43.6	92.6	69.5	49.3	72.8	59.3	58.2	45.4	58.0	56.9	51.2	71.9	83.8	54.1	68.8	50.7	48.1	44.0	40.1	77.7	28.6	73.8	50.6	47.6	116.0	49.4	36.3	48.3	65.8	45.8	67.8	61.6	44.7	49.6	49.3	38.6	52.3	74.3	54.1	78.2	76.9	80.4	38.2	48.4	186.2	576.4	232.9	144.9	105.1	139.3	99.5	162.3	224.1	266.0	249.2	406.1	221.3	168.0	159.3	157.9	216.0	214.5	224.4	235.0	300.0	90.2	85.5	81.2	97.1	479.1	154.7	169.1	172.4	120.9	116.3	315.9	149.6	111.8	254.7	190.5	133.6	78.4	165.2	241.2	278.9	204.1	173.5	171.4	78.4	260.0	128.7	184.3	359.3	208.7	135.7	69.7	431.6	82.0	142.2	119.0	159.0	133.2	115.9	152.2	124.5	102.2	145.5	94.7	227.0	516.6	157.0	138.0	180.0	121.1	57.6	71.5	103.8	80.0	85.0	68.8	76.9	81.8	69.8	63.1	62.8	75.5	17.1	96.4	59.7	124.2	134.6	105.6	52.3	53.9	46.0	69.9	56.9	51.2	50.7	48.1	50.6	44.7	52.3	48.4	36.2	44.8	46.8	44.7	47.2	49.8	49.2	84.0	66.0	22.8	28.6	26.0	25.0	30.0	51.4	62.5	6.2	159.8	66.7	112.7	78.2	66.2	18.8	56.4	33.3	61.7	23.4	38.7	40.9	70.4	94.1	38.4	27.5	87.7	60.2	36.6	43.9	54.9	64.8	30.3	30.4	76.6	83.4	30.1	57.5	22.7	44.4	33.4	62.2	24.4	55.8	63.0	96.8	23.6	39.4	70.5	78.8	44.4	28.1	34.9	75.9	62.9	49.5	31.6	46.0	22.2	36.5	48.1	46.6	44.9	42.3	59.8	54.1	84.8	61.6	50.4
DCAF4	"DKFZp434K114, WDR21, WDR21A"	ENSG00000119599	"DDB1 and CUL4 associated factor 4"	Q8WV16	14	72926377-72959703	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047276	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA047276: AB_10959615"	"unprognostic (6.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.96e-3)"	"unprognostic (2.11e-2)"	6.8	7.9	5.9	4.8	6.0	4.9	7.1	5.2	6.6	7.8	4.6	7.9	4.1	7.0	5.3	7.6	5.6	3.7	5.5	6.5	6.6	9.1	7.4	4.5	6.5	7.4	6.2	9.1	12.5	5.5	3.7	9.3	7.6	6.9	6.5	2.6	6.8	5.2	12.8	12.8	6.9	6.0	5.2	6.7	8.0	7.0	6.1	3.9	11.4	5.1	7.4	8.1	7.5	6.6	20.7	9.4	2.3	10.8	9.9	12.5	19.0	11.6	11.6	14.9	17.4	11.3	8.9	26.0	8.5	21.9	13.6	15.6	16.0	18.2	25.5	13.2	8.9	10.8	4.4	15.1	13.9	7.4	17.8	21.9	17.4	15.5	29.1	10.0	5.2	25.1	16.2	16.1	12.1	35.3	12.7	18.4	6.3	20.2	20.3	8.9	12.2	15.2	22.5	12.3	12.5	4.9	7.0	37.4	14.1	10.4	12.5	9.9	7.8	8.0	18.5	22.6	5.7	22.8	23.5	17.7	11.0	6.1	4.9	0.4	1.6	0.3	4.1	2.5	6.1	11.6	5.0	4.6	3.3	8.7	5.7	6.0	0.9	9.1	5.4	2.5	7.2	3.0	5.9	6.0	5.2	6.6	6.5	6.6	7.4	6.2	7.6	5.2	6.1	6.6	2.9	6.4	5.3	3.3	10.8	6.1	7.3	5.8	8.0	3.4	5.8	5.1	4.0	2.8	8.3	3.7	4.2	20.9	4.4	4.3	3.9	6.7	3.8	4.3	6.6	4.4	4.2	4.2	5.7	5.6	15.3	4.9	12.8	7.5	0.0	10.9	1.1	4.7	5.8	0.0	4.7	4.3	6.1	2.2	4.2	2.6	3.7	1.9	1.8	3.7	4.1	2.1	4.1	3.5	5.8	4.4	7.0	5.7	4.7	4.0	2.9	6.6	2.6	3.5	0.0	4.4	4.0	7.5	18.6	6.4	6.7	5.6	5.3	11.8	7.1	3.3
DEGS1	"DEGS-1, Des-1, DES1, FADS7, MLD"	ENSG00000143753	"Delta 4-desaturase, sphingolipid 1"	O15121	1	224175756-224193441	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skin 1: 535.6"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 246.0;Cytotrophoblasts: 281.8;Suprabasal keratinocytes: 320.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA076422			Supported	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 61: Skin - Cornification"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA076422: AB_2686799"	"unprognostic (2.34e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (7.74e-5)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (7.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (2.53e-4)"	60.3	31.0	30.3	44.9	33.1	69.5	61.9	35.0	36.2	53.4	42.5	50.8	47.0	44.5	29.5	48.6	34.4	40.5	43.8	31.3	35.6	38.1	35.7	49.1	48.0	36.6	35.2	27.1	22.5	31.5	34.8	128.7	35.9	83.2	27.2	20.8	38.7	58.6	20.9	535.6	33.4	70.9	37.9	38.7	38.6	22.7	34.0	34.2	52.3	23.3	50.9	48.4	72.7	44.5	72.8	50.7	65.2	49.5	275.7	181.1	51.2	201.1	223.8	137.5	164.2	47.1	55.2	58.0	252.4	181.0	82.4	76.3	76.5	67.9	153.0	84.2	141.5	41.7	51.1	29.2	167.9	84.2	86.1	177.4	153.6	125.5	69.9	143.0	140.4	31.4	62.8	61.8	181.2	27.5	43.2	46.9	83.3	40.0	76.1	38.8	92.4	37.5	181.1	19.8	42.3	69.8	106.6	169.4	110.4	118.8	57.1	123.4	125.7	133.4	41.4	153.1	197.5	44.5	55.3	52.8	141.9	41.7	154.2	104.6	61.4	120.3	30.9	67.8	59.8	58.2	52.7	43.3	104.4	74.3	40.7	37.0	67.7	43.9	48.7	34.9	59.0	52.8	30.3	33.1	35.0	36.2	31.3	35.6	36.6	35.2	35.9	37.9	34.0	44.5	71.7	83.3	29.3	13.4	69.9	246.0	44.0	33.6	89.4	31.2	40.7	38.4	20.8	10.0	19.8	11.0	14.6	281.8	40.5	4.0	13.7	34.9	27.9	54.0	90.2	66.7	14.9	18.7	17.4	43.3	48.3	77.7	21.4	146.1	106.5	21.3	55.6	20.8	93.0	18.5	20.4	6.2	34.6	57.8	90.5	13.6	63.0	72.8	69.4	20.6	57.1	26.0	10.3	25.6	32.1	29.5	5.9	79.4	50.1	44.2	20.1	29.7	20.1	18.4	105.2	42.7	89.1	84.3	44.0	50.4	320.4	198.9	58.9	43.7	6.6	13.7
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472529	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		8700	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	13.3	12.6	15.0	12.0	18.0	6.5	12.6	19.7	16.5	11.1	14.2	11.3	12.1	11.7	9.8	16.7	13.0	10.8	12.1	14.9	17.2	16.8	13.2	11.3	12.4	17.4	18.7	15.3	11.4	18.0	9.2	20.1	17.5	11.8	12.2	12.2	10.9	12.3	12.3	10.9	11.1	16.1	16.1	10.7	12.1	9.8	18.3	13.3	12.3	13.9	16.2	14.4	10.1	18.3	37.8	36.8	31.0	35.4	25.7	24.3	15.1	52.5	33.6	53.4	39.6	88.4	48.4	79.9	33.1	44.5	29.7	30.3	60.5	62.2	53.7	31.9	41.8	39.9	37.6	35.8	41.8	49.3	25.4	30.5	30.6	84.4	67.4	29.1	41.3	39.3	72.6	17.6	38.4	48.0	48.8	22.2	27.2	28.3	42.4	41.3	37.1	40.1	48.5	28.6	36.5	35.6	48.9	42.1	58.0	26.6	27.0	17.0	43.4	24.9	34.0	46.4	35.0	21.6	32.5	114.3	26.5	45.7	38.5	1.8	11.2	8.6	15.2	9.1	11.7	16.6	10.3	13.5	10.6	15.8	10.7	13.0	1.4	17.5	12.3	12.4	16.2	10.5	15.0	18.0	19.7	16.5	14.9	17.2	17.4	18.7	17.5	16.1	18.3	18.3	26.9	44.8	34.3	3.3	23.5	34.4	39.0	43.8	30.1	21.1	20.5	25.0	23.7	32.9	36.6	18.4	108.4	91.1	22.8	12.6	37.2	46.5	32.0	22.4	31.6	34.0	34.2	15.6	6.5	39.1	64.9	25.1	20.9	23.8	24.7	35.6	31.4	31.0	41.8	20.2	8.3	17.3	28.5	22.9	13.8	73.2	30.1	17.0	10.6	3.7	37.4	23.3	28.8	5.0	6.9	49.1	10.6	32.4	19.3	48.1	25.0	57.8	26.0	34.0	19.7	29.9	26.9	35.7	28.4	32.0	40.6	66.4	18.5	43.9	27.9	38.9
DIPK1A	"FAM69A, FLJ23493"	ENSG00000154511	"Divergent protein kinase domain 1A"	Q5T7M9	1	92832737-92961522	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 30.6;Syncytiotrophoblasts: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015718, HPA017281"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA015718: AB_1848405, HPA017281: AB_1848406"	"prognostic favorable (8.96e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (1.26e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.66e-2)"	18.8	4.2	20.2	14.5	23.3	10.0	9.9	22.3	29.5	7.8	14.6	15.2	11.7	15.7	4.7	12.0	9.5	14.6	6.7	20.4	21.2	7.9	32.8	6.0	14.9	21.7	20.6	7.5	4.5	15.1	3.9	16.9	22.3	11.8	15.9	8.3	7.5	13.8	11.3	7.4	11.0	25.5	23.1	10.6	11.9	8.6	20.9	16.1	8.0	7.5	12.2	14.8	6.2	31.0	11.2	12.6	4.6	11.5	17.6	33.5	5.9	33.9	69.0	18.6	37.8	6.7	2.3	38.3	6.0	62.1	38.0	13.6	0.9	25.3	30.5	15.7	12.2	1.2	9.2	17.1	6.3	3.4	2.1	19.6	19.8	40.8	9.7	31.8	0.3	22.7	13.4	37.7	24.1	4.0	12.4	3.1	8.6	18.4	4.6	11.4	36.2	11.5	2.6	11.2	11.8	9.5	9.7	9.2	12.7	10.6	4.3	1.1	1.3	22.1	17.0	43.0	12.0	57.7	60.2	44.0	10.4	2.2	2.0	0.1	1.8	0.1	19.3	0.9	15.5	43.4	22.3	15.5	8.6	26.9	25.6	22.2	0.5	24.2	0.6	14.1	21.9	12.3	20.2	23.3	22.3	29.5	20.4	21.2	21.7	20.6	22.3	23.1	20.9	31.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	30.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	25.3	0.7	0.0	0.0	0.0
DMAP1	"DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4"	ENSG00000178028	"DNA methyltransferase 1 associated protein 1"	Q9NPF5	1	44213455-44220681	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028419, CAB033018, HPA069527"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB033018: AB_2230431, HPA028419: AB_2672597, HPA069527: "	"unprognostic (1.91e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	19.3	53.8	31.7	13.2	32.3	14.6	20.6	32.4	37.4	22.8	30.1	21.1	13.5	20.3	9.7	18.9	20.0	11.7	26.5	32.6	31.0	26.0	28.7	17.9	16.9	30.9	31.2	26.6	33.9	25.5	25.1	14.6	31.0	24.3	11.7	19.5	21.3	13.2	36.1	21.3	22.0	10.7	30.2	27.6	24.2	25.2	32.0	20.9	23.4	25.2	14.4	21.6	19.5	32.8	21.1	22.2	30.6	16.0	15.5	14.6	35.0	18.3	24.4	43.3	37.2	35.7	25.9	31.5	24.1	29.7	16.9	17.0	27.4	23.6	22.8	25.0	44.3	29.0	41.2	36.2	28.0	28.7	21.2	23.0	25.8	35.8	20.5	27.9	28.3	29.5	20.6	28.2	25.7	24.5	40.4	35.9	43.6	10.8	27.0	40.5	30.8	34.5	23.1	26.2	28.0	23.3	34.4	24.3	35.8	29.1	20.1	32.8	27.5	12.2	36.5	28.5	37.6	33.9	21.8	25.4	23.1	28.2	20.6	45.0	23.1	23.1	30.8	20.9	31.9	27.7	31.2	32.2	24.0	28.3	27.8	27.5	9.9	43.8	17.6	19.2	37.5	24.6	31.7	32.3	32.4	37.4	32.6	31.0	30.9	31.2	31.0	30.2	32.0	32.8	23.4	32.1	23.8	11.1	23.6	19.2	25.9	36.4	19.4	43.0	18.6	22.2	22.8	18.6	24.5	11.0	25.0	72.6	30.9	32.8	29.4	31.9	41.9	15.4	14.1	23.9	54.4	25.7	10.4	41.5	34.4	20.5	28.5	14.8	27.3	38.1	23.6	19.1	32.6	23.5	12.1	32.0	44.7	22.3	12.7	69.2	18.0	15.4	17.8	4.7	26.3	46.3	25.7	9.0	9.6	22.9	38.6	17.7	26.8	9.7	46.9	36.2	26.8	56.1	6.6	23.9	25.1	24.5	47.2	15.7	17.8	52.4	25.5	29.3	29.8	16.3
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133342-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 388.1;Spermatocytes: 229.6;Syncytiotrophoblasts: 323.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	7.1	3.9	0.9	16.9	2.9	23.1	7.0	11.7	3.1	9.1	0.0	6.9	6.6	7.3	3.1	7.7	6.5	6.2	4.8	2.1	6.6	3.0	3.9	7.8	26.2	3.8	4.5	5.6	3.6	4.3	4.5	26.0	5.7	4.5	6.8	7.5	5.6	4.6	5.3	7.9	7.9	8.8	0.3	8.1	6.3	12.4	3.3	20.6	6.3	5.0	24.9	7.3	6.4	10.6	77.0	40.6	49.5	45.8	24.6	24.0	138.8	52.4	43.9	77.5	74.9	50.6	40.8	138.3	33.8	30.0	38.6	46.6	68.4	44.2	68.4	57.5	100.9	181.5	39.5	27.1	9.6	91.5	73.4	11.5	9.3	68.5	24.1	18.4	39.9	37.6	75.0	82.8	63.3	37.6	109.2	50.4	87.5	38.3	76.6	117.1	67.9	77.2	21.5	49.3	64.5	41.5	58.2	26.2	16.5	33.6	28.9	42.2	31.8	111.3	42.2	73.0	84.4	49.6	69.5	166.8	35.0	68.5	87.1	20.3	21.2	5.9	29.8	22.0	25.1	14.2	22.8	20.4	19.3	20.0	25.5	20.5	4.6	42.6	13.8	31.9	21.9	12.6	0.9	2.9	11.7	3.1	2.1	6.6	3.8	4.5	5.7	0.3	3.3	10.6	36.4	6.4	26.5	12.7	38.0	29.6	20.7	26.8	21.1	86.7	32.6	29.6	14.6	7.2	28.2	22.0	56.3	388.1	54.4	29.0	13.7	26.0	46.1	48.1	42.0	38.9	15.7	109.6	17.6	14.3	73.2	33.6	33.6	60.3	37.2	43.6	25.0	14.8	76.8	65.6	22.6	25.5	38.7	31.4	47.8	50.8	28.0	57.9	14.2	15.0	52.5	32.2	123.6	14.6	20.1	21.1	11.3	28.6	73.4	16.3	4.5	9.3	42.8	50.2	13.1	22.6	32.8	229.6	145.3	41.6	22.4	323.7	70.4	38.7	43.1	16.6
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.2;testis: 4.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Erythroid cells: 16.4;Extravillous trophoblasts: 17.2;Spermatogonia: 11.7;Syncytiotrophoblasts: 6.2"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 7.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.3"	"Group enriched"	"Detected in some"	4	"HAP1: 89.7;NTERA-2: 327.5;SuSa: 120.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	12.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	89.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	327.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.5	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	22.3	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	16.4	0.1	0.0	17.2	0.5	0.0	0.0	1.3	0.0	0.4	1.6	1.7	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.7	0.0	0.0	0.9	0.3	0.3	11.7	0.0	0.0	6.2	0.5	0.2	0.0	0.3
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 56.9;placenta: 72.6"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 1171.5;Distal tubular cells: 727.8;Syncytiotrophoblasts: 1735.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Hep G2: 372.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.0	4.1	0.0	3.3	0.0	0.2	1.7	3.8	0.1	1.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	4.0	1.9	56.9	1.1	0.0	0.0	2.1	2.5	0.8	0.5	0.7	0.0	72.6	2.2	0.1	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	1.9	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.7	0.1	2.6	1.6	0.8	0.1	32.6	0.0	0.0	10.3	0.1	0.0	0.0	0.0	6.5	2.0	0.0	15.8	0.0	1.2	7.5	39.9	1.0	0.0	1.1	7.3	0.0	3.0	372.7	0.0	0.0	5.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	9.7	0.0	0.0	2.1	0.1	0.8	1.1	1.8	14.8	0.0	0.0	0.0	0.1	9.4	0.4	1.2	2.3	2.8	1.6	0.9	0.6	3.9	0.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.3	1.7	3.8	4.0	1.9	2.1	2.5	2.2	1.9	2.8	2.6	0.0	0.0	0.0	3.6	0.5	0.6	1.0	0.6	2.8	0.0	0.2	3.4	2.3	1.5	0.0	11.0	0.0	1171.5	0.0	0.0	727.8	0.1	0.0	0.1	0.1	3.1	0.0	0.0	0.7	0.0	84.0	6.1	0.0	0.0	0.0	3.8	0.0	0.9	84.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	0.0	0.8	0.0	3.2	0.4	0.0	0.0	0.0	0.4	0.8	8.9	0.2	0.0	1735.1	0.2	10.8	0.1	1.1
ECH1	HPXEL	ENSG00000104823	"Enoyl-CoA hydratase 1"	Q13011	19	38815422-38831841	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 749.9;skeletal muscle: 906.9"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 796.9;Proximal tubular cells: 880.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002907, HPA005835"	Supported	Supported	Supported	Mitochondria		No	No		720000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA002907: AB_1847964, HPA005835: AB_1847965"	"unprognostic (1.91e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.73e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.54e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.74e-2)"	216.0	343.0	51.2	47.6	53.7	62.3	194.2	54.1	60.3	124.9	58.6	232.9	93.5	115.3	32.3	168.4	114.0	66.8	749.9	49.3	52.5	271.6	556.1	122.1	67.8	51.8	51.8	107.2	141.4	56.0	77.1	67.1	53.4	99.5	99.9	12.8	138.6	43.3	906.9	149.0	167.4	59.7	50.6	192.3	180.5	100.7	55.0	51.0	117.9	455.1	65.7	142.4	132.4	53.3	64.0	273.8	42.0	68.8	161.0	82.0	61.8	31.7	53.2	26.6	27.1	178.8	124.8	98.6	117.2	72.8	24.1	30.1	70.9	72.9	21.1	345.3	37.7	120.7	76.5	146.1	161.3	131.9	116.9	109.0	186.6	35.1	61.2	52.3	63.4	127.3	58.4	160.8	59.6	120.0	91.8	82.2	27.8	278.8	65.9	101.8	126.2	199.0	168.7	142.6	51.4	67.2	161.0	77.1	86.5	27.3	106.4	288.4	53.7	45.5	39.3	46.5	29.6	121.0	153.2	96.4	71.4	164.9	90.7	316.1	312.9	268.0	253.6	248.2	237.2	368.4	243.5	249.1	308.6	361.3	216.5	242.4	41.6	342.7	212.8	221.5	391.8	541.8	51.2	53.7	54.1	60.3	49.3	52.5	51.8	51.8	53.4	50.6	55.0	53.3	125.4	86.6	104.7	13.1	111.1	82.2	220.0	320.8	80.8	22.4	124.0	143.8	302.7	205.9	203.2	145.3	16.7	796.9	103.4	257.7	510.6	195.4	64.5	95.7	56.9	96.4	189.2	99.9	7.1	90.1	370.6	104.1	112.7	77.0	120.9	177.6	90.7	549.4	277.6	37.0	8.6	298.9	193.3	99.0	85.2	56.7	130.8	97.5	145.9	8.4	205.1	53.0	113.3	7.1	16.0	97.0	257.5	143.0	122.1	100.1	383.0	880.0	182.6	21.4	78.9	88.4	119.7	73.3	51.3	121.6	90.8	580.9	118.6	624.2	350.0	218.1
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 367.7;Cytotrophoblasts: 1365.8;Fibroblasts: 309.7;Syncytiotrophoblasts: 889.6"	"Cancer enhanced"	"Detected in all"		"glioma: 94.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 953.6;hTERT-RPE1: 2226.5;HUVEC TERT2: 4270.9;TIME: 3554.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA		1900000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-5)"	240.5	55.7	57.0	57.2	82.8	0.2	115.3	57.1	88.8	54.9	180.7	74.6	22.5	73.2	128.4	51.5	134.8	140.4	187.8	47.5	75.6	57.4	12.9	150.1	27.2	80.8	121.1	175.1	29.2	17.6	22.6	329.7	65.5	58.4	91.0	42.8	87.7	161.2	14.7	55.2	45.3	93.5	72.2	42.4	46.9	8.0	71.0	16.8	139.1	93.8	21.2	203.9	77.3	71.9	358.4	3.1	8.5	0.3	320.9	217.1	0.8	208.1	233.7	25.2	20.5	0.0	18.0	0.5	140.4	234.3	22.1	323.4	1.6	234.6	8.9	1.0	1.0	0.3	87.4	0.2	843.2	0.3	0.6	953.6	117.5	21.9	260.9	2226.5	4270.9	0.5	1.2	0.2	99.2	36.7	2.6	0.5	4.2	0.1	0.8	0.2	0.3	0.9	9.8	7.3	2.0	0.4	284.6	105.0	0.7	8.1	289.8	1.5	3554.3	1.5	107.5	397.9	138.5	13.7	0.5	1.4	73.1	0.3	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	82.8	57.1	88.8	47.5	75.6	80.8	121.1	65.5	72.2	71.0	71.9	26.6	250.0	109.1	234.1	0.1	79.4	79.1	367.7	42.1	2.8	6.2	78.2	12.5	12.8	98.2	27.6	0.0	1365.8	0.4	0.0	9.8	36.2	0.5	2.2	38.9	73.5	0.0	0.0	1.0	25.6	173.0	309.7	6.1	2.1	2.5	3.9	48.5	0.7	94.9	0.0	4.7	0.0	40.7	0.8	33.9	0.9	42.6	3.2	17.8	6.5	0.6	137.3	0.0	2.5	0.8	2.8	0.0	0.0	1.5	24.2	0.0	14.7	88.8	4.7	0.0	7.0	28.7	0.4	1.8	6.0	31.7	889.6	5.0	61.3	0.0	6.2
EID2	"CRI2, EID-2, MGC20452"	ENSG00000176396	"EP300 interacting inhibitor of differentiation 2"	Q8N6I1	19	39538707-39540161	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045477	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA045477: AB_10959785"	"unprognostic (5.91e-2)"	"unprognostic (6.37e-3)"	"prognostic favorable (9.73e-4)"	"unprognostic (5.93e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (6.88e-3)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.51e-1)"	10.5	17.9	13.3	8.8	14.5	6.4	8.5	13.3	19.5	7.7	11.9	9.1	6.8	11.0	8.1	9.2	8.4	6.2	10.1	14.3	15.6	12.6	10.8	8.4	9.1	13.8	11.8	8.4	7.8	12.6	13.0	14.3	14.1	9.0	6.6	15.7	7.7	8.0	11.1	7.4	9.0	9.8	12.5	9.5	8.8	9.0	12.8	14.2	8.3	10.4	8.4	7.8	6.5	12.6	25.0	33.4	31.1	21.2	24.7	15.3	4.6	29.3	22.0	22.5	23.2	21.2	7.7	25.4	23.5	20.6	15.1	10.5	29.0	21.3	29.0	24.6	36.5	11.4	19.1	25.5	24.5	19.9	16.1	18.0	13.3	18.7	14.4	17.8	26.6	49.0	18.8	17.2	19.8	16.5	29.0	17.5	17.4	30.1	14.0	26.6	29.7	11.9	28.9	22.8	29.0	20.6	31.8	12.6	21.0	20.9	17.1	12.9	19.2	14.3	51.0	19.1	22.3	26.9	33.8	32.1	13.3	18.5	11.8	0.0	0.4	0.7	0.8	0.5	0.8	0.5	1.0	1.0	0.5	0.5	1.0	1.4	0.1	0.3	0.5	0.5	0.2	0.4	13.3	14.5	13.3	19.5	14.3	15.6	13.8	11.8	14.1	12.5	12.8	12.6	16.4	19.2	9.2	2.6	7.3	10.1	4.5	2.4	6.2	23.9	11.2	15.6	19.1	17.2	4.0	14.7	10.4	48.9	14.0	6.5	1.9	5.2	3.2	18.3	23.3	14.4	7.2	4.2	7.4	5.0	5.3	10.0	5.1	12.4	1.3	14.4	13.2	12.9	10.8	26.9	8.0	5.3	0.0	8.1	6.5	1.3	10.2	7.8	8.8	3.7	7.5	31.1	12.3	5.0	8.6	6.2	7.4	13.2	7.2	5.3	5.9	9.5	5.5	20.7	6.6	9.7	12.7	11.3	8.8	5.2	7.5	19.4	11.3	25.2	7.5	2.6
EIF2B1	"EIF-2B, EIF-2Balpha, EIF2B, EIF2BA"	ENSG00000111361	"Eukaryotic translation initiation factor 2B subunit alpha"	Q14232	12	123620406-123633766	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034258, HPA049509"	Approved		Approved	Cytosol		NA	NA		16000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB034258: AB_2095995, HPA049509: AB_2680797"	"unprognostic (2.14e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.65e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.78e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.40e-2)"	32.9	32.1	23.5	33.0	25.7	36.4	31.5	27.8	27.9	33.1	23.9	33.2	27.6	34.0	29.5	33.8	31.1	22.0	26.3	24.8	23.7	28.7	29.0	24.4	40.4	25.4	23.8	34.1	32.9	21.7	28.2	31.0	27.4	29.4	30.8	23.5	28.8	26.2	43.1	51.1	29.2	31.5	23.9	33.4	28.7	22.6	25.7	30.0	27.4	27.3	43.1	32.5	31.2	32.2	55.6	47.9	50.0	53.1	45.8	46.2	52.5	66.8	38.2	64.3	46.7	62.8	34.0	104.2	77.3	51.1	28.6	54.3	79.0	52.0	67.3	85.4	87.8	74.9	68.3	55.6	43.3	106.9	90.2	42.0	63.3	55.4	38.9	54.0	59.6	66.8	136.4	34.2	60.2	50.4	86.1	113.3	82.4	59.5	64.1	89.5	61.1	79.2	43.2	46.0	61.9	69.9	49.4	48.7	63.3	46.7	88.5	63.2	56.8	43.8	52.9	63.2	62.4	90.9	102.1	153.6	63.6	71.7	63.9	113.2	87.3	119.3	56.3	104.2	51.3	60.1	57.2	58.9	95.7	53.2	58.0	53.9	9.8	64.8	101.6	59.9	73.2	100.7	23.5	25.7	27.8	27.9	24.8	23.7	25.4	23.8	27.4	23.9	25.7	32.2	29.0	16.0	19.6	10.7	29.3	20.4	17.5	28.3	24.5	19.8	16.0	17.3	20.0	25.8	19.0	18.4	8.4	69.0	33.8	18.3	29.4	33.0	7.6	15.0	28.3	26.0	21.7	21.9	23.4	40.1	58.8	23.6	15.3	14.2	41.2	24.4	22.1	13.1	37.8	16.8	21.2	15.4	18.3	18.6	18.5	5.3	25.1	26.0	19.6	14.0	30.6	34.4	35.0	16.1	21.9	32.8	23.8	16.6	30.7	14.8	26.1	23.9	14.3	21.6	32.9	18.5	29.8	49.2	38.7	27.3	20.5	51.6	26.7	29.3	21.7	14.6
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12991612-13018065	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 394.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Supported	Nucleoplasm		NA	NA		9500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	30.7	35.8	13.7	23.0	14.6	22.7	24.6	14.7	14.3	21.7	18.0	28.7	23.1	24.7	17.1	31.9	25.8	21.1	38.1	13.8	15.0	28.6	32.5	19.8	28.0	16.4	14.6	19.8	23.1	33.8	12.5	23.5	15.3	26.4	32.7	22.5	20.4	33.6	60.2	23.8	21.1	33.6	17.1	28.8	24.8	28.1	13.4	28.4	25.8	35.7	37.6	24.6	18.2	22.1	76.4	102.1	69.8	81.5	53.3	53.9	44.9	75.4	59.6	119.8	79.8	84.3	34.8	127.7	84.9	69.9	45.0	96.6	133.6	80.6	113.5	65.7	163.7	73.0	82.1	54.7	40.7	64.7	99.4	47.3	70.6	88.2	80.5	51.4	88.3	71.5	108.0	34.8	88.7	58.0	112.0	58.3	62.2	132.9	80.7	84.1	122.2	82.2	62.0	59.2	37.5	54.6	97.4	61.0	39.2	394.4	59.1	26.2	82.7	152.3	47.6	57.0	116.3	24.7	51.6	53.3	57.6	64.2	54.6	26.9	31.1	19.2	41.6	41.2	43.4	37.7	39.1	40.7	48.4	34.4	39.7	36.2	4.7	53.5	46.8	30.1	53.4	46.3	13.7	14.6	14.7	14.3	13.8	15.0	16.4	14.6	15.3	17.1	13.4	22.1	11.6	6.4	10.8	6.8	18.0	10.3	10.1	16.7	16.5	11.3	12.5	10.8	28.3	12.8	12.9	16.5	2.1	59.3	15.6	13.2	19.6	27.4	6.4	13.0	13.1	14.1	8.4	24.0	9.8	26.0	32.6	16.6	17.3	14.2	9.5	30.4	11.7	28.4	28.2	11.8	9.2	13.5	24.4	14.2	7.0	5.7	10.5	10.0	14.2	3.7	14.7	16.1	14.4	7.1	10.6	25.9	16.6	21.4	21.6	13.5	15.2	19.5	12.2	14.6	52.6	10.1	14.9	26.4	24.4	22.2	14.5	33.5	15.9	59.0	20.7	8.2
EPN3	"FLJ20778, MGC129899"	ENSG00000049283	"Epsin 3"	Q9H201	17	50532682-50543750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;stomach 1: 37.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 77.9;Distal enterocytes: 27.6;Gastric mucus-secreting cells: 44.9;Intestinal goblet cells: 24.9;Squamous epithelial cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 28.6;HBEC3-KT: 40.3;MCF7: 66.4;OE19: 62.8;RT4: 50.2;SK-BR-3: 25.8;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055546, HPA063224"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA055546: AB_2682844, HPA063224: AB_2684964"	"unprognostic (1.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (3.52e-3)"	0.2	8.9	2.3	0.8	1.3	0.6	2.3	6.4	6.0	6.5	1.2	7.1	6.8	0.4	3.2	35.9	7.5	5.9	7.1	0.7	2.1	6.0	0.1	0.3	0.0	11.5	5.4	13.5	23.0	21.2	0.8	4.2	13.6	9.9	4.4	0.2	11.1	5.6	0.1	30.5	3.2	0.1	0.5	0.0	37.3	2.8	13.4	3.2	1.1	0.0	3.7	5.5	12.9	1.8	20.5	0.3	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	14.7	12.1	0.0	0.2	0.0	0.1	28.6	0.0	40.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.2	0.1	21.8	0.1	3.0	0.0	0.0	0.1	0.0	0.0	0.0	66.4	0.3	0.0	0.0	62.8	0.4	0.0	0.0	0.1	0.2	50.2	0.4	0.0	0.0	25.8	0.0	0.4	57.4	0.2	1.5	0.3	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.3	6.4	6.0	0.7	2.1	11.5	5.4	13.6	0.5	13.4	1.8	0.2	0.0	0.0	0.0	0.4	2.3	4.4	4.1	10.8	2.9	6.5	3.4	5.4	8.6	8.3	18.4	0.0	77.9	0.0	27.6	5.9	9.2	1.0	3.8	0.6	0.4	3.6	0.0	1.0	11.5	7.4	0.8	44.9	5.5	0.0	3.1	0.0	0.0	5.9	0.0	1.7	24.9	2.0	0.0	0.0	2.1	2.8	0.5	0.0	1.0	0.6	0.6	0.0	0.0	0.0	3.4	10.3	0.0	1.3	4.9	2.1	0.3	4.3	0.9	0.0	0.0	0.8	0.0	0.5	30.0	5.5	10.7	0.2	12.4	19.3	7.8
ETV7	"TEL-2, TEL2"	ENSG00000010030	"ETS variant transcription factor 7"	Q9Y603	6	36354091-36387800	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.0;skin 1: 15.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Cytotrophoblasts: 28.8;Exocrine glandular cells: 23.8;Proximal enterocytes: 21.5;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.9;T-reg: 16.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 18.9;monocytes: 5.7;T-cells: 16.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 27.1;BJ hTERT+ SV40 Large T+: 14.7;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HDLM-2: 59.7"					"Low region specificity"	"Detected in all"			HPA029033	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA029033: AB_10601375"	"unprognostic (1.67e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (9.48e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-3)"	"unprognostic (9.08e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.32e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.27e-2)"	"prognostic favorable (2.95e-6)"	1.9	2.1	1.5	6.9	1.5	0.9	2.1	1.0	1.7	2.1	1.4	3.3	16.0	1.0	1.3	3.6	2.2	3.4	0.4	1.5	1.4	2.3	2.9	4.9	5.3	2.2	1.2	1.5	1.6	2.2	3.8	3.6	2.1	2.9	2.6	0.4	8.6	1.5	0.2	15.4	12.7	1.0	2.1	3.1	6.2	1.1	1.4	4.0	1.2	0.3	3.9	5.5	2.5	1.4	3.2	0.0	0.2	0.1	0.0	0.2	27.1	0.0	9.2	14.7	27.8	0.5	6.2	0.1	0.7	0.2	2.3	3.3	0.4	1.7	0.7	59.7	0.5	0.5	0.0	0.0	1.8	0.0	0.3	1.2	2.4	0.7	0.2	0.0	0.4	0.0	0.1	0.2	0.3	0.1	0.2	0.3	0.2	0.3	0.1	6.1	0.1	0.2	0.2	1.1	0.8	0.0	0.6	2.1	0.5	0.0	3.1	0.6	0.2	0.3	0.7	0.3	0.1	0.1	0.1	0.2	0.0	2.7	0.4	0.0	3.7	0.3	1.6	5.7	3.9	3.3	5.4	2.2	0.9	2.4	1.0	1.4	18.9	0.6	1.9	0.0	16.3	2.5	1.5	1.5	1.0	1.7	1.5	1.4	2.2	1.2	2.1	2.1	1.4	1.4	1.4	19.2	14.8	0.3	1.2	2.0	2.2	8.0	6.2	0.2	2.5	2.7	0.5	7.2	7.1	0.0	0.0	28.8	0.7	6.6	0.0	12.4	0.4	0.4	1.4	1.1	3.6	0.0	0.5	23.8	6.6	2.7	8.2	0.7	2.5	1.7	0.0	0.4	2.9	0.0	0.3	6.5	6.1	1.3	1.6	0.5	1.5	1.0	3.6	0.0	6.5	3.1	1.0	0.0	0.3	13.4	7.8	1.2	5.6	4.8	21.5	1.3	3.0	0.6	0.0	1.0	5.5	0.9	26.8	6.4	3.7	8.5	3.6	0.7	7.6	4.8
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895179	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 214.1;Theca cells: 328.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		80000000	"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: AB_2686058"	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	8.8	24.6	11.4	5.0	15.0	2.2	11.5	12.0	16.4	13.9	19.1	10.8	4.8	18.1	13.7	6.5	10.9	11.4	9.2	10.3	15.4	12.9	12.6	8.4	4.2	12.9	14.9	19.6	9.0	14.6	12.9	24.9	13.7	13.4	7.6	13.9	7.1	11.9	6.9	6.5	5.4	17.0	11.2	6.5	7.3	10.7	17.8	8.2	10.1	7.1	3.7	9.2	6.9	11.3	13.0	6.9	50.2	50.7	53.2	39.3	31.4	23.2	37.5	17.5	39.4	6.1	9.9	15.2	21.8	20.9	13.5	12.7	18.3	19.6	35.4	31.8	13.4	19.0	23.6	18.3	17.5	28.9	9.3	47.3	6.8	35.9	6.6	36.5	65.0	19.2	23.9	2.0	45.1	6.9	15.5	15.5	62.2	12.2	15.5	11.2	51.5	12.1	18.4	9.7	20.6	57.5	17.4	4.6	42.0	35.8	10.9	12.7	27.7	44.0	25.8	27.8	24.4	15.5	15.0	9.8	69.2	29.3	14.4	2.0	0.5	0.0	3.4	0.7	1.5	1.2	1.1	2.3	1.7	1.7	1.2	2.7	0.1	3.9	0.5	4.6	0.0	1.2	11.4	15.0	12.0	16.4	10.3	15.4	12.9	14.9	13.7	11.2	17.8	11.3	12.3	12.8	8.4	39.8	4.9	8.5	10.2	13.8	21.1	20.7	13.2	13.5	12.7	10.0	11.0	14.7	35.5	214.1	5.0	3.3	11.7	5.8	45.3	20.3	28.7	13.1	9.5	16.2	47.1	2.1	36.9	36.0	15.3	11.0	17.7	35.3	13.6	16.4	24.3	3.3	49.9	5.6	12.2	7.3	5.7	34.9	25.1	5.8	23.2	12.2	7.4	18.8	8.2	40.7	32.9	2.4	2.6	34.6	5.9	6.2	2.9	11.9	25.3	19.7	13.1	25.4	22.4	37.1	12.3	8.5	8.1	74.3	6.1	328.5	7.1	4.9
FADD	"GIG3, MORT1"	ENSG00000168040	"Fas associated via death domain"	Q13158	11	70203296-70207390	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 75.0;Ductal cells: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 331.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001464, CAB010209"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"CAB010209: AB_2100622, HPA001464: AB_1848348"	"unprognostic (2.08e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (6.91e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (8.22e-5)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (3.45e-4)"	"unprognostic (7.29e-2)"	9.8	13.8	10.6	14.0	10.5	8.8	13.6	10.9	10.1	13.1	10.6	14.8	14.1	12.6	17.6	14.3	13.2	12.1	8.4	9.9	10.8	14.2	16.0	10.6	16.9	12.6	10.8	12.5	8.2	9.1	6.4	15.3	11.6	9.2	12.8	4.0	11.3	13.4	10.9	12.5	13.9	10.3	11.2	13.2	14.8	5.7	11.4	20.3	11.3	9.0	16.9	11.4	9.2	11.3	331.2	54.7	26.6	24.3	31.6	25.4	23.8	55.3	43.6	47.5	31.6	47.1	52.3	48.7	51.9	37.1	44.8	47.7	26.3	49.3	36.8	45.7	28.8	22.3	30.6	24.3	28.5	28.0	28.4	25.4	34.5	51.4	64.7	38.1	45.3	26.7	37.0	24.4	42.1	48.5	34.4	49.5	42.1	75.1	89.1	26.3	64.3	47.0	46.8	24.1	23.5	22.3	41.0	38.0	117.1	30.3	41.3	30.7	51.0	36.6	35.7	56.7	53.9	33.8	27.8	28.6	53.2	28.0	52.6	37.1	36.2	28.2	41.7	38.4	47.5	38.7	44.1	48.9	37.1	33.9	44.6	40.7	88.6	37.7	45.3	33.7	45.7	36.1	10.6	10.5	10.9	10.1	9.9	10.8	12.6	10.8	11.6	11.2	11.4	11.3	7.8	0.0	5.3	0.7	12.1	11.9	14.8	18.1	6.2	6.8	14.0	15.7	0.1	14.3	7.7	18.4	0.0	75.0	9.3	22.9	21.5	55.9	0.7	7.3	11.7	15.6	2.4	19.8	1.4	34.7	37.3	10.0	12.8	10.6	1.3	13.8	14.6	8.5	31.2	3.3	1.6	14.3	0.0	11.0	8.8	2.4	13.4	10.8	32.0	2.8	20.9	10.0	18.6	0.5	1.4	49.0	15.3	16.6	9.6	11.8	24.5	33.7	5.4	4.1	0.0	5.2	14.5	10.4	14.2	14.4	10.5	30.8	13.3	18.9	17.4	14.4
FBN2	"CCA, DA9"	ENSG00000138829	"Fibrillin 2"	P35556	5	128257909-128659185	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"placenta: 81.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 298.1;Syncytiotrophoblasts: 163.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.2"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 134.1;HSkMC: 94.3;hTERT-HME1: 215.2;HUVEC TERT2: 122.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.0"	"Low region specificity"	"Detected in many"			"HPA012853, CAB026401"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		11000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"CAB026401: , HPA012853: AB_1848588"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.79e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.60e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (7.41e-5)"	0.1	5.1	0.4	0.8	0.5	3.1	0.2	0.0	0.3	2.2	3.0	0.8	0.3	1.7	0.1	0.1	0.4	0.3	5.5	0.2	0.6	0.1	0.1	0.2	0.5	1.1	1.9	0.5	0.2	0.0	0.8	81.9	0.5	0.8	1.2	0.9	0.3	0.4	0.2	0.2	0.4	1.3	0.5	0.4	0.8	7.4	0.8	0.2	0.5	0.4	0.9	0.5	0.7	0.3	0.0	16.4	58.2	0.0	9.4	16.6	11.8	62.8	0.0	56.0	41.8	0.2	0.0	0.0	0.1	85.5	0.0	9.2	37.6	9.8	52.7	0.1	13.8	0.0	27.3	0.2	134.1	8.4	0.0	94.3	5.3	24.1	215.2	17.9	122.3	0.0	0.0	0.0	35.8	0.1	0.0	3.4	24.5	0.0	18.2	19.2	18.1	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.6	48.0	0.0	18.7	0.0	22.1	41.9	66.8	0.3	0.0	0.0	0.0	6.9	0.0	23.8	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.2	0.4	0.5	0.0	0.3	0.2	0.6	1.1	1.9	0.5	0.5	0.8	0.3	0.1	0.0	0.5	1.6	0.2	0.0	0.1	1.2	0.6	0.0	0.3	0.3	12.7	0.0	1.4	0.0	0.0	298.1	0.0	0.0	0.0	0.3	3.8	10.0	3.9	1.0	0.0	0.0	1.1	0.0	24.3	8.8	0.0	4.7	0.0	0.1	0.0	0.0	34.0	0.0	50.5	0.0	0.0	10.7	0.4	7.2	1.2	2.7	1.8	1.9	6.2	3.8	0.0	17.6	1.5	0.1	0.0	2.2	0.0	2.0	0.0	0.2	1.6	0.1	6.6	0.1	3.5	10.7	3.5	0.1	0.4	163.5	0.1	8.4	0.1	0.1
FBXO27	"Fbg5, Fbx27"	ENSG00000161243	"F-box protein 27"	Q8NI29	19	38990714-39032785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 37.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.1;Suprabasal keratinocytes: 17.8;Syncytiotrophoblasts: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 35.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA046800, HPA062242"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA046800: AB_2679813, HPA062242: AB_2684723"	"prognostic favorable (2.15e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (1.48e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.80e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.04e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.21e-2)"	13.3	3.7	17.5	2.1	15.9	2.7	6.2	23.8	18.7	6.3	6.4	6.8	2.2	4.7	2.4	15.4	5.3	5.5	19.6	15.4	8.9	6.4	7.5	3.2	3.7	10.7	6.7	10.2	4.8	2.5	4.1	3.8	9.1	8.9	8.7	4.9	7.4	7.8	1.6	37.5	4.9	7.4	4.9	3.1	3.8	4.7	11.1	4.0	4.6	2.4	4.0	7.7	9.7	13.1	9.1	11.4	0.3	7.2	15.3	0.8	3.3	1.2	6.7	5.2	4.9	3.8	3.4	0.9	17.5	10.3	9.0	15.5	0.6	6.6	3.4	0.8	0.4	0.3	3.0	0.6	2.7	0.9	2.5	5.5	10.2	5.4	0.4	8.2	3.3	0.4	5.4	1.2	7.2	8.1	0.6	1.4	8.1	3.0	20.4	0.2	0.1	1.1	3.4	35.3	0.4	10.8	17.7	2.2	0.1	4.8	9.2	1.7	4.0	0.5	0.4	0.3	0.9	3.5	8.9	1.9	9.0	0.2	0.3	1.1	0.3	0.2	0.3	0.3	0.2	0.4	0.2	0.2	0.2	0.6	0.4	0.3	1.7	1.7	0.2	0.5	0.3	0.2	17.5	15.9	23.8	18.7	15.4	8.9	10.7	6.7	9.1	4.9	11.1	13.1	0.2	3.2	15.0	2.3	0.1	5.9	4.1	1.4	9.1	7.5	3.8	4.2	9.5	7.2	6.4	1.8	0.0	36.1	0.5	0.2	1.9	1.5	3.7	1.9	3.6	3.2	0.0	0.0	4.8	0.8	4.8	2.7	6.1	1.6	7.6	2.3	1.4	3.2	4.9	8.4	4.6	0.2	8.2	0.3	4.9	2.5	2.8	2.1	0.0	1.0	1.1	5.6	0.0	3.0	4.1	0.3	0.0	4.1	1.9	2.3	6.9	7.3	4.7	3.0	0.0	1.8	1.5	6.4	2.0	13.5	17.8	27.0	1.3	0.4	0.2	5.3
FLOT2	"ECS-1, ECS1, ESA, ESA1, M17S1"	ENSG00000132589	"Flotillin 2"	Q14254	17	28879335-28897733	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001396, CAB004395, HPA071038"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		170000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: "	"unprognostic (6.04e-2)"	"unprognostic (8.76e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.15e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.20e-2)"	60.2	46.4	38.4	56.8	38.6	97.1	56.2	28.1	47.6	42.8	45.2	58.9	21.0	39.1	21.2	69.3	46.8	27.0	63.5	41.1	42.5	71.4	98.4	59.5	68.2	45.9	37.1	37.7	38.8	30.0	22.3	58.4	41.3	67.8	27.2	20.3	61.7	51.6	51.6	38.2	53.0	35.3	37.5	122.7	44.6	10.4	47.1	47.8	39.6	44.1	63.6	78.8	49.6	36.1	55.5	90.8	69.6	60.2	33.6	44.2	76.6	42.5	57.9	60.9	71.3	96.0	45.7	76.9	79.3	47.6	42.0	63.3	76.5	69.7	25.9	245.5	91.4	92.7	80.5	70.3	43.6	76.8	15.2	53.3	53.6	49.3	66.9	64.1	97.4	21.8	89.0	65.6	28.9	83.5	21.2	54.0	61.4	48.6	24.6	32.6	70.6	189.3	92.0	166.9	61.9	103.3	99.8	69.6	77.5	66.7	72.3	136.3	81.5	21.4	38.2	35.2	65.0	36.5	68.2	39.5	59.9	72.3	40.7	171.9	106.0	213.2	98.8	96.6	72.6	98.5	74.6	84.5	144.3	118.1	55.3	69.0	415.2	78.5	110.2	38.8	97.6	143.2	38.4	38.6	28.1	47.6	41.1	42.5	45.9	37.1	41.3	37.5	47.1	36.1	34.2	22.4	21.9	12.7	46.8	12.6	27.1	20.6	29.6	6.9	24.9	30.1	32.9	22.8	16.5	20.2	10.4	96.6	20.5	29.0	15.6	39.3	13.0	25.8	13.2	37.0	25.8	49.2	17.0	31.1	68.9	14.8	23.0	27.6	6.3	15.6	48.9	45.1	44.4	5.0	19.2	25.9	10.2	43.3	22.6	42.3	10.8	31.1	8.8	22.5	75.2	10.7	35.0	16.1	11.0	32.2	16.5	8.6	27.8	14.8	14.8	26.7	19.1	12.4	19.7	7.1	13.4	1.6	6.9	42.4	9.2	37.1	32.5	4.2	32.0	26.7
FN3KRP	"FLJ12171, FN3KL"	ENSG00000141560	"Fructosamine 3 kinase related protein"	Q9HA64	17	82716706-82730328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056172, HPA065831"	Approved		Approved	Nucleoplasm		NA	NA		44000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA056172: AB_2683055, HPA065831: AB_2685565"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-2)"	23.2	22.1	40.6	13.3	43.7	18.8	19.7	43.3	41.3	23.4	35.1	22.9	15.3	23.1	19.4	20.4	20.4	16.6	16.1	41.1	41.7	23.9	29.3	16.3	18.5	42.5	41.6	32.1	19.3	18.4	17.2	21.8	43.2	20.8	18.0	17.8	22.2	23.2	11.4	23.6	19.4	22.1	42.9	20.9	20.6	13.7	41.7	16.6	16.7	10.6	22.8	19.7	20.7	48.3	31.4	122.3	33.6	44.5	15.9	30.3	27.2	56.9	31.8	54.5	44.3	64.9	21.8	25.6	37.0	46.6	50.5	35.3	30.1	43.5	48.7	17.2	54.3	42.6	66.2	77.5	28.3	30.7	23.2	27.8	50.9	51.7	28.1	33.4	39.8	35.9	42.5	15.8	70.7	59.8	58.8	45.2	15.2	68.7	53.5	44.0	83.4	40.3	38.9	58.7	27.6	58.1	93.7	42.7	47.3	57.4	69.8	43.6	34.8	103.3	35.9	74.2	85.3	32.1	37.8	64.8	48.1	38.2	49.0	32.0	21.9	30.6	29.6	24.7	29.5	23.9	28.8	28.8	18.2	24.8	32.5	24.3	3.4	32.1	13.8	36.0	29.7	26.0	40.6	43.7	43.3	41.3	41.1	41.7	42.5	41.6	43.2	42.9	41.7	48.3	14.3	12.8	11.1	5.5	13.9	15.0	26.0	26.0	15.4	18.1	13.3	15.6	6.9	25.8	15.3	11.0	8.4	100.3	20.0	12.2	23.5	20.6	2.0	10.7	13.0	14.8	7.8	31.2	7.6	11.1	45.3	18.1	13.3	22.3	13.3	18.6	10.8	12.1	33.8	3.3	6.7	15.4	22.4	11.2	11.3	4.2	28.3	12.8	23.2	6.5	20.9	36.1	17.5	5.0	11.8	17.8	15.9	31.6	27.6	15.5	11.1	28.2	10.0	18.5	13.1	13.6	20.9	18.3	36.2	18.0	15.3	62.5	17.2	22.3	15.6	24.0
FNTA	"FPTA, PGGT1A, PTAR2"	ENSG00000168522	"Farnesyltransferase, CAAX box, alpha"	P49354	8	43034194-43085788	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010149, HPA018830"	Approved		Approved	Cytosol		NA	NA		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB010149: AB_2106299, HPA018830: AB_1848992"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.70e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (2.94e-12)"	"unprognostic (3.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-3)"	53.6	33.4	57.7	26.3	69.3	26.8	46.1	74.0	74.0	41.3	52.7	46.3	35.9	34.0	43.2	45.4	33.4	27.1	48.1	54.2	63.7	37.4	47.2	34.7	45.5	75.1	64.8	33.0	43.9	34.3	36.6	50.0	73.6	38.3	32.5	33.8	36.5	34.1	74.3	51.0	32.9	31.4	73.2	36.7	35.4	26.9	61.9	39.9	31.6	64.7	44.2	40.9	43.1	87.6	78.8	37.5	50.9	16.7	88.6	112.5	43.4	44.9	52.4	50.1	46.3	62.1	56.9	88.5	35.5	54.1	67.6	41.9	63.1	71.5	59.4	26.2	42.2	70.9	25.5	54.2	112.7	30.4	35.8	87.6	119.0	36.3	104.2	74.4	89.4	47.9	86.1	50.4	58.5	9.9	72.3	47.1	91.3	66.4	27.1	63.1	83.0	47.8	70.5	58.4	29.7	47.4	56.6	47.3	78.9	59.1	59.1	55.3	69.9	17.9	22.1	68.6	48.0	47.7	46.2	89.2	43.0	56.4	41.3	3.1	7.7	14.3	9.5	10.7	11.3	14.1	9.7	12.6	13.3	15.2	12.9	12.9	4.3	16.1	7.8	12.6	14.3	6.4	57.7	69.3	74.0	74.0	54.2	63.7	75.1	64.8	73.6	73.2	61.9	87.6	68.7	57.7	20.3	33.0	57.4	87.7	82.3	55.3	58.1	22.5	35.5	34.8	44.9	34.3	41.2	33.1	37.5	135.6	69.1	29.6	70.5	73.0	41.2	40.7	55.1	55.8	32.2	38.9	27.9	70.1	124.4	58.7	28.5	46.2	32.4	58.6	56.0	25.9	80.5	20.2	31.9	39.6	34.6	47.5	60.7	52.8	48.1	49.2	94.3	33.7	75.7	42.8	69.0	25.6	79.8	69.4	41.2	60.2	40.8	109.3	67.0	54.8	46.7	57.5	52.6	56.2	47.2	65.9	37.1	73.9	95.6	207.6	60.4	69.6	49.1	76.6
FOXI3		ENSG00000214336	"Forkhead box I3"	A8MTJ6	2	88446787-88452693	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"placenta: 5.2;retina: 2.0"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 3.3;Muller glia cells: 6.4;Syncytiotrophoblasts: 2.7"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 10.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 43.2;SuSa: 55.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (2.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.72e-4)"		"unprognostic (8.11e-3)"		"unprognostic (1.36e-1)"		"unprognostic (6.58e-2)"				"unprognostic (5.29e-2)"	"unprognostic (1.15e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	5.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.5	0.0	0.0	0.0	55.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.5	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0
FOXO4	"AFX1, MLLT7"	ENSG00000184481	"Forkhead box O4"	P98177	X	71095851-71103532	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 116.5"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 260.7;Syncytiotrophoblasts: 307.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	6	"BEWO: 159.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039560, HPA040232"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"	Cytosol	"HPA039560: AB_2676572, HPA040232: AB_2676894"	"unprognostic (4.64e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.16e-2)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.75e-3)"	15.8	33.6	73.9	6.5	80.6	22.0	13.9	58.9	68.7	12.9	43.1	22.1	11.0	17.1	16.4	12.0	17.6	9.4	18.2	58.3	61.8	9.4	7.2	10.0	7.1	71.7	70.5	23.2	12.7	16.0	7.0	116.5	65.3	14.3	8.0	7.5	16.7	19.2	67.3	15.1	14.3	8.2	62.3	13.9	13.5	17.3	68.8	14.5	10.9	49.4	6.4	17.2	13.2	81.6	4.6	1.2	3.4	4.9	7.9	5.7	159.1	3.4	3.9	1.8	4.5	3.3	6.5	5.9	4.7	4.5	1.9	2.1	8.8	4.2	2.2	6.0	13.7	8.5	27.3	5.0	4.8	4.9	6.9	5.1	9.7	1.7	1.1	7.9	4.7	8.4	17.5	12.5	0.8	0.9	8.6	8.0	16.9	11.5	5.6	5.7	8.5	10.1	3.0	2.6	2.8	7.3	7.1	1.1	8.3	24.7	1.9	3.1	4.3	1.1	2.3	8.3	0.8	7.7	4.3	1.0	4.3	13.6	1.3	0.0	0.1	1.0	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.1	0.4	0.9	0.2	0.1	0.0	0.3	0.3	73.9	80.6	58.9	68.7	58.3	61.8	71.7	70.5	65.3	62.3	68.8	81.6	10.1	0.0	2.7	0.3	3.8	5.4	3.9	0.6	9.1	1.3	8.2	7.7	6.6	5.7	1.5	9.2	4.2	260.7	6.5	20.6	1.9	2.7	0.3	3.2	2.8	6.1	6.1	17.7	0.8	3.0	24.3	4.0	5.1	3.1	2.5	3.1	5.0	2.9	22.3	1.7	0.8	12.2	0.0	7.1	5.2	1.4	6.8	4.4	3.6	1.0	2.6	4.4	4.1	1.0	2.2	3.1	8.6	15.4	7.3	2.5	17.1	4.4	1.5	0.8	6.6	4.0	3.8	0.6	0.4	6.0	3.4	307.8	7.0	48.3	7.4	3.8
G6PC3	UGRP	ENSG00000141349	"Glucose-6-phosphatase catalytic subunit 3"	Q9BUM1	17	44070735-44076344	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067052			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA067052: AB_2685771"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.88e-3)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.87e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.49e-2)"	56.7	97.2	64.8	22.5	67.8	16.0	55.6	70.5	79.3	47.6	88.8	42.1	28.7	55.4	63.9	37.1	45.6	23.9	61.9	65.3	77.5	75.2	26.4	42.9	19.3	74.9	86.9	44.3	56.5	66.7	95.1	25.8	96.1	59.5	18.2	17.1	48.7	40.6	54.3	26.8	39.6	23.0	67.9	45.2	51.4	55.1	72.7	15.2	71.1	26.4	12.0	48.7	37.7	72.4	40.0	231.7	73.7	128.5	77.9	58.3	55.3	45.0	86.9	96.2	64.4	97.1	62.3	88.9	62.8	95.1	65.4	67.4	53.5	92.1	44.5	46.4	86.0	49.3	142.5	182.4	84.1	46.1	59.8	77.3	44.3	93.1	62.3	59.6	79.3	35.9	51.5	109.6	72.5	112.1	22.4	71.4	99.3	48.7	133.5	45.6	48.4	207.5	137.6	93.6	92.7	83.0	49.1	57.4	59.3	82.9	158.6	45.1	87.6	98.8	53.1	26.8	63.5	74.0	56.2	26.1	110.3	38.2	128.9	3.0	33.1	7.9	9.9	43.4	12.1	12.1	8.0	9.1	54.2	13.9	9.7	12.9	1.4	17.5	26.3	74.5	8.5	16.9	64.8	67.8	70.5	79.3	65.3	77.5	74.9	86.9	96.1	67.9	72.7	72.4	22.3	3.2	12.9	5.2	10.4	2.5	17.3	31.8	8.0	10.5	20.7	21.5	6.4	21.5	25.2	40.5	12.5	64.3	17.1	12.4	13.7	59.3	5.0	18.9	22.1	26.0	22.9	9.7	2.8	49.4	41.1	25.0	16.8	20.1	18.3	20.2	18.5	7.1	58.7	5.0	4.5	14.1	24.4	21.6	12.2	6.2	20.2	20.9	14.2	0.0	21.8	30.7	10.3	8.0	5.5	33.6	13.6	23.0	27.2	19.5	20.5	36.0	24.6	8.3	13.1	15.3	21.4	31.5	26.7	14.3	2.6	42.5	7.0	43.9	19.7	17.2
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Nucleotidyltransferase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol		NA	NA		260000	"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favorable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.7	14.0	5.3	6.7	5.9	8.1	6.3	5.5	6.5	6.9	4.6	8.5	18.3	6.9	5.3	5.3	7.8	6.8	10.4	5.2	6.3	10.0	50.0	6.6	12.0	5.5	5.7	8.2	7.5	13.0	6.1	9.2	5.3	6.4	6.7	6.3	12.3	7.5	10.2	15.2	16.5	4.0	4.5	9.7	8.1	2.4	6.1	7.8	8.2	7.6	7.7	5.3	6.1	4.7	5.5	7.5	6.8	2.4	9.0	9.2	7.8	4.2	12.1	4.3	5.1	9.5	4.8	6.1	4.2	5.2	1.6	2.9	1.3	11.8	0.8	9.7	4.8	2.5	14.7	9.8	8.7	1.4	2.9	12.6	7.4	2.7	3.6	9.3	10.6	8.3	2.3	6.4	7.3	5.1	5.4	10.3	2.3	6.7	1.3	8.4	5.9	3.3	12.5	7.8	1.6	5.7	5.0	9.8	5.4	5.0	9.2	8.2	1.6	1.7	3.4	3.4	0.0	3.9	2.4	1.3	4.1	4.4	10.8	16.5	23.7	11.7	15.4	21.5	21.3	24.8	25.2	21.1	21.5	13.2	15.3	14.8	4.6	29.0	20.4	18.2	30.0	17.6	5.3	5.9	5.5	6.5	5.2	6.3	5.5	5.7	5.3	4.5	6.1	4.7	12.6	6.4	21.2	10.7	19.0	21.7	13.4	19.3	19.4	44.0	10.5	12.1	25.7	14.3	15.4	16.5	47.9	72.5	13.9	17.3	29.4	18.3	7.6	7.8	11.8	14.6	16.3	13.7	9.1	7.3	36.3	18.3	9.2	8.0	20.3	24.7	23.6	69.9	24.1	47.1	12.5	17.0	26.4	15.5	8.7	36.8	18.3	12.4	21.4	5.6	15.9	18.7	34.0	6.0	3.7	6.9	37.5	13.9	10.7	4.7	67.1	46.3	11.1	38.5	6.6	11.2	12.2	4.8	6.6	8.6	20.2	59.1	25.5	27.4	20.4	9.2
GCNT4	"C2GNT3, LINC01336"	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4"	Q9P109	5	75025346-75052558	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.0;lymphoid tissue: 15.4;stomach 1: 18.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Cytotrophoblasts: 39.6;Glandular and luminal cells: 16.7;Proximal enterocytes: 28.0;Syncytiotrophoblasts: 24.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"amygdala: 1.1;basal ganglia: 1.8;cerebral cortex: 3.3;hippocampal formation: 2.1;white matter: 1.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 22.4"	"Group enriched"	"Detected in many"	53	"granulocytes: 22.4;T-cells: 18.2"	"Cell line enriched"	"Detected in some"	5	"RT4: 37.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favorable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.9	0.8	1.1	2.9	1.8	0.7	1.3	0.0	3.3	1.4	0.0	1.4	24.0	1.2	1.9	2.2	2.1	5.3	0.4	2.1	0.0	4.1	1.1	1.7	4.4	0.0	0.0	1.0	4.6	9.6	0.2	6.3	0.0	1.7	1.3	0.1	0.5	4.8	1.0	2.1	20.2	2.3	0.0	1.7	18.5	1.6	0.0	15.4	0.5	1.4	3.0	4.1	1.8	1.4	0.3	0.2	1.4	2.3	2.5	0.8	0.1	2.8	7.2	1.5	1.2	3.7	0.2	0.0	0.4	2.2	0.8	1.0	1.4	2.5	0.3	0.0	0.1	1.2	0.3	0.3	1.1	0.0	0.0	0.4	3.9	0.1	0.5	0.0	0.0	2.2	0.0	0.5	0.2	0.0	2.1	0.1	0.6	8.0	0.0	0.0	0.0	3.6	0.3	37.1	0.0	0.1	0.3	0.0	0.1	7.0	0.0	0.0	0.0	0.8	0.2	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	22.4	0.0	0.0	1.2	0.0	5.0	0.0	11.4	3.7	0.0	0.0	11.1	8.1	0.2	0.3	0.2	0.1	18.2	2.3	1.1	1.8	0.0	3.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	3.2	5.0	0.7	0.3	0.6	8.7	0.5	0.0	0.0	0.9	2.3	0.5	32.9	2.7	12.9	0.0	39.6	0.8	4.9	9.8	7.1	0.1	11.9	2.4	1.8	0.0	0.0	1.3	4.4	0.9	2.5	14.8	16.7	7.6	2.0	3.3	0.7	2.3	0.0	0.0	2.7	0.0	0.3	0.0	0.3	4.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	6.9	2.6	0.5	3.0	28.0	0.7	0.6	0.0	6.6	1.6	2.5	0.2	1.7	0.6	0.1	24.4	3.7	0.0	4.4	4.2
GGCT	"C7orf24, CRF21, GCTG, Ggc, MGC3077"	ENSG00000006625	Gamma-glutamylcyclotransferase	O75223	7	30496621-30504841	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 414.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020735, HPA029914"	Approved					NA	Yes		2100000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA020735: AB_1845754, HPA029914: AB_10602321"	"prognostic unfavorable (7.68e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.12e-3)"	"unprognostic (2.00e-3)"	"unprognostic (9.92e-2)"	58.6	25.6	18.1	28.4	20.5	22.4	44.8	16.9	24.4	19.2	19.5	38.6	31.3	17.3	105.2	51.7	24.4	25.9	13.0	20.0	18.3	31.9	35.6	16.6	27.8	18.0	18.1	15.5	23.3	43.5	15.9	34.8	17.3	24.9	39.4	10.7	33.4	15.9	16.9	56.5	26.6	21.2	17.3	16.0	22.7	12.1	19.7	21.9	19.3	20.8	32.2	33.1	31.2	17.8	194.0	50.0	79.4	107.7	32.6	58.8	92.5	64.6	25.1	60.5	72.4	66.6	66.1	123.7	42.0	24.3	68.9	238.8	84.1	67.8	78.6	24.0	93.1	87.7	104.6	88.6	42.6	150.1	65.4	57.6	53.4	63.4	81.0	20.9	62.1	58.7	126.8	69.4	48.6	108.6	91.4	202.1	115.6	198.3	79.5	90.1	91.9	123.8	59.5	174.0	100.3	101.2	58.0	355.9	73.5	102.8	228.7	140.7	37.7	39.6	75.6	75.6	128.6	50.8	129.2	96.7	30.9	201.4	75.9	10.4	19.9	7.0	14.1	20.4	19.9	22.7	18.8	18.4	34.2	17.2	17.8	17.4	1.1	25.0	12.2	30.0	26.1	17.2	18.1	20.5	16.9	24.4	20.0	18.3	18.0	18.1	17.3	17.3	19.7	17.8	37.9	16.0	39.4	10.1	25.1	77.0	50.1	96.0	60.3	23.4	107.0	109.5	51.6	24.3	67.0	44.1	4.2	414.7	21.8	56.9	123.3	99.8	29.2	129.6	40.4	46.3	28.3	53.0	26.0	80.1	167.7	41.4	44.9	103.8	27.3	53.5	33.5	51.4	129.8	33.7	10.1	90.1	67.1	44.5	57.4	10.0	24.8	42.8	62.2	12.2	36.2	32.2	24.7	8.5	8.9	60.1	50.6	39.1	33.4	68.8	60.6	188.4	69.4	15.1	26.3	25.2	45.1	63.3	46.7	147.0	74.7	135.6	26.7	67.7	138.0	69.6
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532467-6645729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 173.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 31.3;Cytotrophoblasts: 79.0;Extravillous trophoblasts: 41.6;Hepatocytes: 120.5;Oligodendrocyte precursor cells: 52.3;Proximal tubular cells: 31.6;Syncytiotrophoblasts: 46.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 235.7;CACO-2: 58.2;HMC-1: 45.6;RPTEC TERT1: 95.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		740000	"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.3	0.3	15.3	1.4	15.5	0.5	0.8	14.7	23.7	0.4	12.9	1.0	0.8	0.4	5.2	3.2	0.7	0.8	0.1	14.8	14.4	38.2	173.5	1.0	1.6	14.0	13.6	0.3	0.1	0.0	4.9	15.2	13.4	0.5	0.4	1.6	1.1	1.0	1.3	4.5	0.8	0.0	13.1	1.2	1.0	3.5	15.8	0.0	5.1	0.1	1.2	1.1	0.1	15.3	0.6	4.9	2.1	25.6	0.2	0.4	235.7	0.1	0.0	0.0	0.1	58.2	0.5	0.3	5.6	0.1	0.7	0.4	0.0	0.7	0.2	1.2	13.4	0.2	0.3	38.3	0.0	0.1	45.6	0.0	0.1	1.8	0.3	1.0	9.0	4.3	0.0	0.5	1.2	1.5	0.9	0.2	27.5	4.6	3.8	1.3	0.0	0.5	95.4	1.0	22.6	11.7	0.0	21.4	0.3	13.9	5.3	0.1	3.0	0.6	0.6	2.6	1.3	1.1	34.4	0.1	0.8	2.4	5.1	0.4	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.3	15.3	15.5	14.7	23.7	14.8	14.4	14.0	13.6	13.4	13.1	15.8	15.3	0.2	0.0	0.0	17.6	1.9	0.0	0.0	0.2	1.2	0.4	1.5	0.6	0.7	11.5	0.1	31.3	0.0	79.0	0.2	0.0	5.9	0.0	12.6	5.4	0.5	0.6	0.0	0.0	21.6	0.2	41.6	0.3	0.0	10.7	0.0	1.1	2.2	120.5	7.0	0.0	15.9	0.0	0.0	2.8	0.3	10.8	0.3	0.4	0.0	1.9	0.0	9.6	0.0	52.3	1.8	0.1	0.0	0.0	15.1	0.0	0.0	31.6	0.0	0.4	0.0	1.7	0.8	4.5	5.1	0.4	0.0	46.0	0.8	0.0	0.0	0.1
GLUD2	GLUDP1	ENSG00000182890	"Glutamate dehydrogenase 2"	P49448	X	121047610-121050094	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"liver: 3.9;testis: 15.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.6;Cytotrophoblasts: 4.6;Early spermatids: 2.6;Hepatocytes: 4.6;Proximal tubular cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;K-562: 4.3;OE19: 2.1;SK-MEL-30: 5.5;THP-1: 2.7;WM-115: 6.0"									"HPA042492, HPA044839, HPA061369"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.44e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.96e-2)"	1.7	1.7	0.0	0.1	0.3	0.0	1.2	0.0	0.8	0.4	0.5	0.5	0.0	0.4	1.7	0.5	0.4	0.4	0.9	0.4	0.0	1.6	3.9	0.5	0.1	0.0	0.0	0.4	1.0	0.5	0.4	0.8	0.0	0.4	0.0	0.1	0.6	0.2	0.5	0.6	0.4	0.1	0.0	0.1	0.6	15.4	0.1	0.0	0.4	0.1	0.1	0.4	0.4	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.8	0.0	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.5	0.1	1.2	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.8	0.0	0.0	2.3	0.1	0.0	0.5	0.0	0.6	0.0	0.4	0.1	2.6	0.0	0.0	0.0	2.1	4.6	0.1	0.1	1.9	0.2	2.6	0.6	0.8	0.9	0.0	0.0	1.2	0.4	0.5	0.8	0.0	0.5	0.0	0.1	0.0	4.6	0.5	0.0	0.4	0.1	0.0	1.2	0.3	2.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.2	3.3	0.0	0.1	0.0	0.9	0.4	1.2	1.0	0.1	0.1	2.5	0.3	0.7	0.2	0.3
GPR143	OA1	ENSG00000101850	"G protein-coupled receptor 143"	P51810	X	9725346-9786297	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.2;choroid plexus: 14.4"	"Group enriched"	"Detected in many"	8	"Cytotrophoblasts: 40.6;Melanocytes: 126.3"	"Cancer enriched"	"Detected in all"	9	"melanoma: 84.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 3.1"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 159.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003648	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA003648: AB_2667028"	"unprognostic (4.60e-2)"	"prognostic favorable (8.73e-4)"	"unprognostic (7.43e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.45e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.59e-2)"	0.6	1.1	10.6	0.1	13.0	0.0	1.7	11.8	11.5	2.0	14.4	1.4	0.5	3.2	5.3	2.4	2.8	0.9	0.1	10.8	13.1	4.6	1.7	1.0	0.5	12.6	14.2	3.3	1.2	2.9	2.7	6.1	12.3	2.6	1.4	0.9	3.3	4.4	0.0	8.9	0.5	1.0	11.4	0.0	0.7	0.8	13.1	1.8	3.2	0.0	1.6	1.1	1.1	12.2	1.9	0.4	4.6	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.2	0.0	0.4	0.1	0.2	1.1	0.1	0.1	0.3	0.0	0.2	0.6	2.3	0.0	3.4	0.1	1.6	0.0	0.0	24.2	6.7	0.0	0.0	0.0	0.0	12.1	0.0	0.1	11.1	0.0	0.1	0.0	0.1	0.1	22.2	3.2	0.9	0.0	0.3	0.0	159.6	10.8	1.9	0.0	4.6	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	3.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	10.6	13.0	11.8	11.5	10.8	13.1	12.6	14.2	12.3	11.4	13.1	12.2	0.1	0.0	0.0	9.8	0.2	5.5	1.3	1.8	2.2	0.5	2.1	1.7	0.9	0.0	4.9	7.3	0.0	40.6	0.0	0.8	1.9	4.9	0.2	1.7	1.6	1.5	0.0	0.0	0.6	0.6	2.1	1.0	0.0	1.3	0.0	1.8	2.9	0.3	4.8	0.0	0.3	0.8	2.0	0.0	1.6	1.8	1.8	0.1	126.3	1.0	0.0	1.2	0.0	0.5	0.6	1.2	0.2	6.4	0.0	1.8	0.2	5.0	3.2	0.2	0.0	0.0	0.7	0.2	1.3	4.2	0.6	10.1	0.7	1.0	2.0	1.8
GRAMD2A	GRAMD2	ENSG00000175318	"GRAM domain containing 2A"	Q8IUY3	15	72159806-72197787	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 35.9;placenta: 48.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 70.5;Cytotrophoblasts: 106.2;Extravillous trophoblasts: 29.5;Syncytiotrophoblasts: 147.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BEWO: 165.5;SK-BR-3: 75.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029435	Uncertain		Approved	"Nucleoli,Nuclear speckles,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli, Nuclear speckles"	Cytosol	"HPA029435: AB_10601811"	"unprognostic (5.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (7.01e-4)"	"unprognostic (7.29e-2)"	0.0	0.0	2.1	0.5	1.7	0.0	10.2	2.0	1.3	1.9	2.1	1.2	1.0	0.4	35.9	1.1	5.8	0.3	0.1	2.2	3.9	3.2	0.0	15.0	0.4	6.5	13.1	0.1	0.5	0.1	0.7	48.7	10.1	1.3	0.8	0.9	2.1	5.2	0.0	2.5	3.3	0.2	2.6	0.2	0.8	0.4	3.0	0.2	8.9	0.0	0.4	0.3	0.7	2.0	2.1	0.0	0.1	0.0	0.0	0.0	165.5	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.6	0.0	0.0	1.2	0.0	10.0	0.2	0.0	0.2	0.3	0.1	0.0	1.2	0.0	0.0	0.1	2.1	0.0	7.5	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.5	0.6	0.0	0.1	0.0	0.1	0.2	0.1	1.7	0.1	0.3	75.8	0.1	5.5	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.7	2.0	1.3	2.2	3.9	6.5	13.1	10.1	2.6	3.0	2.0	0.1	70.5	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.3	0.0	0.0	7.4	3.7	0.0	106.2	0.1	0.0	0.0	0.1	0.0	14.0	0.2	0.2	0.0	0.0	0.0	0.0	29.5	0.8	0.0	0.7	1.3	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	10.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	147.1	0.3	0.1	0.0	0.0
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698355-24757940	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.1;Distal tubular cells: 41.1;Extravillous trophoblasts: 26.5;Hofbauer cells: 39.9;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.0;myeloid DC: 5.9;naive B-cell: 8.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	13.5	7.8	16.4	2.9	16.7	0.5	7.6	13.3	18.0	17.3	9.2	6.4	7.7	24.8	15.3	3.6	14.3	8.5	9.7	18.1	15.0	13.3	4.5	4.4	5.8	19.4	18.7	16.9	2.6	7.3	7.0	35.0	16.1	7.5	2.4	6.3	3.1	21.1	7.8	3.0	26.8	15.1	16.5	1.8	3.9	12.9	14.1	5.8	14.5	5.2	3.8	15.0	10.1	26.6	31.4	21.7	9.6	41.2	51.4	28.6	16.4	24.1	63.6	24.5	34.3	22.9	1.1	0.5	20.6	66.4	81.7	20.5	5.8	105.4	42.8	0.1	2.1	0.8	39.3	48.0	43.0	0.1	1.5	31.3	75.3	43.5	103.1	73.0	42.3	13.8	3.0	5.2	55.3	0.4	1.9	0.8	10.2	0.1	15.7	0.2	33.6	0.0	74.5	21.9	0.4	60.0	36.5	0.6	42.3	24.3	2.2	2.8	27.9	23.1	39.7	31.6	29.2	2.4	0.6	15.5	69.8	0.1	5.8	0.0	1.9	0.0	0.0	0.2	0.0	9.0	0.1	0.0	5.9	8.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	16.4	16.7	13.3	18.0	18.1	15.0	19.4	18.7	16.1	16.5	14.1	26.6	1.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.0	0.0	0.6	5.5	0.0	168.1	0.0	0.0	41.1	1.9	0.0	0.7	16.9	1.3	0.0	0.0	0.0	0.9	26.5	4.3	0.0	1.0	0.0	4.8	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	8.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	8.8	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	104.7	0.7	0.9	0.0	0.0
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 466.5;Hofbauer cells: 340.2;Syncytiotrophoblasts: 493.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 746.0;GAMG: 646.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	92.2	72.0	22.1	59.7	25.3	59.9	83.0	22.3	32.5	97.6	39.4	105.0	99.0	71.5	321.4	38.5	66.7	99.0	84.3	23.1	26.2	81.6	137.5	111.3	47.0	23.8	22.9	62.4	103.6	94.2	46.6	319.4	24.7	98.7	116.9	33.6	123.4	54.0	43.3	54.3	75.4	76.1	23.2	64.7	88.4	19.6	28.2	29.1	89.6	38.4	40.4	94.6	64.1	30.4	147.3	111.0	39.4	131.8	746.0	232.3	122.3	173.5	590.4	175.0	375.2	130.6	194.5	0.0	133.0	152.2	646.3	115.2	43.2	185.2	228.7	79.2	72.6	19.1	101.4	101.5	216.5	16.2	152.3	206.7	108.0	180.7	121.3	275.9	204.5	47.3	54.3	236.9	194.9	145.7	19.8	36.6	36.8	142.7	47.8	43.9	56.2	191.8	119.8	130.4	24.5	30.4	134.2	92.6	180.0	68.8	99.1	108.6	118.5	112.1	26.6	207.8	165.6	102.6	191.3	0.9	257.9	143.6	209.8	86.2	343.2	99.1	69.3	129.9	80.7	45.2	56.1	64.0	310.8	28.1	52.6	51.3	125.2	42.4	82.5	93.4	73.2	269.0	22.1	25.3	22.3	32.5	23.1	26.2	23.8	22.9	24.7	23.2	28.2	30.4	49.6	41.7	38.4	5.9	31.5	44.0	82.8	103.2	21.6	10.2	26.3	27.6	19.8	82.9	63.8	29.5	8.4	466.5	32.8	68.2	19.6	151.3	1.3	21.0	21.4	56.2	22.8	23.1	32.2	125.6	175.4	107.2	33.6	26.9	69.8	19.8	74.3	70.1	340.2	10.1	24.3	56.7	107.8	127.3	134.3	3.4	85.1	168.8	72.9	17.8	114.2	35.4	29.9	22.6	13.3	65.8	54.8	72.2	71.5	74.2	99.5	79.6	36.3	16.3	46.0	32.6	49.5	0.3	1.4	23.8	32.5	493.6	35.3	31.4	81.8	71.0
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326895-45328679	"Human disease related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.1;Gastric mucus-secreting cells: 8.2;Undifferentiated cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 111.7;HL-60: 34.2;NB-4: 42.8;SK-BR-3: 72.5"	"Low region specificity"	"Detected in many"							"HPA031997, HPA057346"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Nucleoplasm	"HPA031997: AB_10602909, HPA057346: AB_2683415"	"prognostic favorable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.4	0.2	1.0	1.3	1.3	1.8	0.4	3.1	1.0	1.2	0.0	3.7	2.4	0.6	0.0	2.2	0.6	0.0	0.3	0.9	0.9	0.6	0.1	0.3	1.0	1.3	1.2	0.6	0.3	0.0	0.3	2.1	1.3	0.6	2.8	0.4	1.0	0.2	1.6	0.8	2.5	0.3	0.8	1.8	3.4	0.3	1.3	1.2	0.6	0.6	0.9	0.5	1.1	1.3	0.1	1.1	0.5	0.1	0.1	0.4	111.7	1.5	0.0	2.0	0.4	28.7	7.7	5.8	0.3	1.5	0.0	7.0	0.0	0.4	0.7	0.2	0.3	0.6	13.4	0.0	0.7	34.2	0.9	1.1	0.2	1.2	0.0	0.1	2.2	0.2	0.0	5.2	0.2	14.6	22.1	42.8	0.5	23.0	0.0	6.6	0.1	19.4	0.4	0.4	22.2	1.5	14.6	72.5	11.4	1.6	0.2	6.3	1.0	0.0	0.3	1.3	0.0	0.9	0.6	21.3	0.1	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.1	0.2	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.1	1.0	1.3	3.1	1.0	0.9	0.9	1.3	1.2	1.3	0.8	1.3	1.3	0.1	0.0	0.0	2.9	1.0	0.1	2.3	0.5	1.2	0.2	0.7	1.0	0.4	0.0	0.1	0.0	0.0	29.1	0.3	3.0	3.9	0.4	0.2	0.1	1.5	0.7	1.2	4.2	0.0	0.0	5.8	0.8	8.2	0.2	0.0	0.9	0.4	0.1	2.5	0.0	0.2	3.3	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.8	1.9	0.0	5.2	2.2	0.4	0.3	0.0	0.4	0.0	0.6	0.8	0.0	1.9	2.1	1.1	5.1	0.4	1.2	7.6	1.5
HPS6	"BLOC2S3, FLJ22501"	ENSG00000166189	"HPS6 biogenesis of lysosomal organelles complex 2 subunit 3"	Q86YV9	10	102065349-102068036	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040687	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA040687: AB_2677078"	"unprognostic (4.15e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.50e-2)"	6.2	8.0	4.3	6.5	4.4	7.5	6.0	4.0	5.3	6.1	3.3	8.1	7.8	9.0	3.5	10.3	7.2	4.1	7.1	4.6	4.4	5.6	6.6	6.5	7.7	5.4	4.2	5.5	9.2	6.7	4.4	5.6	4.4	5.0	4.7	1.9	7.6	5.6	8.1	9.0	8.3	5.1	4.1	9.2	8.5	3.6	5.1	5.6	4.9	5.9	6.5	7.0	5.8	4.1	26.0	21.5	6.3	17.3	19.4	14.0	13.5	16.8	25.0	20.0	16.3	11.5	17.4	13.6	16.7	18.8	11.4	25.9	11.9	27.4	5.3	19.8	16.4	14.1	10.1	8.4	12.2	16.5	17.0	15.6	28.0	12.7	16.1	20.2	14.6	11.8	9.6	7.4	15.9	17.5	12.2	21.8	6.2	12.1	17.5	16.7	2.2	11.8	17.3	11.8	4.6	13.0	9.8	11.9	13.1	8.1	23.4	20.9	19.0	7.6	9.3	7.6	17.3	12.7	10.5	9.8	15.4	19.3	6.1	0.0	1.9	2.5	3.1	2.9	2.7	2.3	2.6	2.6	1.8	1.6	1.2	1.5	2.1	3.9	1.4	3.0	2.0	1.2	4.3	4.4	4.0	5.3	4.6	4.4	5.4	4.2	4.4	4.1	5.1	4.1	4.2	9.6	2.6	1.3	6.9	1.9	7.7	4.5	3.4	8.1	2.8	2.8	6.2	4.3	4.3	5.5	12.5	12.4	4.7	9.2	7.9	12.4	0.1	3.0	3.7	4.8	2.4	6.1	1.2	14.9	9.5	4.5	4.6	3.2	0.0	4.6	6.1	6.7	10.6	10.1	1.2	5.8	0.0	6.3	2.7	0.9	7.5	4.8	5.4	1.0	10.5	10.1	10.3	1.5	0.6	12.6	5.8	5.3	4.2	6.3	8.7	6.2	3.7	5.1	0.0	4.3	5.6	2.4	4.2	6.0	2.4	10.1	5.9	5.3	9.0	6.3
HTATSF1	TAT-SF1	ENSG00000102241	"HIV-1 Tat specific factor 1"	O43719	X	136497079-136512346	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000504	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000504: AB_10752094"	"unprognostic (3.56e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.37e-2)"	"prognostic favorable (8.13e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.05e-1)"	38.9	99.7	53.4	31.0	54.1	54.7	35.7	56.0	60.6	33.5	45.9	34.8	25.4	39.4	59.1	30.3	35.1	28.6	65.4	51.5	74.1	43.3	30.8	26.9	34.5	60.8	56.4	60.2	27.7	52.8	144.7	36.4	56.7	35.3	35.3	56.1	28.4	39.6	181.8	35.1	26.0	34.6	56.1	28.5	32.5	41.5	79.9	43.0	47.6	109.2	35.7	35.1	27.8	55.3	151.4	79.3	99.9	70.5	72.1	54.0	87.1	71.5	60.4	57.2	55.5	47.6	66.0	114.1	163.1	68.1	66.3	66.0	120.5	52.3	75.0	86.5	106.9	70.9	99.9	59.2	40.8	138.1	57.7	48.4	66.1	63.2	39.3	40.8	60.3	166.3	67.4	81.0	76.5	114.3	135.7	115.4	58.7	139.4	115.7	104.2	123.7	103.3	62.0	105.9	69.0	106.9	66.7	54.4	56.4	83.9	39.8	96.5	57.4	69.2	52.2	79.5	126.1	47.6	69.1	92.7	44.4	192.4	50.3	48.4	20.6	33.2	41.0	21.5	44.5	33.9	44.4	42.2	28.5	33.3	44.8	40.7	6.7	49.7	35.3	20.6	47.9	27.9	53.4	54.1	56.0	60.6	51.5	74.1	60.8	56.4	56.7	56.1	79.9	55.3	28.2	51.3	42.9	11.4	36.8	29.6	38.0	28.0	38.7	52.5	25.8	23.5	173.3	20.0	53.1	49.7	10.4	95.3	37.6	26.2	49.0	36.7	6.8	51.0	39.3	29.8	81.2	55.5	10.2	34.3	69.8	42.1	42.3	32.9	34.8	48.4	10.4	22.8	38.2	42.1	12.1	37.8	28.5	19.5	19.2	11.7	45.1	30.3	32.0	7.5	34.4	78.0	25.7	8.0	13.6	32.5	18.5	53.8	54.3	37.2	20.4	32.1	44.4	56.7	46.0	46.9	41.0	29.4	92.2	42.7	26.6	116.8	51.6	45.8	32.6	36.8
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2"	P48735	15	90083045-90102477	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 492.6;skeletal muscle: 1302.3;tongue: 1611.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 732.5;Distal tubular cells: 1168.0;Extravillous trophoblasts: 586.7;Syncytiotrophoblasts: 573.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 425.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		NA	NA		5200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	32.8	10.5	56.5	60.2	67.8	161.1	51.1	57.1	59.8	36.6	76.6	95.9	97.2	29.0	12.5	140.6	32.7	31.7	492.6	47.2	55.0	208.3	274.7	32.0	77.1	61.0	61.3	13.6	128.7	104.0	15.5	87.3	54.4	76.2	84.1	5.4	163.1	90.4	1302.3	61.8	84.3	79.8	52.9	36.8	175.7	5.3	71.6	148.7	16.0	1611.3	66.0	53.3	49.4	57.6	61.3	33.5	169.9	169.8	23.3	28.3	144.5	74.5	110.8	68.0	72.6	16.1	51.1	72.7	21.0	61.2	65.1	20.8	25.1	22.4	32.0	143.8	16.9	122.9	12.7	119.7	28.1	85.1	118.2	59.7	12.7	16.3	13.0	82.1	141.0	246.4	18.9	59.3	53.0	175.3	425.0	131.2	51.8	81.9	14.3	352.0	122.4	213.7	105.6	71.3	244.5	125.3	92.1	359.8	29.9	94.2	290.9	256.9	34.0	120.4	17.0	16.1	34.9	101.5	20.5	9.0	38.4	175.0	71.2	45.0	112.8	75.6	105.9	199.1	53.2	70.1	77.0	120.1	136.9	47.7	42.9	71.8	22.9	99.9	252.1	79.4	72.4	163.4	56.5	67.8	57.1	59.8	47.2	55.0	61.0	61.3	54.4	52.9	71.6	57.6	16.9	6.4	21.0	40.1	64.2	39.9	98.8	91.6	12.5	6.2	90.5	48.1	445.9	114.4	95.8	75.4	10.4	732.5	84.0	70.0	1168.0	252.8	5.6	96.4	25.7	41.6	61.7	193.8	11.8	288.8	586.7	44.7	88.2	50.9	31.6	29.2	38.2	283.1	263.7	10.1	8.3	158.3	229.9	77.7	101.1	3.2	14.0	79.0	58.7	5.6	85.3	20.9	119.4	16.6	27.3	116.6	105.0	35.3	185.9	170.3	69.6	205.0	167.9	5.4	13.1	60.8	73.4	0.6	15.6	113.3	67.1	573.0	88.1	14.7	305.1	140.1
IFI6	"6-16, FAM14C, G1P3, IFI-6-16, IFI616"	ENSG00000126709	"Interferon alpha inducible protein 6"	P09912	1	27666064-27672212	"Predicted membrane proteins"	"Antiviral defense, Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 4084.0;Extravillous trophoblasts: 1291.2;Syncytiotrophoblasts: 4273.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 1349.9;BJ hTERT+ SV40 Large T+ RasG12V: 1570.7;EFO-21: 544.1;SK-MEL-30: 1075.0"					"Low region specificity"	"Detected in all"			HPA005543	Approved		Approved	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA005543: AB_1849342"	"unprognostic (4.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.96e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.77e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	84.0	161.4	117.5	37.5	142.0	113.2	73.1	106.8	159.3	99.7	164.7	76.3	44.0	55.6	39.1	30.5	49.6	56.8	114.2	126.4	168.7	154.1	135.6	143.5	14.9	200.8	145.5	81.4	57.2	116.0	316.7	298.2	155.6	60.6	24.5	17.2	334.3	23.0	23.8	35.3	52.1	43.6	299.5	91.0	96.1	61.9	153.1	62.2	166.9	20.1	14.5	43.8	47.4	139.2	15.6	4.4	22.7	14.1	72.4	38.8	90.6	48.5	220.1	1349.9	1570.7	8.0	58.5	6.1	544.1	22.1	352.4	5.2	5.5	10.8	43.7	117.3	18.4	36.4	11.2	4.8	19.4	12.4	45.1	43.3	1.8	82.1	1.1	20.9	12.6	31.6	2.5	95.2	15.3	4.4	44.1	153.4	4.4	28.7	46.4	29.6	12.1	14.9	12.2	0.9	32.2	28.8	59.9	13.6	1075.0	6.7	6.9	46.5	21.7	12.6	19.3	9.4	8.4	113.5	68.1	4.4	24.6	105.3	35.8	193.3	265.8	252.0	128.7	374.6	127.9	57.3	128.2	118.0	117.6	47.0	132.7	130.9	506.8	102.0	259.4	12.8	172.9	113.2	117.5	142.0	106.8	159.3	126.4	168.7	200.8	145.5	155.6	299.5	153.1	139.2	158.0	141.1	74.4	5.2	26.1	23.5	19.8	39.3	29.0	15.2	17.5	14.4	12.9	54.3	42.2	64.4	10.4	4084.0	44.7	13.2	19.6	244.0	3.4	61.4	76.4	194.8	58.4	27.6	3.6	340.0	1291.2	149.3	21.4	91.8	63.3	186.3	82.8	40.4	685.3	3.3	7.4	60.5	67.1	71.8	49.1	11.5	110.6	169.4	71.2	24.4	93.8	95.1	46.4	16.1	3.9	214.2	11.7	204.7	96.0	48.2	16.9	32.7	89.3	5.6	111.7	60.9	63.1	7.9	1.6	5.8	22.4	4273.1	59.6	138.6	13.0	49.0
IGDCC3	"HsT18880, PUNC"	ENSG00000174498	"Immunoglobulin superfamily DCC subclass member 3"	Q8IVU1	15	65327127-65378002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3;parathyroid gland: 5.1;placenta: 6.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 33.3;Cytotrophoblasts: 104.8;Early spermatids: 37.6;Late spermatids: 98.6;Syncytiotrophoblasts: 41.3"	"Group enriched"	"Detected in many"	5	"glioma: 2.2;testis cancer: 5.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 105.8;CACO-2: 27.4;Hep G2: 87.8;SuSa: 41.9"	"Low region specificity"	"Detected in many"							HPA015713			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles"		"HPA015713: "	"unprognostic (7.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.24e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.67e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.77e-5)"	"unprognostic (4.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-2)"	0.0	0.2	2.3	0.0	2.0	0.0	0.8	4.3	3.2	1.0	0.0	0.4	0.0	0.7	0.1	0.0	0.6	0.1	0.1	2.6	1.9	0.2	0.0	0.0	0.0	2.4	2.7	0.8	0.0	5.1	1.9	6.0	2.4	0.1	0.0	1.0	0.0	0.1	0.1	0.1	0.1	0.2	1.6	0.0	0.2	2.8	3.0	1.4	0.9	0.0	0.0	0.1	0.4	1.9	0.0	0.0	105.8	4.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	27.4	0.2	0.0	0.3	0.0	0.0	0.0	7.2	0.0	0.0	0.0	1.0	0.0	0.2	87.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	16.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	2.2	1.5	0.1	0.1	0.0	41.9	3.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.0	4.3	3.2	2.6	1.9	2.4	2.7	2.4	1.6	3.0	1.9	0.1	0.0	0.0	15.3	0.0	0.0	0.2	0.0	0.0	4.1	2.2	1.0	0.6	0.0	0.0	1.8	33.3	104.8	0.0	0.4	0.0	0.0	37.6	0.4	4.8	1.0	0.0	0.0	2.8	0.0	4.3	3.0	0.0	0.6	0.0	0.1	0.0	0.0	7.2	0.0	7.0	0.0	0.0	0.0	0.0	98.6	0.6	0.1	0.0	1.0	0.0	3.7	0.0	16.1	8.9	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.7	0.4	1.3	11.0	0.0	0.0	41.3	0.1	0.1	0.2	0.0
IL36RN	"FIL1, FIL1(DELTA), FIL1D, IL-1F5, IL1F5, IL1HY1, IL1L1, IL1RP3, IL36RA, MGC29840"	ENSG00000136695	"Interleukin 36 receptor antagonist"	Q9UBH0	2	113058638-113065382	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Cytokine	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 26.5;lymphoid tissue: 43.7;skin 1: 60.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 8.9;Extravillous trophoblasts: 2.0;Syncytiotrophoblasts: 3.8"	"Cancer enriched"	"Detected in some"	7	"head and neck cancer: 25.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"BEWO: 26.6;GAMG: 11.1;U-87 MG: 19.9"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	107000			"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (3.88e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"		"unprognostic (4.29e-1)"	"unprognostic (8.68e-3)"		"unprognostic (9.80e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.39e-1)"		"unprognostic (3.99e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.23e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.4	0.0	0.0	0.0	0.0	4.6	0.0	0.1	60.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	43.7	0.0	9.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.1	1.1	0.3	0.0	0.0	11.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.8	0.0	0.0	0.0	0.7
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438167	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 223.6;testis: 223.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1141.3;Sertoli cells: 315.5;Syncytiotrophoblasts: 1034.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.5;NK-cells: 14.4;T-cells: 8.9"	"Cell line enriched"	"Detected in many"	4	"BEWO: 492.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	36.0	32.6	15.2	2.8	13.8	5.8	30.5	12.5	19.5	47.3	223.6	14.2	3.6	44.2	4.4	15.2	78.9	3.7	36.1	19.4	24.5	114.4	13.1	22.2	4.4	16.8	18.8	96.0	40.1	12.8	50.7	46.3	14.2	41.4	0.7	0.9	17.7	26.7	13.2	16.2	16.1	2.8	12.7	35.1	11.3	223.8	25.4	3.0	23.7	3.1	1.8	23.5	31.9	11.3	13.9	42.4	98.6	31.0	0.8	0.2	492.7	6.6	1.0	0.6	0.3	24.5	26.1	0.2	33.5	3.2	0.2	36.6	3.0	0.1	0.0	39.8	116.4	52.0	3.1	80.3	10.2	0.6	1.1	9.4	0.4	2.8	0.4	0.4	6.3	1.1	106.0	2.1	0.0	84.1	4.0	3.4	51.7	14.2	33.7	71.2	0.2	24.6	9.5	0.3	30.4	74.3	1.7	9.9	53.1	20.2	68.2	7.1	18.7	0.5	1.1	0.7	1.6	13.9	7.3	3.2	3.0	1.9	17.7	1.0	0.1	0.0	8.1	0.2	6.2	4.5	8.1	6.9	0.8	2.4	6.2	8.9	0.8	14.4	0.1	2.2	6.2	5.0	15.2	13.8	12.5	19.5	19.4	24.5	16.8	18.8	14.2	12.7	25.4	11.3	38.8	3.2	1.1	2.6	9.0	12.0	82.1	74.9	72.8	0.8	26.1	47.0	4.7	20.0	24.0	47.8	2.1	1141.3	8.4	4.1	52.8	39.4	101.3	33.4	10.9	30.5	64.8	21.5	1.0	8.2	114.0	30.2	7.1	14.8	14.0	36.9	25.7	1.1	84.9	0.0	4.3	4.0	28.5	9.0	7.8	230.1	37.3	4.1	23.2	11.2	5.4	8.6	13.4	0.0	0.3	3.4	1.8	50.4	1.8	21.6	0.7	6.1	23.6	0.7	315.5	5.6	163.6	53.7	21.0	10.6	5.7	1034.6	14.9	14.5	6.2	36.8
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236165-62319434	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6;pancreas: 15.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 31.8;Exocrine glandular cells: 8.0;Extravillous trophoblasts: 19.0;Oligodendrocytes: 34.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.8;Hep G2: 13.4;SCLC-21H: 6.2;SuSa: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Microtubules	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.7	0.5	1.0	0.5	5.8	0.0	2.6	10.1	3.2	0.3	0.1	1.0	0.3	0.2	0.7	0.2	0.3	0.5	0.3	0.8	4.6	1.4	3.0	2.5	0.0	19.2	13.8	0.3	15.2	5.6	0.1	10.8	22.6	1.5	1.0	1.0	8.4	0.6	0.2	0.5	0.3	0.2	5.3	0.8	2.0	0.9	7.6	0.8	0.3	0.8	0.0	0.2	0.5	8.9	0.0	0.0	1.1	0.0	0.0	0.0	31.8	0.1	0.0	0.1	0.0	4.8	0.0	0.0	0.1	1.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	2.4	13.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.2	0.0	1.0	0.6	0.0	27.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	5.8	10.1	3.2	0.8	4.6	19.2	13.8	22.6	5.3	7.6	8.9	0.1	0.0	0.0	1.3	0.0	0.0	2.4	0.4	0.6	0.3	0.5	7.0	0.9	0.0	0.0	0.0	0.0	31.8	0.0	0.5	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	2.3	8.0	19.0	0.9	0.0	0.1	0.0	0.1	0.4	1.5	2.3	0.0	2.3	1.4	0.0	0.0	0.0	0.3	0.0	0.4	1.8	1.0	0.0	0.1	0.0	0.5	34.3	0.4	0.2	3.8	0.0	0.0	0.0	0.8	0.0	0.5	0.0	1.2	4.2	0.0	1.0	0.2	0.0	5.5	0.1	0.0	1.0	0.1
KLHL42	"Ctb9, KIAA1340, KLHDC5"	ENSG00000087448	"Kelch like family member 42"	Q9P2K6	12	27780048-27803040	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Peritubular cells: 172.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020979	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA020979: AB_1852559"	"unprognostic (4.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.46e-2)"	"unprognostic (7.38e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	8.7	7.3	10.8	11.6	12.1	4.6	9.4	8.3	12.7	11.5	1.6	23.0	8.5	19.0	9.6	13.2	13.4	11.7	6.6	13.2	12.3	7.5	6.4	9.2	9.4	9.2	8.9	8.2	21.3	12.3	9.8	14.1	9.3	14.8	12.1	13.9	6.1	18.8	2.6	9.6	10.0	23.1	9.6	8.7	12.2	10.3	11.3	6.6	10.2	2.6	8.1	21.7	9.7	16.1	11.8	14.9	24.2	22.2	25.9	15.9	23.9	22.5	17.0	16.4	17.6	10.5	16.0	14.6	9.5	14.9	12.6	23.8	11.9	15.6	16.4	19.5	14.5	19.4	29.3	6.9	12.0	17.1	15.2	15.7	12.9	14.3	20.4	21.1	18.7	12.0	6.3	8.0	13.3	10.6	11.9	17.1	34.6	7.6	20.6	13.0	22.1	2.8	9.8	19.2	8.4	24.3	16.6	13.2	17.9	33.8	20.0	15.6	30.2	22.8	13.7	27.7	25.1	9.9	5.5	25.5	14.6	11.2	16.2	0.0	0.5	0.2	1.0	0.4	1.0	0.1	1.1	0.7	0.3	0.5	0.8	1.1	0.0	0.8	0.7	0.7	1.8	0.3	10.8	12.1	8.3	12.7	13.2	12.3	9.2	8.9	9.3	9.6	11.3	16.1	16.2	19.2	16.8	33.0	9.3	23.1	12.3	14.9	29.0	49.8	17.0	25.1	9.1	10.0	12.6	7.3	22.9	69.5	13.9	14.6	3.9	8.9	1.7	9.3	28.8	18.8	27.7	16.8	61.5	20.2	19.8	26.2	15.3	23.9	11.4	25.5	19.2	24.7	13.2	35.3	78.9	12.8	12.2	8.8	11.7	6.0	35.1	8.6	28.4	17.8	16.7	73.9	32.0	63.8	95.5	11.2	7.2	172.3	7.6	14.0	8.0	8.8	7.6	25.2	65.7	33.8	34.6	5.0	12.3	13.1	20.5	20.5	14.7	27.9	11.0	7.4
L1TD1	"ECAT11, FLJ10884"	ENSG00000240563	"LINE1 type transposase domain containing 1"	Q5T7N2	1	62194849-62212328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.5;intestine: 5.3;lymphoid tissue: 4.7;placenta: 11.6;testis: 5.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 110.2;Extravillous trophoblasts: 26.2;Intestinal goblet cells: 37.5;Spermatogonia: 53.1;Syncytiotrophoblasts: 28.2"	"Cancer enriched"	"Detected in some"	14	"testis cancer: 120.2"	"Region enriched"	"Detected in some"	4	"cerebellum: 5.5"	"Immune cell enriched"	"Detected in single"	13	"non-classical monocyte: 5.0"	"Lineage enriched"	"Detected in single"	21	"monocytes: 5.0"	"Group enriched"	"Detected in some"	22	"NTERA-2: 255.7;SuSa: 191.2"	"Not detected"	"Not detected"							"HPA028501, HPA030064"			Enhanced	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"HPA028501: AB_10599287, HPA030064: AB_10600538"	"unprognostic (2.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.95e-1)"	0.2	0.3	0.1	4.7	0.5	0.0	0.2	5.5	1.3	0.3	0.0	5.3	0.1	0.1	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.3	0.0	1.5	0.2	0.2	0.1	0.2	0.0	0.0	0.1	11.6	0.3	0.1	1.2	0.0	0.4	0.1	0.0	0.1	0.3	0.3	0.0	0.9	0.1	5.8	0.0	0.2	0.4	0.0	0.1	0.1	0.2	0.6	0.0	0.0	0.2	0.1	0.0	0.0	10.1	0.1	0.0	1.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	191.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.0	0.1	0.5	5.5	1.3	0.3	0.0	0.2	0.1	0.3	0.0	0.0	0.6	0.5	6.4	13.0	0.0	1.8	0.4	0.7	0.1	0.0	2.5	1.0	2.2	0.3	0.0	7.5	0.0	6.2	110.2	2.1	3.6	0.0	0.0	0.5	0.8	0.5	2.3	10.7	0.0	0.6	0.4	26.2	3.6	0.0	1.7	1.3	2.2	0.0	0.1	7.6	3.3	0.4	37.5	0.0	1.4	1.2	1.0	1.8	4.3	0.0	0.0	0.5	0.4	1.0	0.0	0.1	0.3	1.6	18.4	1.1	0.6	0.1	0.1	6.0	3.7	0.0	1.1	2.7	0.7	53.1	0.0	0.1	28.2	1.9	2.3	9.2	0.3
LAMA5		ENSG00000130702	"Laminin subunit alpha 5"	O15230	20	62307955-62367312	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Cytotrophoblasts: 104.4;Glandular and luminal cells: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 114.9;CACO-2: 159.6;EFO-21: 114.4;HaCaT: 107.2;HeLa: 118.3;TIME: 138.4"	"Low region specificity"	"Detected in many"							"HPA058389, CAB078157"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		1800000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"CAB078157: AB_2665809, HPA058389: "	"unprognostic (8.01e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.90e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.98e-3)"	"unprognostic (4.04e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.33e-2)"	27.1	11.8	4.7	5.0	2.2	1.3	27.0	15.2	7.0	26.3	18.9	66.7	5.3	31.3	1.2	24.5	31.8	7.9	26.6	2.4	2.0	32.7	13.2	43.9	3.0	3.2	1.9	9.3	13.9	4.8	12.1	20.0	2.5	36.7	1.2	0.6	17.8	15.4	11.0	36.0	19.9	7.3	0.6	14.0	25.1	4.6	9.3	2.7	28.6	2.8	1.9	32.6	30.2	0.4	15.1	114.9	2.2	14.8	2.7	31.0	85.9	4.2	2.2	3.3	0.6	159.6	59.1	1.3	114.4	0.1	3.6	107.2	3.1	45.8	0.2	0.3	6.5	3.8	118.3	46.1	9.9	0.0	16.6	1.6	29.6	7.9	8.0	5.7	15.0	0.0	7.0	1.7	0.0	22.3	0.1	0.4	7.3	19.3	65.9	0.2	1.4	12.8	28.6	70.3	1.1	44.5	63.2	62.2	1.2	11.6	62.0	0.9	138.4	1.6	41.2	0.7	18.9	0.8	0.2	0.6	31.7	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	2.2	15.2	7.0	2.4	2.0	3.2	1.9	2.5	0.6	9.3	0.4	60.2	76.9	37.1	19.9	6.9	17.1	16.0	56.8	52.9	3.6	16.7	20.8	20.5	12.8	43.9	38.6	8.4	104.4	3.9	0.6	0.0	28.6	4.3	35.5	11.7	49.6	2.4	6.1	5.9	4.5	23.3	13.0	6.1	82.0	2.5	0.9	18.9	12.7	13.1	3.3	12.7	0.3	14.2	0.6	5.4	1.3	9.9	2.2	1.8	10.3	1.1	8.2	1.0	3.5	1.3	13.2	0.1	19.5	8.5	21.9	0.0	12.2	49.6	1.8	26.3	11.0	39.4	0.6	1.7	23.4	12.6	57.3	2.2	1.7	0.6	27.5
LARGE2	"FLJ35207, GYLTL1B, PP5656"	ENSG00000165905	"LARGE xylosyl- and glucuronyltransferase 2"	Q8N3Y3	11	45921621-45929096	"Predicted intracellular proteins"		"Glycosyltransferase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 36.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 189.8;Syncytiotrophoblasts: 116.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.4;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 34.3;NTERA-2: 32.5;SK-BR-3: 23.5;T-47d: 71.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA056621	Approved				"Intracellular and membrane"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA056621: AB_2683194"	"unprognostic (9.82e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.94e-2)"	"prognostic favorable (3.04e-12)"	"unprognostic (2.31e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-2)"	0.2	2.4	0.0	2.3	0.0	0.5	4.4	0.3	0.1	5.1	12.2	1.0	1.3	2.0	4.9	17.1	3.9	0.6	0.2	0.8	0.0	15.9	3.3	1.9	4.7	0.1	0.1	2.0	27.1	12.5	11.5	36.6	0.0	9.9	0.7	3.5	17.7	8.3	0.6	19.7	3.7	0.1	0.0	2.5	11.2	1.6	0.2	4.1	11.3	0.0	2.3	2.2	6.8	0.1	1.2	1.6	0.1	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	8.5	0.6	0.0	0.9	0.0	0.8	8.0	0.1	15.2	0.0	0.0	4.7	0.0	1.2	9.3	0.2	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	2.0	9.7	0.0	0.0	2.7	0.2	0.0	32.5	12.2	1.1	0.9	0.0	3.1	0.5	0.6	9.6	1.1	0.3	23.5	0.1	1.9	71.4	0.0	0.0	0.2	10.4	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.4	0.1	0.4	0.0	2.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	3.2	2.2	0.0	4.0	0.0	0.0	0.0	0.0	0.0	13.5	8.3	0.0	0.0	0.6	7.3	0.0	189.8	0.4	0.0	3.9	4.6	0.0	10.9	3.4	0.9	0.0	0.0	0.0	6.4	11.3	0.9	0.0	28.0	0.0	9.4	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	116.2	0.8	0.1	0.0	0.0
LPCAT3	"C3F, MBOAT5, nessy, OACT5"	ENSG00000111684	"Lysophosphatidylcholine acyltransferase 3"	Q6P1A2	12	6976185-7018477	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 103.5;Proximal enterocytes: 121.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 156.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (1.74e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (4.89e-5)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.23e-1)"	36.6	52.1	8.4	21.6	9.3	28.4	36.3	11.1	9.5	20.3	10.3	51.4	123.0	18.8	21.5	32.0	21.2	18.6	37.4	8.3	9.0	44.4	109.2	46.0	17.0	11.0	9.7	17.7	50.8	19.6	15.2	38.0	9.2	35.9	47.9	4.0	37.3	16.3	45.6	34.0	99.7	21.7	9.2	20.1	58.7	11.2	9.9	21.5	27.7	57.5	21.2	35.3	21.7	9.3	20.2	34.0	15.8	44.3	109.4	51.2	32.9	11.8	49.5	31.7	53.4	78.6	103.9	21.9	6.5	19.1	65.7	50.8	19.2	43.0	24.3	52.7	21.3	44.7	28.2	71.5	23.6	23.3	45.8	81.2	24.7	30.2	15.1	20.1	30.0	33.0	24.4	15.4	20.9	30.0	29.1	28.7	53.1	73.1	20.2	29.9	21.5	22.4	38.7	156.0	13.6	12.5	68.5	107.3	7.9	49.5	10.9	31.4	12.0	19.2	27.8	34.1	8.3	19.1	14.5	30.9	24.0	23.5	17.0	44.4	55.7	91.0	21.5	80.5	25.4	12.3	22.3	24.8	37.2	12.3	20.1	21.3	53.7	32.3	98.7	21.1	29.7	38.3	8.4	9.3	11.1	9.5	8.3	9.0	11.0	9.7	9.2	9.2	9.9	9.3	17.9	70.5	38.5	15.7	13.1	23.6	39.4	35.8	36.5	5.2	19.8	13.8	0.6	12.8	30.3	20.2	0.0	103.5	11.6	47.0	11.7	29.9	2.5	18.8	21.4	13.1	43.2	57.7	20.7	33.0	51.7	14.3	49.5	26.6	14.0	10.6	15.0	62.9	41.6	11.8	16.7	26.8	26.4	21.9	9.6	1.7	18.3	15.2	7.2	6.5	15.8	12.2	15.5	25.6	22.4	18.1	27.1	6.4	17.5	24.7	121.9	37.2	16.4	4.0	19.7	6.0	18.2	24.3	35.3	17.7	22.3	66.4	18.9	17.0	41.2	25.9
LRATD1	"FAM84A, FLJ35392, NSE1"	ENSG00000162981	"LRAT domain containing 1"	Q96KN4	2	14632700-14650814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.2;intestine: 41.0"	"Group enriched"	"Detected in some"	8	"Cytotrophoblasts: 162.2;Syncytiotrophoblasts: 207.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 35.0"	"Group enriched"	"Detected in many"	7	"amygdala: 19.7;basal ganglia: 10.8;cerebral cortex: 18.1;hippocampal formation: 13.0;white matter: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 9.4;hTCEpi: 18.0;RT4: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047703	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA047703: AB_2680123"	"unprognostic (1.05e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.36e-1)"	0.5	1.4	19.7	4.9	10.8	0.0	2.4	0.0	18.1	10.6	0.0	41.0	26.3	2.7	32.2	28.6	2.9	3.4	2.1	13.0	2.0	4.0	1.4	3.0	0.2	0.0	0.2	8.2	3.2	5.2	3.3	5.3	0.0	13.6	36.2	0.9	13.9	2.0	0.9	18.5	25.3	2.8	0.0	0.2	3.0	12.3	1.4	1.3	2.2	0.1	1.4	14.8	16.6	6.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	2.5	0.6	0.5	0.0	0.3	0.0	0.0	0.3	0.0	9.4	1.0	4.2	1.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	18.0	0.0	5.9	0.2	0.0	0.0	0.0	0.0	1.3	7.8	0.0	0.2	0.8	0.0	4.0	0.0	0.0	0.1	6.9	49.3	4.3	2.0	0.0	1.8	0.0	0.3	0.0	0.0	2.9	8.2	0.7	0.0	3.2	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	10.8	0.0	18.1	13.0	2.0	0.0	0.2	0.0	0.0	1.4	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	162.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	22.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	207.8	0.0	0.0	0.0	0.0
LRPAP1	"A2MRAP, HBP44, RAP"	ENSG00000163956	"LDL receptor related protein associated protein 1"	P30533	4	3503612-3532446	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 584.3;Syncytiotrophoblasts: 693.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008001, CAB025518"	Enhanced	Supported	Supported	"Endoplasmic reticulum"		NA	NA		810000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB025518: , HPA008001: AB_1853292"	"unprognostic (3.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (4.67e-11)"	"unprognostic (6.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.61e-2)"	6.6	9.0	6.6	2.6	10.3	6.0	6.4	8.6	7.6	8.9	10.7	7.6	3.3	8.6	3.2	5.8	7.5	1.9	19.3	5.8	8.1	12.7	9.6	8.5	2.1	8.0	6.9	9.5	14.4	7.7	14.4	6.3	7.9	8.2	1.7	2.8	10.1	4.1	8.9	6.3	6.7	1.9	5.2	8.6	9.2	9.2	7.5	1.6	8.9	2.4	1.4	7.3	6.3	6.3	3.7	7.4	5.7	8.2	5.5	2.9	12.5	5.9	4.8	4.3	3.1	14.9	7.0	2.1	6.0	4.2	7.0	6.2	3.4	5.8	2.4	1.6	7.9	2.9	7.8	10.4	4.2	4.7	12.5	4.0	4.3	3.9	1.9	4.7	5.2	3.9	5.1	7.0	3.6	5.9	3.1	18.4	4.9	5.1	7.8	4.3	4.2	7.1	4.8	8.6	5.6	4.6	7.4	3.0	8.1	3.4	6.7	8.6	5.6	5.1	4.7	4.1	8.2	4.2	2.9	2.8	5.9	13.3	7.2	21.9	23.2	60.1	9.3	19.7	8.1	9.9	8.6	8.8	13.3	10.0	9.4	8.6	20.5	11.7	19.1	10.2	11.5	27.3	6.6	10.3	8.6	7.6	5.8	8.1	8.0	6.9	7.9	5.2	7.5	6.3	95.0	109.0	90.9	21.2	78.0	67.8	174.6	267.7	52.9	70.6	75.3	84.2	165.9	108.7	158.7	195.0	45.9	584.3	75.8	147.7	50.9	159.3	40.4	85.5	229.6	88.2	82.6	35.7	22.5	107.9	184.0	152.5	79.0	71.2	81.1	102.3	62.4	92.6	243.1	38.7	20.6	121.6	164.8	100.5	80.2	60.0	126.2	154.2	147.7	16.9	107.1	140.0	91.6	28.1	16.7	95.4	153.4	151.6	205.2	124.5	204.6	273.7	144.8	86.2	78.9	82.8	108.1	272.5	161.4	40.7	61.4	693.5	86.0	99.9	109.9	140.5
LRRC47	"KIAA1185, RP1-286D6.3"	ENSG00000130764	"Leucine rich repeat containing 47"	Q8N1G4	1	3778559-3796498	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 69.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008512, HPA012018"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		29000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli fibrillar center"		"HPA008512: AB_1853324, HPA012018: AB_1853322"	"unprognostic (2.25e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.75e-4)"	"unprognostic (9.07e-2)"	"unprognostic (4.81e-2)"	"unprognostic (9.89e-2)"	"unprognostic (2.25e-1)"	14.7	17.4	17.5	7.0	17.2	11.7	14.6	15.8	18.3	15.2	15.3	19.8	9.9	18.4	8.6	17.6	16.2	6.3	27.3	17.6	18.0	13.7	23.8	11.2	9.9	19.9	17.1	18.7	23.0	12.2	16.3	9.5	17.7	15.9	6.4	8.2	15.9	11.3	69.9	21.8	14.3	8.5	15.7	15.3	17.4	13.5	17.1	9.4	14.3	25.9	8.2	18.6	14.7	18.6	17.9	20.7	14.7	24.2	15.4	12.3	14.6	15.2	11.6	19.6	15.3	25.6	19.4	18.6	21.8	16.5	15.0	24.4	18.1	18.8	10.7	23.8	33.1	34.1	23.5	28.6	23.8	23.3	12.3	14.6	16.3	19.5	15.5	12.7	14.0	23.6	31.9	5.3	14.4	18.9	25.9	27.1	33.4	17.6	31.3	25.1	14.6	22.2	13.6	13.0	30.5	30.1	19.0	28.3	30.5	14.3	15.4	17.4	19.2	16.2	9.4	24.4	20.0	39.6	39.6	21.1	9.7	31.6	6.6	3.8	2.8	1.5	2.3	3.3	2.4	1.7	2.5	3.6	3.5	1.9	2.9	3.0	1.8	3.1	2.6	3.0	2.6	1.7	17.5	17.2	15.8	18.3	17.6	18.0	19.9	17.1	17.7	15.7	17.1	18.6	18.4	16.0	24.1	10.4	20.5	15.6	16.6	8.0	22.2	32.1	18.7	13.1	62.0	27.1	13.3	27.6	14.6	58.3	30.7	22.6	19.6	13.4	1.6	15.6	19.0	16.7	21.6	18.7	11.4	15.0	39.0	22.0	26.5	14.4	11.4	28.2	21.4	33.1	26.7	38.7	11.6	24.7	10.2	17.9	8.8	3.5	22.1	16.8	8.8	7.5	20.6	31.9	29.9	12.5	12.7	13.7	21.6	23.7	21.6	19.5	25.3	22.5	11.4	20.9	13.1	27.3	23.9	20.4	37.1	26.2	21.6	48.2	20.5	32.4	33.1	13.3
MAB21L4	"C2orf54, FLJ22671"	ENSG00000172478	"Mab-21 like 4"	Q08AI8	2	240886048-240896889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 262.6;vagina: 80.4"	"Cell type enriched"	"Detected in single"	7	"Cytotrophoblasts: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 45.9;HaCaT: 34.3;SK-BR-3: 117.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052722			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA052722: "	"unprognostic (5.86e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.77e-4)"		"unprognostic (1.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.05e-1)"	0.2	0.1	0.3	1.0	0.5	0.0	1.8	0.5	1.3	36.0	0.0	2.9	11.5	0.2	0.1	262.6	0.9	0.5	0.1	0.8	0.0	13.3	13.0	10.0	0.3	0.3	0.0	0.1	1.2	0.0	0.2	0.8	0.5	1.5	2.5	0.3	29.2	0.2	0.3	60.8	4.9	0.1	0.0	0.2	5.8	0.2	0.2	1.1	0.1	0.0	23.5	2.0	80.4	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	45.9	2.7	0.3	0.3	0.0	0.0	34.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	5.7	0.1	0.1	0.2	7.3	0.0	0.1	0.0	11.4	0.3	5.9	2.3	0.0	0.0	117.0	0.0	0.2	0.9	0.7	0.0	0.0	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.3	0.8	0.0	0.3	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MAGEA8	"CT1.8, MAGE8, MGC2182"	ENSG00000156009	"MAGE family member A8"	P43361	X	149881141-149885835	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 13.3"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 74.6;Extravillous trophoblasts: 35.2;Syncytiotrophoblasts: 77.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"U-2 OS: 33.8;U-266/70: 63.6"									HPA003998	Enhanced					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA003998: AB_10965020"	"unprognostic (6.81e-2)"	"unprognostic (7.56e-2)"		"unprognostic (1.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.80e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	63.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	74.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.9	6.3	0.0	0.0	77.7	0.0	0.0	0.0	0.0
MAGED1	"DLXIN-1, NRAGE"	ENSG00000179222	"MAGE family member D1"	Q9Y5V3	X	51803007-51902354	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 335.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 534.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043645			Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA043645: AB_2678597"	"unprognostic (5.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.14e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.71e-3)"	32.4	125.4	69.8	37.7	73.1	16.7	38.0	34.7	71.1	99.7	99.2	40.0	32.4	57.3	102.4	26.6	64.7	58.8	70.2	70.7	108.8	43.0	71.5	40.4	29.2	57.4	66.2	62.5	80.2	76.8	157.0	116.2	76.3	71.7	39.6	37.1	85.3	89.0	46.8	29.9	32.3	77.6	62.0	35.4	54.6	56.5	84.7	49.0	73.7	39.1	31.6	45.4	35.5	49.7	21.3	76.2	238.5	205.8	184.3	330.4	128.1	281.2	357.7	152.5	240.0	157.3	71.0	29.9	53.6	534.9	54.4	15.6	215.5	99.6	113.2	31.8	83.1	20.3	0.4	205.7	140.9	75.8	35.8	312.2	35.0	128.6	29.1	267.7	184.8	77.1	31.5	57.6	310.5	194.8	87.7	25.4	187.6	69.4	154.3	88.4	154.2	4.1	156.7	37.4	60.9	340.1	0.0	80.6	41.9	232.0	145.6	18.8	185.6	66.1	166.5	234.7	31.8	37.5	59.5	60.3	257.9	6.9	175.1	1.5	4.4	3.1	21.1	6.0	18.7	17.2	13.7	18.5	13.2	19.4	17.1	20.5	1.3	16.3	6.1	55.8	21.1	14.3	69.8	73.1	34.7	71.1	70.7	108.8	57.4	66.2	76.3	62.0	84.7	49.7	12.2	76.9	34.5	85.8	17.1	11.5	20.4	48.1	12.5	33.2	41.9	27.9	53.4	32.9	63.8	35.0	8.4	335.2	17.1	18.6	29.4	47.9	2.5	35.6	73.4	24.5	57.1	13.9	97.5	49.9	171.5	69.5	34.7	54.3	17.7	60.7	39.7	62.5	114.6	45.4	138.5	74.4	54.9	9.2	6.8	10.0	43.2	6.3	24.9	42.2	4.9	39.7	13.4	101.6	55.0	33.5	13.5	57.6	72.6	20.2	15.9	33.2	48.3	12.5	13.1	28.2	50.0	5.7	5.9	12.4	8.2	185.7	11.9	169.9	25.2	18.8
MANSC4		ENSG00000205693	"MANSC domain containing 4"	A6NHS7	12	27762427-27780236	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 2.1;Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA039454, HPA039682"	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"		"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA039454: AB_2676515, HPA039682: AB_10805483"	"unprognostic (1.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.25e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.50e-3)"	"unprognostic (7.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.10e-2)"	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.6	0.3	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.4	0.0	0.2	0.5	0.3	0.1	0.2	0.2	0.0	0.7	0.5	0.1	0.1	0.0	0.5	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	1.5	0.3	0.1	0.1	0.1	0.3	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.6;epididymis: 36.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 93.0;Excitatory neurons: 45.5;Inhibitory neurons: 55.2;Spermatocytes: 57.8;Spermatogonia: 134.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"A549: 13.3;CACO-2: 19.3;HEK 293: 25.0;HeLa: 21.4;Hep G2: 11.4;SCLC-21H: 29.1;SiHa: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA051508: AB_2681513, HPA059537: AB_2684054"	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.2	2.8	11.6	0.3	15.3	0.7	0.4	12.5	66.6	0.3	0.0	0.7	0.7	0.6	36.4	0.2	2.3	0.5	0.4	13.9	16.3	3.5	0.1	0.2	0.2	35.8	7.0	0.3	1.1	0.0	3.9	7.6	28.9	0.8	0.8	14.6	0.2	2.0	0.5	0.9	1.2	0.4	3.0	0.1	8.7	9.6	17.1	2.3	0.1	0.1	0.3	0.1	0.3	20.0	0.0	13.3	1.1	0.1	0.1	0.3	0.0	1.4	0.0	0.2	0.1	19.3	0.5	2.3	2.0	0.0	0.2	0.0	0.0	0.0	0.1	1.0	25.0	0.0	21.4	11.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	5.0	1.0	0.0	0.3	0.0	0.0	1.5	0.0	29.1	5.0	12.8	4.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.5	1.4	0.1	1.4	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	11.6	15.3	12.5	66.6	13.9	16.3	35.8	7.0	28.9	3.0	17.1	20.0	0.2	3.2	0.0	4.6	0.6	1.8	0.3	7.2	0.6	29.1	0.9	1.1	1.2	0.0	2.5	0.0	2.1	93.0	0.8	2.2	3.9	1.3	16.4	0.6	0.2	0.7	9.6	0.0	45.5	0.9	9.2	1.1	28.1	0.7	0.0	12.3	0.0	0.2	6.1	18.5	55.2	0.6	2.0	0.0	0.7	17.8	0.6	0.7	0.0	6.5	0.0	2.8	0.0	11.1	3.6	0.8	4.8	1.9	0.9	1.0	3.5	18.8	6.9	8.1	0.0	0.6	0.8	57.8	134.9	0.9	1.6	30.6	0.4	0.9	1.3	0.5
MBNL3	"CHCR, FLJ11316, MBLX39, MBXL"	ENSG00000076770	"Muscleblind like splicing regulator 3"	Q9NUK0	X	132369317-132489968	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.3;placenta: 170.8"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 328.3;Hepatocytes: 119.6;Syncytiotrophoblasts: 344.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 123.8;Hep G2: 171.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001584	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Golgi apparatus"	"HPA001584: AB_1079326"	"unprognostic (3.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.37e-1)"	6.8	11.6	1.3	8.7	1.9	14.8	4.7	1.7	1.0	3.7	2.4	11.7	9.9	4.9	24.3	10.9	9.4	5.7	9.7	1.1	4.4	8.0	59.3	5.9	13.8	3.6	3.1	4.8	10.0	4.2	1.6	170.8	3.2	4.0	11.5	0.1	6.6	11.1	0.6	12.6	9.8	4.0	2.0	11.3	13.0	42.8	1.6	14.3	8.2	3.4	15.1	8.5	2.8	3.7	7.2	0.0	8.6	1.4	1.6	3.6	15.7	0.5	3.2	1.1	0.0	123.8	22.7	32.6	0.7	1.3	1.1	7.7	19.8	8.2	0.8	3.3	7.6	29.1	25.9	171.5	1.5	32.9	10.2	1.5	7.1	0.0	3.6	0.1	1.1	20.4	2.6	9.2	1.6	19.2	56.3	12.5	1.3	27.5	1.6	53.2	10.7	18.6	5.7	18.6	3.1	10.5	14.8	8.6	4.3	15.1	3.1	8.4	3.9	6.3	1.2	8.2	6.7	18.2	13.0	47.0	1.2	21.8	20.2	11.9	7.9	5.5	16.6	9.9	14.4	20.6	9.8	11.6	8.8	25.5	10.0	11.2	1.2	18.7	21.7	17.0	2.2	9.1	1.3	1.9	1.7	1.0	1.1	4.4	3.6	3.1	3.2	2.0	1.6	3.7	4.1	3.2	6.8	16.0	16.9	8.8	2.2	2.1	5.2	0.7	3.5	3.6	14.7	41.5	5.0	11.0	0.0	328.3	9.5	12.8	3.9	1.5	5.8	12.6	1.3	3.6	6.7	55.8	0.9	5.4	56.6	7.5	15.3	6.6	8.8	6.8	6.4	119.6	29.3	0.0	0.9	9.8	0.0	27.2	6.5	9.4	23.0	9.6	7.2	30.0	10.6	0.2	9.2	0.0	20.6	1.3	3.6	50.8	12.2	1.4	6.4	9.7	4.5	1.9	0.0	3.1	2.7	2.1	1.7	13.6	8.5	344.1	10.3	5.7	10.3	3.3
MDFI	I-mfa	ENSG00000112559	"MyoD family inhibitor"	Q99750	6	41636882-41654244	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 221.7;Extravillous trophoblasts: 113.7;Pancreatic endocrine cells: 134.9;Syncytiotrophoblasts: 138.7;Urothelial cells: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 80.5;HBEC3-KT: 117.2;OE19: 100.0;REH: 315.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 17.0"	"Low region specificity"	"Detected in all"			HPA049973	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA049973: AB_2680975"	"unprognostic (9.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.82e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.32e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.66e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.22e-2)"	33.0	4.3	3.9	5.7	4.2	0.2	23.1	4.1	5.8	23.2	4.3	2.5	1.7	5.8	1.2	44.7	10.0	12.8	8.8	3.5	4.3	5.5	1.5	18.6	1.7	8.2	5.8	15.6	3.2	1.6	9.1	11.0	6.3	14.3	0.4	0.1	22.4	2.2	0.9	15.4	3.2	2.5	3.6	0.3	4.6	5.0	4.6	1.5	4.6	1.1	2.5	13.6	27.1	4.2	60.1	0.2	50.4	0.1	0.1	0.0	80.5	0.0	0.0	0.0	0.0	0.0	28.2	0.1	18.2	0.0	0.3	48.4	13.8	117.2	0.0	0.0	0.0	0.4	0.0	2.5	2.2	0.0	0.3	3.6	53.3	0.6	24.6	0.0	38.4	16.1	0.2	0.3	0.0	0.0	41.8	0.4	34.4	100.0	1.6	315.3	29.6	0.5	3.3	9.2	9.4	23.2	0.6	43.1	0.0	34.5	0.2	4.0	40.3	0.1	44.1	0.5	1.7	0.1	0.3	0.1	0.3	2.8	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.2	4.1	5.8	3.5	4.3	8.2	5.8	6.3	3.6	4.6	4.2	1.8	0.0	0.0	0.0	0.0	24.5	48.6	36.8	12.0	0.5	18.9	16.9	0.9	0.0	8.2	5.5	0.0	221.7	0.2	0.4	0.0	33.8	0.5	0.5	1.7	12.7	0.0	0.0	0.1	51.2	113.7	12.8	0.0	0.7	0.0	10.0	7.9	0.1	19.6	0.0	0.3	1.2	6.1	0.0	4.5	0.5	39.1	0.4	0.0	2.8	0.6	0.0	0.0	4.5	0.2	134.9	0.0	6.0	0.0	55.6	0.0	0.0	3.5	0.0	0.0	19.7	9.1	0.1	7.9	10.7	9.1	138.7	0.6	2.7	0.3	73.5
MEAK7	"KIAA1609, mEAK-7, TLDC1"	ENSG00000140950	"MTOR associated protein, eak-7 homolog"	Q6P9B6	16	84476355-84554033	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 40.4;Syncytiotrophoblasts: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041020	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA041020: AB_10794184"	"unprognostic (8.35e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.97e-4)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (3.94e-1)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (7.05e-5)"	"unprognostic (2.92e-2)"	"unprognostic (6.78e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-2)"	3.0	2.2	3.5	3.6	3.0	1.3	4.7	2.1	2.8	4.6	3.4	4.8	4.1	4.7	5.6	12.8	3.7	4.3	2.4	4.0	2.0	4.5	3.4	4.1	4.5	4.1	1.7	5.1	2.6	6.4	2.0	10.8	4.2	4.7	4.9	6.4	3.8	3.8	3.0	7.2	5.4	4.2	0.3	3.4	4.0	2.2	2.3	4.5	4.9	2.1	6.4	7.2	6.6	4.2	29.1	20.0	17.1	9.2	7.8	13.3	8.1	21.1	18.8	21.2	6.1	11.5	34.2	4.0	11.1	40.8	15.5	31.5	4.9	56.1	27.7	2.2	4.2	3.2	9.7	10.0	9.6	2.5	9.6	9.5	23.9	19.8	25.8	17.1	9.0	11.1	5.3	4.7	14.3	6.8	2.2	2.5	5.2	15.1	7.0	9.0	4.3	1.3	18.7	15.9	5.6	4.0	19.1	13.5	9.4	17.9	19.1	3.9	22.0	14.6	6.7	7.8	8.8	3.7	6.7	10.6	8.8	1.3	5.1	16.9	2.9	4.0	3.3	2.4	3.1	2.8	5.6	4.6	2.5	2.3	6.1	3.8	2.3	2.8	3.2	0.6	8.0	2.5	3.5	3.0	2.1	2.8	4.0	2.0	4.1	1.7	4.2	0.3	2.3	4.2	5.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	40.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	10.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	47.1	0.2	0.0	0.0	0.0
MED20	"DKFZp586D2223, PRO0213, SRB2, TRFP"	ENSG00000124641	"Mediator complex subunit 20"	Q9H944	6	41905354-41921139	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040717	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Centrosome	Nucleoplasm	"HPA040717: AB_10794146"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.58e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.31e-1)"	8.1	11.8	6.3	7.7	7.3	6.1	10.9	9.1	8.0	10.6	7.9	10.6	10.5	9.7	13.5	9.8	9.9	7.7	11.6	6.5	7.1	12.8	10.4	7.4	10.0	6.6	6.6	8.2	9.3	10.6	6.4	13.6	7.0	11.2	11.8	5.9	8.7	10.2	14.5	9.7	8.7	12.0	5.8	9.2	9.7	7.4	7.2	12.7	11.9	16.6	13.3	10.2	7.6	9.0	28.5	23.0	25.7	32.1	23.1	24.8	31.7	18.2	17.1	25.9	20.5	29.5	20.3	41.4	34.3	23.0	15.5	22.0	39.7	26.4	31.2	22.2	14.7	37.5	19.6	28.6	23.9	30.5	22.2	18.6	36.8	22.5	33.3	19.6	33.9	36.4	49.0	19.3	32.7	25.7	36.3	22.3	35.1	93.5	19.3	48.0	29.4	15.1	34.9	19.9	23.7	18.6	25.3	12.6	26.5	28.7	24.7	32.4	33.2	18.2	38.9	11.4	22.5	19.3	27.1	85.7	9.9	33.3	26.3	18.7	24.9	18.4	10.7	29.4	14.0	19.0	7.3	12.2	26.1	23.6	9.4	11.3	9.3	17.4	20.7	23.5	14.4	16.7	6.3	7.3	9.1	8.0	6.5	7.1	6.6	6.6	7.0	5.8	7.2	9.0	4.4	9.6	3.9	2.3	6.6	3.7	4.2	7.2	6.8	2.4	7.0	5.1	5.2	2.8	6.8	7.3	0.0	22.7	7.3	6.6	7.9	6.9	0.6	5.1	7.1	4.2	9.6	8.0	2.8	3.3	18.6	5.0	6.1	6.7	7.0	8.3	8.6	8.3	8.7	1.7	2.8	5.6	14.2	6.3	2.6	0.7	3.4	3.7	1.8	4.7	6.3	3.7	7.2	5.5	3.0	4.9	3.1	6.8	5.7	4.7	5.8	10.1	4.6	4.2	0.0	3.6	4.9	8.3	13.6	5.8	5.7	24.9	3.0	7.1	7.2	5.4
METTL21C	"C13orf39, LOC196541"	ENSG00000139780	"Methyltransferase like 21C"	Q5VZV1	13	102685744-102694504	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"epididymis: 34.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 3.1;Early spermatids: 2.4;Late spermatids: 4.8;Syncytiotrophoblasts: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"		"Cluster 47: Cytotrophoblasts - Unknown function"								"unprognostic (2.07e-1)"					"unprognostic (1.63e-6)"		"unprognostic (2.64e-1)"						0.0	0.0	0.6	0.0	0.7	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.3	34.6	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.0	0.0	1.5	0.3	1.1	0.0	0.1	0.0	2.1	5.2	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.5	1.3	0.4	0.1	0.2	0.3	0.3	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0
MFSD5	"HsMOT2, MGC11308"	ENSG00000182544	"Major facilitator superfamily domain containing 5"	Q6N075	12	53251251-53254406	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039773	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA039773: AB_10793920"	"unprognostic (9.42e-3)"	"unprognostic (9.03e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.43e-6)"	"unprognostic (2.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.25e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.19e-2)"	18.5	28.8	15.9	12.2	16.9	22.1	16.5	18.1	17.7	19.7	18.8	19.1	13.5	16.6	12.8	61.3	13.3	11.4	21.8	16.0	17.0	19.3	15.8	15.6	14.7	17.4	17.2	9.9	22.1	19.8	11.7	16.1	17.2	15.7	14.6	26.9	26.1	13.3	19.0	60.1	18.5	13.4	17.4	20.4	19.6	10.6	17.7	9.8	12.9	14.0	20.3	18.2	30.6	18.9	23.8	51.1	15.2	27.9	57.7	32.7	17.6	34.7	43.3	36.4	34.1	27.2	43.8	19.4	29.6	50.1	34.4	43.1	24.9	28.7	24.2	25.0	34.7	14.8	18.6	36.2	40.0	28.6	35.8	40.8	39.5	34.5	17.1	39.4	33.7	18.7	27.8	34.4	35.5	89.2	14.0	35.3	26.4	27.3	44.5	17.1	15.3	26.3	26.8	41.1	12.5	18.8	25.0	34.3	28.0	17.8	59.6	26.4	32.2	30.9	20.0	32.0	22.8	20.8	27.3	15.1	41.1	27.4	30.2	58.3	32.3	103.7	26.6	25.9	32.7	50.1	31.4	30.2	38.1	44.6	23.4	22.4	17.5	27.8	17.7	31.9	27.9	23.4	15.9	16.9	18.1	17.7	16.0	17.0	17.4	17.2	17.2	17.4	17.7	18.9	5.5	9.6	10.6	6.2	12.1	13.0	5.8	15.9	14.2	5.4	9.4	7.4	9.5	10.0	18.1	12.9	31.3	38.4	7.8	20.3	5.9	20.4	0.5	5.2	8.0	10.8	2.4	9.9	2.2	26.5	24.5	12.1	9.2	7.7	5.7	7.6	11.4	10.9	28.6	3.3	2.7	10.9	10.2	18.8	13.4	2.0	6.2	11.7	16.0	0.0	17.2	7.8	14.4	3.5	3.4	21.9	13.3	4.9	10.9	8.7	12.0	10.9	10.3	14.3	6.6	7.7	8.4	4.7	14.2	21.3	17.0	33.2	12.1	6.2	8.5	7.9
MGST3	GST-III	ENSG00000143198	"Microsomal glutathione S-transferase 3"	O14880	1	165631213-165661796	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 2092.0;Syncytiotrophoblasts: 2371.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 793.9;OE19: 781.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053311, HPA077929"	Enhanced		Approved	Nucleoplasm		NA	NA		27000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA053311: AB_2682108, HPA077929: "	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	260.2	163.3	218.0	57.7	224.9	126.2	196.5	245.4	273.1	96.6	214.1	219.6	358.6	91.9	520.6	97.6	112.3	114.4	770.2	232.6	258.0	254.3	166.8	117.5	48.9	239.5	228.8	118.0	90.1	139.1	86.1	173.2	248.3	113.4	217.8	89.9	164.0	114.8	568.0	87.8	301.6	118.8	227.4	54.4	163.0	64.2	230.3	51.9	142.9	578.7	47.7	107.2	90.0	240.5	178.2	128.0	150.0	106.1	533.4	312.1	653.1	158.1	244.2	119.1	205.2	126.8	219.1	10.9	117.1	198.6	117.8	204.7	36.2	155.2	118.5	793.9	94.5	27.1	84.7	60.4	144.9	45.0	58.9	284.2	107.5	178.0	62.3	239.4	202.0	54.2	72.3	65.6	233.6	37.0	48.9	97.4	292.3	781.6	165.8	44.8	63.0	22.2	599.8	159.4	104.1	134.2	148.7	181.1	313.2	308.4	139.1	215.9	174.7	135.8	82.6	92.9	110.8	49.7	37.0	5.8	239.8	109.7	92.3	44.8	172.9	81.2	107.2	150.2	107.9	79.3	130.5	117.3	138.0	78.2	81.4	89.1	32.3	62.3	195.0	58.2	125.5	185.0	218.0	224.9	245.4	273.1	232.6	258.0	239.5	228.8	248.3	227.4	230.3	240.5	915.1	102.5	164.8	48.3	87.6	228.3	251.8	603.8	111.0	144.6	177.0	267.6	670.1	301.7	292.6	557.3	266.9	2092.0	96.5	500.3	1001.8	380.2	18.2	325.6	132.6	268.0	152.8	785.4	75.8	425.9	1327.2	300.3	193.7	257.7	91.8	519.5	257.7	295.0	837.4	131.2	86.4	302.9	374.3	130.0	243.1	46.1	388.0	234.9	519.4	43.1	296.6	257.9	87.6	45.8	90.6	401.8	613.9	399.8	92.9	173.9	1004.1	1227.6	459.9	162.5	506.2	197.5	652.1	23.1	40.4	157.1	232.6	2371.4	123.1	288.6	440.7	237.6
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.7;Hepatocytes: 36.2;Sertoli cells: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.4;JURKAT: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045783, HPA058177, HPA075505"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	33.7	9.5	14.6	3.2	17.9	0.0	26.8	16.8	14.7	8.8	11.2	11.7	16.2	10.0	10.1	6.7	10.3	5.5	22.0	12.7	16.0	20.4	40.3	22.9	4.5	17.4	18.8	9.0	11.9	9.6	5.3	35.6	16.2	5.3	5.6	3.0	6.1	7.5	25.7	7.3	12.7	9.2	15.6	2.6	7.6	3.2	17.3	3.3	16.0	45.0	3.4	10.0	6.6	16.4	0.0	2.1	7.0	11.4	19.3	7.2	15.2	8.7	15.0	12.1	10.0	40.4	0.1	0.0	8.4	7.4	7.0	0.4	8.2	9.8	8.7	0.0	8.6	0.0	0.0	13.7	12.2	0.0	3.1	12.0	3.7	7.9	4.2	7.2	10.1	51.1	8.4	0.7	11.7	5.0	16.0	0.0	7.9	0.1	4.6	0.0	6.3	1.1	7.6	8.2	6.1	8.5	0.0	4.2	7.0	6.3	5.2	1.4	16.2	12.2	9.8	7.7	4.1	0.0	1.7	0.0	1.3	0.0	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	0.0	0.2	14.6	17.9	16.8	14.7	12.7	16.0	17.4	18.8	16.2	15.6	17.3	16.4	5.7	6.4	1.5	6.2	0.1	0.6	0.6	0.7	1.2	1.6	9.3	6.5	11.6	8.6	0.3	9.2	12.5	33.7	0.5	3.6	5.9	4.4	0.8	0.9	1.6	3.3	0.0	0.0	3.2	4.1	2.3	4.3	1.1	1.4	1.3	6.3	3.3	36.2	2.9	3.3	2.6	3.5	0.0	2.8	1.0	1.8	3.7	0.4	1.8	2.8	0.0	4.6	0.0	1.0	4.4	1.0	9.1	3.0	1.3	0.2	13.2	17.8	0.0	2.2	78.9	3.9	20.3	1.6	1.9	1.2	1.1	6.2	0.3	0.8	5.5	0.6
MORC4	"FLJ11565, ZCW4, ZCWCC2"	ENSG00000133131	"MORC family CW-type zinc finger 4"	Q8TE76	X	106813871-107000212	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 79.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Alveolar cells type 2: 130.4;Cytotrophoblasts: 329.8;Syncytiotrophoblasts: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000395, HPA015547, HPA050250"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.69e-2)"	13.4	30.9	24.8	7.8	35.5	11.8	12.2	47.8	51.0	12.1	17.8	8.5	10.4	11.5	16.3	9.6	10.4	10.1	7.0	32.4	22.4	10.8	21.1	8.8	5.6	11.1	11.4	17.4	15.1	11.7	6.2	79.9	16.6	12.4	10.8	22.3	10.9	11.5	20.2	18.7	10.0	11.4	3.9	6.0	8.4	20.2	16.6	5.6	10.2	10.3	7.0	7.5	11.1	55.7	29.8	121.0	11.4	26.4	35.0	40.3	60.5	28.7	30.8	14.6	18.3	64.6	13.1	3.7	14.2	30.5	23.9	22.5	39.8	25.5	17.1	4.6	23.0	6.4	40.7	27.1	25.6	4.7	13.9	20.8	24.3	19.6	28.6	85.7	13.1	4.1	3.9	41.4	32.7	26.7	10.7	6.4	8.9	82.0	45.2	4.2	22.9	4.3	47.0	23.3	9.2	11.5	35.4	33.9	23.0	15.9	19.7	5.0	12.6	22.5	21.4	44.7	15.7	11.1	16.2	11.5	24.0	3.8	16.2	8.3	1.5	1.8	1.9	1.3	1.7	1.7	1.9	1.5	0.7	2.7	2.1	1.7	3.7	1.5	1.7	2.5	1.5	0.4	24.8	35.5	47.8	51.0	32.4	22.4	11.1	11.4	16.6	3.9	16.6	55.7	8.6	131.4	130.4	6.2	5.1	17.5	19.1	4.9	21.1	5.4	11.5	9.5	3.0	10.0	61.8	5.5	4.2	329.8	10.4	3.6	21.5	9.9	0.9	6.2	11.5	13.6	1.8	0.4	4.2	7.4	28.2	33.4	10.2	15.5	66.3	10.3	7.5	24.0	23.4	1.7	6.5	10.5	6.1	2.1	5.0	1.8	11.1	8.2	12.4	3.7	0.3	6.7	3.1	15.1	8.7	7.5	6.7	11.7	5.8	16.4	4.4	12.7	62.2	7.2	26.3	16.9	12.0	9.9	26.6	19.7	16.1	257.8	11.9	10.1	10.1	11.8
MOV10	"fSAP113, gb110, MGC2948"	ENSG00000155363	"Mov10 RISC complex RNA helicase"	Q9HCE1	1	112673141-112700746	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031627			Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA031627: AB_2673966"	"unprognostic (1.44e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (9.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.48e-11)"	"unprognostic (4.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.21e-3)"	7.6	13.2	3.4	9.7	3.7	4.7	7.6	2.9	3.4	10.2	4.7	10.9	22.1	10.2	9.5	13.2	13.5	9.4	5.2	3.1	6.2	10.3	19.4	9.1	8.5	4.7	4.1	9.7	8.2	12.8	11.2	23.6	4.0	11.5	10.7	3.0	14.3	11.2	3.1	27.2	20.2	10.8	4.1	12.1	10.7	16.6	5.4	16.2	9.8	4.2	7.0	9.3	10.8	3.4	29.5	17.9	10.4	40.2	8.3	23.5	39.1	19.8	46.5	56.9	80.7	33.2	31.7	0.0	13.2	27.4	21.1	30.5	39.7	47.4	19.6	32.4	24.2	20.2	26.7	37.8	35.3	8.5	19.3	39.9	14.2	34.6	10.9	37.4	49.2	40.7	27.2	9.8	17.8	54.7	32.7	6.6	23.4	12.2	18.1	57.9	26.2	1.3	26.4	31.9	4.4	15.0	40.9	27.5	31.5	20.2	21.4	19.4	29.7	17.6	31.0	12.4	17.8	11.3	3.3	0.1	34.9	17.4	51.4	0.9	3.5	0.7	12.5	10.3	12.4	2.1	10.8	11.1	6.8	1.5	10.3	8.0	1.1	12.7	12.2	1.0	10.2	7.6	3.4	3.7	2.9	3.4	3.1	6.2	4.7	4.1	4.0	4.1	5.4	3.4	13.0	9.6	10.5	26.4	6.3	8.8	10.4	15.5	8.0	2.4	7.8	7.0	4.1	8.6	17.4	16.5	0.0	54.7	5.6	29.2	3.9	15.5	5.9	5.8	7.3	16.9	15.0	3.8	4.1	15.5	18.4	9.4	23.9	7.0	1.3	36.5	16.8	18.3	15.8	5.0	2.3	18.0	12.2	7.5	6.0	6.2	9.3	10.3	3.6	12.2	14.4	15.1	10.3	18.1	3.3	12.4	26.9	7.5	3.6	11.1	46.2	13.9	18.4	1.1	13.1	4.0	7.4	2.7	3.4	11.7	7.0	38.2	9.2	22.4	15.5	12.1
MPP1	"DXS552E, PEMP"	ENSG00000130830	"Membrane palmitoylated protein 1"	Q00013	X	154778684-154821007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 116.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 410.9;Erythroid cells: 393.8;Hofbauer cells: 291.9;Macrophages: 155.9;Syncytiotrophoblasts: 454.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 215.7;neutrophil: 202.1"	"Group enriched"	"Detected in all"	8	"dendritic cells: 57.7;granulocytes: 215.7;monocytes: 98.8"	"Cell line enhanced"	"Detected in many"		"HEL: 218.0;REH: 136.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076675	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		650000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"HPA076675: "	"unprognostic (2.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.60e-6)"	"unprognostic (6.69e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.68e-2)"	"unprognostic (6.67e-3)"	24.1	27.2	21.0	27.1	22.0	116.8	16.5	26.2	29.7	11.6	18.6	17.2	59.4	13.4	5.3	10.5	15.7	24.3	26.0	22.5	25.2	42.9	37.5	28.3	24.9	28.3	21.9	10.6	34.6	30.7	9.7	86.5	30.7	15.5	17.6	10.6	23.7	18.1	29.2	10.2	47.3	19.7	22.5	40.9	11.8	7.1	27.3	72.8	14.0	27.2	12.5	21.3	10.0	28.2	41.4	8.3	18.7	18.7	19.0	20.1	59.5	15.3	23.3	25.3	30.8	23.7	3.7	32.8	29.3	17.1	67.9	4.6	21.6	6.9	19.9	34.9	38.0	218.0	5.7	25.3	28.6	44.4	121.4	19.4	9.0	28.2	7.0	25.9	58.5	42.1	96.1	5.3	28.7	0.2	102.6	60.3	1.9	3.8	28.2	136.0	4.8	15.5	14.8	3.3	4.7	7.5	12.7	1.2	13.3	18.5	3.2	25.8	26.6	23.2	12.5	51.8	41.7	36.6	52.9	12.5	32.7	61.7	11.1	49.7	95.6	215.7	5.1	76.6	6.0	7.8	5.9	5.7	57.7	2.7	15.4	7.9	202.1	10.1	98.8	15.5	3.5	79.1	21.0	22.0	26.2	29.7	22.5	25.2	28.3	21.9	30.7	22.5	27.3	28.2	18.3	3.2	11.2	8.1	6.3	8.7	4.8	0.2	8.0	10.2	7.1	5.1	17.0	41.5	6.2	7.3	4.2	410.9	6.9	16.3	21.5	11.7	0.6	3.5	5.7	18.9	11.5	393.8	16.1	2.8	27.0	11.4	1.1	6.4	90.6	9.6	11.7	10.6	291.9	16.8	17.1	4.4	0.0	104.7	30.2	2.4	8.7	155.9	10.6	15.9	52.5	15.4	9.2	6.0	5.9	3.7	4.1	13.2	8.1	3.1	57.4	66.3	2.2	8.2	0.0	8.6	10.3	0.7	6.8	6.4	6.0	454.4	9.9	14.5	5.8	1.2
MRFAP1	"PAM14, PGR1"	ENSG00000179010	"Morf4 family associated protein 1"	Q9Y605	4	6640091-6642745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB042447, HPA056367"	Approved		Supported	Nucleoplasm		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB042447: AB_2145271, HPA056367: AB_2683107"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.03e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (2.90e-7)"	"unprognostic (1.24e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	227.9	291.8	348.2	126.4	355.0	108.2	209.1	360.6	382.1	222.2	330.6	254.2	147.1	254.8	207.9	189.0	221.4	134.3	260.4	335.9	359.7	266.1	245.3	203.4	114.8	409.8	362.8	243.2	156.1	260.7	262.1	194.2	367.5	193.0	132.7	165.7	164.8	207.0	372.3	179.8	163.4	215.1	358.3	181.3	196.1	154.7	359.7	131.0	177.7	308.2	132.8	220.3	194.6	389.3	344.4	371.8	311.7	360.9	373.9	336.6	245.7	444.2	407.3	401.1	398.9	368.7	362.7	214.4	333.0	411.9	455.0	192.2	425.4	462.3	482.5	85.4	306.6	319.6	430.5	405.8	349.7	241.6	151.2	351.0	416.2	369.2	371.6	380.2	452.2	185.9	427.9	136.4	401.2	432.5	182.2	565.1	387.7	297.6	472.6	233.6	564.5	182.3	490.3	255.6	488.0	381.6	287.7	204.2	429.7	270.4	569.8	291.2	408.6	350.3	235.2	262.6	592.2	196.8	266.4	351.5	362.5	507.6	347.7	202.0	186.2	163.2	126.9	154.0	127.9	89.4	125.3	127.0	177.8	94.8	127.8	126.3	198.6	137.1	153.1	143.8	147.1	196.4	348.2	355.0	360.6	382.1	335.9	359.7	409.8	362.8	367.5	358.3	359.7	389.3	141.8	160.3	158.9	14.4	84.7	188.5	262.6	155.6	130.9	113.9	148.6	155.2	227.0	163.0	124.4	88.3	16.7	547.5	103.7	83.8	219.2	241.8	43.1	161.8	184.2	196.4	178.1	123.1	18.7	204.2	312.7	197.2	69.8	166.8	150.4	141.4	171.4	179.7	200.4	111.0	20.9	129.7	130.2	144.4	114.1	65.1	314.0	106.8	126.3	12.2	158.5	270.7	113.3	12.5	33.7	189.0	121.3	304.6	61.1	257.3	168.0	252.6	126.0	111.5	216.9	230.7	197.7	349.3	211.8	126.3	173.8	322.2	121.4	337.1	138.3	236.7
MRPL44	"FLJ12701, FLJ13990"	ENSG00000135900	"Mitochondrial ribosomal protein L44"	Q9H9J2	2	223957463-223967714	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038147, HPA038148"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Mitochondria"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"HPA038147: AB_10671521, HPA038148: AB_2675863"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.33e-2)"	"unprognostic (6.65e-2)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-1)"	16.2	26.9	16.2	14.9	17.4	45.4	17.6	17.1	20.3	12.9	19.0	21.8	19.3	12.7	13.2	18.0	16.3	17.5	33.8	17.1	18.8	37.4	39.3	12.5	32.5	16.2	16.1	15.2	17.4	19.7	11.6	20.0	16.8	15.3	22.9	10.0	16.1	13.2	42.6	15.7	17.9	14.4	17.5	17.8	16.2	18.2	17.8	21.4	16.2	40.6	26.5	17.1	11.5	17.9	27.3	22.6	33.1	38.3	30.6	36.1	52.4	30.0	33.6	48.0	50.4	81.0	33.4	41.1	31.9	26.0	43.9	35.3	54.5	41.5	44.1	39.0	38.7	45.0	24.0	64.4	44.9	50.0	33.1	42.5	50.9	29.1	38.7	40.4	47.8	41.4	43.7	31.6	38.9	31.9	37.8	62.9	49.4	54.8	23.6	43.8	40.6	25.5	64.3	22.8	45.0	25.7	22.0	49.0	74.8	48.6	41.4	71.2	31.5	31.8	24.7	27.3	24.5	34.5	25.9	58.7	32.2	47.4	35.6	55.7	44.5	35.3	28.5	44.8	36.5	45.9	30.4	34.4	42.2	42.3	36.5	32.3	58.1	33.8	41.2	33.9	33.7	36.3	16.2	17.4	17.1	20.3	17.1	18.8	16.2	16.1	16.8	17.5	17.8	17.9	11.7	6.4	13.1	3.9	31.3	17.8	27.4	52.6	23.9	17.3	15.6	17.4	10.4	27.1	30.0	27.6	0.0	95.3	29.5	25.0	82.2	45.3	8.1	17.1	22.3	20.7	13.1	26.5	6.5	35.1	64.8	24.9	14.3	26.6	18.4	22.0	20.7	51.5	46.6	11.8	6.9	22.0	48.8	33.3	14.5	7.9	18.0	25.4	33.8	4.7	35.3	16.5	20.6	7.5	9.7	37.2	18.1	18.0	24.8	21.7	23.6	106.1	25.6	12.7	19.7	14.2	18.8	41.1	56.3	22.8	16.6	48.7	20.9	40.9	28.3	37.6
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724582-174730896	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 25.8;placenta: 33.6;urinary bladder: 17.5"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 162.6;Endometrial ciliated cells: 65.7;Glandular and luminal cells: 62.2;Syncytiotrophoblasts: 233.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 18.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 322.0"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.2"	"Low region specificity"	"Detected in many"			HPA005652	Uncertain		Supported	"Nuclear speckles"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.1	0.3	0.7	0.5	1.0	0.0	8.1	4.3	1.1	2.7	1.1	0.9	0.3	6.8	0.0	0.6	0.9	0.9	1.6	1.2	1.4	0.3	0.0	0.8	0.1	7.8	1.3	0.2	0.4	25.8	0.3	33.6	4.1	2.5	0.1	0.0	0.8	0.8	1.9	6.9	0.8	1.4	5.4	0.8	2.8	5.6	1.3	0.1	0.7	1.8	0.1	17.5	1.8	5.4	0.4	4.0	1.1	3.2	0.0	0.0	322.0	2.2	3.6	0.7	0.1	56.6	23.0	0.0	8.6	0.2	19.6	6.2	17.6	6.4	0.2	0.0	10.7	0.0	1.4	0.0	2.4	0.0	3.0	3.7	4.5	3.1	3.5	0.0	0.0	0.0	0.0	0.0	5.0	27.7	0.0	0.4	2.5	38.3	8.5	0.0	8.8	0.1	4.0	35.3	0.0	2.5	0.0	43.0	2.9	69.6	25.7	0.2	0.0	1.1	5.5	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	4.3	1.1	1.2	1.4	7.8	1.3	4.1	5.4	1.3	5.4	1.5	0.0	0.0	2.3	0.0	9.6	2.4	0.1	3.4	0.2	15.8	18.9	1.7	0.0	0.1	0.0	0.0	162.6	0.2	0.3	0.0	0.6	0.2	65.7	4.9	0.7	0.0	0.0	0.0	0.0	13.9	5.3	5.1	62.2	4.5	0.1	0.4	0.0	11.3	0.0	0.0	1.9	0.0	0.6	2.9	0.6	0.0	1.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.3	1.9	0.1	0.1	0.0	0.0	8.9	4.8	1.4	4.5	2.0	11.4	233.8	1.0	0.6	1.2	9.8
MTARC1	"FLJ22390, MARC1, MOSC1"	ENSG00000186205	"Mitochondrial amidoxime reducing component 1"	Q5VT66	1	220786913-220819659	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 192.3;breast: 86.2;liver: 84.5"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 109.8;Extravillous trophoblasts: 47.9;Syncytiotrophoblasts: 75.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"basophil: 30.2;classical monocyte: 33.6;eosinophil: 12.3;neutrophil: 42.8"	"Group enriched"	"Detected in many"	31	"granulocytes: 42.8;monocytes: 33.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 126.5;HeLa: 56.2;Hep G2: 67.6;NTERA-2: 57.8;OE19: 49.4"									HPA028702	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA028702: AB_10601135"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.50e-1)"	192.3	7.4	9.4	6.8	10.5	17.9	86.2	9.8	13.2	7.9	7.9	18.9	7.6	2.8	14.0	7.6	6.2	4.1	8.4	10.0	11.7	10.2	84.5	9.3	2.8	10.1	11.8	5.5	9.6	5.4	7.0	16.0	9.6	36.2	17.3	5.7	27.2	13.5	11.0	3.6	9.7	4.0	9.1	10.2	9.3	1.4	14.3	1.6	53.5	9.2	2.1	8.8	5.0	8.5	15.0	7.8	5.9	0.2	1.3	0.3	126.5	1.4	1.2	0.8	1.5	45.4	1.0	0.1	5.3	1.6	0.1	0.1	28.3	2.9	2.1	0.2	25.7	0.1	56.2	67.6	2.7	0.3	0.5	4.5	1.3	0.2	0.0	0.2	1.1	0.1	4.3	0.3	1.1	14.7	0.1	31.9	57.8	49.4	23.8	0.1	0.0	0.3	7.1	17.4	16.4	36.1	8.1	11.4	0.2	16.4	38.5	34.7	0.4	0.1	12.6	0.1	0.1	0.2	0.1	0.1	0.2	0.0	1.1	30.2	33.6	12.3	0.1	2.5	0.0	0.4	0.0	0.0	1.2	0.2	0.1	0.0	42.8	0.0	1.3	0.3	0.0	9.2	9.4	10.5	9.8	13.2	10.0	11.7	10.1	11.8	9.6	9.1	14.3	8.5	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	109.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	47.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	75.1	0.0	0.0	0.0	0.0
MTERF3	"CGI-12, FLJ10939, MTERFD1"	ENSG00000156469	"Mitochondrial transcription termination factor 3"	Q96E29	8	96239398-96261610	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007355			Supported	Mitochondria,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA007355: "	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (5.88e-5)"	"unprognostic (8.67e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.74e-3)"	15.0	16.3	16.3	15.3	16.9	11.5	17.9	18.6	21.8	14.0	20.9	14.7	12.6	13.5	22.9	11.6	12.7	12.4	27.8	16.1	17.3	18.3	23.1	12.1	18.2	16.4	16.3	12.1	15.5	22.3	12.6	16.7	17.2	13.5	14.4	16.0	12.9	17.2	30.2	17.0	11.5	16.6	15.9	16.0	12.7	11.8	16.6	16.7	11.9	38.2	19.4	16.4	12.0	17.8	41.1	25.9	38.1	30.3	26.4	27.4	17.5	30.8	25.0	43.9	44.2	18.8	29.6	36.5	63.3	18.2	22.5	22.8	39.7	24.1	53.2	35.6	29.3	52.5	20.6	22.8	37.1	17.9	20.7	27.5	35.4	35.6	33.5	22.9	36.5	39.0	45.1	18.7	44.7	26.9	76.6	52.8	19.8	71.6	39.8	45.9	31.2	28.8	32.7	21.8	25.9	20.4	23.0	6.6	33.8	24.5	34.3	25.0	16.3	30.9	20.8	36.0	27.7	21.3	28.9	43.2	33.4	47.3	41.3	39.5	13.4	6.1	15.6	15.9	22.6	20.4	17.7	17.8	20.2	17.7	19.8	20.2	2.2	23.8	15.8	24.3	18.6	10.1	16.3	16.9	18.6	21.8	16.1	17.3	16.4	16.3	17.2	15.9	16.6	17.8	10.4	3.2	6.9	7.8	10.8	0.0	21.2	0.0	10.8	0.0	6.6	8.5	31.2	5.7	5.6	5.5	0.0	30.4	10.8	0.9	13.7	12.5	5.6	6.2	10.1	8.1	0.0	12.4	12.9	9.8	21.0	12.7	4.1	5.4	6.3	11.2	6.1	8.0	16.2	0.0	12.6	3.6	0.0	5.2	0.0	4.1	13.7	7.1	0.0	4.7	16.0	0.0	15.5	7.5	14.2	7.7	3.3	13.9	7.0	22.9	3.3	11.1	5.1	0.0	13.1	10.3	9.9	28.2	21.2	9.1	0.0	17.4	8.8	9.5	5.3	11.7
MUL1	"C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218"	ENSG00000090432	"Mitochondrial E3 ubiquitin protein ligase 1"	Q969V5	1	20499448-20508151	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026827			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA026827: AB_10601137"	"unprognostic (1.39e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.05e-1)"	"unprognostic (9.10e-2)"	"prognostic favorable (6.15e-14)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	16.7	18.1	18.1	12.0	18.7	28.8	16.2	19.9	19.4	15.9	23.3	21.2	14.2	20.4	11.1	21.2	19.6	14.9	33.7	17.8	19.4	19.5	24.6	15.8	13.6	20.3	19.1	19.1	19.8	36.3	14.6	16.3	20.1	16.0	15.7	7.4	19.3	20.0	35.5	21.8	15.8	20.0	18.7	15.2	18.7	12.2	19.5	12.0	16.2	50.4	15.0	19.2	15.5	19.9	34.1	32.1	18.1	37.9	38.5	21.6	19.6	32.9	39.1	40.1	38.2	19.9	54.8	25.4	35.9	46.8	30.4	50.3	32.9	47.5	28.9	25.4	26.1	19.4	20.4	29.2	45.2	27.0	32.0	35.3	61.6	41.1	42.3	23.4	26.5	22.5	25.8	30.1	44.1	17.3	16.4	18.1	18.7	28.1	30.3	15.8	22.8	32.9	47.1	18.7	18.4	27.3	29.6	31.2	40.5	14.6	22.0	25.6	30.2	38.8	22.3	34.1	29.9	34.9	32.9	27.3	30.4	36.1	36.7	36.2	30.0	38.2	33.1	34.7	34.4	25.3	24.8	33.8	29.6	22.8	28.1	27.6	26.7	32.3	30.7	22.8	37.9	34.0	18.1	18.7	19.9	19.4	17.8	19.4	20.3	19.1	20.1	18.7	19.5	19.9	14.5	22.4	10.3	10.4	9.8	5.2	9.2	13.9	5.2	13.5	12.3	11.9	16.6	10.0	9.5	18.4	6.2	37.1	13.2	21.6	11.7	26.3	2.2	7.7	9.5	13.1	8.5	8.6	4.9	23.4	22.5	13.9	7.7	9.4	3.8	14.7	13.6	17.6	23.0	13.5	6.8	12.9	16.2	10.0	6.5	4.0	13.1	9.3	19.6	2.8	15.5	16.0	16.5	5.5	6.0	25.6	14.6	15.4	13.1	9.2	13.2	10.6	9.6	11.9	19.7	11.9	14.7	14.6	15.4	7.4	7.1	37.6	9.2	18.0	12.2	10.7
MUTYH	MYH	ENSG00000132781	"MutY DNA glycosylase"	Q9UIF7	1	45329163-45340893	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008732	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA008732: AB_1854219"	"unprognostic (6.30e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (4.76e-8)"	"unprognostic (2.80e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.05e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.49e-3)"	5.0	5.0	11.9	5.5	12.7	6.7	5.3	16.7	15.6	7.6	10.6	6.0	6.4	6.3	4.6	5.1	5.7	4.2	4.0	11.6	11.9	7.0	5.9	4.4	7.7	12.8	12.4	7.3	5.1	5.1	5.9	6.4	12.7	5.8	5.6	4.9	4.5	5.0	5.6	5.9	6.1	3.6	11.7	7.8	5.8	3.3	12.2	9.8	6.6	4.7	7.0	5.9	5.8	14.4	7.9	6.9	15.5	10.5	11.3	8.4	26.6	5.7	7.4	11.8	9.2	14.3	11.2	22.5	9.0	3.6	9.5	11.3	8.7	11.0	5.4	18.1	7.0	10.2	11.4	10.5	10.0	9.4	7.1	4.6	10.3	16.0	25.7	3.1	8.6	28.6	17.5	7.4	5.0	13.3	27.3	8.7	39.6	19.5	7.9	36.2	12.6	12.3	6.1	14.6	14.5	11.8	11.3	8.7	18.2	20.1	6.7	11.1	4.9	8.3	6.2	7.2	8.2	11.6	14.6	13.3	8.0	14.6	7.5	1.6	7.0	2.9	11.5	11.8	17.2	8.1	11.8	11.5	8.1	8.0	12.7	12.2	1.4	8.8	9.1	6.5	13.4	8.6	11.9	12.7	16.7	15.6	11.6	11.9	12.8	12.4	12.7	11.7	12.2	14.4	10.0	0.0	5.6	17.0	12.1	6.9	10.7	8.1	6.2	15.6	6.7	8.8	3.2	1.5	6.9	7.3	2.1	40.2	8.8	16.5	3.9	6.5	0.9	3.2	5.1	7.6	7.8	6.7	4.0	5.3	14.3	7.5	16.8	3.2	10.8	8.4	5.7	4.3	10.0	5.0	7.0	15.1	12.2	4.0	10.2	1.6	10.8	5.6	7.2	8.4	8.2	12.0	10.3	11.6	12.7	3.8	16.4	12.0	7.5	9.5	12.9	12.2	8.6	20.1	13.1	8.7	7.6	10.5	11.2	5.2	5.4	22.2	13.9	9.5	13.5	8.0
MYCBP	AMY-1	ENSG00000214114	"MYC binding protein"	Q99417	1	38862493-38873368	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 106.0;Respiratory ciliated cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041188, HPA078331"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (2.42e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (7.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.34e-3)"	"unprognostic (5.81e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.41e-2)"	11.5	11.0	2.6	16.9	3.4	16.1	18.7	3.4	4.3	12.5	3.7	22.6	16.3	9.6	17.4	23.1	27.1	11.3	8.4	2.4	2.9	18.0	11.5	12.4	16.3	5.6	7.4	6.7	16.1	18.6	8.7	19.3	4.5	14.9	22.5	8.6	16.8	16.1	12.1	13.2	21.6	11.7	2.7	11.2	16.1	15.5	3.2	12.6	18.5	5.6	17.9	16.8	11.7	5.6	51.3	22.5	18.0	13.0	10.7	18.4	74.4	38.9	12.9	38.6	29.7	27.8	56.5	42.1	43.3	18.3	6.5	35.8	29.1	51.9	46.0	52.3	49.7	44.1	29.5	26.7	2.8	107.7	38.9	16.4	38.9	32.3	20.3	14.7	28.3	45.6	64.1	35.8	41.4	31.3	35.1	54.9	47.3	75.3	53.4	33.4	54.4	58.0	50.3	40.6	34.9	23.5	37.0	47.5	25.7	42.4	33.5	52.6	23.2	20.4	33.5	31.2	45.6	25.3	48.7	45.1	20.5	63.9	26.0	51.6	32.8	85.2	18.8	39.7	21.6	22.0	22.1	22.5	40.9	17.7	18.8	21.4	64.4	27.2	38.0	54.3	33.8	22.6	2.6	3.4	3.4	4.3	2.4	2.9	5.6	7.4	4.5	2.7	3.2	5.6	9.2	9.6	13.1	0.0	18.7	10.6	15.7	31.8	22.2	0.7	25.9	14.1	7.9	20.0	37.5	27.6	0.0	106.0	26.7	35.1	64.6	27.0	68.3	84.1	11.4	11.8	9.6	38.7	0.0	27.2	86.2	9.5	21.9	17.9	26.1	9.3	8.9	15.3	21.0	10.1	0.0	25.2	26.4	15.0	14.8	25.2	7.2	20.5	19.6	0.0	31.0	5.5	18.6	0.0	0.0	29.7	40.2	9.1	69.6	18.2	31.2	50.3	142.2	5.0	6.6	6.7	14.8	29.9	64.5	53.4	17.8	88.1	19.3	14.0	31.5	22.4
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474207-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 171.9;Excitatory neurons: 221.3;Inhibitory neurons: 151.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"		NA	NA		28000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364"	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (6.42e-4)"	27.3	16.9	12.6	6.1	18.9	13.4	14.7	7.0	29.0	19.6	12.6	12.2	2.3	27.8	16.8	6.6	25.2	26.1	38.9	17.9	8.0	32.5	18.9	66.9	6.5	9.6	7.3	25.9	9.8	13.8	17.7	53.4	9.6	17.7	3.8	22.5	6.6	26.6	4.9	7.9	5.8	22.1	0.5	4.6	9.5	7.4	11.0	5.8	13.6	8.2	4.0	10.5	10.3	13.2	54.1	35.1	216.3	72.7	27.7	33.1	97.1	44.2	39.7	52.2	55.8	94.5	8.0	0.5	28.6	43.9	28.4	5.2	108.7	53.0	58.1	1.2	88.3	62.3	21.7	83.0	64.7	5.4	4.2	47.3	18.9	67.7	26.1	32.1	85.3	70.9	88.1	0.2	32.9	21.6	67.2	1.7	102.1	3.6	7.7	105.9	64.2	0.2	59.1	22.3	17.7	96.8	69.2	3.4	68.1	165.0	18.3	3.6	2.8	48.7	35.6	0.3	38.5	8.3	10.8	13.4	0.3	5.0	111.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	12.6	18.9	7.0	29.0	17.9	8.0	9.6	7.3	9.6	0.5	11.0	13.2	43.0	22.4	14.1	43.1	1.1	4.7	9.5	11.2	9.6	37.1	18.7	16.4	33.5	12.8	11.5	101.2	50.1	171.9	1.0	0.8	17.6	13.7	49.1	28.1	37.6	30.6	2.4	43.5	221.3	1.7	88.6	58.0	3.1	28.5	1.3	41.6	55.6	15.3	15.8	35.3	151.1	1.9	6.1	2.7	3.7	28.6	3.7	1.3	1.8	15.9	0.7	25.9	2.1	96.5	15.5	1.9	0.7	39.9	0.6	7.6	0.0	14.0	21.7	39.4	0.0	12.4	23.6	15.6	27.8	9.5	4.0	76.5	2.0	28.0	2.2	4.4
MYO7A	"DFNA11, DFNB2, NSRD2, USH1B"	ENSG00000137474	"Myosin VIIA"	Q13402	11	77128246-77215241	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 41.9;choroid plexus: 53.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 47.9;Cytotrophoblasts: 42.3;Hofbauer cells: 30.1;Kupffer cells: 17.8;Rod photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.6;intermediate monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.8;CACO-2: 9.0;RH-30: 19.5;RPMI-8226: 13.8;SK-BR-3: 10.5;U-937: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB034059	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB034059: AB_2148626"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.03e-2)"	5.2	41.9	2.5	3.0	2.9	1.0	3.1	2.2	2.7	1.9	53.2	2.8	2.2	1.5	1.2	1.0	2.7	2.8	2.5	4.0	8.6	4.3	23.3	2.3	2.9	5.0	8.3	5.2	5.4	0.5	19.1	16.0	8.4	2.4	1.2	27.4	1.5	0.8	1.4	0.8	2.8	2.2	3.5	15.8	2.2	24.5	5.1	1.4	2.0	0.7	1.1	2.0	1.6	4.4	0.0	1.3	0.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	9.0	2.0	0.0	2.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.7	0.0	0.3	5.7	0.2	0.4	0.0	0.1	0.0	0.0	0.5	0.0	3.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.3	0.0	19.5	13.8	0.0	0.3	2.9	0.9	0.1	10.5	0.1	2.2	1.3	1.3	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	2.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	2.5	2.9	2.2	2.7	4.0	8.6	5.0	8.3	8.4	3.5	5.1	4.4	1.7	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.0	14.2	0.5	0.5	4.4	4.3	0.0	0.0	47.9	42.3	0.3	0.2	0.0	0.6	1.9	0.1	0.5	2.2	1.2	0.0	0.7	1.7	10.5	1.4	5.6	0.3	0.0	0.8	16.4	16.1	30.1	0.0	0.8	0.7	0.0	17.8	0.9	6.4	3.1	7.3	0.0	6.5	0.8	17.0	0.0	3.0	0.1	0.7	0.2	0.4	0.1	0.1	1.7	2.7	0.1	31.4	0.0	5.2	0.3	0.4	0.6	0.1	0.3	16.1	1.4	3.2	0.6	0.2
MYORG	"KIAA1161, NET37"	ENSG00000164976	"Myogenesis regulating glycosidase (putative)"	Q6NSJ0	9	34366666-34376898	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Cytotrophoblasts: 55.5;Exocrine glandular cells: 11.8;Pancreatic endocrine cells: 10.3;Proximal tubular cells: 9.2;Syncytiotrophoblasts: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 35.4;SK-BR-3: 56.8;T-47d: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060533, HPA067487"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA060533: AB_2684311, HPA067487: AB_2685848"	"unprognostic (6.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.20e-13)"	"unprognostic (4.08e-3)"	"unprognostic (3.68e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.00e-3)"	8.1	6.2	30.6	3.4	30.3	2.0	3.4	27.1	31.5	1.7	16.8	19.0	27.3	2.7	1.9	5.3	4.5	6.1	3.9	28.4	28.2	14.5	41.5	3.2	1.5	34.0	33.5	1.0	11.1	1.5	5.5	19.8	28.7	3.2	16.2	3.4	5.6	5.2	84.2	3.7	25.8	4.4	24.5	1.4	15.0	1.3	31.8	1.1	1.9	39.2	1.8	3.1	2.4	24.2	8.1	5.5	9.2	5.6	3.8	1.2	19.7	1.4	1.1	0.8	1.3	13.9	8.3	4.4	15.9	1.4	4.0	16.4	6.7	15.5	1.1	1.4	3.6	0.8	24.6	35.4	0.5	0.8	2.7	1.8	7.2	2.6	3.0	4.3	3.8	3.3	1.1	4.2	2.0	13.4	2.5	1.2	5.5	27.4	4.4	4.0	4.6	1.3	4.9	2.9	1.3	13.0	10.8	56.8	0.9	7.8	52.8	1.3	3.2	1.8	11.0	1.6	3.5	2.8	6.5	1.6	1.6	3.1	1.6	0.4	0.1	0.2	0.7	0.1	0.5	0.2	0.4	0.4	0.0	0.2	0.2	0.3	0.3	0.4	0.1	0.1	0.6	0.1	30.6	30.3	27.1	31.5	28.4	28.2	34.0	33.5	28.7	24.5	31.8	24.2	3.9	9.6	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	0.0	2.5	3.7	0.0	55.5	0.3	0.0	1.9	5.7	0.0	3.4	0.7	2.1	0.0	0.0	0.0	11.8	3.6	1.1	0.0	2.0	1.3	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	9.2	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	17.4	0.3	0.1	0.0	0.0
NCSTN	"APH2, KIAA0253"	ENSG00000162736	Nicastrin	Q92542	1	160343316-160358952	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021982, HPA054846, HPA070642"	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB021982: , HPA054846: AB_2682624, HPA070642: AB_2686289"	"unprognostic (1.08e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.75e-9)"	"unprognostic (1.36e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.89e-2)"	51.0	36.6	30.6	42.1	36.1	38.1	43.9	38.5	32.5	52.4	42.0	58.4	80.4	40.3	56.4	35.1	49.7	42.9	50.6	29.9	35.8	59.7	59.3	56.0	38.3	40.0	34.0	51.7	63.8	86.0	30.1	98.7	41.6	45.2	60.9	48.1	60.5	47.3	37.6	38.9	63.5	52.1	37.3	46.2	45.7	41.8	36.4	40.0	63.8	38.4	43.0	45.6	31.5	48.9	52.1	57.4	100.4	82.8	301.0	153.4	108.3	104.0	177.0	95.4	109.9	47.9	140.0	36.6	208.6	209.3	67.1	81.5	47.3	95.9	82.4	56.5	42.3	36.6	70.9	70.0	118.6	82.8	152.0	155.7	92.3	94.3	93.6	207.2	139.9	54.3	66.9	100.2	142.2	34.3	26.8	39.8	82.2	130.6	33.8	35.1	59.9	103.6	130.5	69.9	34.2	75.6	109.1	118.5	70.9	158.0	108.2	186.3	125.5	70.3	46.4	48.8	79.9	130.8	194.4	38.6	106.6	49.8	129.4	71.4	79.0	67.8	27.4	79.0	26.2	31.1	23.5	24.0	75.1	27.8	23.9	23.3	69.2	36.6	79.6	45.1	26.5	52.2	30.6	36.1	38.5	32.5	29.9	35.8	40.0	34.0	41.6	37.3	36.4	48.9	28.0	6.4	9.3	0.0	23.0	10.5	23.8	59.5	15.9	20.0	27.9	23.1	14.6	45.8	42.6	53.3	52.1	107.7	27.8	53.3	7.9	38.9	2.6	19.2	19.7	23.9	20.3	17.2	0.0	27.0	95.7	33.7	17.9	30.2	13.3	25.8	29.6	31.4	58.0	18.5	0.0	31.8	46.8	47.1	18.8	4.7	27.1	33.4	17.8	0.0	31.7	35.0	20.6	0.0	0.0	34.8	33.4	21.1	33.2	15.6	66.1	24.7	28.7	26.3	26.3	23.8	19.6	44.6	35.9	15.5	11.4	147.4	16.5	32.5	29.6	20.5
NELFCD	"HSPC130, NELF-C, NELF-D, TH1, TH1L"	ENSG00000101158	"Negative elongation factor complex member C/D"	Q8IXH7	20	58981208-58995133	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050641, HPA066262, HPA074936"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear bodies"	"Vesicles, Cytosol"	"HPA050641: AB_2681198, HPA066262: AB_2685644, HPA074936: "	"unprognostic (1.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (4.98e-5)"	"unprognostic (6.20e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.07e-3)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	18.9	29.5	20.5	17.7	22.8	23.8	24.5	21.7	23.4	20.7	21.2	18.2	19.3	18.2	16.3	32.9	24.4	16.2	16.9	19.6	21.0	31.7	31.2	14.7	26.4	21.2	20.9	25.2	21.2	30.7	31.8	25.6	21.8	20.4	17.9	31.9	30.0	17.1	29.4	25.9	19.6	14.1	20.8	20.7	19.3	27.9	21.5	31.5	28.5	20.5	27.9	22.6	22.7	24.3	54.7	57.6	68.5	71.9	22.5	38.9	49.6	42.4	38.8	117.1	66.8	189.6	70.7	68.3	64.0	39.8	60.8	89.1	90.1	98.0	94.8	22.4	64.1	90.5	72.4	150.5	26.7	64.2	60.1	40.9	34.3	44.2	32.8	32.8	68.3	54.0	118.1	51.8	53.3	198.2	135.6	95.4	40.3	151.5	122.9	78.4	56.6	121.1	49.0	76.5	75.9	112.6	126.0	148.3	85.9	38.2	157.5	75.0	30.2	91.6	88.8	36.3	67.7	44.4	80.0	71.1	53.7	57.3	80.6	20.0	44.6	22.9	42.0	51.5	50.0	48.6	39.7	51.2	64.9	44.5	37.7	40.1	5.6	47.1	68.8	33.0	39.7	49.0	20.5	22.8	21.7	23.4	19.6	21.0	21.2	20.9	21.8	20.8	21.5	24.3	23.0	9.6	27.6	18.3	50.5	30.2	62.6	43.8	40.9	67.3	32.7	34.2	10.9	47.1	24.3	22.0	41.7	133.1	35.5	14.5	50.9	57.0	18.8	26.2	33.3	26.7	23.4	60.0	23.0	31.4	69.2	26.2	26.5	27.4	16.5	50.9	23.2	24.1	36.9	55.5	22.8	21.9	26.4	15.3	24.0	32.1	37.0	24.0	26.6	10.3	48.1	52.9	49.4	21.1	23.6	34.9	14.4	26.4	37.4	37.8	27.8	49.9	15.0	61.5	39.5	31.6	34.2	63.1	94.9	40.5	31.4	103.0	48.5	43.9	36.2	52.8
NFYC	"CBF-C, NF-YC"	ENSG00000066136	"Nuclear transcription factor Y subunit gamma"	Q13952	1	40691648-40771603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 347.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055011			Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA055011: AB_2682671"	"unprognostic (1.20e-3)"	"unprognostic (1.51e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (1.47e-2)"	"unprognostic (5.66e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.25e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.12e-1)"	"unprognostic (7.75e-3)"	27.2	26.9	29.4	29.8	30.6	40.6	29.6	37.7	35.3	31.9	37.2	31.3	28.9	32.4	24.0	33.6	31.1	23.7	60.8	31.0	28.9	31.8	33.8	24.3	37.1	28.6	29.6	40.6	32.7	50.2	20.9	30.2	28.5	25.8	23.5	27.7	46.7	24.5	72.9	42.9	29.6	28.9	28.0	39.7	31.2	22.7	31.4	41.1	34.8	63.5	33.8	29.4	30.3	33.8	34.7	46.6	67.3	51.0	26.6	24.1	67.2	28.3	31.5	49.4	46.2	65.4	85.7	83.0	43.2	27.1	43.7	40.8	54.6	42.5	51.5	50.6	57.7	90.1	33.8	59.9	31.6	48.0	73.8	26.8	45.2	48.9	51.4	38.0	32.6	62.4	40.3	51.5	23.7	47.6	86.6	47.3	58.2	41.4	36.0	64.2	71.7	74.9	46.6	41.9	45.8	42.4	33.9	73.4	77.4	77.2	33.3	347.6	29.8	22.9	77.9	40.5	42.4	47.6	84.0	68.9	53.2	61.1	62.8	54.8	61.8	64.7	28.4	69.3	29.2	47.0	37.6	32.2	59.8	43.1	40.3	30.5	103.2	41.3	81.1	46.2	44.2	41.0	29.4	30.6	37.7	35.3	31.0	28.9	28.6	29.6	28.5	28.0	31.4	33.8	27.3	19.2	21.3	51.6	40.0	29.2	28.1	25.5	31.3	18.6	22.6	24.5	32.6	15.7	20.6	11.0	10.4	74.4	22.6	23.7	37.2	27.6	9.2	14.8	22.0	29.0	16.3	39.5	37.6	37.5	51.9	21.7	25.5	21.7	38.0	25.2	26.0	23.1	51.9	25.2	46.8	21.9	30.5	30.5	31.6	6.2	27.7	33.0	17.8	49.6	44.2	29.3	25.7	39.2	41.9	26.8	18.7	21.4	33.6	19.6	25.2	22.3	10.7	12.6	19.7	24.0	27.5	43.8	39.1	27.3	32.4	76.1	30.2	27.7	27.4	25.1
NMRAL1	"FLJ25918, HSCARG, SDR48A1"	ENSG00000153406	"NmrA like redox sensor 1"	Q9HBL8	16	4461691-4495763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041353, HPA062287"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA041353: AB_10796343, HPA062287: AB_2684738"	"unprognostic (2.56e-1)"	"prognostic favorable (3.33e-7)"	"unprognostic (4.16e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	20.8	39.6	40.2	8.8	42.5	13.4	25.5	41.2	49.4	25.5	36.7	23.3	16.1	24.0	24.7	27.4	23.8	16.1	25.3	41.0	40.4	36.7	57.3	19.9	18.1	42.5	40.4	30.3	44.1	16.2	27.3	13.9	42.4	36.7	11.5	5.0	32.8	19.3	5.2	34.3	23.6	13.6	39.6	26.2	41.4	11.5	41.2	18.6	27.3	4.3	14.8	22.2	24.0	43.5	36.7	47.6	10.3	28.5	26.1	23.7	34.9	26.5	12.0	32.9	25.3	44.3	69.2	0.8	46.2	41.8	9.9	35.3	26.3	43.7	15.7	28.5	10.5	31.1	38.0	24.5	50.5	36.5	22.2	32.4	54.4	41.5	16.7	28.6	39.8	116.3	32.7	0.9	19.2	116.0	81.7	39.2	31.4	55.8	39.7	73.7	0.7	42.4	42.1	21.2	12.9	26.6	50.4	78.1	27.4	6.5	66.5	39.4	17.9	17.5	0.8	14.9	0.3	0.9	0.6	57.1	8.9	35.6	31.5	13.1	59.3	6.1	61.1	35.9	45.6	38.9	42.6	57.2	53.9	35.0	43.2	44.3	32.5	27.9	26.6	52.7	42.3	53.7	40.2	42.5	41.2	49.4	41.0	40.4	42.5	40.4	42.4	39.6	41.2	43.5	16.2	25.6	26.0	11.1	19.3	27.3	38.1	48.8	43.3	11.7	48.7	46.4	22.6	40.0	38.7	42.3	0.0	105.8	30.6	29.1	52.8	34.6	12.5	24.9	21.8	19.0	20.4	20.8	9.1	49.8	102.5	23.8	46.4	34.4	20.8	41.3	26.4	78.7	67.1	5.0	11.1	38.2	30.5	29.5	18.7	35.7	29.2	23.1	35.6	8.4	30.9	45.5	54.6	7.5	19.0	37.4	36.5	30.5	27.8	29.0	46.3	114.5	35.7	10.0	26.3	10.6	24.0	5.4	37.3	29.6	30.5	64.2	32.9	37.9	38.5	32.8
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822539-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.1;ovary: 32.5;placenta: 24.2"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 79.4;Leydig cells: 113.4;Syncytiotrophoblasts: 67.9;Theca cells: 70.2"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	11	"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 58.1;HSkMC: 10.6;RH-30: 12.8;RPTEC TERT1: 34.8;SuSa: 40.5"	"Region enriched"	"Detected in single"	28	"cerebellum: 14.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.6"	HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	0.8	16.1	0.0	0.9	0.0	0.0	0.7	7.0	0.3	1.8	0.0	1.4	0.1	1.7	4.6	0.6	0.9	10.1	3.5	0.0	0.1	6.2	0.1	0.2	0.0	0.1	0.6	32.5	0.4	0.1	0.3	24.2	0.5	4.9	0.3	0.1	1.1	0.9	0.2	0.1	0.3	1.7	0.1	0.0	0.5	3.3	0.0	0.1	0.2	3.3	0.0	1.0	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	10.6	0.0	0.1	0.0	3.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.8	0.0	34.8	0.7	0.0	0.2	0.0	1.8	0.0	40.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.1	0.1	0.6	0.5	0.1	0.0	0.4	3.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.0	1.2	1.0	4.8	0.0	0.0	0.0	0.0	79.4	0.0	0.2	19.6	0.2	1.3	0.0	3.2	0.7	0.0	0.0	0.9	0.0	10.1	8.9	0.0	0.0	0.0	2.1	0.0	0.0	7.1	0.0	0.9	0.0	0.0	0.0	0.0	2.6	113.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	13.5	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.7	1.6	1.7	0.1	0.0	67.9	0.0	70.2	0.2	0.1
NXPH4	NPH4	ENSG00000182379	"Neurexophilin 4"	O95158	12	57216794-57226449	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4;skin 1: 19.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 14.5;Cytotrophoblasts: 29.0;Muller glia cells: 18.5;Suprabasal keratinocytes: 10.4;Syncytiotrophoblasts: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 76.8;RH-30: 62.3;RPMI-8226: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted in brain"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (1.08e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavorable (6.21e-4)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (7.68e-6)"	"unprognostic (7.83e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-3)"	2.5	0.6	6.3	0.3	4.1	0.4	0.7	8.3	3.6	2.3	0.6	0.1	0.0	0.0	0.2	3.0	0.1	0.0	2.7	8.3	13.8	0.7	0.8	0.3	0.5	13.3	7.1	0.0	1.5	1.7	0.3	2.7	18.4	4.4	0.0	5.0	4.0	0.0	0.2	19.4	0.2	0.1	7.5	0.4	0.1	1.2	7.1	0.1	0.4	0.0	0.3	0.1	2.8	5.0	18.1	1.4	0.4	76.8	8.6	2.2	7.1	4.9	11.5	2.1	2.7	5.0	0.9	19.4	7.6	5.1	3.2	16.2	10.3	2.4	0.6	3.4	20.6	0.1	0.6	0.3	7.4	0.7	2.5	2.0	4.0	2.0	3.2	2.5	0.0	1.2	0.8	20.0	1.5	18.6	0.0	0.0	0.7	0.4	13.5	1.0	62.3	43.1	0.0	3.2	12.3	0.7	11.0	22.5	23.2	0.2	22.4	0.6	0.0	5.4	17.8	2.3	5.8	10.8	2.3	6.9	3.5	9.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	4.1	8.3	3.6	8.3	13.8	13.3	7.1	18.4	7.5	7.1	5.0	0.8	0.0	0.0	0.7	8.0	14.5	0.4	1.1	3.4	4.7	0.7	0.9	0.8	0.0	0.7	0.0	8.4	29.0	0.3	0.1	0.0	0.8	0.0	0.1	0.4	0.5	7.2	0.0	0.7	0.0	1.9	1.1	0.5	0.1	0.0	1.1	0.0	0.1	2.0	1.7	1.4	0.0	2.0	0.0	0.8	0.0	0.0	0.4	3.6	0.0	0.0	18.5	0.0	0.0	0.1	0.6	0.0	0.4	0.3	3.3	0.0	0.0	1.0	0.5	0.0	2.4	3.6	0.7	4.5	1.8	10.4	29.3	0.4	0.0	0.0	0.4
OLR1	"CLEC8A, LOX-1, SCARE1"	ENSG00000173391	"Oxidized low density lipoprotein receptor 1"	P78380	12	10158301-10172138	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.6;lung: 100.2;placenta: 114.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 399.0;Hofbauer cells: 202.1;Macrophages: 202.6;Syncytiotrophoblasts: 463.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 125.4;HaCaT: 64.9;HHSteC: 125.1;hTCEpi: 58.4;SiHa: 248.8;SK-BR-3: 96.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050798			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA	1060000		"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050798: AB_2756318"	"unprognostic (2.30e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (6.34e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.42e-1)"	3.0	3.3	9.0	29.1	13.1	23.8	3.6	18.9	16.9	3.3	8.8	0.7	1.3	1.6	1.3	0.5	2.1	7.4	1.5	9.4	13.3	8.2	3.1	100.2	0.7	25.5	15.6	0.3	2.2	4.1	2.7	114.5	26.0	2.3	1.0	5.1	3.8	1.0	0.5	0.6	1.2	2.1	27.6	0.8	2.3	4.7	24.0	2.8	2.5	0.0	0.8	6.0	0.3	52.6	7.3	0.5	0.1	0.3	0.3	0.0	16.8	12.1	2.2	7.3	2.6	125.4	0.1	1.6	0.0	15.8	0.5	64.9	0.0	0.7	4.9	0.0	0.0	0.0	6.1	0.0	125.1	0.1	0.3	1.0	58.4	0.3	0.0	0.0	0.3	0.1	0.1	0.7	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.2	0.3	0.2	13.3	0.4	0.2	248.8	96.9	0.0	17.4	27.1	0.0	0.1	0.2	1.4	0.0	0.0	0.4	0.3	0.4	0.1	0.1	0.1	0.6	0.6	1.3	0.1	0.1	0.1	0.1	0.1	0.0	2.8	0.2	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.6	9.0	13.1	18.9	16.9	9.4	13.3	25.5	15.6	26.0	27.6	24.0	52.6	1.9	28.9	27.4	0.0	4.0	1.5	0.4	0.5	0.0	0.4	1.1	4.6	0.1	1.5	4.4	0.0	0.0	399.0	0.3	0.0	0.0	0.1	13.4	0.1	0.0	10.8	0.0	0.4	2.3	0.0	14.6	10.9	0.5	0.1	15.2	0.0	0.0	0.5	202.1	0.0	0.2	0.0	0.0	18.9	79.5	11.6	0.3	202.6	0.0	40.3	21.3	0.1	0.0	0.5	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.2	6.6	0.2	0.0	0.2	0.4	0.1	0.2	0.8	0.6	463.1	1.6	0.1	0.0	0.3
OSBPL9		ENSG00000117859	"Oxysterol binding protein like 9"	Q96SU4	1	51577179-51798427	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 216.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027378, HPA027397"	Supported	Approved	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027378: AB_1854816, HPA027397: AB_1854817"	"unprognostic (5.99e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.37e-1)"	27.5	38.1	17.9	18.1	23.8	30.1	32.6	26.3	23.5	25.5	28.3	20.8	17.4	31.1	31.0	17.7	23.3	17.6	37.0	17.6	23.9	42.8	60.8	27.5	25.9	25.0	21.8	30.5	33.3	60.0	21.1	21.8	26.6	27.8	19.1	53.5	22.0	22.4	70.0	19.6	21.7	24.2	23.0	27.2	34.3	28.4	22.2	21.8	24.7	35.2	33.0	23.7	24.7	32.2	66.3	31.7	69.0	11.2	38.1	17.9	90.7	30.1	50.8	54.9	60.0	53.0	46.6	105.8	54.4	34.1	120.9	26.9	59.2	57.4	76.9	71.9	41.9	77.4	62.7	104.7	36.9	81.7	35.5	44.7	55.0	56.8	31.4	66.8	68.9	52.1	154.4	31.1	26.7	45.4	20.3	92.5	97.0	26.8	15.1	58.2	102.8	110.5	74.0	47.4	31.8	45.2	22.4	79.6	93.7	154.7	38.0	82.8	22.9	11.6	51.2	17.2	58.1	80.2	52.5	120.4	39.3	32.8	23.0	52.7	12.2	30.5	20.1	9.9	28.9	32.6	19.7	20.8	25.0	23.9	21.0	22.2	16.9	16.3	9.4	23.2	20.5	16.4	17.9	23.8	26.3	23.5	17.6	23.9	25.0	21.8	26.6	23.0	22.2	32.2	32.5	80.1	56.8	75.4	39.2	17.7	33.8	25.7	34.1	102.0	34.2	33.0	47.9	38.6	50.5	46.0	41.7	89.2	30.4	20.5	125.2	47.6	40.7	36.3	46.3	30.1	29.8	35.7	64.8	47.8	50.2	48.6	54.0	52.9	33.6	75.7	18.2	61.7	40.1	26.9	113.0	18.3	38.7	22.7	16.0	38.3	62.4	25.3	65.8	63.7	50.1	43.8	29.9	62.8	216.4	41.9	14.3	50.0	81.4	38.5	26.4	59.7	32.1	35.3	46.0	36.9	62.9	32.3	18.9	26.9	18.9	75.5	32.0	52.2	21.2	27.4
P2RY2	P2U	ENSG00000175591	"Purinergic receptor P2Y2"	P41231	11	73218281-73242427	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.7;skeletal muscle: 50.2;tongue: 31.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.5;Distal enterocytes: 18.0;Pancreatic endocrine cells: 18.9;Proximal enterocytes: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 57.6"	"Group enriched"	"Detected in many"	12	"granulocytes: 57.6;monocytes: 20.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 32.8;HL-60: 30.8;MCF7: 25.1;NB-4: 26.1;PC-3: 24.5;SK-BR-3: 29.6;THP-1: 76.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB022642	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB022642: "	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (6.50e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (9.69e-2)"	"unprognostic (4.92e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.57e-3)"	0.8	3.8	1.4	1.8	1.6	15.8	1.7	1.3	1.0	6.9	1.1	3.3	2.7	0.5	0.3	29.7	1.4	0.7	10.0	1.3	1.8	2.7	3.9	3.5	0.1	2.1	1.9	0.4	0.7	4.8	1.6	2.0	1.6	2.1	2.8	1.2	6.2	1.2	50.2	6.0	5.9	0.5	1.3	3.9	1.1	1.2	2.6	0.2	8.8	31.3	2.8	2.2	19.0	1.4	7.2	6.7	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	17.2	5.4	0.0	10.4	0.4	0.0	32.8	0.9	15.2	0.0	0.0	0.6	2.3	0.6	3.2	0.1	30.8	0.0	0.0	6.8	2.3	0.5	0.0	1.4	0.0	1.4	0.0	0.0	25.1	0.1	26.1	0.4	6.8	24.5	0.0	0.0	1.1	2.4	17.9	0.0	0.0	0.5	29.6	0.0	0.2	12.9	76.5	10.2	0.0	0.3	0.0	0.0	1.0	0.4	0.0	0.0	5.6	0.0	0.5	6.6	57.6	0.0	20.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	13.5	0.0	0.0	2.5	1.4	1.6	1.3	1.0	1.3	1.8	2.1	1.9	1.6	1.3	2.6	1.4	0.7	3.2	0.5	0.0	0.2	3.7	8.6	13.2	1.2	0.7	2.8	0.5	6.1	5.7	10.3	0.0	0.0	16.5	0.0	18.0	1.9	5.8	6.0	1.4	0.1	1.5	0.0	0.8	0.0	6.3	1.3	0.7	0.5	0.8	0.0	1.2	0.0	5.2	2.6	0.0	0.0	5.1	0.0	3.7	0.7	8.8	0.0	4.5	0.0	0.0	2.8	6.0	0.0	0.0	0.1	18.9	10.9	0.0	0.2	5.3	14.2	0.3	2.8	0.4	0.0	0.8	1.4	0.1	0.1	12.6	7.2	10.9	0.1	0.1	3.0	11.7
PAGE4	"CT16.7, GAGEC1, PAGE-4"	ENSG00000101951	"PAGE family member 4"	O60829	X	49829260-49834264	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 871.9;placenta: 1023.1"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 13314.7;Syncytiotrophoblasts: 8524.1"	"Group enriched"	"Detected in some"	17	"liver cancer: 14.8;prostate cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.2;U-266/70: 11.7;U-266/84: 45.1"					"Not detected"	"Not detected"			HPA023880	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Golgi apparatus"	"HPA023880: AB_1854930"				"unprognostic (8.56e-2)"			"unprognostic (1.47e-1)"			"unprognostic (1.04e-1)"		"unprognostic (4.82e-3)"			"unprognostic (5.37e-2)"			0.3	5.7	0.1	0.3	0.2	0.0	0.0	0.1	0.5	7.0	0.1	0.2	0.4	51.2	871.9	0.0	21.4	0.0	0.4	0.1	0.2	3.1	0.3	0.2	0.0	0.1	0.1	3.7	2.5	0.0	1.3	1023.1	0.1	171.8	0.0	0.0	0.6	77.2	2.3	0.0	0.3	24.2	0.0	0.3	0.2	5.6	0.1	0.1	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.0	0.1	11.7	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13314.7	0.0	0.0	0.0	0.0	4.4	1.9	72.5	25.9	0.0	0.0	0.0	0.0	905.4	72.5	0.0	1.9	0.0	0.0	0.0	0.0	1052.1	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	48.8	20.7	0.0	0.0	8524.1	0.3	0.0	0.0	0.1
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40217428-40277487	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 25.6;skin 1: 28.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;NK-cells: 16.5;Suprabasal keratinocytes: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.5;HaCaT: 32.2;hTCEpi: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.2	8.2	11.6	0.4	15.9	0.9	2.1	8.5	16.6	4.5	0.0	1.3	1.5	0.9	1.0	25.6	4.3	1.1	8.3	17.6	3.0	4.7	0.3	2.5	0.9	1.4	1.1	0.6	8.0	8.0	12.1	7.6	1.9	4.4	1.1	0.8	6.1	3.8	4.5	28.2	1.5	0.3	1.8	0.9	3.9	17.7	3.0	0.5	7.5	1.3	1.9	3.5	9.4	5.4	3.9	0.0	0.2	0.0	0.0	0.0	6.0	0.0	0.2	0.7	0.7	26.5	2.9	0.1	3.6	0.0	1.3	32.2	4.5	6.9	0.3	0.2	1.0	0.0	3.0	0.2	0.0	0.1	0.3	0.0	19.4	0.3	4.5	0.2	0.0	5.5	1.8	0.3	0.0	4.5	0.0	0.5	0.5	3.9	2.9	0.2	0.2	2.9	1.5	8.4	7.3	2.0	2.6	10.9	0.3	1.7	1.7	10.3	0.0	0.3	0.6	0.0	0.3	0.1	0.3	0.1	0.7	0.6	0.2	1.2	0.1	1.2	2.3	0.1	0.8	0.6	0.1	1.9	0.3	0.1	0.1	0.4	0.5	0.9	0.1	0.1	0.0	0.6	11.6	15.9	8.5	16.6	17.6	3.0	1.4	1.1	1.9	1.8	3.0	5.4	0.0	0.0	4.2	0.7	0.3	9.8	9.6	4.8	8.6	3.5	2.8	2.9	0.0	4.3	5.4	5.5	0.0	52.7	2.1	0.3	13.7	4.4	8.6	3.3	0.4	0.3	4.9	0.0	8.9	4.3	3.0	0.7	0.5	5.1	0.0	0.7	0.0	0.0	4.1	0.0	7.3	1.1	2.0	0.6	0.9	5.8	1.8	0.3	1.8	1.0	0.0	1.3	16.5	0.5	0.3	2.5	1.0	1.9	0.1	5.2	0.2	0.2	3.9	0.2	0.0	0.3	0.4	1.9	3.3	13.9	19.0	9.0	1.0	0.8	2.0	11.3
PARP1	"ADPRT, ARTD1, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360210-226408154	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		150000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	32.0	26.4	33.9	63.9	41.9	29.4	29.5	46.2	33.2	26.2	20.6	43.5	29.3	30.2	19.8	31.3	28.9	20.4	55.1	30.3	36.2	22.4	37.1	27.4	125.5	48.4	39.7	27.5	50.8	94.7	38.0	58.2	47.7	40.7	37.2	44.9	28.9	46.4	94.5	21.1	36.8	45.6	41.9	57.7	29.6	40.5	40.9	64.6	28.4	70.2	150.8	38.7	24.6	58.1	182.4	108.9	295.4	209.3	75.9	61.3	137.1	101.3	119.1	178.2	144.9	175.4	98.1	559.3	147.2	80.9	77.9	135.1	411.6	132.4	144.4	204.1	396.6	216.2	135.9	114.5	44.6	372.2	93.3	61.7	50.5	144.2	101.3	49.3	140.5	132.2	346.9	291.8	94.1	99.6	114.7	110.0	476.2	290.5	165.1	334.2	484.5	533.4	76.4	144.5	264.0	229.2	165.2	190.3	100.1	205.3	159.6	225.8	99.3	93.3	140.9	120.6	235.1	110.9	151.8	472.6	78.2	125.7	214.3	11.1	11.7	12.3	31.2	20.5	45.3	72.2	37.3	36.7	28.2	69.9	28.2	32.5	2.2	22.0	42.3	16.2	49.3	25.7	33.9	41.9	46.2	33.2	30.3	36.2	48.4	39.7	47.7	41.9	40.9	58.1	33.4	54.5	73.6	13.7	169.1	72.3	83.9	56.4	51.2	96.1	58.8	43.3	115.0	44.3	69.8	57.0	141.8	469.2	53.8	27.7	72.4	88.9	34.1	53.3	66.5	62.0	75.0	100.5	16.5	107.0	111.7	49.8	37.8	55.2	122.1	116.2	34.2	69.4	139.6	90.9	17.5	50.0	57.0	47.8	35.7	20.5	40.0	48.3	62.2	16.9	76.9	80.1	95.8	10.1	31.9	48.5	24.2	35.0	186.9	82.8	25.6	48.5	56.4	118.1	46.0	58.7	48.0	88.8	199.6	77.2	48.2	137.6	85.0	103.5	61.9	41.7
PEF1	PEF1A	ENSG00000162517	"Penta-EF-hand domain containing 1"	Q9UBV8	1	31629866-31644896	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061608			Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		570000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles, Cytosol"		"HPA061608: AB_2684567"	"unprognostic (2.92e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-3)"	57.3	67.1	76.4	28.5	78.6	37.9	56.4	80.1	81.3	56.3	77.8	59.0	31.3	63.3	84.4	62.1	54.6	38.6	63.8	77.9	81.6	69.4	71.3	61.3	38.5	81.9	78.6	50.2	40.9	69.1	52.1	61.4	84.7	59.4	45.1	26.6	39.9	59.1	42.5	85.7	44.0	60.0	79.9	55.9	51.3	40.1	78.9	56.6	110.9	39.3	61.6	61.9	52.2	81.4	56.9	65.0	53.1	41.3	61.2	63.8	51.0	52.8	89.8	124.4	109.0	38.7	83.2	60.2	71.9	118.3	63.9	58.1	103.9	134.5	100.1	76.0	112.6	49.9	49.4	78.6	107.9	49.0	45.3	66.3	152.6	122.0	113.2	79.2	122.2	72.6	52.4	60.6	90.4	67.1	75.6	47.5	74.3	69.7	72.9	72.5	51.7	66.2	98.6	60.8	75.8	43.9	60.2	56.1	81.0	82.9	50.0	35.5	65.7	54.0	46.0	92.7	71.3	38.7	42.2	65.4	67.7	71.8	65.9	147.3	75.6	93.0	90.2	69.4	86.8	70.9	75.5	81.4	77.5	76.4	70.2	70.6	76.2	87.4	67.2	71.4	84.0	104.8	76.4	78.6	80.1	81.3	77.9	81.6	81.9	78.6	84.7	79.9	78.9	81.4	58.2	41.7	37.7	5.9	31.6	36.2	66.6	70.8	29.6	41.2	34.7	36.2	20.4	21.5	35.3	69.9	12.5	160.0	33.9	36.6	113.5	72.0	81.3	17.4	20.0	60.3	44.3	40.0	8.0	61.9	106.1	34.0	21.9	19.8	72.9	34.3	35.3	24.4	61.9	53.8	7.4	49.8	50.8	18.5	21.8	87.5	45.1	27.8	49.8	7.5	81.6	59.6	46.4	6.0	13.8	59.1	44.0	58.6	23.6	65.4	48.9	57.8	23.5	26.5	19.7	25.8	38.8	44.1	44.2	24.6	51.4	182.8	33.6	50.9	39.5	58.3
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 172.1;brain: 348.9;placenta: 467.0"	"Group enriched"	"Detected in many"	11	"Cytotrophoblasts: 2015.8;Syncytiotrophoblasts: 2856.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 773.3;HAP1: 1015.3;Hep G2: 805.0;SCLC-21H: 488.6"	"Region enhanced"	"Detected in all"		"hypothalamus: 110.7"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	3.2	172.1	101.2	2.6	111.9	0.9	24.6	43.7	46.4	7.5	0.0	5.5	0.8	5.6	1.9	2.3	10.0	3.2	1.6	43.5	331.8	7.3	2.4	15.4	5.1	55.2	122.0	65.1	11.4	2.1	88.3	467.0	136.0	2.7	2.0	23.0	9.1	2.6	2.2	0.6	1.5	3.9	32.2	2.0	2.8	41.1	348.9	13.2	11.4	3.3	3.2	3.6	1.6	23.0	22.8	111.6	773.3	329.0	16.0	28.5	45.0	60.7	35.3	42.8	57.3	187.6	37.0	2.5	2.2	70.2	87.5	6.9	1015.3	43.1	58.9	2.9	107.0	0.1	121.8	805.0	12.0	129.6	0.2	63.9	13.9	105.7	73.0	37.1	25.8	0.0	0.5	243.7	84.5	5.8	0.5	0.1	355.4	19.1	70.5	48.5	247.6	67.4	194.3	83.2	488.6	28.2	0.4	16.9	59.9	192.8	105.8	0.3	0.0	33.7	2.0	4.2	46.9	65.2	46.4	97.1	76.3	0.1	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	101.2	111.9	43.7	46.4	43.5	331.8	55.2	122.0	136.0	32.2	348.9	23.0	4.0	153.8	82.4	11.4	37.1	0.8	9.1	2.5	0.6	87.5	49.4	74.3	42.8	5.7	69.8	16.5	8.4	2015.8	3.3	0.9	64.6	18.1	4.5	9.7	3.0	8.4	60.4	0.0	15.8	5.3	205.1	45.3	2.0	15.4	2.5	24.2	4.2	4.7	175.8	37.0	21.9	0.6	8.2	0.0	0.6	18.9	9.0	1.7	14.2	4.7	0.0	109.0	0.0	10.1	12.8	5.2	0.0	4.1	1.5	9.6	0.0	22.0	8.9	29.7	6.6	173.1	23.0	52.9	51.5	2.5	0.9	2856.1	2.6	68.9	0.7	0.6
PEX11B		ENSG00000131779	"Peroxisomal biogenesis factor 11 beta"	O96011	1	145911350-145918717	"Disease related genes, Predicted membrane proteins"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA017150, HPA050104"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA017150: , HPA050104: AB_2681017"	"unprognostic (4.59e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.67e-4)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.62e-3)"	"unprognostic (4.28e-1)"	17.5	25.1	34.7	19.0	35.8	13.3	31.2	32.5	42.5	24.6	33.3	24.9	24.6	23.4	33.1	34.3	25.7	17.0	28.0	36.3	38.1	32.4	27.1	20.1	27.4	33.3	33.0	24.6	27.2	33.5	24.5	23.1	35.1	24.3	27.6	20.2	28.7	25.6	39.8	28.1	25.9	21.0	31.6	27.7	28.3	30.8	34.1	30.2	26.4	34.9	34.7	23.2	22.2	34.2	27.1	24.4	21.0	21.1	48.6	37.9	21.9	26.8	35.3	34.4	26.5	11.3	30.7	25.2	28.1	38.3	16.6	31.9	18.6	40.0	24.0	28.4	14.1	15.6	14.8	29.2	68.3	46.9	27.5	49.9	49.3	23.3	22.8	43.9	44.5	34.8	28.7	40.5	54.7	43.1	35.8	43.5	7.5	57.4	29.5	33.0	31.5	55.5	58.8	19.1	14.7	24.0	20.2	38.4	24.7	20.5	53.2	72.0	39.7	23.1	18.2	30.3	19.8	43.1	54.0	35.1	38.5	26.3	16.0	89.6	64.7	47.3	58.5	60.9	64.8	93.2	67.5	65.4	70.8	84.1	74.7	67.9	32.4	71.1	60.5	94.9	79.6	82.7	34.7	35.8	32.5	42.5	36.3	38.1	33.3	33.0	35.1	31.6	34.1	34.2	5.0	16.0	10.3	9.8	17.0	19.4	9.2	41.3	26.7	8.0	16.8	17.0	12.8	17.2	20.7	40.5	0.0	37.9	19.6	20.2	45.0	13.7	12.2	8.2	7.0	12.3	12.7	14.1	13.0	13.8	13.9	11.1	19.4	7.4	3.8	9.3	18.2	32.9	23.0	5.0	13.5	16.0	20.3	18.3	10.7	21.1	14.0	12.9	21.4	4.7	27.1	12.6	25.7	9.5	12.9	16.0	11.4	19.9	17.4	10.1	20.1	34.5	22.9	5.1	6.6	5.8	10.3	41.1	24.3	34.0	22.0	20.0	13.8	11.6	15.8	9.4
PIDD1	"DKFZp434D229, LRDD, MGC16925, PIDD"	ENSG00000177595	"P53-induced death domain protein 1"	Q9HB75	11	799179-809753	"Predicted intracellular proteins"	Apoptosis	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 26.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012647, HPA055473, HPA066948"	Supported		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Cytosol"		"CAB012647: , HPA055473: AB_2682827, HPA066948: "	"unprognostic (1.38e-1)"	"prognostic favorable (8.19e-5)"	"unprognostic (5.07e-3)"	"prognostic favorable (3.32e-5)"	"unprognostic (7.25e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (8.17e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.22e-2)"	3.3	3.1	2.3	2.3	2.8	7.4	3.3	2.5	4.1	3.6	2.8	3.9	3.0	3.0	0.1	4.0	3.3	1.1	2.9	2.1	2.2	3.1	5.5	2.7	3.2	3.6	2.6	2.8	3.7	0.9	2.8	1.9	3.5	4.3	0.6	0.2	3.2	1.0	6.5	5.5	4.5	0.7	2.5	5.0	4.0	2.4	3.0	3.2	3.8	0.8	1.0	3.2	3.1	4.6	5.4	6.2	2.9	6.2	0.6	2.2	26.6	7.5	2.0	2.7	3.6	5.7	10.2	4.4	2.3	1.1	2.5	7.9	2.1	3.0	0.5	9.0	12.3	3.8	5.0	12.0	6.8	4.3	9.4	8.4	5.3	1.4	0.3	0.5	5.0	10.3	4.5	3.3	1.1	2.6	12.0	7.2	4.0	5.8	4.3	19.4	4.2	8.6	1.1	1.9	5.1	6.8	3.1	8.2	2.0	1.6	6.0	7.3	2.7	3.4	7.6	2.5	4.9	10.5	6.4	8.5	4.4	3.5	5.6	0.0	0.5	0.0	0.4	0.4	0.4	0.3	0.3	0.4	0.8	0.4	0.4	0.4	0.0	0.1	0.4	0.2	0.9	0.4	2.3	2.8	2.5	4.1	2.1	2.2	3.6	2.6	3.5	2.5	3.0	4.6	4.9	3.2	8.8	25.8	7.2	0.0	3.6	0.0	6.2	14.9	7.3	8.1	4.2	5.7	5.6	3.7	10.4	29.2	8.9	12.0	1.9	2.5	1.4	6.7	4.2	3.7	9.0	5.7	12.8	4.6	7.5	4.4	10.7	4.2	1.3	14.0	2.2	10.3	5.5	1.7	14.2	8.1	0.0	3.5	0.0	1.9	7.2	3.8	0.0	7.5	4.1	7.0	2.1	6.6	26.9	3.5	9.9	4.1	6.0	4.4	10.0	3.8	0.0	15.4	0.0	5.7	3.5	25.2	20.8	6.7	0.0	9.7	6.3	7.5	10.5	3.6
PIGC		ENSG00000135845	"Phosphatidylinositol glycan anchor biosynthesis class C"	Q92535	1	172370189-172444086	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036663	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA036663: AB_10669912"	"unprognostic (3.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.72e-3)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (7.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.43e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-1)"	18.2	20.8	12.8	13.0	13.2	27.2	21.8	13.8	16.2	21.4	13.8	20.7	15.4	24.3	38.9	16.6	23.5	18.1	14.9	13.3	14.4	20.0	16.0	15.0	19.7	14.1	13.8	22.4	25.9	19.6	18.1	20.2	14.4	16.4	19.3	17.7	20.7	17.5	13.6	40.7	21.6	18.9	13.6	20.3	19.6	18.3	13.7	27.6	15.3	11.1	20.9	18.8	18.8	14.5	33.3	28.1	37.2	25.5	27.8	25.0	27.8	21.1	23.5	35.6	30.9	25.6	47.6	17.7	30.4	25.4	28.3	35.0	24.6	30.8	28.6	39.5	28.4	21.8	25.5	31.9	30.6	44.9	27.4	37.4	36.0	25.6	27.9	27.7	23.0	33.5	33.5	32.9	29.2	17.3	34.4	40.1	38.5	67.4	38.7	27.9	30.3	31.9	55.5	24.1	19.5	37.1	30.5	35.6	50.3	52.4	31.9	31.6	21.0	22.6	37.8	28.0	22.8	21.8	33.1	27.6	16.2	29.0	43.9	71.5	28.1	55.6	35.4	26.9	29.8	37.2	40.6	37.4	24.3	33.8	60.1	43.4	18.2	51.6	29.5	24.1	40.0	40.9	12.8	13.2	13.8	16.2	13.3	14.4	14.1	13.8	14.4	13.6	13.7	14.5	19.4	9.6	10.3	0.0	24.2	13.5	19.7	31.2	18.2	15.7	20.9	29.5	20.7	17.2	17.7	29.5	8.4	61.6	23.9	20.6	33.2	31.9	78.2	15.2	19.3	20.0	7.8	58.9	0.0	41.1	50.9	31.0	15.8	18.6	7.6	21.6	22.9	15.4	35.3	20.2	0.0	19.6	32.6	23.7	16.9	80.8	47.2	20.0	26.6	0.0	27.6	30.1	42.2	0.0	0.0	34.8	27.6	40.6	12.4	14.2	25.2	20.9	20.1	17.9	32.9	22.2	18.7	30.0	18.8	17.7	19.0	23.7	29.1	21.5	18.9	15.5
PIR		ENSG00000087842	Pirin	O00625	X	15384799-15493564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 96.1;Syncytiotrophoblasts: 85.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 48.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 292.4;HUVEC TERT2: 683.9;SK-MEL-30: 267.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000697	Approved		Supported	Cytosol		NA	NA		35000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA000697: AB_1079621"	"unprognostic (3.46e-3)"	"prognostic favorable (2.78e-4)"	"unprognostic (4.26e-2)"	"unprognostic (5.62e-3)"	"unprognostic (4.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.94e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (6.11e-7)"	"unprognostic (1.99e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	19.1	19.9	20.2	5.2	23.7	5.7	15.4	23.5	24.3	12.4	21.2	10.0	6.5	11.7	15.3	29.6	13.3	11.4	17.3	18.7	22.9	11.4	21.0	15.4	2.7	23.0	22.6	13.1	3.3	4.9	11.3	10.5	22.8	10.1	6.7	7.9	10.3	14.2	14.7	11.9	8.6	10.4	22.5	20.1	11.9	6.2	22.5	6.2	15.7	6.4	7.1	30.4	17.4	25.7	14.3	76.6	45.0	66.3	26.1	29.0	14.4	4.2	26.5	11.0	24.5	21.5	118.9	0.0	147.2	12.3	292.4	96.7	52.8	21.3	4.0	0.0	11.6	8.4	80.7	63.9	33.4	4.4	29.8	8.3	72.3	41.9	14.4	19.2	683.9	0.0	6.4	19.2	9.4	29.8	3.3	4.1	48.4	62.1	47.7	0.0	8.9	37.9	22.2	136.0	17.2	47.5	36.7	20.5	267.9	76.8	42.4	26.7	43.2	5.9	11.0	28.5	8.7	9.1	39.6	0.3	28.6	15.8	59.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	20.2	23.7	23.5	24.3	18.7	22.9	23.0	22.6	22.8	22.5	22.5	25.7	24.5	0.0	4.1	0.0	1.1	8.7	24.3	48.4	10.8	2.8	4.2	4.8	5.8	10.0	19.4	1.8	0.0	96.1	0.0	4.8	9.8	5.9	0.6	59.6	3.8	40.3	11.3	11.6	0.2	2.5	12.8	15.6	15.8	20.0	0.0	21.7	22.9	24.0	22.0	20.2	0.2	3.4	38.7	6.4	3.4	4.0	37.6	4.1	40.9	0.0	11.9	30.8	0.0	0.0	0.0	3.4	1.7	28.6	3.6	18.1	5.9	12.0	38.0	4.8	13.1	8.4	11.3	0.6	3.5	34.5	12.6	85.6	0.6	56.2	4.3	50.9
PISD	"dJ858B16.2, PSDC"	ENSG00000241878	"Phosphatidylserine decarboxylase"	Q9UG56	22	31618491-31662432	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Decarboxylase, Lyase"	"Cataract, Deafness, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 223.5;Syncytiotrophoblasts: 245.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 80.7"					"Low region specificity"	"Detected in all"			"HPA031090, HPA031091"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Cytosol"		"HPA031090: AB_10600114, HPA031091: AB_10600893"	"unprognostic (7.96e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.44e-3)"	"unprognostic (8.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.27e-5)"	34.1	13.7	6.7	12.2	6.3	18.7	16.0	14.3	9.8	7.4	7.5	8.9	8.8	10.1	4.8	7.3	10.8	7.1	7.3	6.1	7.5	18.9	6.3	14.7	8.4	7.0	6.0	7.6	9.2	5.0	12.6	19.9	6.8	9.0	2.0	3.5	7.5	5.3	5.3	7.8	7.8	3.2	3.8	18.0	8.2	20.3	7.2	3.8	11.5	3.2	4.3	7.3	7.1	5.1	21.7	19.7	5.8	5.8	17.3	6.6	13.2	17.4	13.6	11.9	12.9	28.6	6.6	12.9	18.0	8.8	15.8	24.0	7.9	15.5	1.9	14.4	16.9	13.5	12.8	23.7	35.9	28.7	34.2	12.4	8.5	21.2	9.1	4.9	10.6	9.0	40.3	7.6	6.9	80.7	12.5	12.4	5.7	14.2	8.1	17.4	6.5	13.0	7.6	18.9	14.2	8.4	10.1	31.8	11.0	4.7	26.5	15.5	21.0	14.9	17.7	9.6	16.3	8.9	13.3	16.2	14.2	19.0	12.1	24.1	21.7	16.1	10.6	15.8	10.3	11.9	7.7	9.0	18.3	11.9	10.3	8.6	47.0	10.4	8.7	8.9	8.2	13.8	6.7	6.3	14.3	9.8	6.1	7.5	7.0	6.0	6.8	3.8	7.2	5.1	11.1	16.0	15.6	17.3	12.4	25.6	34.7	31.5	38.7	26.0	18.6	12.6	55.5	12.8	31.1	42.3	20.9	223.5	12.9	12.0	11.7	33.2	60.0	36.2	17.9	19.6	20.9	32.4	40.3	16.8	25.9	13.6	17.3	87.3	18.3	13.2	8.9	7.5	36.4	18.5	35.5	12.9	22.4	36.4	12.7	81.9	9.6	19.8	3.6	9.4	27.1	11.8	24.7	16.1	19.9	15.9	8.4	7.2	11.4	52.1	12.3	13.9	10.9	25.8	19.7	4.9	11.1	25.0	17.9	27.7	21.3	245.0	11.8	8.3	14.2	43.5
PLD2		ENSG00000129219	"Phospholipase D2"	O14939	17	4807152-4823434	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013397	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA013397: AB_1855328"	"unprognostic (1.87e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.48e-2)"	17.4	8.1	19.9	10.0	22.8	2.6	17.9	21.5	21.3	32.3	16.0	11.2	6.9	15.2	6.9	63.3	14.5	14.3	10.2	19.4	21.9	11.7	12.1	16.1	9.5	30.4	24.3	21.5	14.0	8.9	10.4	14.2	22.3	19.0	9.0	4.9	22.6	14.5	5.1	33.5	10.7	13.4	24.7	12.6	11.3	4.3	24.5	12.9	11.9	6.7	18.0	15.0	37.1	23.5	13.0	20.2	17.4	18.8	15.0	19.9	20.0	8.2	17.2	14.2	11.3	21.7	15.1	5.6	9.4	21.3	5.3	30.2	13.9	18.3	12.8	7.3	7.0	1.8	15.7	13.2	10.8	0.1	13.3	29.4	27.0	12.8	12.1	20.0	33.2	3.9	2.1	5.2	12.0	9.9	0.7	2.4	9.2	10.7	8.7	6.3	11.2	1.4	12.9	20.9	5.9	10.2	15.5	18.1	11.6	14.1	13.0	3.0	26.1	9.4	9.5	21.6	12.8	4.6	2.3	1.2	14.4	2.6	5.6	4.0	4.8	1.2	1.2	4.9	0.9	1.6	1.3	0.9	3.6	0.9	0.3	0.4	0.3	0.8	5.4	1.6	2.3	2.4	19.9	22.8	21.5	21.3	19.4	21.9	30.4	24.3	22.3	24.7	24.5	23.5	10.9	0.0	1.1	26.8	2.8	12.6	9.8	11.2	14.8	1.2	11.6	10.3	2.8	7.2	8.9	1.8	0.0	21.8	2.6	7.1	1.9	8.7	0.0	2.5	4.6	12.0	1.2	0.0	1.6	11.5	14.8	7.7	10.7	5.4	5.7	12.0	12.8	2.9	12.9	0.0	2.7	7.0	6.1	8.1	13.8	0.5	9.6	10.7	7.2	5.6	19.9	7.8	1.0	3.5	5.8	10.4	10.2	8.6	1.4	14.0	3.8	4.2	9.2	1.7	0.0	4.1	5.0	0.2	2.7	9.8	12.1	17.4	3.1	7.2	5.7	10.5
PMPCA	"Alpha-MPP, CLA1, INPP5E, KIAA0123, SCAR2"	ENSG00000165688	"Peptidase, mitochondrial processing subunit alpha"	Q10713	9	136410641-136423761	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	29.2	58.1	27.0	20.6	27.6	31.4	27.1	27.0	34.6	29.2	36.8	32.2	24.8	26.8	10.4	34.5	27.5	17.9	73.2	28.0	27.3	37.3	110.8	25.4	27.1	27.1	27.6	29.3	28.8	26.9	38.8	20.8	27.9	31.8	15.3	8.8	28.4	16.1	69.2	37.6	30.6	15.3	25.6	38.2	35.3	37.8	27.9	21.4	29.4	50.0	17.0	28.0	27.8	26.7	48.7	87.7	41.8	84.5	30.8	45.0	63.2	49.3	39.6	67.2	48.9	101.1	56.5	67.4	50.5	50.3	36.2	110.2	77.9	72.0	30.0	97.2	92.8	54.6	113.2	123.6	53.9	71.7	44.9	66.3	48.9	52.6	27.0	38.2	58.0	61.2	140.2	43.4	42.6	132.1	68.1	90.1	85.4	86.2	82.2	83.0	59.1	149.9	46.3	33.9	85.4	56.1	66.6	92.9	58.6	28.6	127.6	95.5	48.2	47.8	50.7	39.8	63.8	26.2	37.4	73.5	62.9	61.3	43.9	37.4	50.5	36.5	53.2	51.9	51.4	52.5	49.0	57.2	61.7	48.8	57.9	50.2	11.9	67.2	51.5	31.4	52.7	62.2	27.0	27.6	27.0	34.6	28.0	27.3	27.1	27.6	27.9	25.6	27.9	26.7	17.3	16.0	26.7	14.7	24.2	27.5	40.2	65.0	27.9	24.7	19.3	15.2	35.9	15.7	32.8	22.0	22.9	103.1	22.5	28.0	49.0	32.9	24.6	25.6	23.5	21.7	20.8	23.5	13.8	30.7	50.4	23.7	21.9	26.2	24.7	44.2	19.6	57.2	37.8	18.5	11.4	24.2	44.7	19.2	14.6	15.8	19.0	17.4	16.0	6.5	21.0	22.9	14.4	8.5	8.0	31.6	20.9	22.6	26.6	22.6	25.6	46.9	22.6	27.4	39.5	22.4	27.9	37.7	42.4	23.2	26.9	103.8	21.7	77.0	38.6	28.5
PMVK	"HUMPMKI, PMK, PMKA"	ENSG00000163344	"Phosphomevalonate kinase"	Q15126	1	154924740-154936719	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 266.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029900	Approved					NA	NA		15000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA029900: AB_10601390"	"unprognostic (2.52e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.47e-2)"	"unprognostic (8.22e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.10e-1)"	39.9	56.4	99.0	29.8	100.1	15.3	35.0	97.9	108.9	33.4	95.0	39.9	45.9	25.9	17.7	77.7	37.2	17.2	63.1	93.9	96.4	53.8	91.9	30.1	34.6	98.6	97.4	35.8	41.6	58.2	60.3	23.7	96.0	32.4	22.2	19.8	34.0	27.1	79.1	69.2	44.2	27.7	96.4	45.7	40.5	26.6	102.3	27.9	31.5	47.4	36.8	31.9	37.9	99.8	51.8	72.9	46.7	72.5	43.6	30.9	48.5	40.5	29.3	38.9	37.0	30.6	101.0	75.1	75.9	49.3	40.5	49.4	65.3	63.9	17.8	103.3	28.9	34.1	104.1	29.0	40.0	51.4	29.3	36.3	58.7	70.2	49.6	19.5	40.0	65.9	36.8	221.7	41.3	108.3	40.8	51.0	41.0	121.7	95.0	60.3	29.8	171.1	66.1	38.4	37.7	91.1	44.1	75.7	51.9	35.0	146.7	91.1	32.7	35.8	29.2	84.4	62.1	174.0	153.2	131.8	58.9	83.9	46.7	28.0	80.9	91.8	68.2	205.6	110.1	114.8	93.1	70.6	93.6	111.1	59.1	59.1	6.9	59.7	219.4	96.5	134.3	80.0	99.0	100.1	97.9	108.9	93.9	96.4	98.6	97.4	96.0	96.4	102.3	99.8	22.7	57.7	37.5	9.4	42.2	69.8	105.9	95.8	51.8	38.5	67.1	68.3	57.3	78.6	42.2	53.3	8.4	235.7	31.5	65.0	266.1	69.6	9.0	45.0	28.5	29.8	66.4	35.6	5.1	71.3	108.1	45.1	46.9	44.2	22.2	49.8	39.3	146.9	141.0	37.0	7.0	78.9	67.1	67.9	49.5	13.5	42.6	47.8	65.8	3.7	49.5	119.1	41.2	8.0	11.8	61.7	61.7	47.8	58.8	53.7	219.3	246.1	22.1	27.4	32.9	46.0	48.4	51.3	51.3	81.0	90.5	227.7	45.1	162.6	79.9	76.2
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477089	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 333.9;epididymis: 594.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 360.6;Erythroid cells: 227.3;Syncytiotrophoblasts: 646.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 531.3;U-937: 593.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol		NA	NA		58000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	78.6	24.8	16.1	46.8	16.6	333.9	34.6	22.6	22.7	25.3	18.9	52.2	120.3	14.2	594.8	87.4	18.2	56.8	29.0	17.7	19.6	206.8	98.0	48.6	46.7	20.3	18.1	5.0	23.2	32.0	19.8	132.6	20.1	15.0	61.8	27.1	22.6	27.4	7.3	29.6	60.3	38.7	23.1	44.5	50.6	7.4	21.1	33.5	17.8	10.0	64.4	100.4	41.5	20.1	86.1	113.4	24.0	53.9	26.0	21.0	71.8	85.2	40.3	68.2	67.0	66.1	76.5	227.1	96.8	45.5	81.5	89.9	125.2	159.8	89.5	75.0	109.6	189.1	89.9	109.3	24.2	531.3	94.7	14.4	57.4	206.0	91.0	37.8	295.9	141.0	95.4	137.4	86.7	79.1	157.6	311.3	67.5	215.7	186.1	130.2	35.9	88.3	243.7	79.6	101.9	22.6	163.4	205.0	13.2	32.6	75.5	92.5	240.0	46.1	62.6	105.1	148.4	63.1	113.3	258.9	39.3	593.0	4.6	12.0	30.6	10.3	39.8	27.3	73.6	25.7	44.2	45.0	48.1	28.8	27.6	35.9	3.7	38.5	26.6	27.3	16.7	31.1	16.1	16.6	22.6	22.7	17.7	19.6	20.3	18.1	20.1	23.1	21.1	20.1	149.6	0.0	23.5	5.9	50.3	84.6	67.4	12.6	112.7	4.7	56.3	62.6	3.5	27.1	13.4	82.8	14.6	360.6	45.2	61.1	39.2	43.2	1.3	36.0	12.7	139.4	46.4	227.3	0.6	51.5	41.8	32.4	106.5	65.3	57.7	5.0	24.3	30.6	70.9	16.8	1.1	51.3	18.3	18.1	58.4	0.8	0.3	83.3	30.2	3.7	13.2	78.8	29.9	3.0	0.9	130.8	83.9	0.7	88.6	27.5	41.2	118.9	10.5	18.1	0.0	23.9	41.3	0.4	0.7	114.7	63.9	646.2	62.3	3.1	51.4	77.1
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Club cells: 34.3;Cytotrophoblasts: 48.0;Respiratory ciliated cells: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 70.2;SH-SY5Y: 215.4;THP-1: 100.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.6	0.5	1.4	1.6	0.9	0.1	2.2	0.6	1.3	14.5	14.4	6.7	2.7	1.9	0.6	3.2	10.5	9.8	0.0	2.7	0.5	0.8	0.6	7.6	0.1	0.5	1.9	1.6	7.7	0.1	0.6	10.6	0.7	1.4	6.4	0.3	2.5	2.0	0.2	5.9	4.8	1.3	0.5	0.0	9.2	10.0	1.2	1.0	0.2	1.2	5.7	3.8	12.6	0.5	5.2	0.2	1.8	0.0	0.2	13.3	0.1	46.0	41.5	9.7	16.1	0.1	18.7	0.0	0.2	70.2	4.9	0.8	31.1	9.5	12.7	0.2	7.2	0.0	3.6	0.0	1.4	0.0	0.2	4.1	17.5	3.4	9.9	31.2	0.1	0.6	0.0	0.0	8.0	0.3	0.5	9.6	2.2	36.4	2.9	0.0	38.7	0.0	0.0	7.0	5.1	215.4	0.0	0.2	3.0	30.9	0.0	100.6	0.0	19.2	2.8	12.2	9.1	1.0	0.1	0.0	1.0	3.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.6	1.3	2.7	0.5	0.5	1.9	0.7	0.5	1.2	0.5	0.3	6.4	4.6	0.7	0.2	8.4	0.8	16.4	2.2	0.6	0.8	0.8	1.4	10.0	34.3	1.8	0.0	48.0	0.0	26.8	0.0	0.4	9.9	19.7	16.8	0.9	5.3	0.0	10.5	10.2	4.5	7.1	17.9	2.6	7.0	3.3	0.0	0.4	3.8	0.0	14.3	2.7	10.2	0.0	4.2	18.3	0.0	0.4	5.4	7.5	0.0	0.0	0.0	0.5	0.2	8.1	12.8	0.0	0.2	0.4	9.4	0.6	76.1	0.2	0.0	0.6	4.9	10.1	13.3	3.6	4.3	11.9	0.7	21.8	5.3	4.7
PRSS16	TSSP	ENSG00000112812	"Serine protease 16"	Q9NQE7	6	27247701-27256624	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	58	"lymphoid tissue: 826.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 42.1;Extravillous trophoblasts: 25.4;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.4;RPMI-8226: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (1.50e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.46e-5)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.62e-2)"	0.2	0.4	0.0	0.3	0.0	0.0	6.0	0.1	0.3	3.6	0.0	5.7	4.4	0.7	13.5	2.9	5.6	4.0	0.0	0.1	0.0	1.8	0.0	3.8	0.1	0.0	0.0	2.5	14.1	7.8	1.4	4.1	0.1	3.2	6.7	0.1	7.5	4.2	0.0	5.1	3.3	0.2	0.0	0.3	4.8	1.0	0.0	826.7	13.1	0.0	1.4	2.5	1.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	3.8	4.7	0.0	0.7	0.0	0.0	1.5	2.7	3.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.1	0.5	0.0	20.4	0.0	4.1	0.5	0.0	1.7	2.5	1.9	0.0	1.2	0.5	0.0	0.7	2.1	0.5	0.0	0.0	11.5	2.4	3.6	0.0	0.0	1.4	3.2	0.0	4.5	2.0	0.9	0.0	0.0	0.7	0.0	0.0	0.7	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.7	2.1	0.9	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.6	7.7	0.0	2.6	6.4	10.8	4.6	8.6	0.0	16.6	9.5	0.4	15.7	4.6	14.7	0.0	42.1	0.2	22.9	1.9	10.0	0.6	2.5	0.8	0.4	4.2	0.0	0.7	17.6	25.4	0.7	12.8	8.0	5.7	0.1	0.0	0.0	4.0	0.0	0.2	20.0	14.2	0.3	0.4	0.5	0.6	0.3	5.4	0.0	0.2	1.2	0.0	0.0	0.1	9.4	18.7	0.0	13.7	6.9	16.5	0.7	3.4	0.0	0.0	0.0	1.2	2.0	6.1	8.6	6.5	31.7	1.1	0.0	14.9	8.5
PSMA1	"HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30"	ENSG00000129084	"Proteasome 20S subunit alpha 1"	P25786	11	14504874-14643635	"Enzymes, Predicted intracellular proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033765, HPA037646, HPA043891, CAB079995"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Centrosome"		NA	NA		20000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Nuclear bodies, Centrosome"	"CAB033765: AB_2253026, CAB079995: , HPA037646: AB_10670386, HPA043891: AB_2678718"	"unprognostic (1.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.66e-3)"	"prognostic unfavorable (3.79e-5)"	"unprognostic (3.28e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.27e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (4.03e-11)"	"unprognostic (1.93e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.23e-2)"	87.2	85.5	55.1	94.9	57.8	135.8	96.2	55.4	68.2	76.8	58.7	92.5	96.4	80.7	108.0	94.7	79.4	79.6	140.5	59.4	64.4	98.4	139.2	77.5	114.9	55.8	56.6	79.4	54.6	78.5	50.4	113.0	58.8	81.7	101.9	63.2	74.4	85.8	168.7	80.5	86.1	96.1	56.6	75.6	75.7	56.2	60.2	122.2	88.4	152.6	109.9	111.2	56.0	58.6	408.8	279.8	227.8	275.7	223.7	225.5	193.3	232.9	305.2	348.3	283.9	244.2	500.1	349.5	262.1	248.6	315.4	303.1	259.3	290.1	328.3	344.0	389.6	220.4	190.5	326.1	291.0	355.3	277.5	217.8	171.6	188.9	390.7	252.7	347.0	271.6	398.9	283.4	315.2	277.8	334.0	319.5	191.6	340.5	414.1	223.3	336.1	217.5	313.0	304.7	188.2	119.3	246.6	273.9	229.0	233.8	164.4	222.9	272.0	226.2	222.9	402.7	295.4	123.3	366.1	319.9	334.8	291.1	296.6	115.5	191.2	47.5	97.7	139.8	128.0	104.1	110.8	109.7	243.3	95.3	98.5	94.4	36.3	145.1	137.5	138.7	154.9	235.8	55.1	57.8	55.4	68.2	59.4	64.4	55.8	56.6	58.8	56.6	60.2	58.6	119.0	83.3	90.2	64.3	101.7	142.9	231.2	365.7	76.2	50.3	105.7	125.9	0.0	82.9	176.1	88.3	18.8	469.5	135.3	49.2	256.3	228.5	75.5	84.0	94.0	135.5	40.1	163.9	56.8	233.1	370.6	128.5	66.8	79.8	78.2	134.7	95.3	127.9	292.9	57.2	66.3	63.6	231.9	161.8	170.5	36.3	116.5	153.6	144.1	122.7	263.7	111.6	168.9	64.8	35.3	223.2	88.6	127.5	112.1	209.1	135.0	257.1	115.1	54.8	85.5	99.2	129.8	174.9	80.1	114.3	151.9	627.3	130.7	137.2	97.1	248.1
PUDP	"DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A"	ENSG00000130021	"Pseudouridine 5'-phosphatase"	Q08623	X	6667865-7148158	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000292, HPA072672"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA000292: , HPA072672: AB_2732208"	"unprognostic (1.84e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.00e-3)"	"unprognostic (3.22e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (3.42e-2)"	8.3	9.1	8.3	12.4	8.8	3.5	8.8	9.2	8.6	9.3	10.6	17.4	18.0	6.4	4.8	8.4	19.9	8.2	20.4	8.0	10.3	15.1	9.8	11.9	16.8	9.0	8.7	10.4	6.7	8.4	3.7	20.1	9.7	6.9	12.3	7.4	11.1	7.7	33.0	5.1	12.3	10.9	8.8	8.9	19.3	4.4	10.1	13.3	10.3	20.2	14.1	9.2	7.2	9.6	48.0	42.1	68.4	28.3	34.7	34.0	11.8	14.8	15.7	18.6	18.7	64.2	28.7	21.9	31.5	16.5	61.5	14.4	31.7	37.9	28.1	20.1	60.4	23.4	15.7	35.7	16.3	20.7	24.4	16.5	14.6	50.7	23.0	12.1	56.2	27.2	45.3	17.8	29.3	23.3	22.5	30.6	29.1	19.9	21.1	16.2	26.0	60.8	26.7	18.0	15.4	16.1	12.7	24.4	25.5	59.6	27.2	18.9	17.4	10.4	6.6	43.7	13.0	55.6	0.2	33.8	15.9	11.5	21.5	2.6	17.8	2.2	7.4	18.9	7.6	8.1	7.8	7.1	13.6	5.9	5.8	6.5	1.9	6.8	19.3	4.3	12.2	10.1	8.3	8.8	9.2	8.6	8.0	10.3	9.0	8.7	9.7	8.8	10.1	9.6	6.6	12.8	4.6	0.0	7.8	0.0	4.1	0.0	5.7	3.9	5.2	3.9	0.0	15.7	3.7	18.4	4.2	48.0	2.4	20.8	9.8	21.1	0.4	10.7	5.3	7.0	0.0	3.4	0.0	16.9	27.6	4.6	10.2	6.1	1.3	10.7	6.8	11.1	22.1	5.0	0.0	10.7	0.0	19.8	0.0	1.6	6.2	8.3	0.0	0.0	13.2	11.9	1.0	0.0	0.0	19.7	20.8	4.9	14.6	8.0	23.5	24.6	5.1	3.9	6.6	6.1	4.0	11.1	15.9	6.0	0.0	28.2	4.8	9.4	14.6	6.1
RAB38	NY-MEL-1	ENSG00000123892	"RAB38, member RAS oncogene family"	P57729	11	88113251-88175443	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 48.6;skin 1: 44.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.4;Basal respiratory cells: 74.8;Cytotrophoblasts: 94.5;Melanocytes: 131.6;Suprabasal keratinocytes: 98.5;Syncytiotrophoblasts: 54.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 73.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"NK-cell: 18.0"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 18.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 87.7;hTCEpi: 308.0;hTERT-HME1: 271.4;SK-MEL-30: 175.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	HPA071701			Uncertain	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies, Mitochondria"		"HPA071701: "	"unprognostic (2.85e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	2.6	27.8	0.4	1.4	0.4	1.6	8.6	0.3	0.8	11.8	6.3	1.9	2.4	4.7	6.7	48.6	5.6	6.0	1.1	0.7	0.6	4.5	1.8	5.8	1.7	0.5	0.7	3.3	1.6	1.8	2.8	14.7	0.5	2.4	1.3	2.9	7.7	6.4	0.6	44.3	2.3	3.6	0.4	1.6	1.6	2.5	0.8	3.5	7.9	0.4	17.9	8.7	23.5	0.6	10.7	1.4	0.3	0.5	0.4	2.4	0.6	6.5	26.1	10.4	19.0	4.7	4.8	0.5	6.3	6.9	1.2	71.2	5.7	87.7	14.1	1.3	5.1	54.0	6.2	0.0	1.0	0.6	0.6	2.2	308.0	1.4	271.4	13.0	12.3	1.0	0.3	0.9	0.0	0.0	0.7	18.4	8.2	0.7	0.1	0.5	0.1	0.8	20.0	40.6	1.9	1.2	0.3	0.1	175.6	6.2	15.7	4.6	6.7	0.0	4.6	0.0	1.1	1.5	6.5	0.2	1.7	2.2	1.2	0.0	0.8	0.1	1.5	0.6	0.8	0.0	0.4	1.8	1.6	0.0	0.1	0.8	0.6	18.0	1.3	4.4	1.0	0.7	0.4	0.4	0.3	0.8	0.7	0.6	0.5	0.7	0.5	0.4	0.8	0.6	1.0	0.0	6.7	0.7	0.1	46.4	15.9	74.8	21.1	0.1	6.9	9.7	0.2	8.6	25.0	0.0	0.0	94.5	2.7	0.5	3.9	1.7	0.0	2.1	0.9	2.7	0.0	5.5	0.6	1.1	10.5	9.1	3.1	2.3	16.5	5.3	1.1	0.0	17.5	0.0	0.4	0.3	14.2	1.6	21.2	0.1	3.4	3.9	131.6	3.7	6.3	0.6	1.0	2.0	0.1	2.6	2.6	1.2	0.1	9.5	2.1	5.3	7.4	6.4	0.0	0.6	5.3	0.1	5.9	38.1	98.5	54.7	2.7	5.9	2.5	23.3
RAD1	"HRAD1, REC1"	ENSG00000113456	"RAD1 checkpoint DNA exonuclease"	O60671	5	34905260-34918989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006692	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles"		"HPA006692: AB_2667645"	"prognostic unfavorable (6.30e-4)"	"unprognostic (1.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-3)"	3.5	8.1	3.2	4.8	3.5	8.4	5.8	3.9	4.6	6.8	5.3	4.1	4.9	5.6	5.4	4.9	3.9	4.6	8.9	3.8	4.6	5.1	4.3	7.5	8.9	3.5	2.7	5.7	4.4	5.1	3.5	8.1	3.2	6.8	4.3	8.7	4.9	4.8	10.9	6.7	4.8	4.6	1.9	4.9	4.8	7.9	3.4	6.3	6.3	8.6	6.2	5.2	4.7	3.8	8.5	10.2	12.3	20.5	7.9	9.4	17.2	15.1	12.0	13.0	10.6	12.2	12.3	25.0	5.2	11.2	15.7	8.4	12.6	7.6	14.4	10.1	12.7	12.9	34.0	8.0	11.9	16.5	11.9	7.8	7.3	13.9	9.3	6.1	6.2	11.0	22.7	13.2	11.2	10.2	19.6	13.9	15.4	6.0	15.7	17.1	24.0	8.6	6.7	9.0	12.4	13.3	30.0	19.9	13.3	7.6	12.5	14.8	6.2	17.9	13.3	9.7	14.4	7.9	13.8	20.3	11.1	28.6	12.5	7.4	2.9	6.5	5.3	2.8	6.9	8.6	5.8	7.6	3.1	9.1	8.2	6.8	1.6	4.5	2.8	6.9	4.9	2.6	3.2	3.5	3.9	4.6	3.8	4.6	3.5	2.7	3.2	1.9	3.4	3.8	11.5	22.4	43.2	5.9	18.3	29.2	20.2	29.3	13.1	25.3	23.9	18.4	25.7	14.3	21.3	20.2	27.1	82.3	20.4	11.9	19.6	18.1	22.0	13.1	16.6	14.1	13.1	28.2	6.6	22.5	54.4	18.7	6.1	12.0	21.5	39.1	10.0	14.8	23.4	23.5	9.0	12.7	30.5	12.0	19.3	16.8	25.1	13.1	17.8	6.5	12.7	23.9	9.2	7.5	9.1	17.8	13.8	21.8	18.0	21.9	13.4	16.4	14.6	35.6	13.1	19.6	19.4	72.5	58.6	15.6	28.6	80.6	22.3	27.4	13.0	25.8
RASL11B		ENSG00000128045	"RAS like family 11 member B"	Q9BPW5	4	52862317-52866835	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.6;ovary: 66.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 33.1;Cytotrophoblasts: 102.6;Extravillous trophoblasts: 62.2;Granulosa cells: 26.6;Peritubular cells: 68.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.1;CACO-2: 11.1;NTERA-2: 15.2;RPTEC TERT1: 10.2;SH-SY5Y: 38.5;SuSa: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057803	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"		"HPA057803: AB_2683533"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.72e-2)"	"unprognostic (7.20e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.00e-6)"	"unprognostic (1.10e-1)"	2.0	2.0	3.1	0.5	3.8	0.0	1.1	2.8	5.8	4.5	0.1	0.9	0.0	9.8	2.7	0.5	4.1	0.9	14.7	5.2	3.2	17.9	0.6	1.0	0.8	0.3	0.4	66.4	0.9	7.9	0.7	4.7	0.2	2.0	0.1	0.3	1.4	9.1	0.4	3.8	0.9	1.9	0.2	27.6	4.1	5.9	1.4	0.1	1.0	0.1	0.9	2.2	4.9	3.2	0.3	0.0	5.9	0.0	5.2	2.4	14.1	0.1	0.1	0.3	0.0	11.1	0.0	0.0	0.5	0.0	0.1	0.0	0.7	3.5	0.0	0.0	1.4	0.5	0.0	0.0	1.0	0.0	0.4	2.5	6.2	0.0	0.2	0.0	0.0	0.3	0.7	0.0	0.0	1.3	1.1	0.0	15.2	1.3	0.2	0.0	6.8	0.0	10.2	1.5	3.2	38.5	0.2	2.6	1.3	10.1	1.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	3.1	3.8	2.8	5.8	5.2	3.2	0.3	0.4	0.2	0.2	1.4	3.2	1.1	6.4	0.0	0.3	0.9	0.9	1.5	2.8	0.0	4.9	7.5	6.5	5.3	0.0	1.8	33.1	0.0	102.6	1.5	7.1	0.0	1.5	0.4	1.6	6.9	1.2	0.0	0.0	2.7	0.5	62.2	4.6	9.7	2.7	0.0	26.6	1.1	0.0	8.0	0.0	1.1	3.6	0.0	0.3	1.7	3.3	24.2	0.8	0.0	4.7	0.6	1.9	0.0	0.5	0.9	0.5	5.6	68.4	0.1	0.5	1.6	0.1	0.1	1.2	0.0	5.8	5.7	4.6	10.9	1.2	0.4	23.1	0.9	6.1	2.8	0.2
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870362	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 440.4;Syncytiotrophoblasts: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	47.1	280.4	28.9	57.0	35.7	99.8	63.8	27.7	39.8	133.1	40.1	73.0	55.0	90.5	293.7	67.1	96.3	49.8	86.5	32.0	31.0	60.9	56.7	42.9	89.8	29.4	25.9	132.8	46.8	194.2	42.5	96.4	28.8	81.9	73.0	61.4	62.1	166.4	132.8	61.2	57.2	101.0	30.1	47.7	64.4	94.5	27.4	88.7	57.9	90.0	106.5	67.9	51.7	34.2	298.0	219.5	159.5	212.2	99.8	116.6	103.0	143.7	144.7	207.7	233.9	128.6	190.4	328.0	215.2	141.6	236.3	153.1	291.5	214.4	275.2	186.2	400.6	138.9	247.7	153.1	83.8	212.1	160.3	91.3	77.8	240.6	174.9	133.3	211.9	134.6	141.5	167.2	166.9	200.2	236.1	194.0	181.7	141.5	199.5	204.3	295.3	386.7	151.9	197.6	149.3	110.7	271.9	128.3	133.9	225.8	426.8	126.5	99.0	99.5	102.1	265.7	162.8	116.6	178.6	429.3	127.7	140.8	123.3	50.9	45.3	62.3	85.1	79.5	82.6	92.0	70.6	89.4	63.6	80.0	73.3	82.9	18.2	89.2	111.7	74.1	72.1	77.2	28.9	35.7	27.7	39.8	32.0	31.0	29.4	25.9	28.8	30.1	27.4	34.2	52.0	51.3	65.0	18.6	69.5	74.8	105.7	98.0	33.6	31.4	53.5	51.1	105.1	42.9	80.8	55.2	29.2	440.4	89.8	41.9	78.2	87.3	14.5	55.0	58.0	50.7	60.7	70.2	26.6	74.3	170.8	87.7	44.9	54.8	57.7	101.8	41.4	36.4	109.3	25.2	20.7	57.4	81.4	33.5	39.6	31.2	113.7	43.7	83.6	16.9	60.4	79.4	72.1	46.3	24.7	75.7	39.0	187.3	89.6	75.3	48.6	64.2	63.8	43.6	138.1	73.8	134.3	109.9	121.1	52.5	61.1	532.2	67.8	81.9	79.3	74.2
RHBDD3	"C22orf3, PTAG"	ENSG00000100263	"Rhomboid domain containing 3"	Q9Y3P4	22	29259872-29268209	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043979	Approved		Approved	Microtubules		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Microtubules		"HPA043979: AB_10960539"	"unprognostic (9.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.67e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (2.11e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.42e-3)"	7.6	20.7	6.8	2.4	7.7	2.9	6.9	6.7	10.8	7.2	6.4	7.3	4.9	9.0	1.3	8.6	8.6	1.7	10.2	6.4	7.2	10.0	16.8	6.7	1.9	8.7	7.9	8.0	11.8	2.6	14.8	2.1	7.7	13.4	0.6	0.9	7.7	4.4	10.1	6.2	7.1	1.6	7.1	10.7	7.1	22.2	7.3	2.3	10.7	0.5	0.9	7.0	6.0	7.6	4.6	7.7	4.2	12.3	1.3	2.2	23.5	2.9	3.8	3.5	4.4	6.9	10.1	12.6	12.4	2.8	2.1	14.2	2.5	2.3	0.4	16.7	19.9	4.6	6.5	8.6	15.0	10.4	11.5	6.6	6.2	1.5	4.2	2.5	4.8	5.1	5.6	8.3	2.6	9.0	6.8	15.8	19.8	2.9	8.6	11.9	7.8	14.6	1.5	4.6	9.2	4.8	9.9	10.6	12.3	1.0	7.0	9.0	7.0	9.5	4.2	4.0	4.4	20.3	6.6	15.1	4.0	4.6	8.1	0.0	4.6	1.9	2.5	4.1	3.1	1.8	2.4	3.7	4.7	0.9	1.8	2.5	1.4	3.6	3.8	11.2	3.9	2.5	6.8	7.7	6.7	10.8	6.4	7.2	8.7	7.9	7.7	7.1	7.3	7.6	8.4	6.4	7.0	22.2	5.1	6.1	11.7	19.9	5.2	17.2	12.1	9.8	8.4	8.6	16.0	14.7	6.2	44.4	12.8	19.0	0.0	18.6	9.0	19.0	12.8	10.0	8.4	11.2	14.4	19.8	18.7	14.1	21.9	24.6	0.0	21.7	12.8	15.7	25.6	16.8	16.5	15.1	12.2	9.7	5.5	7.4	14.0	7.5	7.2	12.2	7.8	14.5	7.2	11.1	9.9	13.2	16.1	12.0	9.5	16.0	15.9	7.1	12.1	22.9	6.6	9.0	10.2	29.8	26.6	8.6	6.0	38.3	7.4	26.3	17.7	9.6
RMI2	"BLAP18, C16orf75, MGC24665"	ENSG00000175643	"RecQ mediated genome instability 2"	Q96E14	16	11249619-11381662	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 123.8;Erythroid cells: 38.5;Extravillous trophoblasts: 34.1;Peritubular cells: 42.5;Spermatocytes: 36.6;Spermatogonia: 51.8;Syncytiotrophoblasts: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Group enriched"	"Detected in many"	6	"B-cells: 4.2;T-cells: 1.4"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040995	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear speckles"	Cytosol	"HPA040995: AB_10795531"	"unprognostic (2.76e-1)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.03e-1)"	1.4	1.5	2.2	12.3	2.0	9.9	5.1	1.0	2.2	4.8	0.9	12.5	7.5	2.9	3.9	10.8	2.1	2.2	1.6	2.3	1.3	3.4	4.3	1.9	31.4	1.2	1.3	3.0	1.8	1.3	0.6	19.3	1.2	3.2	14.4	0.5	2.4	2.1	0.9	10.2	8.8	2.3	1.0	3.5	7.0	14.0	1.4	36.8	1.5	0.6	34.9	4.5	4.4	1.8	60.3	39.5	75.2	32.6	3.3	15.8	33.0	35.9	26.8	31.6	51.8	15.4	69.2	83.8	29.1	15.8	35.3	34.4	32.4	32.5	50.5	16.6	30.5	45.3	22.6	102.5	1.3	17.6	19.5	3.7	6.1	14.5	13.3	12.3	17.4	36.2	65.3	63.2	16.5	70.3	60.9	83.1	64.1	82.6	15.7	73.1	81.1	89.3	18.7	38.0	44.1	35.0	28.5	47.4	26.1	43.5	80.4	25.8	5.6	25.1	23.3	49.3	5.0	18.1	30.9	99.3	23.3	57.4	47.2	0.0	0.0	0.4	0.3	0.0	0.0	4.2	0.1	0.0	0.2	1.1	0.8	0.3	0.1	0.1	0.0	0.2	1.4	0.1	2.2	2.0	1.0	2.2	2.3	1.3	1.2	1.3	1.2	1.0	1.4	1.8	1.3	0.0	0.5	0.0	4.5	6.8	5.4	1.4	6.2	0.2	3.4	3.2	1.0	4.3	1.6	7.3	0.0	123.8	0.5	3.3	5.9	2.6	3.0	0.8	2.1	2.8	2.4	38.5	0.0	0.5	34.1	6.4	4.1	2.2	0.0	19.7	1.1	1.1	18.5	0.0	0.0	7.7	0.0	0.8	6.5	5.9	15.8	3.7	3.6	0.0	1.1	0.2	1.0	0.0	0.0	1.0	4.0	42.5	2.4	2.1	1.3	0.4	0.1	0.6	32.9	0.0	2.2	36.6	51.8	11.3	5.4	47.7	1.9	6.5	10.3	7.5
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691673-88750929	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.6"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 234.3;Erythroid cells: 167.9;Syncytiotrophoblasts: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		2500000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: AB_2683563"	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	17.2	11.0	7.4	19.6	7.6	89.6	16.0	8.3	8.9	13.4	8.0	22.7	22.1	13.2	9.5	24.1	14.6	11.7	16.0	7.3	8.2	10.6	7.8	12.2	28.0	7.8	7.5	13.7	17.9	7.4	8.2	33.8	7.5	8.9	23.0	4.1	15.9	8.1	29.9	11.9	18.9	12.5	7.8	19.2	18.9	9.6	8.0	40.4	9.7	17.1	32.4	16.5	12.5	7.9	29.7	17.0	33.7	26.9	23.4	23.9	73.8	16.1	15.1	26.1	17.8	61.1	38.2	150.1	34.3	18.7	35.8	17.7	42.4	13.5	40.9	71.9	55.3	60.2	11.0	60.7	23.7	111.5	42.4	22.1	11.2	23.3	35.9	13.0	37.4	78.7	65.7	25.3	24.8	46.5	123.4	97.2	30.7	97.6	27.7	63.5	40.1	36.8	21.7	47.1	24.0	27.4	19.4	24.8	39.3	18.3	13.5	45.3	21.4	15.5	40.7	51.2	46.7	19.7	17.2	149.3	15.9	99.4	22.5	10.6	16.0	36.4	16.9	16.7	21.4	31.4	23.5	25.1	22.7	23.5	33.4	27.8	3.9	21.9	21.9	10.9	22.0	20.6	7.4	7.6	8.3	8.9	7.3	8.2	7.8	7.5	7.5	7.8	8.0	7.9	38.9	12.8	13.2	4.6	43.2	37.3	21.3	31.2	21.6	8.7	22.2	18.2	13.7	14.3	22.7	20.2	2.1	234.3	37.1	20.6	9.8	21.7	8.1	28.0	23.3	35.0	19.2	167.9	13.3	34.2	98.9	23.5	31.1	43.2	21.6	30.7	24.3	7.1	43.8	13.5	15.7	26.9	26.4	23.1	33.9	4.0	19.9	23.7	40.9	11.2	32.4	5.2	60.8	13.6	13.3	22.8	28.1	18.8	35.8	41.7	20.6	18.7	10.1	4.8	19.7	19.8	18.0	28.4	33.4	37.6	40.9	225.6	38.8	37.8	58.5	43.7
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.0;dendritic cells: 75.0;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 10.5;monocytes: 2.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	15.0	13.1	14.8	11.8	16.1	10.9	12.5	17.0	17.9	13.7	10.5	16.8	9.8	16.5	2.8	31.0	12.0	4.7	16.2	15.3	13.7	14.2	12.0	16.4	12.0	14.7	14.7	8.5	12.2	3.3	6.8	11.7	14.7	13.1	5.6	2.1	12.5	5.6	16.0	22.8	17.1	6.8	14.4	25.0	15.8	3.5	15.1	5.7	10.2	5.0	9.5	16.6	14.6	14.3	76.1	41.5	5.9	15.0	12.8	11.9	84.0	39.4	20.6	30.2	14.9	41.7	38.8	7.9	44.9	22.9	38.6	69.1	7.1	32.1	14.7	24.1	14.0	17.8	36.8	21.6	12.8	18.0	32.0	12.0	29.7	25.7	20.9	10.9	18.4	14.2	7.4	10.6	15.6	69.2	16.6	28.4	6.5	29.2	88.1	31.8	24.4	25.3	21.1	34.4	8.7	6.9	40.7	24.8	35.6	8.5	28.6	22.3	37.0	41.0	51.7	74.7	35.9	12.5	10.4	7.8	27.0	20.6	21.2	1.3	2.7	1.4	0.7	2.1	0.7	0.4	0.5	0.6	2.2	0.2	0.3	0.3	0.2	0.2	1.3	10.5	0.5	2.6	14.8	16.1	17.0	17.9	15.3	13.7	14.7	14.7	14.7	14.4	15.1	14.3	11.8	3.2	3.0	8.5	6.4	12.1	6.8	8.6	8.6	7.3	5.4	4.8	15.2	7.2	5.4	3.7	4.2	70.0	75.0	25.2	5.9	20.1	0.8	3.5	8.7	9.9	8.4	9.9	6.6	25.2	38.2	9.3	26.0	7.6	19.1	5.7	10.8	7.8	29.6	8.4	5.3	14.3	2.0	30.5	13.2	1.5	11.1	25.8	8.8	11.2	26.6	3.6	10.3	4.5	5.4	65.1	12.8	6.8	5.7	10.2	16.2	8.4	3.1	2.1	0.0	6.0	10.2	0.7	6.5	13.9	10.7	46.7	11.3	7.5	19.9	9.6
RTL8B	"CXX1c, FAM127C, MAR8B, SIRH4"	ENSG00000212747	"Retrotransposon Gag like 8B"	Q17RB0	X	135020513-135022542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 103.8;Distal tubular cells: 29.4;Extravillous trophoblasts: 31.2;Syncytiotrophoblasts: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 52.9;U-2197: 67.7"															NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"				"prognostic unfavorable (2.41e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.32e-3)"	"unprognostic (4.34e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (2.56e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-2)"	15.9	22.2	6.7	4.3	7.7	0.2	14.4	7.2	7.9	18.4	4.1	18.3	2.4	21.4	6.3	19.8	15.6	6.8	19.2	6.0	7.8	12.4	2.5	12.4	2.1	7.8	7.1	14.6	6.6	8.2	13.4	9.2	7.4	15.3	3.2	15.0	13.7	12.3	8.6	14.4	7.5	12.1	7.3	7.6	11.7	5.2	7.3	1.5	10.7	7.5	2.9	18.7	17.2	7.3	0.0	6.0	19.6	16.0	14.4	9.3	0.1	21.8	30.1	17.2	18.3	10.7	0.8	0.0	52.9	32.0	5.3	0.9	3.8	2.8	12.8	0.1	10.7	2.7	19.1	0.0	23.6	0.0	0.0	40.7	2.4	13.1	0.0	0.6	12.5	0.0	0.0	0.0	29.4	26.2	0.0	1.6	5.6	0.0	25.1	0.0	22.4	0.1	20.1	4.9	13.3	31.9	16.9	10.6	9.0	5.2	8.9	11.6	16.9	0.1	9.3	67.7	0.6	0.0	0.0	0.1	26.0	0.0	10.9	0.0	1.6	0.0	0.0	1.0	0.0	0.0	0.1	0.2	0.9	0.0	0.5	0.3	0.2	0.0	1.6	0.6	0.0	0.8	6.7	7.7	7.2	7.9	6.0	7.8	7.8	7.1	7.4	7.3	7.3	7.3	14.4	12.8	7.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	13.5	14.0	0.0	0.0	3.7	11.0	0.0	103.8	0.4	0.0	29.4	12.6	0.0	8.2	16.1	9.7	0.0	0.0	0.0	9.6	31.2	6.9	0.0	14.3	0.0	4.8	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	17.0	0.7	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	30.9	0.4	8.9	0.0	0.0
S1PR2	"AGR16, DFNB68, EDG5, Gpcr13, H218"	ENSG00000267534	"Sphingosine-1-phosphate receptor 2"	O95136	19	10221433-10231331	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 92.9;Early spermatids: 92.3;Late spermatids: 184.9;Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 45.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 45.0;T-cells: 12.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.4;Daudi: 54.1;U-266/70: 38.9;U-698: 57.3;WM-115: 38.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014255, HPA014307"	Approved		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	"Nuclear speckles"	"HPA014255: , HPA014307: AB_1847989"	"unprognostic (5.38e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.50e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.91e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.09e-2)"	7.7	2.5	1.9	6.4	1.8	1.2	5.5	1.7	1.8	10.4	1.9	4.8	1.8	8.3	2.7	3.3	8.4	6.2	6.6	1.6	2.0	3.1	5.6	13.7	10.9	2.8	1.9	5.6	2.9	2.5	3.0	18.5	2.2	6.9	2.4	1.2	4.1	2.3	0.8	5.4	4.8	4.2	2.0	1.9	4.3	13.2	2.1	1.4	3.4	1.3	10.9	8.3	7.0	2.9	3.0	0.4	3.4	6.9	18.2	22.2	29.4	4.4	8.9	1.9	4.1	1.9	1.7	54.1	5.1	8.2	2.3	1.7	1.2	2.1	1.3	5.5	2.7	1.2	1.2	1.3	6.1	1.4	1.1	12.2	1.1	3.8	1.3	5.3	0.2	2.6	1.3	11.1	1.3	2.5	0.6	2.5	3.4	0.9	1.7	3.8	1.4	2.0	1.6	2.5	2.4	4.7	2.5	1.5	3.8	2.6	1.2	1.3	0.4	6.9	2.2	15.9	1.3	38.9	19.6	57.3	2.6	2.7	38.6	45.0	2.8	0.6	7.2	2.4	8.9	0.3	9.2	7.0	2.6	0.5	3.7	3.8	0.7	3.6	1.0	0.4	12.4	2.0	1.9	1.8	1.7	1.8	1.6	2.0	2.8	1.9	2.2	2.0	2.1	2.9	2.0	0.0	1.1	0.3	2.0	0.0	4.6	0.0	1.2	0.6	8.3	4.6	0.6	2.8	0.6	1.8	2.1	92.9	5.4	0.0	0.0	3.6	92.3	8.6	21.5	2.0	2.4	0.0	0.3	3.3	18.1	17.7	0.0	18.1	0.0	2.0	3.9	7.6	13.2	0.0	0.9	0.5	0.0	3.1	0.0	184.9	22.1	7.2	0.0	0.0	4.0	7.1	3.1	6.6	0.5	2.7	0.3	13.2	2.6	4.9	0.0	0.9	0.0	0.5	13.1	2.0	4.6	1.5	1.2	2.0	0.0	68.4	4.2	1.1	0.2	4.1
SETMAR	metnase	ENSG00000170364	"SET domain and mariner transposase fusion gene"	Q53H47	3	4303304-4317567	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA057999			Supported	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoli		"HPA057999: AB_2683574"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.61e-6)"	"unprognostic (5.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-3)"	6.5	3.7	2.6	2.2	4.3	2.6	8.5	4.2	3.3	8.4	1.9	3.9	2.7	10.3	4.6	4.5	8.5	5.3	3.4	3.0	2.3	6.4	3.3	2.7	2.9	3.6	2.8	12.1	5.1	3.4	3.7	3.7	3.4	7.9	4.3	2.1	5.7	6.1	3.8	4.8	3.1	10.4	2.5	2.8	3.7	4.2	4.0	6.0	7.4	5.1	2.8	5.5	5.2	6.5	3.7	3.2	9.8	2.1	23.1	7.6	9.9	4.1	1.2	3.9	3.7	3.5	2.9	9.9	4.2	2.3	7.2	3.1	8.9	6.1	4.3	6.8	7.6	12.5	6.1	5.6	2.7	5.9	5.1	9.1	4.7	3.0	0.9	3.6	5.7	11.2	8.3	3.6	6.2	5.2	8.9	3.7	9.5	2.4	5.7	10.3	9.6	4.1	3.6	5.1	7.8	11.4	4.9	6.1	5.3	6.2	5.9	3.4	3.8	5.8	8.0	4.9	5.4	4.9	12.3	24.1	2.1	6.7	4.9	0.7	0.4	0.5	0.8	1.2	0.7	1.0	1.0	1.1	0.4	1.3	1.6	2.0	0.0	0.2	0.8	0.6	0.7	0.6	2.6	4.3	4.2	3.3	3.0	2.3	3.6	2.8	3.4	2.5	4.0	6.5	4.8	0.0	5.0	4.9	2.4	2.4	8.0	12.0	10.8	5.8	6.6	13.7	6.6	2.8	10.8	0.0	0.0	25.5	1.9	2.7	13.7	11.2	0.7	3.8	6.3	5.6	3.6	5.5	6.4	13.4	12.1	8.9	5.6	4.4	1.3	13.9	4.2	2.6	5.7	0.0	6.9	2.8	10.2	2.1	1.5	1.9	9.6	2.7	0.0	4.7	4.1	4.6	2.1	7.1	11.7	6.6	4.4	13.2	1.8	4.4	2.0	6.0	6.7	2.8	6.6	7.0	8.1	7.5	6.4	6.0	0.6	16.3	2.8	16.9	5.6	3.6
SH2D4A	"FLJ20967, PPP1R38, SH2A"	ENSG00000104611	"SH2 domain containing 4A"	Q9H788	8	19313693-19396218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 87.7;Pancreatic endocrine cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 181.7;OE19: 102.5;U-2197: 130.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001871, HPA001919"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA001871: AB_1079949, HPA001919: AB_1079947"	"unprognostic (9.08e-2)"	"unprognostic (8.40e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.70e-2)"	"unprognostic (8.84e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (6.02e-8)"	"unprognostic (1.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.11e-2)"	5.0	8.8	1.6	4.1	1.4	0.1	6.2	1.2	2.0	13.6	1.9	13.6	12.7	4.0	1.7	20.4	9.1	11.1	3.1	1.6	1.5	12.6	39.1	15.8	1.0	1.6	1.6	36.9	13.1	18.2	1.4	17.7	1.9	7.4	10.8	9.6	24.0	10.1	0.6	7.2	12.6	2.0	1.3	3.3	29.9	2.2	1.5	1.3	16.8	1.6	7.4	18.3	10.5	2.0	60.5	67.3	0.2	0.1	6.5	8.0	44.9	73.9	36.6	70.7	68.3	55.7	53.4	0.0	17.4	181.7	11.2	30.5	2.7	20.0	73.6	0.2	1.0	0.0	40.7	8.6	38.3	1.6	0.3	7.8	24.5	48.4	8.8	42.5	0.3	0.0	0.1	0.1	12.0	27.2	0.1	0.7	15.8	102.5	25.4	0.1	0.0	19.5	19.5	62.6	4.1	0.1	66.0	70.6	0.2	10.4	13.3	5.3	1.2	22.9	0.1	130.8	22.4	0.0	0.7	0.2	23.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.2	0.0	1.8	0.1	0.0	0.0	0.1	0.0	1.6	1.4	1.2	2.0	1.6	1.5	1.6	1.6	1.9	1.3	1.5	2.0	8.5	64.1	33.9	6.5	0.9	1.5	15.0	22.2	5.2	2.2	9.4	5.6	2.0	34.3	26.2	46.0	27.1	87.7	0.3	20.1	43.0	50.3	25.3	30.9	6.0	5.4	3.0	0.0	1.5	67.0	69.4	11.7	67.8	34.4	1.3	43.3	2.5	45.5	37.7	1.7	1.0	24.8	54.9	8.5	1.6	53.5	6.2	6.3	0.0	1.9	0.6	3.5	0.0	11.1	0.3	99.1	8.3	11.3	0.4	14.6	20.5	10.9	46.9	36.2	19.7	3.0	6.5	0.5	2.8	31.9	2.6	30.6	1.0	52.0	26.3	31.2
SH3GLB2	KIAA1848	ENSG00000148341	"SH3 domain containing GRB2 like, endophilin B2"	Q9NR46	9	129007036-129028331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 127.9;Syncytiotrophoblasts: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 234.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021438, HPA024734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA021438: AB_1856820, HPA024734: AB_1856821"	"unprognostic (2.59e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.88e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-3)"	"prognostic favorable (4.28e-4)"	32.7	49.1	86.7	19.2	93.6	59.4	46.0	69.4	127.6	60.5	63.5	56.3	42.1	47.9	17.1	101.4	52.7	22.0	32.4	95.0	74.5	63.9	25.3	35.4	24.9	81.3	71.1	45.2	71.5	69.1	88.4	37.7	82.2	71.8	16.1	11.7	60.8	50.2	50.0	116.7	47.9	18.5	68.8	42.1	71.2	24.4	78.0	37.2	45.9	19.0	22.6	72.6	66.8	93.1	49.7	41.2	19.9	27.1	11.7	14.8	59.2	17.0	37.8	33.0	30.0	25.8	83.2	51.9	13.3	30.1	25.5	119.2	6.3	36.7	9.3	34.0	27.5	13.2	70.5	22.9	24.4	11.9	30.7	10.6	41.1	16.8	14.9	36.2	28.0	66.8	17.8	67.2	16.9	121.5	68.4	31.5	17.8	83.2	28.7	136.3	37.2	234.3	36.7	59.1	62.0	50.3	24.7	62.6	26.3	16.4	90.5	17.5	25.8	15.3	26.1	39.3	37.7	65.6	34.0	33.8	35.6	14.7	8.3	2.1	1.6	3.5	1.9	0.8	2.3	3.5	2.2	1.8	1.3	2.0	1.6	1.3	1.3	2.6	2.5	3.7	2.0	1.5	86.7	93.6	69.4	127.6	95.0	74.5	81.3	71.1	82.2	68.8	78.0	93.1	36.3	16.0	28.4	28.1	20.3	20.8	27.5	11.6	9.6	26.9	59.7	62.9	10.6	18.6	19.8	47.8	8.4	127.9	29.4	58.2	15.6	14.5	11.2	36.3	19.6	15.6	25.3	29.5	24.4	26.0	19.2	23.3	84.6	63.6	6.3	29.9	12.1	9.9	20.7	47.1	14.2	35.9	12.2	11.9	11.6	24.4	19.0	14.3	14.2	17.8	6.9	36.0	6.2	23.6	95.6	24.6	50.3	20.3	25.9	23.0	39.4	7.6	21.5	20.6	13.1	32.0	39.7	8.6	6.6	27.6	53.6	149.5	16.3	18.3	34.6	58.3
SHISA5	"hShisa5, SCOTIN"	ENSG00000164054	"Shisa family member 5"	Q8N114	3	48467798-48504826	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 279.7;Extravillous trophoblasts: 229.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042295	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA042295: AB_10794794"	"unprognostic (3.52e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.72e-6)"	"unprognostic (3.82e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.64e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.08e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.74e-2)"	97.5	71.8	74.2	68.3	71.9	65.0	82.2	58.8	92.2	99.6	113.0	82.1	60.6	91.4	45.3	140.6	94.9	70.6	75.0	72.3	88.9	94.3	115.0	101.7	80.1	76.8	73.6	86.3	58.3	48.0	70.2	138.4	72.0	107.9	39.5	13.7	69.1	69.8	22.8	60.1	74.5	67.1	70.8	114.3	73.5	35.5	87.6	84.4	76.8	31.7	66.9	116.8	98.3	65.2	71.0	141.9	82.4	132.0	153.1	194.7	417.7	115.3	209.0	254.3	187.9	157.4	175.6	97.7	123.2	200.9	240.9	91.7	91.5	148.3	70.7	116.4	63.6	89.2	91.2	128.2	256.7	61.9	164.0	200.9	169.3	205.7	141.7	141.7	193.2	129.0	56.6	115.6	138.2	154.1	70.4	111.1	150.4	101.2	113.0	48.2	36.7	133.4	130.5	446.6	24.6	13.8	74.9	79.1	155.6	136.8	91.5	91.2	153.6	90.5	100.8	155.2	112.0	87.0	76.3	85.8	128.2	118.3	90.2	205.9	301.6	252.5	320.7	267.5	283.4	165.0	264.1	293.8	167.3	222.6	210.9	219.4	910.2	138.7	306.9	126.7	345.7	500.0	74.2	71.9	58.8	92.2	72.3	88.9	76.8	73.6	72.0	70.8	87.6	65.2	69.8	41.7	39.4	12.1	55.8	27.8	73.0	52.2	114.4	22.7	29.6	29.8	17.3	51.5	37.6	64.4	16.7	279.7	56.3	43.0	11.7	79.4	4.2	29.2	49.8	79.4	37.8	22.9	10.8	104.3	229.9	57.4	36.2	31.2	34.8	41.5	66.0	88.0	103.0	6.7	11.0	48.3	14.2	57.5	27.3	5.7	49.0	47.7	46.2	18.7	46.5	30.1	101.0	10.6	10.4	80.2	31.2	39.1	54.5	50.2	64.9	43.3	38.0	5.0	32.9	22.1	43.9	5.1	8.8	85.9	32.1	120.5	74.0	49.9	40.3	50.5
SLC12A9	CIP1	ENSG00000146828	"Solute carrier family 12 member 9"	Q9BXP2	7	100826820-100867010	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 90.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 61.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067536	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA067536: AB_2732768"	"unprognostic (6.53e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.38e-3)"	"prognostic favorable (5.97e-4)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.52e-2)"	"unprognostic (6.00e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.38e-2)"	6.9	8.1	7.4	8.7	11.2	7.6	6.3	10.7	10.8	8.3	6.5	8.3	7.8	8.2	1.2	7.3	6.7	9.5	4.2	7.3	8.7	7.4	6.8	8.2	7.3	12.5	10.6	6.7	10.5	6.3	3.6	14.0	11.4	8.0	5.6	0.7	7.4	6.4	2.6	7.9	8.3	6.7	10.1	14.1	7.0	2.7	9.3	5.9	5.8	3.1	3.8	9.2	6.1	13.1	16.1	12.4	4.2	33.9	12.4	7.3	42.2	7.9	15.1	11.7	16.6	17.7	26.7	11.5	25.1	15.0	18.8	17.3	7.3	17.6	3.1	12.3	12.1	4.4	13.8	12.6	15.1	5.4	18.0	18.0	9.9	9.3	9.4	9.5	23.2	9.1	10.5	6.1	16.8	49.8	5.7	25.5	8.3	33.3	24.6	13.3	4.2	17.9	11.6	14.3	7.0	15.8	8.7	61.7	16.7	7.0	7.7	19.1	14.5	14.4	14.3	23.8	14.4	3.2	13.7	4.0	10.2	18.0	17.4	0.0	1.5	0.0	0.2	1.8	0.3	0.6	0.1	0.1	2.4	0.6	0.2	0.1	1.4	0.2	1.9	1.2	0.3	0.9	7.4	11.2	10.7	10.8	7.3	8.7	12.5	10.6	11.4	10.1	9.3	13.1	10.6	3.2	16.1	3.9	12.3	11.0	12.0	6.9	10.8	6.6	12.6	11.0	2.1	11.5	10.1	18.4	2.1	90.0	21.7	14.1	0.0	12.7	0.9	5.6	9.1	13.6	11.4	1.7	2.0	13.4	28.2	10.2	18.3	9.5	1.3	14.7	15.7	6.9	31.2	6.7	2.6	13.6	10.2	23.9	18.3	0.7	9.0	27.2	8.8	3.7	24.6	18.7	8.2	6.0	5.8	14.9	23.7	6.4	9.7	8.3	14.7	10.9	4.8	6.7	13.1	9.4	7.3	1.7	7.8	12.9	11.4	50.2	13.4	17.2	19.6	9.6
SLC27A6	"ACSVL2, FACVL2, FATP6, VLCS-H1"	ENSG00000113396	"Solute carrier family 27 member 6"	Q9Y2P4	5	128538013-129033642	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 24.4;fallopian tube: 21.3;heart muscle: 23.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 25.0;Cardiomyocytes: 29.6;Cytotrophoblasts: 54.8;Extravillous trophoblasts: 37.3;Muller glia cells: 33.0;Skeletal myocytes: 18.0;Syncytiotrophoblasts: 27.5"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 19.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 43.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008987	Approved		Approved	"Nuclear bodies"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"		"HPA008987: AB_1857065"	"unprognostic (5.39e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.53e-1)"		"unprognostic (2.64e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.66e-4)"	0.4	24.4	1.8	0.3	2.4	0.1	3.0	3.0	1.4	3.9	0.7	0.9	0.4	4.3	0.2	4.2	21.3	2.7	23.5	1.2	3.6	0.0	0.1	0.8	0.2	9.7	5.2	9.7	0.1	0.0	6.0	6.7	7.5	3.6	1.7	7.4	3.5	0.3	0.4	2.0	1.1	0.8	5.8	0.1	0.5	13.0	5.5	9.6	1.8	0.9	5.7	1.1	2.9	8.4	0.0	0.0	0.1	0.0	0.0	0.0	43.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.9	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	3.5	0.0	3.3	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.3	4.4	0.0	5.1	0.0	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.4	3.0	1.4	1.2	3.6	9.7	5.2	7.5	5.8	5.5	8.4	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	25.0	0.6	0.2	5.5	29.6	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	13.2	3.8	1.0	0.3	0.0	0.0	0.4	0.0	37.3	2.7	0.0	1.9	0.0	1.7	0.0	0.0	3.8	3.3	4.6	0.0	0.0	0.0	0.4	2.8	0.3	0.2	0.0	0.0	0.0	33.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.0	18.0	0.3	1.1	1.0	1.8	0.9	27.5	0.0	2.3	0.1	0.1
SLC29A2	"DER12, ENT2, HNP36"	ENSG00000174669	"Solute carrier family 29 member 2"	Q14542	11	66362521-66372214	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 90.8;tongue: 47.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.3;CAPAN-2: 53.5;T-47d: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018168	Approved		Uncertain	Nucleoplasm		NA	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA018168: AB_1857077"	"unprognostic (3.20e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.37e-1)"	"unprognostic (5.08e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.38e-3)"	6.7	0.9	4.2	2.5	4.3	0.8	7.4	9.8	5.6	1.9	4.2	5.7	7.8	0.9	3.1	3.3	3.6	1.4	11.9	4.1	4.0	6.9	1.5	4.4	2.8	7.4	6.9	0.7	8.7	12.9	6.1	4.1	8.2	5.2	4.1	3.1	7.2	2.4	90.8	2.8	7.4	0.3	4.1	2.1	9.4	0.5	5.9	2.3	5.4	47.3	1.9	1.2	2.6	3.7	14.2	11.4	8.2	1.8	1.2	0.3	44.3	0.6	0.0	0.4	0.6	20.2	53.5	6.1	10.4	0.1	3.1	12.9	11.4	9.7	0.0	0.5	18.6	11.7	12.4	1.5	1.3	21.9	0.4	0.7	4.3	1.5	4.1	5.2	0.5	5.1	33.0	0.0	0.0	34.5	1.6	31.9	21.8	35.1	8.1	1.3	0.3	26.4	22.2	10.4	16.1	6.6	1.0	18.4	1.2	2.4	55.2	4.1	0.0	0.3	11.2	0.4	0.0	0.3	0.8	0.5	0.9	0.5	0.7	0.0	0.0	0.0	1.3	0.0	0.4	0.2	0.7	1.7	0.3	0.7	1.7	1.7	0.1	0.0	0.0	0.6	0.1	0.5	4.2	4.3	9.8	5.6	4.1	4.0	7.4	6.9	8.2	4.1	5.9	3.7	0.6	3.2	6.3	9.4	2.2	0.6	4.7	5.4	1.2	2.5	7.6	5.8	12.3	4.3	6.5	14.7	12.5	46.4	0.7	6.0	3.9	5.0	0.1	2.1	0.5	0.9	2.4	2.1	11.2	6.7	16.5	1.7	11.2	5.4	4.5	1.8	0.4	0.9	4.4	5.0	10.8	9.2	4.1	0.8	0.4	0.0	0.0	0.5	0.0	2.8	0.9	2.3	0.0	7.5	0.8	3.5	4.7	0.4	1.5	4.7	1.6	0.5	3.8	3.7	0.0	4.4	2.1	0.4	0.5	3.5	0.0	13.5	2.1	0.4	10.6	3.4
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319259-71381423	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.8;Hep G2: 35.9;RT4: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.43e-3)"	4.7	2.6	3.1	4.1	3.9	1.1	4.8	3.7	3.7	7.3	2.7	4.4	2.1	6.8	2.5	2.2	5.8	4.4	2.4	3.0	3.6	2.5	9.4	6.7	7.1	4.7	3.7	9.7	5.2	3.5	1.7	11.2	4.2	5.1	3.5	0.3	4.9	2.9	1.4	2.6	3.7	5.1	4.2	6.5	6.1	3.7	4.4	3.7	3.8	0.6	3.8	9.8	4.4	5.0	2.1	12.3	1.8	7.8	6.8	5.3	31.8	2.3	2.2	0.7	0.4	13.8	8.8	7.4	6.4	4.7	3.2	18.3	5.7	2.9	0.1	5.6	5.6	2.2	1.0	35.9	3.3	1.8	4.5	5.2	12.9	0.3	0.6	1.5	3.2	8.5	6.5	6.8	0.9	19.1	4.2	3.8	4.2	19.2	4.5	5.7	0.6	5.9	2.3	29.5	8.5	9.6	6.4	20.3	1.7	5.2	3.2	4.0	5.2	0.2	3.8	2.3	0.1	1.8	3.1	4.0	7.6	24.0	1.3	4.2	19.3	2.2	5.4	15.3	4.6	4.9	4.5	5.1	29.1	1.9	3.5	5.0	1.5	9.4	10.3	20.2	5.5	9.5	3.1	3.9	3.7	3.7	3.0	3.6	4.7	3.7	4.2	4.2	4.4	5.0	2.0	3.2	1.1	2.0	3.1	0.3	1.5	4.0	1.8	2.3	2.7	3.8	0.8	1.5	3.8	0.0	0.0	46.1	6.3	2.6	0.0	6.1	3.6	1.8	3.2	1.8	1.8	4.2	2.4	8.9	45.3	4.7	7.1	2.4	2.5	10.2	3.3	5.4	34.7	0.0	1.3	2.5	8.2	11.8	4.4	15.2	2.8	10.9	1.8	16.9	8.5	3.0	3.1	2.5	2.7	7.9	13.1	1.5	6.0	3.2	0.1	2.0	2.6	0.4	0.0	0.2	2.5	0.6	5.0	0.7	0.0	31.7	2.9	10.0	2.5	1.7
SLC35B4	"FLJ14697, YEA4"	ENSG00000205060	"Solute carrier family 35 member B4"	Q969S0	7	134289332-134316930	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 95.2;Syncytiotrophoblasts: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049779	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA049779: AB_2680878"	"unprognostic (1.84e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.00e-1)"	5.1	6.4	8.8	5.2	8.7	1.9	3.3	9.8	8.5	4.0	7.6	4.0	2.9	6.0	6.3	3.3	4.4	3.9	2.5	8.5	8.9	10.4	8.5	3.3	4.5	8.0	8.5	6.4	2.6	4.6	4.2	11.8	7.7	5.2	3.5	12.3	2.3	6.1	2.5	3.1	4.1	7.1	7.7	4.2	3.5	4.7	10.1	4.8	3.4	2.9	4.8	4.0	2.8	8.7	6.8	22.5	19.3	29.0	18.4	15.3	9.9	16.9	14.1	14.7	12.4	8.7	6.3	22.9	5.6	18.3	19.2	7.2	29.0	15.0	24.3	14.5	21.4	15.5	12.9	11.6	13.6	22.1	13.4	13.6	6.3	17.7	14.9	11.0	14.4	15.6	15.2	8.2	22.2	6.1	19.7	16.1	40.0	7.0	20.0	14.1	17.0	11.2	8.3	8.3	6.7	39.5	15.1	5.0	19.0	16.0	2.7	12.4	16.1	19.0	6.2	11.5	16.9	26.9	39.9	25.9	34.0	20.5	22.4	0.7	1.5	0.3	1.6	2.1	2.5	1.3	1.5	2.1	3.1	1.4	1.4	2.1	0.1	1.9	1.7	2.1	1.7	1.4	8.8	8.7	9.8	8.5	8.5	8.9	8.0	8.5	7.7	7.7	10.1	8.7	7.2	9.6	5.4	22.9	10.2	2.2	5.7	10.7	6.2	52.6	4.9	3.4	6.9	11.5	8.5	1.8	45.9	95.2	3.7	2.2	11.7	8.1	2.4	5.3	15.2	11.8	4.2	8.8	33.4	5.3	27.8	13.3	14.8	6.5	1.3	27.8	7.5	15.1	20.9	42.1	36.6	5.7	22.4	9.3	3.9	3.4	11.1	11.9	5.4	14.0	8.4	16.2	14.4	24.1	24.3	9.0	4.9	12.4	9.2	4.9	7.0	13.9	6.2	21.6	6.6	10.0	10.0	10.8	24.0	9.3	3.3	83.2	10.7	31.3	4.1	3.7
SLC35C2	"bA394O2.1, C20orf5, CGI-15, OVCOV1"	ENSG00000080189	"Solute carrier family 35 member C2"	Q9NQQ7	20	46345980-46364458	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027011	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA027011: AB_2672082"	"unprognostic (7.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (9.31e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.88e-1)"	23.2	36.3	23.1	17.2	22.3	27.1	23.2	21.3	25.2	26.4	22.6	23.9	21.3	23.1	17.4	31.8	23.2	18.2	17.2	21.8	20.6	27.7	38.3	22.8	24.0	22.6	23.1	25.5	34.9	14.9	20.3	18.2	22.3	31.2	10.1	11.3	30.3	14.0	18.3	32.7	26.4	10.4	21.2	33.6	27.7	25.0	23.4	14.4	29.2	8.2	13.4	22.4	25.6	22.8	35.9	45.1	17.5	15.0	23.9	23.2	36.3	17.6	33.7	19.7	22.6	60.9	54.6	22.5	63.2	19.9	24.7	49.0	9.3	40.5	6.7	19.6	32.5	20.2	29.5	49.0	46.6	27.6	23.6	33.6	51.0	27.4	29.8	20.8	15.2	23.7	33.3	41.5	14.2	85.0	19.8	40.7	24.3	34.1	36.7	18.9	19.7	45.3	25.8	35.1	28.1	39.6	16.4	87.1	60.9	10.4	56.0	47.8	15.7	53.2	33.7	27.5	32.0	55.6	51.5	25.2	58.0	29.7	23.9	42.7	37.9	48.0	37.5	39.9	35.4	29.7	39.0	38.8	42.4	27.9	44.5	40.3	33.5	33.4	30.8	72.9	41.1	44.1	23.1	22.3	21.3	25.2	21.8	20.6	22.6	23.1	22.3	21.2	23.4	22.8	17.0	16.0	19.1	24.5	27.6	14.4	29.0	35.5	29.0	41.3	32.4	25.4	6.7	21.5	29.2	27.6	41.7	89.5	32.6	26.9	13.7	41.3	5.9	12.8	13.0	18.4	21.0	12.4	13.6	61.8	49.2	24.0	26.0	13.9	14.7	20.3	31.8	27.5	38.7	18.5	13.6	35.1	26.4	22.8	8.2	6.7	19.3	23.6	21.4	14.0	36.4	23.4	34.0	11.1	14.2	35.0	26.9	19.2	28.8	50.0	34.8	18.3	18.7	33.6	19.7	20.1	19.0	16.1	23.6	24.8	16.6	79.2	25.9	24.8	30.2	33.1
SLC39A1	"ZIP1, ZIRTL"	ENSG00000143570	"Solute carrier family 39 member 1"	Q9NY26	1	153959099-153968184	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 342.4;Ductal cells: 219.3;Extravillous trophoblasts: 297.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (6.27e-2)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (5.26e-5)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (2.36e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-2)"	67.1	73.2	39.0	48.6	42.7	10.6	62.5	41.9	41.6	56.7	45.1	53.8	36.2	59.9	33.8	50.1	53.8	55.2	62.1	37.4	42.1	77.0	76.7	87.4	35.3	51.7	43.8	54.7	48.9	65.5	30.5	94.9	44.5	56.8	38.2	10.2	51.9	46.4	45.4	65.3	48.4	49.9	44.8	56.0	59.0	20.6	45.3	26.1	56.6	38.7	36.2	60.5	48.3	43.7	122.5	138.3	111.5	93.7	103.4	105.2	244.2	76.8	188.7	128.1	140.2	203.6	303.0	47.2	240.0	108.5	106.8	266.8	114.8	118.9	72.6	146.5	92.5	64.3	138.9	92.9	118.3	49.4	71.1	128.6	108.9	101.1	99.8	119.2	92.7	54.2	62.6	53.5	104.5	251.5	51.0	64.1	158.6	253.4	107.2	56.3	96.3	57.2	202.7	88.1	49.3	116.0	143.6	363.4	136.4	142.9	195.7	104.8	81.6	114.7	105.6	84.3	113.6	64.8	87.1	61.8	82.0	38.8	157.0	16.6	68.1	20.3	33.9	78.9	21.1	34.8	25.1	25.6	56.0	39.8	27.2	24.7	67.3	30.6	95.5	51.3	26.9	58.1	39.0	42.7	41.9	41.6	37.4	42.1	51.7	43.8	44.5	44.8	45.3	43.7	71.0	9.6	3.3	7.5	21.9	56.5	97.7	105.8	59.2	7.7	56.7	50.2	13.5	61.5	39.0	53.3	2.1	342.4	35.6	33.9	13.7	219.3	1.0	21.4	38.9	70.1	19.2	17.4	1.8	113.8	297.2	60.6	17.3	35.7	36.8	22.2	49.6	25.6	116.5	18.5	3.1	28.4	40.7	63.6	43.4	3.4	48.4	57.8	48.0	8.4	78.6	36.5	28.8	6.0	6.6	127.8	33.9	62.1	19.8	127.4	49.8	39.6	19.2	6.9	46.0	41.3	55.2	31.3	35.7	26.1	53.4	153.1	21.3	42.5	32.3	74.0
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 232.0"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 125.4;Proximal enterocytes: 100.9;Syncytiotrophoblasts: 106.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Group enriched"	"Detected in some"	11	"midbrain: 232.0;pons: 86.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;CACO-2: 3.9;Hep G2: 10.4"	"Region enriched"	"Detected in some"	4	"midbrain: 58.4"	"Group enriched"	"Detected in some"	7	"midbrain: 38.9;pons: 29.1"	"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.5	10.3	0.0	0.0	2.8	1.7	0.0	0.9	0.1	0.2	0.2	0.0	28.8	0.1	14.8	232.0	0.1	1.4	0.2	0.0	18.4	86.1	0.1	0.1	0.1	0.7	0.2	0.1	0.5	40.3	0.0	0.0	0.1	0.9	0.3	0.2	0.0	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	10.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.2	14.8	232.0	86.1	0.0	0.2	0.2	1.1	16.0	5.0	0.3	0.0	0.1	0.4	0.1	17.1	1.2	0.1	0.0	1.0	0.0	1.9	1.8	0.0	125.4	1.5	0.2	0.0	0.0	2.8	0.2	0.6	3.2	0.0	0.0	0.9	0.0	8.6	1.3	0.0	0.5	2.5	0.2	2.2	0.3	9.5	0.0	0.6	2.3	0.0	1.0	1.2	2.2	0.3	5.9	0.0	0.0	0.1	0.5	2.1	0.5	0.5	0.4	0.0	0.4	0.1	0.3	100.9	0.4	0.7	0.8	0.0	1.3	0.5	0.5	0.9	4.8	0.3	106.4	0.5	0.2	4.1	0.3
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270415	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 139.8;placenta: 102.1"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 1219.9;Syncytiotrophoblasts: 842.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 131.2;OE19: 163.9"	"Low region specificity"	"Detected in all"							HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	14.0	17.2	2.7	9.9	2.7	3.5	16.1	5.2	3.2	33.8	3.4	57.5	17.6	6.5	20.7	139.8	8.3	16.2	10.3	3.0	2.5	43.0	10.2	17.7	6.0	2.8	2.9	11.4	16.5	11.1	4.3	102.1	2.8	10.5	59.3	1.0	24.1	8.6	3.4	34.8	19.6	8.5	2.6	13.7	35.9	8.1	3.3	1.5	8.7	6.8	27.6	17.5	67.9	3.0	81.6	24.2	2.9	2.7	10.5	40.9	131.2	61.1	60.9	30.6	18.7	48.9	83.2	1.0	10.5	37.9	11.6	28.3	17.1	23.5	42.6	4.1	14.2	10.9	3.3	16.5	28.8	2.7	10.1	26.7	17.8	66.3	59.4	69.4	74.6	20.6	8.7	4.7	49.9	71.4	13.4	9.8	12.3	163.9	93.9	0.8	0.8	3.1	44.0	18.5	3.3	4.1	13.4	53.2	10.2	31.3	45.0	4.2	26.1	33.9	32.7	1.7	37.8	1.7	2.4	1.6	49.8	26.3	18.7	4.6	6.6	12.0	15.4	4.6	10.0	36.9	6.8	11.1	4.7	38.1	6.3	11.0	16.0	19.8	5.4	2.9	5.3	6.8	2.7	2.7	5.2	3.2	3.0	2.5	2.8	2.9	2.8	2.6	3.3	3.0	44.1	0.0	25.7	0.3	26.3	21.7	74.3	35.5	12.0	1.3	23.4	25.8	1.7	55.8	44.7	16.5	0.0	1219.9	21.7	85.0	49.0	43.6	11.7	4.8	2.3	60.9	20.4	8.6	0.6	108.7	108.0	11.4	47.9	8.7	12.7	19.7	51.4	6.7	96.8	1.7	0.5	121.5	26.4	6.3	11.2	3.2	13.1	6.1	14.2	6.5	7.9	4.1	38.1	0.0	0.5	142.5	88.1	9.8	5.7	73.7	35.0	22.6	17.4	1.7	26.3	4.8	11.1	6.2	31.3	80.7	29.7	842.5	13.8	9.8	121.7	105.2
SMIM43		ENSG00000164112	"Small integral membrane protein 43"	Q4W5P6	4	121758881-121765427	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	18	"brain: 8.3"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 16.7;Syncytiotrophoblasts: 4.5"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basal ganglia: 8.3;cerebral cortex: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"MOLT-4: 3.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 24.8"											NA	NA					"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (9.67e-3)"	"unprognostic (3.25e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.82e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.04e-1)"	0.0	0.0	0.4	0.0	8.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.3	0.0	2.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
SMS	"MRSR, SPMSY, SpS, SRS"	ENSG00000102172	"Spermine synthase"	P52788	X	21940709-21994837	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	Transferase	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 644.3;Distal tubular cells: 608.4;Syncytiotrophoblasts: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029849, HPA029852"	Approved		Approved	"Nuclear bodies,Cytosol"		No	No		16000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"	Cytosol	"HPA029849: AB_10602072, HPA029852: AB_10611521"	"unprognostic (2.51e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (7.49e-4)"	"prognostic unfavorable (7.79e-8)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (7.85e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.50e-2)"	29.7	94.3	52.0	34.7	53.5	50.8	49.6	56.0	61.9	42.7	43.7	52.0	54.9	44.7	63.6	30.6	28.6	40.5	53.0	53.9	50.2	119.9	44.3	36.2	47.8	48.6	46.7	91.2	24.1	28.0	31.5	114.2	49.1	136.0	50.4	49.5	39.7	42.2	34.6	21.4	50.9	39.6	47.0	41.3	39.3	30.2	53.9	50.7	55.3	32.5	47.3	55.1	32.0	49.6	664.3	161.2	265.3	107.1	71.9	121.4	86.3	174.6	102.6	261.7	249.1	204.0	213.0	239.5	59.8	180.0	722.9	142.2	265.5	318.2	508.2	111.0	128.6	124.4	201.0	145.5	129.4	242.2	103.8	76.8	93.7	266.4	497.2	189.2	254.5	93.6	270.6	32.7	366.7	139.2	181.3	244.1	474.9	149.0	244.3	176.0	188.5	182.9	354.3	90.1	131.4	105.7	143.1	181.8	489.1	687.6	163.9	101.3	232.3	194.4	193.6	405.0	294.5	23.8	52.6	142.2	378.4	107.5	275.6	9.1	57.5	102.5	18.9	59.9	23.7	34.6	29.6	33.3	51.1	22.0	19.1	22.8	55.7	31.4	73.9	10.7	55.4	37.3	52.0	53.5	56.0	61.9	53.9	50.2	48.6	46.7	49.1	47.0	53.9	49.6	43.4	25.6	21.9	33.6	61.5	65.9	203.0	206.1	42.1	35.7	116.2	66.3	36.1	81.5	115.0	110.3	12.5	644.3	46.7	61.2	608.4	246.3	1.9	126.4	70.4	61.9	58.8	95.2	45.6	152.3	313.1	86.6	57.6	215.9	40.5	249.5	59.6	49.8	364.7	21.9	40.2	103.6	146.5	157.3	200.3	7.1	95.4	153.1	92.5	21.5	250.7	46.8	48.4	22.1	8.1	165.6	63.9	103.4	45.6	276.2	137.0	466.7	78.9	43.2	65.7	76.6	114.2	6.0	181.3	54.1	50.6	869.6	63.7	271.2	119.1	153.1
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 198.8;skeletal muscle: 92.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 148.0;Cytotrophoblasts: 168.7;Early spermatids: 134.5;Extravillous trophoblasts: 110.5;Late spermatids: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Mitochondria	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	15.5	15.0	12.4	9.0	13.0	8.9	18.7	13.5	32.1	12.2	17.8	12.9	13.8	9.5	7.5	18.1	27.6	9.3	198.8	14.6	16.1	20.4	26.2	18.1	13.5	14.7	16.7	12.0	19.1	6.9	17.1	27.3	14.2	12.1	14.3	14.3	13.7	8.1	92.4	11.4	12.6	10.1	14.5	15.1	19.2	24.3	14.4	22.6	20.3	4.2	14.2	11.8	10.1	14.4	64.4	14.5	22.7	16.8	21.7	37.7	102.4	36.6	28.8	41.8	46.6	68.3	52.0	34.6	36.7	39.8	19.7	28.9	21.3	63.5	36.8	28.3	29.8	10.1	30.0	46.7	19.9	47.6	7.4	42.9	31.2	30.5	21.6	27.2	32.1	29.5	35.0	7.5	36.4	33.5	32.6	26.1	21.3	32.4	26.3	20.6	59.9	27.8	33.9	45.2	23.7	55.3	28.9	95.0	73.3	47.8	75.5	30.1	38.6	32.9	49.6	18.0	55.2	33.2	13.0	39.2	43.1	35.1	37.8	15.8	10.0	14.4	15.0	5.7	17.8	15.4	22.5	19.9	9.5	7.5	19.3	18.0	0.9	29.2	1.9	6.4	26.7	13.0	12.4	13.0	13.5	32.1	14.6	16.1	14.7	16.7	14.2	14.5	14.4	14.4	10.5	19.2	9.7	7.5	13.7	20.6	16.5	40.0	25.0	8.7	16.8	19.9	148.0	24.3	17.7	3.7	0.0	168.7	12.2	10.0	31.3	34.3	134.5	48.7	9.9	15.6	4.2	8.6	60.7	20.0	110.5	11.1	11.7	17.4	3.8	27.9	17.2	20.3	38.4	15.2	26.9	13.4	14.2	21.5	10.6	120.4	11.8	11.4	16.0	22.5	11.7	28.1	9.2	7.1	10.3	26.1	11.7	3.8	16.4	16.1	21.9	34.6	69.6	8.0	13.1	6.8	16.7	13.9	39.6	28.9	18.0	85.9	16.8	30.0	19.3	10.9
SND1	"p100, TDRD11"	ENSG00000197157	"Staphylococcal nuclease and tudor domain containing 1"	Q7KZF4	7	127652194-128092609	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 255.0;Syncytiotrophoblasts: 267.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002529, HPA002632, CAB019323"	Enhanced		Enhanced	Cytosol		NA	NA		1800000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316"	"unprognostic (2.06e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (5.10e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.26e-3)"	48.5	52.5	19.1	57.8	22.6	65.8	56.7	25.3	21.4	76.9	41.0	51.3	54.2	67.2	90.6	47.7	65.1	37.3	45.3	19.9	33.3	33.9	67.5	46.7	53.0	29.7	29.4	87.3	179.0	50.8	52.7	86.7	29.9	59.0	49.4	32.1	102.2	57.7	41.9	43.7	45.3	66.5	26.2	45.8	65.7	38.5	25.4	67.5	66.0	40.0	65.3	50.0	41.8	33.5	160.0	141.8	106.3	193.5	156.6	162.7	145.3	183.5	214.8	163.8	182.5	184.6	134.6	210.6	90.4	225.7	137.8	130.4	150.7	198.1	158.6	116.1	127.2	116.1	153.0	177.9	284.2	181.9	109.6	241.3	216.3	140.0	232.3	185.7	206.2	85.1	131.3	204.9	165.0	118.6	199.5	135.6	119.5	159.7	173.6	136.8	94.6	476.1	128.1	110.5	133.0	143.7	132.8	606.6	217.5	157.8	76.2	127.2	207.3	132.3	86.4	243.3	144.7	250.1	101.1	217.0	265.6	153.6	245.2	49.7	86.4	17.1	67.0	76.6	78.0	70.1	50.0	54.0	87.4	44.6	34.9	39.8	6.2	59.7	66.1	92.9	43.4	92.9	19.1	22.6	25.3	21.4	19.9	33.3	29.7	29.4	29.9	26.2	25.4	33.5	20.3	16.0	44.7	60.4	56.7	19.6	24.7	32.9	22.2	17.1	41.0	28.6	29.2	35.8	28.9	29.5	20.9	255.0	44.3	28.8	17.6	62.8	20.1	21.9	51.9	30.3	73.1	47.5	128.0	96.7	106.1	40.7	54.6	39.5	34.9	54.4	25.0	49.8	81.9	30.3	116.0	59.4	18.3	52.8	36.7	68.1	45.7	50.8	33.8	78.7	72.5	16.7	32.0	84.9	89.9	58.6	29.8	41.3	124.6	42.8	38.2	33.1	19.0	32.7	32.9	27.0	34.4	23.4	28.0	37.6	27.4	267.6	37.2	74.0	58.3	27.0
SNX12		ENSG00000147164	"Sorting nexin 12"	Q9UMY4	X	71056332-71073426	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070423	Approved					NA	NA		89000	"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB070423: AB_11153407"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (4.83e-3)"	"unprognostic (9.88e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favorable (1.51e-7)"	"unprognostic (3.52e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	26.6	37.6	36.4	27.4	38.3	28.1	29.6	34.4	39.9	31.9	26.0	35.9	37.4	36.1	34.2	49.7	33.2	30.0	40.7	33.7	40.2	42.1	25.0	26.9	23.4	36.8	38.7	39.2	24.8	59.6	18.8	35.6	37.2	33.7	34.3	28.5	27.9	43.9	44.3	43.3	42.8	41.0	37.4	24.1	32.6	16.1	40.6	25.2	42.0	51.3	29.3	40.4	31.2	34.4	67.9	97.6	53.6	46.8	79.9	73.2	58.7	75.8	75.7	74.1	65.7	73.2	110.7	36.4	62.9	89.7	120.3	57.4	104.8	89.4	64.3	29.0	55.4	39.3	108.8	40.7	65.4	38.4	46.0	57.9	94.3	94.5	67.5	61.3	87.1	37.6	60.8	61.3	108.6	69.7	46.5	28.9	71.6	109.7	84.6	45.2	81.6	57.2	60.5	58.3	36.9	28.4	101.4	55.9	65.1	65.2	35.5	30.1	101.5	66.8	64.8	92.6	46.0	35.0	54.8	42.7	64.8	83.9	47.8	6.9	2.9	4.9	2.6	4.2	3.0	4.2	2.9	2.3	3.3	3.1	2.2	3.5	2.5	3.5	2.5	2.7	4.7	1.6	36.4	38.3	34.4	39.9	33.7	40.2	36.8	38.7	37.2	37.4	40.6	34.4	12.2	0.0	6.7	2.9	11.8	15.3	22.5	17.2	22.2	10.1	15.4	13.5	21.4	21.5	12.8	11.0	2.1	40.2	5.6	21.8	11.7	27.3	0.5	3.6	11.8	16.8	10.8	10.1	6.4	24.4	22.5	13.5	10.7	8.2	14.5	6.6	16.8	13.8	24.3	15.2	6.0	16.8	16.2	17.6	11.2	1.2	10.8	12.8	17.8	1.9	24.1	12.5	15.5	7.1	4.8	31.5	9.0	19.9	5.9	12.3	48.1	29.7	3.4	10.2	26.3	8.7	14.8	5.9	14.7	22.2	16.3	33.1	10.1	25.8	16.5	18.0
SNX17	KIAA0064	ENSG00000115234	"Sorting nexin 17"	Q15036	2	27370496-27377535	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043867	Supported		Enhanced	Vesicles,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Cytosol	"HPA043867: AB_10961129"	"unprognostic (2.57e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.32e-3)"	62.5	74.6	32.2	23.1	32.6	19.8	57.0	35.3	31.8	59.7	32.1	58.5	17.3	62.8	16.6	62.2	57.7	22.1	60.3	30.3	32.7	54.6	62.9	53.8	32.3	33.5	33.1	62.4	53.9	42.5	61.1	28.1	37.1	54.2	23.3	12.8	50.3	31.6	49.2	57.0	53.3	33.4	36.3	80.8	54.1	34.1	35.0	43.9	54.3	33.9	33.8	59.8	50.9	37.0	40.1	70.0	45.3	56.4	85.9	71.5	29.0	47.3	85.2	71.8	52.2	43.5	37.8	39.5	55.4	113.9	61.9	23.7	42.4	63.8	57.9	40.7	72.5	44.8	20.3	55.4	80.9	47.6	41.6	66.9	56.7	49.6	59.5	54.1	78.3	32.7	35.5	32.8	87.2	47.7	50.2	31.3	29.2	62.5	67.1	22.7	74.0	64.9	53.5	34.1	46.3	55.1	38.6	39.0	18.1	31.9	30.5	29.6	50.6	57.4	31.6	33.8	45.5	56.8	47.5	49.4	50.0	49.8	60.9	87.5	138.7	88.9	65.6	135.2	66.9	72.7	61.2	67.6	135.6	73.2	57.5	60.6	30.8	72.2	146.9	73.8	78.5	231.9	32.2	32.6	35.3	31.8	30.3	32.7	33.5	33.1	37.1	36.3	35.0	37.0	60.8	16.0	39.1	6.5	68.3	32.5	48.2	78.3	32.5	30.9	47.1	61.3	31.5	35.8	43.3	29.5	14.6	173.5	69.3	56.9	82.2	84.0	8.9	34.4	39.9	52.7	55.1	49.2	6.8	63.9	132.7	60.3	35.2	25.6	43.1	64.5	47.5	64.9	134.9	45.4	7.7	48.3	79.3	118.1	42.7	9.7	58.4	83.4	69.4	2.8	141.9	80.1	76.2	11.1	11.2	64.8	54.1	85.0	60.3	41.4	75.4	95.3	38.6	23.2	32.9	41.4	68.4	58.0	53.2	55.0	34.4	99.6	63.2	102.1	60.0	34.9
SOX14	SOX28	ENSG00000168875	"SRY-box transcription factor 14"	O95416	3	137764315-137766334	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 12.5"	"Cell type enriched"	"Detected in some"	5	"Cytotrophoblasts: 18.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 2.8"	"Region enhanced"	"Detected in many"		"thalamus: 12.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hypothalamus: 1.7;midbrain: 4.9"	"Group enriched"	"Detected in some"	6	"midbrain: 7.1;pons: 4.5;thalamus: 11.8"							NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 47: Cytotrophoblasts - Unknown function"						"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"								"unprognostic (1.88e-2)"		"unprognostic (2.49e-3)"	"unprognostic (5.08e-1)"			0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	1.7	2.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.5	0.1	0.0	2.5	0.4	4.3	2.7	0.2	12.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.8;skin 1: 14.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 57.5;Syncytiotrophoblasts: 98.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 11.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 92.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"		Yes	No				"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.72e-4)"	0.9	0.9	0.1	0.6	0.1	0.0	3.9	0.4	0.1	1.3	0.1	1.4	1.6	0.3	3.9	5.5	1.1	0.1	0.3	0.1	0.2	1.0	0.0	3.1	0.6	0.7	0.4	0.9	0.4	6.2	0.2	22.8	1.0	1.8	0.7	0.1	0.9	10.2	0.1	14.6	4.7	0.3	0.5	0.8	0.3	0.2	0.2	1.1	1.1	0.1	1.9	2.7	3.9	0.1	6.8	0.8	0.0	0.0	0.0	0.0	92.3	0.4	0.4	1.8	0.4	20.1	1.9	0.0	0.6	0.0	1.3	2.8	0.1	3.4	0.5	0.2	0.7	0.1	1.5	0.6	0.1	0.0	0.0	0.1	1.8	0.0	1.8	0.2	0.2	0.2	4.7	0.1	0.1	1.8	0.0	0.1	0.0	8.2	1.6	0.0	0.0	0.2	0.5	11.9	2.9	0.1	0.1	11.9	0.0	16.8	4.8	0.0	6.3	0.4	2.6	0.0	0.5	0.8	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.2	0.7	0.4	1.0	0.5	0.2	0.1	1.3	0.0	0.0	1.0	0.2	0.1	2.6	4.6	4.0	0.0	6.0	6.1	0.5	0.0	0.8	1.8	0.0	57.5	0.3	5.2	0.0	0.7	0.1	0.4	0.1	2.7	1.8	0.0	0.2	0.8	3.9	0.7	0.0	0.7	0.0	0.2	0.7	0.1	4.1	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	3.2	0.0	0.1	3.8	13.4	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.6	1.1	0.9	98.8	0.3	0.1	3.3	6.3
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 255.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1254.0;Distal enterocytes: 477.6;Proximal enterocytes: 514.5;Syncytiotrophoblasts: 1673.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 323.2;HaCaT: 377.6;hTCEpi: 264.0;RT4: 308.2;SK-BR-3: 558.8;T-47d: 267.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		7400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.8	0.7	0.9	16.4	1.5	1.4	34.7	5.0	1.3	42.8	6.4	108.7	159.9	13.2	78.9	255.5	33.6	38.0	1.3	0.9	2.0	79.9	3.5	47.6	6.4	2.8	3.2	2.4	69.2	132.9	31.4	144.9	2.2	52.3	89.2	0.4	162.7	31.4	0.6	148.9	138.2	4.3	1.7	6.9	88.3	1.8	3.2	9.9	34.7	0.4	45.5	57.1	90.1	2.3	124.8	1.0	0.0	0.9	0.1	0.0	323.2	2.3	3.0	4.0	2.4	195.3	202.4	0.3	141.2	0.4	3.6	377.6	30.8	181.9	2.4	1.0	10.6	5.6	3.3	10.8	2.2	21.9	93.9	0.3	264.0	3.9	16.5	3.4	14.7	12.1	2.7	1.1	0.2	96.5	0.9	16.6	37.4	207.6	17.7	12.6	0.0	24.9	179.3	308.2	79.8	3.9	9.3	558.8	15.7	56.9	267.7	16.1	0.0	0.2	2.0	1.2	0.5	1.2	24.5	0.8	0.8	16.3	1.1	0.0	19.7	14.3	0.4	15.9	0.8	8.4	3.0	1.4	32.4	6.0	1.1	0.3	25.9	5.5	18.1	4.0	0.5	7.6	0.9	1.5	5.0	1.3	0.9	2.0	2.8	3.2	2.2	1.7	3.2	2.3	0.8	57.7	14.7	0.0	7.6	76.0	96.7	220.0	55.8	0.1	96.2	63.5	0.5	105.8	207.3	134.3	0.0	1254.0	1.4	477.6	25.4	429.4	0.8	63.3	14.2	6.9	147.3	4.8	0.5	255.1	105.1	10.4	106.5	155.6	10.2	1.9	0.4	0.5	135.4	0.0	0.5	169.4	221.8	10.0	23.8	1.1	3.7	19.8	14.2	0.0	68.6	0.0	0.0	0.0	0.0	309.8	375.2	0.0	2.1	135.7	514.5	44.2	46.6	0.3	0.0	0.1	12.6	0.6	5.9	93.2	87.9	1673.8	6.6	0.1	182.7	222.3
SPINT2	"HAI-2, Kop"	ENSG00000167642	"Serine peptidase inhibitor, Kunitz type 2"	O43291	19	38244035-38292615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1371.3;Syncytiotrophoblasts: 1413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 852.5;CAPAN-2: 1219.1;OE19: 1500.4;RPTEC TERT1: 896.7;SK-BR-3: 789.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011101, CAB018969"	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"		No	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Intermediate filaments, Cytosol"		"CAB018969: , HPA011101: AB_1079039"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.68e-2)"	10.5	44.6	56.9	65.3	57.3	81.1	178.5	47.2	66.3	145.6	80.0	297.0	247.4	44.6	269.6	351.9	189.7	105.1	13.6	58.9	92.9	216.1	14.3	138.3	37.4	52.0	54.8	83.3	234.2	252.9	435.9	156.4	56.2	181.8	251.7	23.6	503.9	111.3	1.8	257.0	267.0	19.0	47.6	50.2	219.4	215.7	70.3	82.6	321.3	0.9	101.3	140.1	157.6	51.0	852.5	603.0	3.0	3.4	0.4	0.0	387.4	16.2	1.7	1.2	2.6	426.8	1219.1	6.7	65.8	4.6	1.2	274.6	42.7	587.0	1.4	7.9	51.7	159.4	15.3	0.9	0.9	1.5	0.8	0.1	662.5	0.7	278.6	71.5	2.0	144.2	4.0	0.4	1.0	652.8	25.6	2.8	60.4	1500.4	172.1	87.9	0.6	386.2	896.7	707.4	222.2	3.4	246.5	789.2	2.1	231.0	353.7	104.5	0.7	1.2	4.7	3.4	3.2	56.1	76.4	47.6	1.0	11.2	1.0	515.9	127.4	531.9	3.8	91.1	7.9	143.2	44.2	21.5	297.7	160.4	86.1	80.4	56.4	19.0	64.4	523.5	19.1	142.8	56.9	57.3	47.2	66.3	58.9	92.9	52.0	54.8	56.2	47.6	70.3	51.0	8.0	368.6	233.9	10.4	90.9	376.9	563.9	954.0	278.9	14.3	487.2	518.2	2.8	316.0	655.6	559.1	6.2	1371.3	79.5	1028.3	101.8	866.9	61.8	401.4	47.3	24.3	360.5	83.9	20.7	659.8	502.0	34.6	234.5	490.4	115.5	371.8	32.5	2.0	230.3	3.3	39.8	672.8	734.5	55.5	139.0	55.6	19.0	133.6	88.9	24.4	364.3	129.6	1.0	4.5	9.0	910.4	889.4	17.0	61.3	684.9	918.6	208.8	495.1	17.2	52.6	1.2	76.7	545.2	264.1	507.7	428.3	1413.2	42.6	3.4	582.2	989.6
SPTSSA	"C14orf147, ssSPTa"	ENSG00000165389	"Serine palmitoyltransferase small subunit A"	Q969W0	14	34432788-34462240	"Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 405.2;Melanocytes: 435.8;Suprabasal keratinocytes: 443.8;Syncytiotrophoblasts: 512.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 180.0"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.86e-2)"	25.1	71.1	13.5	21.1	13.6	5.7	39.3	13.8	17.9	21.0	13.8	38.4	20.8	16.9	25.6	25.3	21.4	27.1	16.2	12.6	15.8	23.5	46.9	33.6	12.2	18.6	15.4	20.1	13.9	18.2	13.3	28.8	17.0	22.5	36.0	15.3	34.2	24.7	24.4	22.2	21.9	27.3	15.1	13.2	20.5	7.1	14.6	8.5	19.8	19.0	13.0	30.6	26.0	16.2	67.4	38.3	37.6	14.0	61.6	42.8	44.4	44.1	27.2	34.1	41.0	31.3	39.4	56.0	38.8	25.1	25.0	28.2	34.1	37.5	53.7	29.7	21.1	35.2	74.0	153.7	48.5	46.5	19.9	39.8	58.9	25.2	40.8	26.4	40.9	15.7	25.6	58.3	30.4	71.0	19.2	47.0	28.9	32.2	47.4	24.8	180.0	41.2	42.8	29.5	24.6	32.6	100.9	87.7	71.3	29.4	39.9	50.0	43.4	26.8	17.5	27.7	33.4	48.1	34.1	41.0	18.0	40.8	30.4	21.5	36.9	4.9	5.4	29.9	5.3	8.3	4.9	5.3	19.6	7.1	5.1	6.2	2.0	20.8	25.5	7.0	5.3	21.5	13.5	13.6	13.8	17.9	12.6	15.8	18.6	15.4	17.0	15.1	14.6	16.2	51.0	144.2	123.5	14.4	33.1	405.2	166.6	192.0	217.9	40.9	165.5	63.1	33.2	70.1	108.9	88.3	10.4	265.8	31.5	189.6	154.6	257.7	1.3	62.2	165.4	65.5	49.7	66.1	11.2	96.8	126.2	100.9	34.7	100.6	32.4	24.1	50.3	79.1	78.3	40.4	13.5	74.9	120.1	67.1	127.6	2.7	45.7	56.5	435.8	15.0	71.0	43.8	18.6	14.1	30.5	71.0	102.4	60.2	70.9	118.3	75.0	96.7	30.8	31.2	46.0	78.5	98.6	1.9	6.1	167.7	443.8	512.4	33.8	82.9	107.6	153.5
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023302-132075943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 70.0;epididymis: 56.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 55.2;dendritic cells: 42.7;NK-cells: 53.5;Syncytiotrophoblasts: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 140.1;U-937: 144.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		Yes	No		360000	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: AB_2684163"	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	6.0	2.5	1.0	15.2	2.7	70.0	6.0	1.7	1.3	6.8	2.5	11.5	9.6	46.6	56.3	13.1	7.4	5.6	1.4	0.7	1.5	3.5	5.2	7.2	26.2	0.8	0.8	2.1	3.7	23.5	5.0	25.2	0.7	20.0	11.6	0.2	7.3	35.8	0.9	7.8	6.9	38.1	0.6	13.2	12.2	2.2	3.8	41.3	3.7	1.2	23.5	11.8	7.4	0.7	32.9	11.3	1.3	0.0	5.2	4.9	72.0	1.0	4.0	0.5	0.6	30.1	29.0	44.6	19.4	7.3	22.1	36.5	80.8	51.1	0.0	39.1	66.6	64.6	25.9	28.4	4.7	135.3	5.1	6.9	30.0	0.1	33.7	15.1	14.2	60.0	29.2	40.4	12.2	29.0	140.1	124.9	64.4	22.0	4.3	99.9	39.7	57.9	32.6	51.8	26.6	29.6	19.2	17.0	0.9	54.9	22.0	35.4	0.3	12.8	13.7	39.0	47.9	31.0	52.0	49.8	11.7	144.8	6.5	59.1	9.5	31.6	22.8	12.4	22.4	14.5	15.2	19.6	11.3	12.6	19.7	20.6	18.2	41.0	22.7	4.2	7.2	20.4	1.0	2.7	1.7	1.3	0.7	1.5	0.8	0.8	0.7	0.6	3.8	0.7	0.9	22.4	15.6	0.0	24.7	0.0	36.4	0.0	6.8	0.0	5.9	10.9	1.3	5.7	8.1	11.0	0.0	55.2	42.7	6.5	3.9	4.5	0.6	7.4	1.8	1.7	1.2	12.8	2.0	7.1	34.7	9.6	15.3	17.9	11.4	0.5	1.4	4.4	11.8	0.0	1.4	4.8	0.0	8.8	0.0	0.4	3.4	17.3	0.0	2.8	13.5	0.0	53.5	0.0	0.2	10.9	4.0	2.2	14.5	33.6	1.9	1.5	6.6	0.0	6.6	6.7	3.6	1.8	2.5	16.1	0.0	59.1	27.4	0.6	6.5	18.2
TAF6	"MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85"	ENSG00000106290	"TATA-box binding protein associated factor 6"	P49848	7	100107070-100119841	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006566			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA006566: AB_1080194"	"unprognostic (5.60e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.37e-1)"	24.2	37.0	28.9	23.4	29.2	23.4	24.4	24.1	42.7	39.5	23.8	38.9	17.2	42.9	21.9	27.3	34.9	20.5	32.2	31.3	25.2	30.9	20.6	24.8	22.6	25.2	23.2	41.2	23.0	30.5	41.1	24.9	24.4	30.7	19.5	19.2	25.5	31.1	45.0	26.5	28.0	33.9	19.0	28.3	28.0	38.5	25.4	29.3	32.9	35.8	25.7	37.3	29.9	25.6	55.1	101.8	64.4	105.7	84.1	44.5	89.3	60.0	66.4	77.2	70.6	76.1	65.6	50.4	65.5	92.7	130.4	45.7	90.6	73.2	81.3	82.0	57.0	49.4	99.3	50.8	86.6	46.2	43.5	46.4	44.5	111.0	121.7	61.0	63.0	87.7	84.6	89.0	69.2	194.4	101.1	76.9	94.7	50.1	82.4	73.2	78.7	75.0	54.5	44.8	57.9	84.4	73.7	115.3	49.3	93.2	42.1	47.2	60.4	113.2	114.6	146.2	77.6	55.0	104.0	85.1	74.9	65.7	99.2	17.2	13.5	17.5	18.0	14.4	21.5	11.9	17.3	18.3	17.6	17.9	17.0	16.3	7.1	18.8	35.3	10.3	18.3	17.5	28.9	29.2	24.1	42.7	31.3	25.2	25.2	23.2	24.4	19.0	25.4	25.6	13.0	9.6	11.8	10.1	15.4	11.3	21.0	25.1	12.5	12.7	13.2	15.9	0.9	18.6	15.7	25.8	0.0	72.1	13.0	12.9	17.6	25.7	28.3	20.7	18.5	14.8	15.6	12.8	12.6	16.6	34.5	16.3	18.3	14.6	0.0	25.6	13.6	6.1	20.9	13.5	10.7	11.9	26.4	8.8	6.9	50.7	21.8	12.3	12.4	3.7	18.7	18.7	18.6	6.0	7.3	14.9	18.7	31.2	12.8	13.0	14.2	25.8	21.8	14.0	26.3	14.6	23.8	25.5	52.3	15.4	11.8	34.5	18.3	16.2	17.4	14.4
TBC1D17	FLJ12168	ENSG00000104946	"TBC1 domain family member 17"	Q9HA65	19	49877425-49888750	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068119	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA068119: AB_2685958"	"unprognostic (5.88e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.33e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.18e-4)"	"unprognostic (6.41e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.02e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.38e-1)"	"unprognostic (9.52e-2)"	29.8	26.4	31.7	9.6	34.9	6.5	26.6	32.8	41.1	22.7	17.6	32.2	14.1	30.2	12.5	17.7	24.3	10.6	35.9	31.2	28.5	20.4	28.3	15.8	10.3	38.8	32.6	30.6	27.6	18.1	21.1	13.2	34.6	20.6	5.8	13.2	28.0	17.7	124.2	38.2	19.0	12.3	29.3	15.4	27.8	10.3	32.4	12.3	20.6	39.4	7.1	30.9	20.1	41.2	12.4	25.3	7.9	11.5	36.0	24.5	18.2	14.2	48.0	15.5	25.0	13.8	18.0	7.3	13.8	26.6	26.5	13.7	7.0	19.3	8.4	22.3	18.3	8.7	20.6	15.3	30.4	4.5	12.8	29.0	19.7	14.7	11.5	27.9	14.6	11.5	9.9	41.9	13.7	14.3	5.9	9.4	13.4	13.5	20.4	8.9	11.1	20.1	21.3	22.9	14.5	16.0	18.6	20.0	12.3	10.2	18.5	6.9	17.8	34.2	11.5	12.8	7.3	26.4	37.0	5.3	35.6	5.1	13.2	13.8	3.9	8.5	7.9	3.9	7.1	8.1	7.2	8.3	3.7	10.9	7.1	6.0	5.1	10.8	3.7	4.9	4.4	6.0	31.7	34.9	32.8	41.1	31.2	28.5	38.8	32.6	34.6	29.3	32.4	41.2	18.1	12.8	12.2	19.2	14.9	14.5	16.3	27.1	17.6	32.0	22.4	23.2	7.8	25.8	15.9	20.2	39.6	49.5	15.3	21.3	25.4	16.1	2.8	16.9	12.3	14.4	48.7	12.2	6.9	18.9	17.6	17.7	23.4	23.7	4.5	12.7	21.8	27.7	13.6	48.8	8.9	28.7	28.5	13.1	26.5	5.0	27.4	12.9	14.2	5.6	22.0	23.9	15.5	11.6	16.0	12.2	19.1	31.2	16.2	15.1	31.7	22.5	7.5	52.6	13.1	18.1	17.7	10.5	13.1	10.8	12.9	66.4	17.2	16.1	16.2	10.5
TCEAL9	"DKFZp313K1940, WBP5, WEX6"	ENSG00000185222	"Transcription elongation factor A like 9"	Q9UHQ7	X	103356489-103358462	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1165.9;Distal tubular cells: 360.0;Extravillous trophoblasts: 456.2;Syncytiotrophoblasts: 780.1;Theca cells: 323.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 23.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA011790	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA011790: AB_2214932"	"unprognostic (1.26e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.31e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.58e-2)"	93.9	178.7	62.9	49.8	65.5	13.8	71.7	69.0	116.6	82.8	86.4	67.6	24.8	101.5	185.0	51.1	71.6	82.0	78.7	65.6	68.0	96.7	34.7	81.2	23.4	67.8	68.7	272.5	46.5	107.0	82.9	219.3	69.4	86.0	55.9	45.4	45.5	105.4	14.4	36.4	38.3	97.5	66.6	55.4	76.2	72.4	67.6	36.0	120.0	31.5	25.6	115.9	60.8	74.4	130.5	64.1	195.0	100.8	412.6	397.8	146.6	267.7	355.5	185.7	300.7	122.0	135.2	0.5	387.2	219.4	342.5	77.2	33.8	169.8	247.8	0.6	73.6	133.2	156.0	79.6	282.8	0.2	0.3	275.6	162.1	248.5	245.0	323.5	312.7	55.2	119.9	9.7	445.4	0.2	66.2	0.8	121.8	0.1	120.4	0.3	389.7	0.7	227.4	239.7	88.3	106.2	168.8	5.4	188.5	209.0	27.0	7.3	258.1	165.0	71.9	502.2	75.9	0.1	7.8	1.1	400.9	0.2	134.4	1.2	1.6	0.0	0.3	1.0	0.0	2.4	1.9	0.7	1.3	1.6	4.0	3.5	0.0	1.6	0.1	23.6	1.2	1.4	62.9	65.5	69.0	116.6	65.6	68.0	67.8	68.7	69.4	66.6	67.6	74.4	121.4	173.1	70.4	0.0	3.8	0.0	0.0	0.0	0.0	0.0	81.5	125.3	0.0	0.0	47.0	233.6	0.0	1165.9	2.1	0.0	360.0	250.1	0.0	100.6	149.7	85.3	0.0	0.0	0.0	139.8	456.2	130.2	0.0	115.6	11.4	268.5	0.0	0.0	141.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	120.8	0.0	0.0	0.9	0.0	0.0	298.6	10.2	0.0	0.0	0.0	74.1	0.0	0.0	0.0	0.0	780.1	4.9	323.7	0.0	0.0
TEAD4	"EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1"	ENSG00000197905	"TEA domain transcription factor 4"	Q15561	12	2959330-3040676	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 127.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 50.3;Exocrine glandular cells: 38.3;Hepatic stellate cells: 32.2;Proximal enterocytes: 37.9;Syncytiotrophoblasts: 34.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 78.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 364.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.1"	"Low region specificity"	"Detected in all"			HPA056896	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA056896: AB_2683268"	"unprognostic (3.68e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.21e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.78e-9)"	"unprognostic (5.05e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-3)"	17.4	5.2	4.2	7.1	3.6	0.4	12.0	5.6	5.5	10.4	4.0	8.1	4.8	9.7	1.0	7.8	8.3	4.5	20.0	3.5	3.9	33.7	4.6	26.0	1.6	5.3	4.8	4.5	51.1	1.6	3.4	10.9	6.1	8.5	4.1	0.5	8.0	5.0	127.3	16.4	8.4	8.9	4.0	9.0	8.1	3.7	6.4	1.6	23.6	46.7	2.4	11.3	7.1	3.6	37.6	51.5	13.0	36.2	4.0	8.7	137.8	29.5	15.6	49.7	27.8	99.6	39.0	0.3	22.2	22.5	34.0	52.5	51.2	364.1	46.1	0.2	41.2	59.1	43.7	87.7	18.8	12.8	10.7	12.2	14.8	43.3	66.7	20.8	42.9	23.4	38.4	0.5	17.5	53.2	0.7	0.3	99.5	48.0	30.0	27.4	73.7	28.9	23.6	15.3	7.4	13.2	36.4	89.9	27.1	93.8	61.2	21.8	49.4	28.7	100.1	20.2	15.7	0.1	0.2	0.4	23.3	0.0	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.6	5.6	5.5	3.5	3.9	5.3	4.8	6.1	4.0	6.4	3.6	17.1	12.8	4.7	0.0	0.1	12.2	12.6	6.1	9.1	0.1	6.6	3.7	2.4	5.7	2.3	7.3	0.0	50.3	0.4	3.7	5.9	17.7	0.3	3.0	5.1	25.9	0.0	0.0	1.6	38.3	18.3	6.6	4.1	5.0	5.7	3.4	32.2	0.4	5.2	0.0	0.5	3.7	2.0	0.8	1.5	2.3	0.0	0.5	8.8	3.7	0.0	0.0	0.0	0.0	0.4	21.1	0.9	0.4	1.2	28.9	37.9	21.1	1.5	0.1	0.0	9.3	12.2	0.5	6.4	5.4	7.7	34.6	0.5	0.4	7.1	4.9
TEX10	"bA208F1.2, FLJ20287, Ipi1"	ENSG00000136891	"Testis expressed 10"	Q9NXF1	9	100302077-100352942	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045434			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Mitochondria	"HPA045434: AB_10965650"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.28e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-3)"	"unprognostic (9.63e-3)"	9.3	7.0	4.0	8.7	4.3	12.2	9.9	7.2	4.8	9.7	5.2	7.4	5.3	11.2	8.2	9.1	10.2	8.6	6.5	4.3	4.4	6.3	6.9	6.4	14.3	3.9	4.1	11.4	5.7	8.1	5.4	18.8	4.1	7.5	6.8	5.5	6.9	7.4	16.0	12.2	6.5	8.8	4.1	7.9	6.5	22.3	4.9	22.3	8.4	11.6	13.6	10.8	8.7	5.5	26.5	28.5	36.6	41.3	13.2	23.1	56.6	32.7	33.7	41.8	38.7	29.5	30.4	74.6	17.2	21.4	38.3	35.2	52.9	42.1	48.6	30.2	23.3	40.6	17.5	25.8	28.2	59.6	29.1	20.3	23.3	42.5	44.6	20.3	23.1	26.0	46.3	23.8	54.5	41.5	44.0	38.1	75.4	51.1	33.9	42.1	62.2	22.8	30.8	17.0	32.3	27.4	17.9	29.3	29.4	22.4	12.2	17.3	23.6	27.5	24.5	37.3	30.9	16.7	30.6	29.9	28.1	26.3	29.4	18.1	7.4	2.6	9.1	8.9	9.7	12.2	9.0	9.1	9.1	12.9	9.7	11.5	1.8	10.7	6.9	5.3	11.4	7.0	4.0	4.3	7.2	4.8	4.3	4.4	3.9	4.1	4.1	4.1	4.9	5.5	8.6	3.2	9.3	10.7	14.7	22.2	10.6	8.4	20.5	7.8	10.8	8.1	15.4	0.0	13.0	9.2	12.5	53.5	9.6	3.8	3.9	7.7	13.9	11.0	15.8	10.9	5.3	11.1	24.1	8.8	15.7	14.7	5.1	21.9	17.1	13.9	5.0	7.9	9.8	8.4	23.3	5.7	2.0	4.1	8.1	11.4	8.7	8.1	17.8	18.7	7.8	3.4	7.2	21.1	23.9	7.5	5.6	7.9	7.1	9.7	3.0	4.5	5.6	6.5	0.0	14.5	14.7	33.0	33.4	12.9	22.6	46.1	10.3	12.0	6.9	9.5
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629306-56639283	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.1;skin 1: 53.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 132.4;Basal squamous epithelial cells: 120.1;Breast glandular cells: 66.1;Breast myoepithelial cells: 79.6;Cytotrophoblasts: 91.7;Extravillous trophoblasts: 59.7;Squamous epithelial cells: 81.0;Suprabasal keratinocytes: 149.3;Syncytiotrophoblasts: 105.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"BEWO: 190.6;MCF7: 169.2;SK-BR-3: 308.9;T-47d: 86.8;WM-115: 114.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 2.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.4"	"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm		Yes	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329"	"unprognostic (1.74e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.8	0.3	1.3	0.2	0.6	0.1	26.1	0.5	1.5	18.3	0.5	4.0	0.2	6.2	5.2	29.1	2.6	1.0	0.3	1.7	0.7	2.0	0.0	2.6	0.1	0.9	0.8	0.3	1.0	2.6	0.8	17.0	1.2	7.1	1.2	2.7	20.7	4.4	2.1	53.3	0.3	1.1	0.5	0.1	0.7	1.0	0.6	0.7	2.3	0.1	3.0	3.9	19.2	1.0	12.8	15.8	0.1	0.2	0.0	0.0	190.6	20.1	36.4	25.0	4.5	3.2	0.3	0.0	1.3	13.3	13.3	42.7	27.3	5.5	17.0	0.1	2.8	0.0	1.7	0.0	0.0	0.0	1.7	0.3	21.4	7.4	7.2	0.0	0.0	8.1	0.2	3.2	0.0	169.2	20.8	1.2	9.5	9.9	20.7	0.1	0.0	7.0	0.0	10.1	5.1	0.1	13.6	308.9	21.8	28.3	86.8	4.6	0.2	16.2	0.4	8.6	15.4	0.1	0.0	0.1	4.0	0.1	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.5	1.5	1.7	0.7	0.9	0.8	1.2	0.5	0.6	1.0	0.7	0.0	9.5	3.9	0.3	132.4	29.9	2.4	120.1	4.1	66.1	79.6	1.0	0.0	5.6	9.2	0.0	91.7	1.5	1.7	0.0	0.3	0.3	7.8	18.7	2.0	3.0	0.0	0.0	0.0	59.7	7.4	1.5	16.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	1.7	10.2	0.3	8.2	0.0	0.0	1.6	21.4	3.7	0.0	0.3	0.0	0.0	0.0	1.0	0.6	0.0	3.8	18.6	0.0	0.0	5.2	0.0	0.0	0.5	2.1	0.0	1.8	81.0	149.3	105.6	1.3	0.0	1.0	18.5
TINAGL1	"ARG1, LCN7, LIECG3, P3ECSL, TINAGRP"	ENSG00000142910	"Tubulointerstitial nephritis antigen like 1"	Q9GZM7	1	31576485-31587686	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1235.1;Sertoli cells: 427.3;Syncytiotrophoblasts: 1946.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 87.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 322.7;CAPAN-2: 178.9;EFO-21: 403.6;HaCaT: 181.4;HBEC3-KT: 211.9;HUVEC TERT2: 173.4;TIME: 376.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048695	Approved				"Secreted to extracellular matrix"	NA	NA		370000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA048695: AB_2680497"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.29e-3)"	"unprognostic (6.02e-3)"	"unprognostic (4.18e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (7.42e-2)"	"unprognostic (6.64e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.43e-2)"	173.7	40.8	19.0	18.5	17.7	0.9	150.5	17.9	19.9	86.8	16.4	83.2	26.7	101.8	10.7	31.0	82.4	23.9	230.7	15.2	17.9	177.7	22.7	85.7	8.5	19.6	18.3	38.8	31.0	13.2	25.3	183.6	19.8	71.2	16.5	1.0	63.8	40.6	46.6	37.0	51.6	36.5	16.4	119.6	66.4	6.2	21.2	3.8	115.1	30.6	5.3	88.4	70.2	17.1	96.6	0.2	0.0	0.5	0.8	0.2	322.7	14.9	1.9	0.7	0.4	44.5	178.9	0.2	403.6	13.4	7.0	181.4	0.2	211.9	0.1	0.7	0.1	0.1	7.3	11.5	4.5	0.1	0.5	0.2	37.9	0.0	7.6	0.1	173.4	0.1	2.4	0.4	0.0	0.0	0.7	0.6	0.9	52.6	6.1	0.4	0.1	0.4	57.0	72.6	0.4	0.5	38.0	125.6	4.2	18.8	7.5	0.3	376.6	0.3	91.6	0.7	2.8	0.4	0.5	1.6	0.2	0.2	3.3	2.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	0.8	0.4	0.1	0.1	0.1	0.0	19.0	17.7	17.9	19.9	15.2	17.9	19.6	18.3	19.8	16.4	21.2	17.1	345.4	9.6	5.8	0.7	2.7	11.0	121.5	244.1	8.0	0.0	32.0	73.0	46.7	37.1	28.6	132.4	0.0	1235.1	2.6	158.9	1.9	378.7	1.4	8.4	3.2	161.4	11.4	13.5	0.1	92.2	223.5	35.0	50.0	14.4	14.7	49.7	306.6	4.4	89.3	0.0	1.1	35.5	14.2	8.8	10.3	0.7	7.5	4.2	23.2	13.1	2.0	0.2	0.0	0.5	0.0	344.6	115.3	4.1	0.2	131.4	45.2	80.9	9.1	0.4	427.3	9.5	357.4	0.3	0.8	4.9	6.5	1946.1	3.8	2.7	59.7	219.4
TLCD4-RWDD3	TMEM56-RWDD3	ENSG00000271092	"TLCD4-RWDD3 readthrough"		1	95117923-95247225	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"Cytotrophoblasts: 1.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 11.7"															NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.42e-2)"	1.2	2.6	1.6	1.5	1.8	2.4	2.7	2.2	1.9	1.9	0.6	2.6	2.9	2.2	3.1	1.3	2.1	1.8	3.3	1.4	1.7	1.8	8.7	1.3	2.6	1.5	1.4	2.3	3.1	2.0	1.6	3.1	1.8	2.5	2.6	3.0	2.4	1.5	3.1	3.2	2.2	1.8	1.5	1.8	2.9	1.8	1.5	1.2	3.0	1.1	2.0	1.3	1.0	2.3	5.8	3.4	3.1	4.1	1.3	2.4	3.5	1.1	0.7	2.1	2.4	5.3	2.3	2.1	3.8	1.2	5.9	1.4	3.0	1.5	2.3	1.6	1.9	2.6	3.8	1.3	1.1	0.8	0.8	1.4	1.7	1.9	0.5	2.5	1.0	1.9	4.3	1.3	1.2	1.6	1.8	2.1	1.5	1.0	1.7	1.5	11.7	0.4	2.9	5.9	3.0	3.4	4.2	3.2	4.1	2.2	2.3	1.9	2.1	2.3	3.1	2.2	3.1	1.9	1.3	1.3	1.1	0.5	1.6	0.1	0.1	0.2	0.2	0.1	0.1	0.6	0.4	0.1	0.3	0.5	0.4	0.1	0.0	0.1	0.1	0.1	0.3	0.2	1.6	1.8	2.2	1.9	1.4	1.7	1.5	1.4	1.8	1.5	1.5	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TMEM150A	"FLJ90024, TM6P1, TMEM150, TTN1"	ENSG00000168890	"Transmembrane protein 150A"	Q86TG1	2	85598547-85603196	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 133.5;Early spermatids: 137.5;Proximal tubular cells: 85.0;Syncytiotrophoblasts: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 52.9;HHSteC: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019015	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA019015: AB_2204758"	"unprognostic (2.80e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.09e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.54e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.87e-3)"	18.7	16.3	10.0	5.2	10.8	1.2	17.0	9.8	11.1	16.3	11.1	21.0	6.5	17.7	6.3	11.0	17.1	10.4	15.5	9.7	10.3	32.8	38.5	19.3	6.0	11.9	10.7	17.1	37.9	8.0	11.7	22.4	10.9	17.4	4.1	1.4	14.9	10.2	53.7	9.3	12.9	11.5	10.6	9.7	20.6	24.4	11.3	2.5	14.9	27.2	4.2	22.2	13.1	10.1	2.7	5.1	6.3	9.3	52.9	23.7	15.3	5.2	9.1	4.3	2.0	23.6	7.1	0.8	19.8	15.3	8.0	2.2	6.8	13.7	2.0	1.2	6.7	1.5	3.0	39.9	49.6	0.4	4.7	28.5	18.4	7.0	9.9	20.6	15.2	1.0	14.0	1.5	17.5	11.9	0.4	6.9	11.5	10.8	5.1	4.1	0.6	15.8	13.4	10.6	1.0	3.9	5.4	35.4	13.5	5.9	8.7	6.2	12.6	5.2	4.4	4.5	1.8	10.6	2.8	5.2	8.5	6.0	2.3	0.0	15.2	7.2	5.5	17.9	6.5	5.3	6.2	5.6	12.8	8.1	6.9	4.2	0.7	8.4	15.1	7.6	1.5	6.0	10.0	10.8	9.8	11.1	9.7	10.3	11.9	10.7	10.9	10.6	11.3	10.1	24.1	9.6	14.9	10.7	9.0	4.5	15.3	16.0	10.2	6.8	15.3	12.7	5.2	12.8	16.2	14.7	0.0	133.5	10.4	3.5	29.4	16.9	137.5	5.0	9.0	14.9	3.0	1.7	3.9	14.4	18.2	14.3	5.6	6.0	10.2	5.2	15.7	19.7	37.9	3.3	5.0	5.2	16.2	10.3	13.1	64.8	19.9	14.6	10.6	9.4	15.2	6.5	7.2	5.5	5.9	12.8	7.0	24.5	5.9	20.3	16.4	85.0	8.3	3.4	13.1	14.6	11.7	2.4	5.6	7.9	3.7	146.0	7.0	9.2	7.0	13.1
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059958-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 8.4;skeletal muscle: 5.8;tongue: 2.2"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 10.4;Cytotrophoblasts: 16.0;Early spermatids: 7.0;Late spermatids: 19.7;Rod photoreceptor cells: 9.1;Sertoli cells: 6.6;Spermatogonia: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	5	"cerebellum: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 58.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 26.8"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: AB_2732552"	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.0	0.9	0.9	0.0	1.0	0.0	0.1	8.4	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.5	0.0	0.5	0.1	0.6	0.8	0.0	1.1	0.0	1.2	0.9	0.7	0.1	0.0	1.1	0.0	0.0	5.8	0.5	0.0	0.0	0.5	0.1	0.0	0.6	1.4	0.3	0.0	2.2	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	8.4	1.7	1.2	0.9	0.6	0.8	0.7	0.5	1.4	0.8	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.5	0.5	0.0	0.0	0.0	1.8	10.4	16.0	0.0	0.0	1.9	0.0	7.0	0.2	0.1	0.4	0.0	0.0	0.0	0.2	2.2	0.9	1.5	0.1	0.0	0.2	0.4	0.4	4.5	1.7	0.0	0.0	0.0	0.3	0.0	19.7	0.0	0.4	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.7	0.0	1.0	0.0	0.7	1.5	9.1	6.6	1.3	0.2	0.5	6.3	0.0	0.0	5.9	0.2	0.5	0.0	0.7
TOMM34	"HTOM34P, TOM34"	ENSG00000025772	"Translocase of outer mitochondrial membrane 34"	Q15785	20	44942130-44960397	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 119.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 128.3;monocytes: 176.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018845, HPA056875"	Enhanced		Supported	Vesicles,Mitochondria,Cytosol		NA	NA		26000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Vesicles, Mitochondria"	"HPA018845: AB_1858184, HPA056875: AB_2683264"	"unprognostic (4.96e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (4.47e-5)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (2.55e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.45e-4)"	"unprognostic (5.79e-3)"	13.4	46.0	31.4	13.6	40.3	20.1	14.6	24.3	51.7	14.5	28.3	14.6	11.8	14.8	49.0	19.5	49.1	13.6	16.0	54.6	32.6	28.6	18.8	14.0	15.2	29.0	26.1	26.4	18.0	24.4	26.6	29.6	28.0	18.8	18.4	9.0	15.7	16.9	18.0	14.6	13.7	15.4	24.7	14.9	15.8	119.4	33.6	18.3	16.5	15.2	22.0	26.2	12.7	35.7	133.6	46.0	40.1	85.6	36.3	35.6	90.2	75.6	109.6	92.8	67.1	187.4	48.6	90.9	63.5	59.6	94.2	82.1	98.8	164.0	107.3	16.1	46.2	71.7	58.2	133.7	46.2	47.5	42.3	38.7	45.2	129.8	230.8	80.9	95.8	36.6	82.6	36.4	89.3	88.2	50.2	65.4	47.1	70.7	172.8	43.1	42.2	98.9	76.1	73.7	68.3	40.4	103.5	71.0	91.8	30.7	53.5	40.8	57.2	121.5	80.0	58.9	114.8	31.2	40.1	75.4	110.9	55.8	48.2	15.9	16.9	15.3	14.8	17.5	15.4	25.4	15.3	15.7	39.7	28.6	17.1	13.7	4.6	14.8	18.8	21.1	19.3	17.3	31.4	40.3	24.3	51.7	54.6	32.6	29.0	26.1	28.0	24.7	33.6	35.7	7.3	6.4	11.5	3.6	15.0	13.8	84.6	17.2	14.8	3.1	14.1	11.2	10.3	5.7	15.5	12.9	4.2	128.3	8.7	7.7	31.3	38.4	18.5	17.5	7.2	13.0	12.0	17.2	6.8	30.7	38.0	14.8	16.8	14.8	9.5	28.2	6.4	9.1	22.7	3.3	4.8	9.3	8.2	5.9	47.2	32.9	6.8	10.3	7.2	5.6	176.9	17.4	7.2	3.5	2.7	46.2	9.5	6.4	16.9	69.1	6.9	22.5	44.3	4.2	0.0	5.6	13.6	43.0	56.2	15.7	11.1	56.5	8.8	24.0	13.6	55.9
TRBV20OR9-2	"TCRBV20S2, TCRBV2O, TCRBV2S2O, TRBV20/OR9-2"	ENSG00000205274	"T cell receptor beta variable 20/OR9-2 (non-functional)"		9	33617762-33618506	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 11.4;pituitary gland: 2.8;placenta: 2.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 1.0"	"Region enhanced"	"Detected in many"		"pons: 11.4"	"Immune cell enhanced"	"Detected in many"		"T-reg: 17.0"	"Lineage enriched"	"Detected in single"	31	"T-cells: 17.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HEL: 1.4;MOLT-4: 1.0;RH-30: 5.0;SuSa: 1.1"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 47: Cytotrophoblasts - Unknown function"					"unprognostic (1.53e-1)"				"unprognostic (3.70e-2)"						"unprognostic (3.01e-2)"			"unprognostic (1.31e-1)"		"unprognostic (1.51e-1)"	0.0	0.0	0.4	0.1	0.7	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	6.7	6.3	0.0	0.8	0.0	2.8	2.1	11.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	1.0	0.3	0.3	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	5.7	0.0	6.9	4.0	0.0	0.0	6.4	5.3	0.0	0.0	0.0	0.0	17.0	1.9	0.4	0.7	1.2	1.1	0.3	0.7	6.7	6.3	11.4	1.2	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TREX2		ENSG00000183479	"Three prime repair exonuclease 2"	Q9BQ50	X	153444720-153470587	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 24.5"	"Cell type enhanced"	"Detected in single"		"Suprabasal keratinocytes: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	11	"basophil: 1.7;eosinophil: 2.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.4;U-698: 7.3;U-937: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA054060	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA054060: AB_2682362"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.13e-3)"	"unprognostic (7.18e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-2)"	0.9	0.5	0.4	0.6	0.4	0.7	0.8	0.5	1.1	3.2	5.0	0.6	0.2	1.2	0.6	2.9	1.2	0.7	1.0	0.7	0.2	1.4	0.6	1.1	1.4	0.5	0.3	0.9	0.8	0.2	0.7	0.9	0.5	1.3	0.2	0.0	1.9	2.4	0.3	24.5	1.1	0.5	0.3	2.4	0.7	1.0	0.4	0.5	1.3	0.1	1.1	0.6	3.2	0.4	2.1	2.6	0.2	0.9	0.3	0.5	0.2	0.6	0.5	0.5	1.4	0.7	0.5	0.2	1.3	0.5	0.1	2.2	0.9	1.4	0.0	2.3	5.4	0.2	0.5	0.3	0.2	0.6	1.4	0.6	1.3	0.6	0.5	0.3	0.2	0.4	0.3	2.5	0.1	2.5	1.5	1.6	0.8	0.4	1.7	3.5	0.7	1.7	0.2	0.7	0.6	0.3	0.2	0.2	0.8	0.0	0.4	0.7	0.0	0.9	1.6	2.0	0.8	2.8	2.1	7.3	0.2	7.0	1.1	1.7	0.0	2.7	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.5	1.1	0.7	0.2	0.5	0.3	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.7	0.1	0.1	0.0	0.1
TRIAP1	"HSPC132, MDM35, P53CSV, WF-1"	ENSG00000170855	"TP53 regulated inhibitor of apoptosis 1"	O43715	12	120443964-120446384	"Predicted intracellular proteins, Transporters"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053640	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA053640: AB_2682213"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.87e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.97e-2)"	21.8	24.6	16.6	18.9	16.8	32.9	28.4	17.1	23.0	16.6	18.0	24.6	19.2	14.1	20.8	22.9	17.2	15.4	19.4	16.8	17.5	21.1	66.4	16.8	24.8	16.9	16.7	12.1	52.5	14.7	12.3	29.1	17.1	20.1	30.5	8.8	25.3	15.3	60.4	27.0	18.5	20.9	17.2	16.3	19.6	13.2	16.9	25.7	15.7	39.1	27.5	24.1	15.6	18.2	56.2	75.1	67.4	46.3	57.5	88.1	161.0	71.8	51.2	62.5	51.6	63.2	30.4	110.0	59.6	59.2	25.0	37.4	79.3	118.6	65.8	49.1	88.5	66.9	48.7	167.9	85.4	113.6	49.6	91.6	146.7	61.4	87.0	62.3	131.1	59.8	109.3	27.7	92.1	70.3	86.0	152.7	96.5	67.9	60.4	70.4	63.5	114.4	81.1	62.0	66.3	43.2	82.7	28.1	64.6	105.7	93.9	65.6	74.8	40.0	60.7	40.7	44.1	70.6	120.6	118.5	61.5	86.9	71.2	26.7	47.1	18.2	41.0	52.7	48.8	35.1	39.2	39.0	59.1	31.8	48.3	43.1	4.0	49.6	36.5	53.1	37.3	45.0	16.6	16.8	17.1	23.0	16.8	17.5	16.9	16.7	17.1	17.2	16.9	18.2	25.8	3.2	15.2	3.6	30.5	51.2	28.5	108.2	44.3	10.6	35.9	44.1	12.1	45.8	36.0	7.3	6.2	128.5	29.4	16.9	66.5	48.4	8.3	22.4	27.7	34.3	22.1	23.7	3.9	50.4	91.2	23.1	15.3	16.4	17.2	34.9	24.3	63.3	52.0	3.3	2.9	22.6	40.7	23.3	27.6	5.7	16.4	19.1	39.2	1.0	48.0	15.4	44.3	3.0	4.7	43.2	20.7	18.4	19.8	37.7	30.1	49.4	25.4	9.5	19.7	18.9	27.3	34.5	31.4	45.6	71.3	75.4	28.3	47.0	39.5	28.9
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 4.1;testis: 2.6"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 16.5;Early spermatids: 17.3;Extravillous trophoblasts: 6.7;Late spermatids: 5.2;Spermatocytes: 6.4;Spermatogonia: 6.4;Syncytiotrophoblasts: 8.9"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	33.8	0.0	0.0	0.0	0.1	18.3	0.2	1.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	7.5	0.9	6.4	0.1	0.0	2.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	145.3	0.0	0.0	0.2	0.1	7.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	1.6	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.5	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	6.4	0.0	0.0	8.9	0.1	0.0	0.0	0.3
TRIT1	"FLJ20061, IPT"	ENSG00000043514	"TRNA isopentenyltransferase 1"	Q9H3H1	1	39838110-39883511	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024174, HPA027330"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA024174: AB_1858346, HPA027330: "	"unprognostic (4.61e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (8.80e-4)"	"unprognostic (4.00e-2)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (5.34e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.68e-3)"	"prognostic unfavorable (7.08e-8)"	"unprognostic (6.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.90e-2)"	9.0	9.9	13.1	7.0	13.1	5.6	12.9	14.7	16.1	15.6	12.8	13.6	6.3	14.7	15.3	18.5	13.1	6.0	15.2	13.1	14.0	15.3	13.0	9.2	8.4	12.1	12.1	14.3	21.5	9.7	16.7	11.8	12.6	19.9	10.5	14.7	13.6	10.9	9.5	21.6	11.1	10.0	12.0	12.6	12.0	11.9	13.9	11.8	16.8	4.4	9.9	15.3	16.8	14.3	20.5	9.4	23.0	18.4	10.6	16.5	29.8	11.1	17.3	22.0	21.8	20.0	20.6	11.5	17.4	11.3	12.2	18.9	29.4	22.7	29.7	17.0	15.6	25.6	22.8	13.5	21.8	21.0	14.4	13.3	21.3	25.0	26.9	25.9	18.0	27.1	31.7	14.1	13.8	11.5	14.3	30.7	31.6	17.4	6.2	21.1	21.6	23.3	21.1	27.3	21.9	16.6	15.2	10.3	17.7	23.0	12.5	37.5	11.0	12.8	18.2	21.1	21.3	19.4	13.2	22.5	14.2	24.6	12.1	0.0	5.4	0.6	2.0	3.9	3.7	2.9	1.8	2.2	10.4	2.2	1.9	2.7	0.2	2.0	5.3	10.1	2.3	2.4	13.1	13.1	14.7	16.1	13.1	14.0	12.1	12.1	12.6	12.0	13.9	14.3	4.9	22.4	7.8	16.6	8.0	14.8	17.1	14.4	10.2	4.6	7.8	9.1	10.8	5.7	11.7	7.3	2.1	34.1	10.3	2.9	7.9	12.2	5.9	13.5	10.8	6.2	10.2	13.3	31.3	9.3	32.8	9.6	3.1	6.1	2.5	9.4	8.9	7.0	8.2	15.2	26.6	8.8	16.2	5.9	5.1	3.1	9.6	7.3	5.4	26.2	12.3	4.9	3.1	34.7	31.3	9.5	5.8	11.3	3.3	8.8	4.5	9.2	25.7	7.3	0.0	8.8	6.9	24.9	16.2	13.2	17.0	16.6	6.1	10.7	9.0	11.2
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2 ribosome maturation factor"	Q969E8	X	54440404-54448032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	35.2	45.1	50.9	11.2	49.9	11.9	35.6	43.4	59.4	36.8	39.3	42.2	10.2	34.9	23.0	34.6	32.2	7.7	45.5	46.2	52.9	43.8	36.7	30.4	12.6	48.9	48.0	34.6	30.2	25.0	47.1	14.6	47.3	33.3	13.3	27.4	32.6	16.9	51.7	40.7	31.3	13.2	50.3	32.4	38.8	16.5	50.6	14.9	41.1	18.6	15.8	36.3	35.0	47.8	24.1	26.6	23.9	20.6	19.9	13.0	18.7	22.4	17.5	19.6	17.3	26.2	24.1	23.5	15.8	18.2	35.7	24.9	47.9	28.3	24.8	29.8	26.8	19.3	20.8	19.6	12.5	32.7	19.4	12.9	18.0	26.4	27.1	19.7	13.8	22.9	20.5	16.9	19.3	37.9	27.4	29.9	34.6	23.6	33.0	26.5	38.2	19.6	20.6	18.3	25.9	20.5	42.1	19.9	28.0	38.0	45.4	14.7	21.0	16.2	27.1	38.0	19.9	19.8	32.3	29.7	24.4	27.5	23.2	29.7	16.6	32.0	36.3	23.1	30.0	44.8	34.0	33.6	15.1	46.3	42.6	32.3	10.4	29.7	26.0	16.7	40.8	24.9	50.9	49.9	43.4	59.4	46.2	52.9	48.9	48.0	47.3	50.3	50.6	47.8	39.1	25.6	30.2	1.6	39.8	32.8	43.0	42.7	26.7	61.6	27.4	28.6	49.0	28.6	38.6	35.0	27.1	98.5	36.0	26.3	125.2	43.9	1.2	17.7	23.7	35.6	18.1	18.1	5.7	32.9	71.5	33.8	16.8	22.9	45.0	20.3	31.8	25.2	46.6	57.2	5.6	35.5	61.1	18.2	31.4	2.8	34.8	24.6	40.9	6.5	48.6	85.6	44.3	2.5	6.5	38.1	29.5	45.1	22.3	36.7	32.6	64.6	33.8	67.0	46.0	29.8	38.0	20.5	43.3	25.4	31.7	75.9	37.8	36.2	30.9	33.9
TXNRD2	"SELZ, TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941820	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 139.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Mitochondria,Cytosol		NA	NA		2800000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	10.5	44.4	11.9	8.9	12.0	14.5	12.3	18.1	19.3	11.7	21.2	14.9	10.3	10.6	6.2	10.2	10.6	6.2	30.0	12.9	11.9	24.8	65.4	13.6	9.1	11.8	12.1	16.5	15.9	13.5	14.4	9.8	11.5	26.8	4.6	4.4	15.4	8.2	23.0	10.9	12.0	5.1	11.3	16.9	26.4	14.6	12.4	4.9	15.2	16.1	6.1	11.8	10.4	11.8	19.4	39.2	3.5	14.9	6.9	9.6	8.8	18.8	21.1	31.8	23.4	36.7	19.4	10.9	43.2	19.0	32.7	33.2	17.8	25.2	12.1	21.6	46.5	18.8	34.4	22.4	12.9	21.1	8.4	9.2	18.5	16.2	13.8	12.9	91.3	2.2	106.4	17.4	24.8	47.1	7.2	30.1	17.7	46.9	27.6	10.5	85.2	10.0	19.3	21.0	19.1	16.4	32.0	39.9	21.8	5.8	33.7	27.6	52.2	23.0	139.5	19.8	38.4	17.6	14.0	6.9	22.4	15.5	30.3	2.7	10.5	5.8	3.5	8.2	2.6	3.9	3.0	3.2	7.8	2.6	3.9	3.2	0.9	3.8	7.9	2.9	2.1	4.6	11.9	12.0	18.1	19.3	12.9	11.9	11.8	12.1	11.5	11.3	12.4	11.8	5.6	16.0	23.6	11.1	10.3	4.2	23.1	15.1	3.4	22.1	11.4	9.1	16.7	15.7	15.7	20.2	10.4	60.7	8.8	14.7	58.7	22.0	26.4	9.8	8.4	14.4	1.2	33.1	9.2	32.0	24.3	12.4	23.4	10.0	1.3	27.6	8.9	49.5	25.9	10.1	8.5	16.9	20.3	22.0	7.8	18.2	15.5	14.6	5.4	10.3	27.2	18.7	10.3	8.5	7.2	22.3	13.9	9.1	12.2	17.8	15.6	52.0	16.6	11.0	6.6	11.3	13.3	10.9	14.0	6.4	5.3	42.0	11.4	36.4	16.4	15.7
UPK2	"MGC138598, UP2, UPII"	ENSG00000110375	"Uroplakin 2"	O00526	11	118925164-118958559	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"urinary bladder: 70.1"	"Group enriched"	"Detected in some"	7	"Club cells: 3.2;Cytotrophoblasts: 10.5;Syncytiotrophoblasts: 9.6;Urothelial cells: 6.9"	"Cancer enriched"	"Detected in many"	72	"urothelial cancer: 339.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 144.4;RT4: 160.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043312, HPA061106"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA043312: AB_2678420, HPA061106: AB_2684429"	"unprognostic (6.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.12e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (7.30e-7)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.00e-1)"	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.2	70.1	2.4	0.2	4.0	0.4	0.1	0.4	0.0	0.1	26.2	0.0	0.0	0.0	0.1	0.2	9.0	0.0	0.2	0.4	0.2	6.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	144.4	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.1	160.9	0.0	0.1	0.3	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.2	0.9	0.0	0.4	0.6	1.0	0.0	0.0	3.2	0.0	0.0	10.5	0.4	0.0	0.0	0.1	0.5	0.3	0.1	0.5	0.0	0.0	0.1	0.2	0.8	0.1	0.0	0.2	0.0	1.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.0	0.0	0.6	0.9	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.5	0.1	9.6	0.1	0.4	0.0	6.9
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699986-84779922	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 742.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 742.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	24.8	21.7	19.6	29.4	20.3	29.5	23.4	22.1	22.9	21.0	17.8	31.2	29.5	25.9	23.9	29.1	27.0	18.5	25.4	20.8	20.7	28.8	33.8	18.7	36.7	18.8	18.7	27.1	23.0	41.5	6.0	40.3	19.0	28.3	26.4	52.5	21.0	25.9	46.6	25.7	27.4	31.0	19.8	32.6	23.8	22.0	20.4	29.1	27.4	39.5	37.7	32.1	10.1	21.6	63.6	72.9	78.5	104.7	31.4	50.2	111.5	58.0	60.1	96.9	51.5	106.9	54.9	102.9	65.2	61.1	47.7	69.8	108.2	89.7	139.0	41.3	63.3	63.2	37.3	92.2	39.4	95.0	37.9	30.0	74.8	95.6	112.3	57.5	76.4	68.5	153.4	22.7	73.1	129.4	92.4	96.8	102.5	71.8	56.7	119.9	44.5	55.0	81.9	48.4	73.0	48.6	130.5	48.7	54.0	72.3	108.4	76.8	55.7	66.9	60.2	39.4	62.2	38.8	53.7	272.3	44.5	64.6	73.2	29.0	77.3	15.6	46.1	61.9	58.0	60.6	148.0	53.9	92.6	59.7	82.9	49.6	742.4	65.9	58.6	30.7	57.3	97.3	19.6	20.3	22.1	22.9	20.8	20.7	18.8	18.7	19.0	19.8	20.4	21.6	21.3	54.5	50.0	26.4	51.5	51.5	46.1	25.8	54.1	25.1	27.6	28.6	66.6	25.8	45.2	27.6	29.2	106.9	38.1	25.8	31.3	29.0	63.3	31.0	35.8	30.4	28.9	42.5	39.3	25.1	73.4	40.1	35.7	42.1	58.0	38.7	21.0	37.2	31.4	20.2	38.9	28.1	16.2	34.8	33.4	116.6	23.6	40.6	24.9	41.2	52.6	23.7	32.0	49.8	35.8	23.6	23.9	22.6	50.8	48.6	30.4	45.0	90.7	52.7	26.3	58.4	34.3	35.0	29.5	54.5	49.6	60.9	42.5	33.6	40.6	45.2
USP27X	USP27	ENSG00000273820	"Ubiquitin specific peptidase 27 X-linked"	A6NNY8	X	49879484-49882558	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.5;Bipolar cells: 15.8;Cytotrophoblasts: 44.5;Syncytiotrophoblasts: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077264			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA077264: AB_2686831"	"unprognostic (4.12e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.14e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (5.37e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.58e-1)"	1.6	2.5	6.0	1.3	6.2	0.5	2.0	8.0	5.8	3.0	3.1	3.2	1.0	3.9	2.9	1.6	3.5	1.6	1.8	5.3	14.4	2.7	1.8	2.7	1.7	4.9	8.4	6.3	2.6	3.0	7.3	11.7	5.9	3.0	1.4	3.8	1.6	2.8	4.4	2.1	2.1	2.8	3.6	1.8	2.4	1.3	10.5	2.6	2.4	2.1	1.7	3.0	2.2	4.4	1.6	3.8	4.2	4.8	3.8	3.1	3.6	1.6	2.6	1.8	1.4	6.9	1.6	0.9	1.6	4.2	6.0	2.6	6.0	4.0	2.6	2.0	3.1	1.6	1.1	6.2	2.6	0.5	3.4	4.4	2.7	2.6	2.6	4.4	2.5	4.2	3.4	1.5	2.9	3.7	2.5	1.2	4.8	2.7	2.7	2.7	3.7	0.3	2.9	1.4	1.1	3.2	3.4	3.0	4.0	12.9	3.5	1.1	1.9	2.1	4.3	3.8	0.7	1.6	0.4	0.6	2.5	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	6.2	8.0	5.8	5.3	14.4	4.9	8.4	5.9	3.6	10.5	4.4	3.5	19.2	15.5	0.7	2.5	2.9	4.5	0.3	2.2	15.8	1.9	2.7	2.6	0.0	7.5	0.0	0.0	44.5	1.4	1.7	5.9	1.5	0.1	2.1	4.1	5.2	4.2	0.0	2.9	0.7	3.6	2.7	1.1	2.1	2.5	4.0	2.5	1.9	4.0	5.0	3.3	1.3	0.0	0.6	1.0	0.3	2.1	1.2	0.0	0.0	1.5	8.3	0.0	3.5	0.8	1.2	0.5	3.4	0.5	3.3	0.5	2.9	13.2	2.5	6.6	2.5	2.6	0.2	1.3	0.9	2.3	26.1	2.0	8.8	1.6	1.7
USP39	"CGI-21, SAD1, SNRNP65"	ENSG00000168883	"Ubiquitin specific peptidase 39"	Q53GS9	2	85602856-85649283	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034823, HPA077350"	Supported	Supported	Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA034823: AB_10602488, HPA077350: "	"unprognostic (1.10e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.46e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (1.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (4.05e-7)"	"unprognostic (3.95e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-1)"	22.6	16.1	18.1	19.8	18.7	40.8	21.3	19.0	20.6	22.2	22.7	24.2	17.1	23.5	26.1	22.7	19.5	12.7	22.7	17.9	19.5	21.7	18.5	21.4	26.5	18.9	18.4	20.1	17.2	21.8	14.3	26.9	18.9	18.7	22.7	22.0	19.0	21.2	55.2	23.8	19.5	21.3	18.9	20.9	20.6	15.6	18.8	41.0	19.8	42.6	32.2	24.7	20.6	19.8	71.0	70.0	70.0	77.5	49.7	38.7	79.5	59.2	54.6	84.1	74.5	113.9	49.8	83.0	53.4	54.6	62.3	50.6	135.7	62.5	105.8	83.9	86.4	103.4	39.1	100.6	49.0	127.4	67.5	27.9	49.3	65.1	57.8	39.3	68.1	85.3	129.8	47.2	62.8	81.4	125.2	94.8	92.8	84.9	64.2	114.1	150.0	63.1	45.0	53.8	65.1	53.7	36.4	58.9	51.4	56.7	39.5	60.5	43.9	51.7	65.0	62.7	97.2	42.0	83.0	87.7	44.9	130.5	63.6	51.1	35.8	44.5	40.2	42.4	46.6	34.7	41.8	41.7	40.6	37.0	40.4	37.0	23.1	40.4	41.6	32.0	53.4	43.6	18.1	18.7	19.0	20.6	17.9	19.5	18.9	18.4	18.9	18.9	18.8	19.8	18.4	19.2	25.2	19.9	17.5	20.5	16.7	17.9	22.2	8.5	14.1	14.0	17.3	11.5	19.9	12.9	8.4	54.1	17.8	14.8	21.5	21.1	26.1	9.8	15.4	17.1	12.1	18.3	13.9	18.8	31.8	17.1	9.7	11.7	17.1	16.3	17.5	14.2	25.6	5.0	18.2	13.4	24.4	11.9	14.7	13.0	19.3	17.6	19.6	17.8	26.4	15.3	12.3	16.1	33.1	19.2	8.5	18.8	14.0	16.0	11.2	14.6	15.6	11.6	0.0	13.0	17.7	19.5	17.1	15.5	16.2	35.7	21.3	12.7	15.7	16.3
VGLL1	"TDU, TONDU"	ENSG00000102243	"Vestigial like family member 1"	Q99990	X	136532215-136556807	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 203.9"	"Group enriched"	"Detected in some"	11	"Cytotrophoblasts: 1282.0;Extravillous trophoblasts: 582.3;Syncytiotrophoblasts: 1788.6"	"Group enriched"	"Detected in many"	4	"ovarian cancer: 13.7;urothelial cancer: 47.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 130.7;BEWO: 189.5;CAPAN-2: 72.7;RT4: 328.6;SK-BR-3: 328.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042403, HPA064616"	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA042403: AB_2677980, HPA064616: AB_2685300"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (4.54e-4)"		"unprognostic (5.16e-2)"		"unprognostic (1.80e-1)"	"unprognostic (4.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.37e-2)"		"unprognostic (5.53e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-2)"	0.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.4	1.5	1.3	0.6	0.1	0.0	0.0	6.6	0.1	2.1	0.0	0.0	0.0	0.1	1.5	0.0	1.4	203.9	0.0	1.4	0.0	0.0	5.1	6.7	0.0	0.2	0.2	0.0	0.0	0.1	0.9	0.1	0.1	0.2	0.0	0.0	1.1	22.7	1.6	0.0	130.7	0.0	0.0	0.1	0.0	0.0	189.5	0.0	0.0	0.0	0.0	18.1	72.7	0.0	0.0	0.0	0.0	5.9	0.0	7.5	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.3	0.4	0.1	2.1	0.0	0.1	0.0	0.1	0.0	328.6	0.2	0.2	0.0	328.7	0.3	13.2	5.6	0.4	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.4	0.0	0.0	0.0	0.0	2.3	1.7	0.0	0.0	4.9	1.8	0.2	0.0	16.6	36.8	0.0	1282.0	0.1	0.0	0.0	2.1	0.0	3.3	0.1	2.7	0.0	0.0	0.0	0.2	582.3	5.8	0.0	2.0	1.3	0.0	0.0	0.0	108.2	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.3	0.0	0.1	8.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1788.6	0.0	0.0	0.0	30.5
VIPAS39	"C14orf133, hSPE-39, SPE-39, SPE39, VIPAR, VPS16B"	ENSG00000151445	"VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog"	Q9H9C1	14	77426675-77457952	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003589, HPA003593"	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA003589: AB_10599707, HPA003593: AB_10601879"	"unprognostic (1.30e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-3)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (2.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.09e-2)"	12.4	11.8	15.3	9.4	16.0	9.1	12.2	15.4	17.9	12.1	15.6	14.3	10.1	12.1	14.7	13.2	10.8	9.1	14.8	15.7	15.6	11.2	13.6	9.9	12.4	15.2	15.3	18.5	11.9	14.6	13.4	15.5	15.6	11.8	12.7	14.4	10.0	13.7	13.7	13.7	11.1	14.6	15.6	13.2	11.6	15.9	15.9	16.5	11.7	15.0	14.7	13.9	11.6	17.7	10.6	17.8	18.3	26.6	32.5	26.5	18.3	17.5	16.1	20.8	20.2	11.9	24.7	18.4	15.1	14.3	10.8	20.4	17.0	15.5	24.9	15.8	5.8	13.7	10.7	14.7	26.3	8.6	23.2	25.4	24.2	17.8	24.2	27.7	36.3	25.5	10.9	17.4	19.9	25.1	17.7	18.4	16.5	31.0	19.3	17.6	23.0	12.7	20.9	15.3	13.0	15.0	22.7	16.7	20.2	21.7	39.1	18.1	25.9	14.1	12.5	15.5	9.8	14.8	15.1	14.6	15.3	15.9	17.0	1.8	9.4	17.6	5.0	15.6	6.5	4.8	6.5	5.6	10.8	5.6	5.7	5.6	7.8	13.0	20.3	5.5	7.8	6.1	15.3	16.0	15.4	17.9	15.7	15.6	15.2	15.3	15.6	15.6	15.9	17.7	6.0	3.2	1.5	16.0	6.3	3.2	3.0	4.7	2.8	8.5	5.3	5.3	9.0	4.3	3.4	9.2	20.9	20.7	6.3	7.2	7.9	9.3	5.7	4.0	7.4	6.8	5.4	11.2	14.6	6.3	16.6	8.2	5.1	6.2	2.5	12.2	8.2	6.6	13.3	10.1	14.4	5.4	2.0	17.6	3.8	3.8	11.5	8.3	0.0	13.1	17.6	7.4	9.2	15.1	17.2	9.1	9.4	15.4	4.0	2.5	10.7	5.8	3.6	13.3	6.6	5.5	6.8	11.0	9.2	6.3	4.3	19.2	6.3	15.5	7.2	2.8
VPS33B	FLJ14848	ENSG00000184056	"VPS33B late endosome and lysosome associated"	Q9H267	15	90998673-91022603	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA040415	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA040415: AB_10795419"	"unprognostic (7.49e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.78e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.70e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.00e-2)"	5.7	5.4	5.9	5.1	7.2	2.8	6.1	6.3	7.6	6.6	6.7	6.7	5.8	6.3	7.0	6.8	8.1	4.7	3.8	6.6	7.1	5.9	4.3	5.6	6.9	6.3	6.3	6.8	6.9	8.1	5.3	6.8	6.4	6.6	6.4	5.8	6.7	6.7	4.1	11.0	6.9	6.2	6.3	6.9	7.9	6.1	7.2	5.4	5.5	4.3	6.5	6.1	6.4	7.7	5.6	16.4	3.4	6.0	8.9	15.1	17.7	6.8	12.7	10.7	10.9	7.0	11.0	7.1	9.4	11.9	9.6	10.0	4.7	10.3	5.6	3.8	4.9	7.7	6.6	10.3	10.9	9.6	10.3	17.0	10.7	8.0	9.5	9.3	15.2	8.6	12.6	1.7	7.9	11.9	6.5	6.8	8.3	14.8	5.8	4.9	8.9	8.7	12.2	12.3	5.2	9.6	10.0	7.9	17.5	8.1	8.1	12.6	10.4	7.0	7.8	5.0	5.2	3.6	12.9	2.7	14.7	9.3	6.4	12.5	7.1	12.1	7.7	11.8	8.9	5.6	6.8	6.9	9.5	7.8	7.8	11.0	3.2	7.9	13.4	4.7	5.9	6.4	5.9	7.2	6.3	7.6	6.6	7.1	6.3	6.3	6.4	6.3	7.2	7.7	2.2	0.0	7.3	5.5	5.3	2.2	3.0	3.5	1.8	9.2	2.6	1.8	4.8	2.8	4.4	3.7	2.1	16.8	5.0	6.9	5.9	9.0	3.1	3.0	2.7	4.7	2.4	5.7	11.4	9.4	10.8	2.9	7.7	2.9	8.2	6.7	5.7	4.9	8.0	8.4	11.3	5.1	4.1	6.0	4.1	4.0	3.7	4.5	8.8	3.7	7.7	6.3	3.1	7.5	9.7	9.3	5.0	5.3	4.9	4.1	7.9	4.3	7.9	7.0	6.6	2.7	3.5	11.0	8.2	2.3	2.6	12.3	5.0	3.6	4.3	3.0
VSTM5	"C11orf90, LOC387804"	ENSG00000214376	"V-set and transmembrane domain containing 5"	A8MXK1	11	93818232-93850618	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;placenta: 4.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Excitatory neurons: 5.2;Inhibitory neurons: 9.2;Syncytiotrophoblasts: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.2;OE19: 3.7;PC-3: 5.4;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029525, HPA063591"	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA029525: AB_10600789, HPA063591: AB_2732704"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-4)"	"unprognostic (2.45e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	0.2	0.2	2.2	0.1	1.9	0.0	0.4	1.0	3.4	1.1	0.1	1.1	0.1	0.4	1.2	0.1	0.2	0.4	0.1	1.8	3.7	0.8	0.0	0.1	0.0	3.1	2.0	0.1	0.5	0.1	0.6	4.4	3.3	0.5	1.7	0.5	0.4	0.4	0.0	0.1	0.7	0.7	1.4	0.0	1.9	0.2	3.3	0.0	0.1	0.0	0.1	0.2	0.1	2.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.5	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.4	0.0	0.0	0.1	0.0	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	1.0	3.4	1.8	3.7	3.1	2.0	3.3	1.4	3.3	2.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.9	0.5	0.5	0.3	0.0	0.1	0.0	0.0	22.3	0.1	1.1	0.0	0.4	0.0	0.3	0.2	0.1	0.0	0.0	5.2	3.0	0.7	0.3	1.5	0.7	0.0	0.1	0.0	0.0	1.5	0.0	9.2	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	1.1	2.1	0.4	0.0	0.1	0.5	1.5	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.1	5.9	0.0	0.0	1.6	0.1
VWA1	"FLJ22215, VWA-1, WARP"	ENSG00000179403	"Von Willebrand factor A domain containing 1"	Q6PCB0	1	1434861-1442882	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 275.1;Endothelial cells: 142.7;Syncytiotrophoblasts: 290.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 47.2;CACO-2: 46.7;CAPAN-2: 136.6;Hep G2: 84.4;SCLC-21H: 47.6;T-47d: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		250000		"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (2.78e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.52e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (6.71e-2)"	36.2	15.2	55.3	31.5	91.7	0.2	38.4	79.4	76.7	51.0	24.4	114.3	15.3	70.4	11.5	41.3	50.4	22.4	38.0	59.4	58.9	58.6	133.3	29.6	13.7	103.4	81.6	22.5	55.3	12.5	20.0	38.4	87.9	131.3	5.3	2.3	64.0	203.6	10.1	26.2	37.6	20.4	74.2	11.7	52.6	27.1	88.3	3.0	67.4	3.4	5.1	118.5	50.6	151.2	47.2	15.4	2.2	15.7	0.4	1.4	24.5	3.1	0.1	2.2	0.1	46.7	136.6	0.0	43.0	1.3	5.0	12.1	15.9	8.1	0.3	3.0	11.3	1.5	0.1	84.4	3.5	0.0	5.5	2.7	0.4	1.0	0.0	0.4	0.6	0.0	1.6	0.0	0.1	11.7	0.1	0.9	6.1	16.5	4.3	0.6	0.8	2.2	2.7	7.9	47.6	7.4	0.0	41.7	5.8	3.7	61.1	0.6	1.4	0.1	0.6	0.4	15.2	0.3	0.2	0.2	2.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	91.7	79.4	76.7	59.4	58.9	103.4	81.6	87.9	74.2	88.3	151.2	103.4	19.2	36.1	5.9	2.8	6.5	19.1	5.2	12.0	7.6	40.4	59.4	3.6	44.3	14.2	53.3	4.2	275.1	1.4	24.2	7.9	82.0	0.6	16.0	46.2	142.7	12.5	2.7	0.5	65.0	99.2	28.3	16.8	17.7	1.3	2.0	8.2	49.4	22.8	15.2	1.5	8.9	6.1	1.0	4.3	4.0	34.2	1.1	24.9	18.7	2.6	52.1	0.0	13.0	48.7	48.0	11.0	59.0	2.6	21.5	0.8	5.4	10.7	4.3	6.6	62.4	17.2	0.8	2.1	11.9	8.5	290.3	1.3	6.3	10.4	14.9
XAGE3	"CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3"	ENSG00000171402	"X antigen family member 3"	Q8WTP9	X	52862525-52868083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	121	"placenta: 382.1"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 2223.5;Extravillous trophoblasts: 1309.1;Syncytiotrophoblasts: 2678.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;U-266/70: 2.2;U-266/84: 2.1"									"HPA052507, HPA060900"	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Plasma membrane"	"HPA052507: AB_2681855, HPA060900: AB_2684383"							"unprognostic (6.04e-2)"						"unprognostic (2.30e-1)"		"unprognostic (2.92e-1)"			3.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	382.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.4	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2223.5	0.0	0.1	0.0	0.2	0.3	0.1	0.0	4.5	0.0	0.0	0.0	0.4	1309.1	11.1	0.0	0.3	0.0	0.0	0.0	4.6	191.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	15.1	7.0	0.0	0.0	2678.1	0.0	0.0	0.1	0.0
XKR8	FLJ10307	ENSG00000158156	"XK related 8"	Q9H6D3	1	27959588-27968093	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"eosinophil: 202.8;neutrophil: 101.6"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 202.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049984, HPA053529"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"		"HPA049984: AB_2680982, HPA053529: AB_2682179"	"prognostic favorable (8.63e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.87e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-2)"	5.8	4.4	17.7	8.6	18.0	22.7	6.6	18.7	19.1	6.2	18.5	6.0	7.0	5.7	8.1	5.3	7.7	6.7	8.1	18.3	19.3	6.8	15.3	7.4	8.8	18.9	18.6	9.1	14.0	9.7	4.5	15.2	18.0	6.3	6.1	5.4	10.3	8.0	6.2	5.6	6.0	9.3	17.9	9.4	9.0	6.3	19.1	6.9	6.5	11.7	7.4	7.0	4.7	17.9	10.9	8.6	12.4	13.4	10.5	15.5	13.5	8.8	17.1	19.5	18.7	18.2	7.6	4.1	9.1	21.1	14.5	4.6	19.0	9.5	9.8	15.0	18.2	13.8	5.2	15.4	15.7	6.8	4.7	16.9	18.8	21.8	15.2	19.7	19.3	12.5	21.6	8.9	14.1	10.0	8.5	19.7	40.3	9.1	12.6	15.1	4.0	8.8	15.6	6.3	2.9	4.1	3.8	9.6	6.2	21.7	6.2	16.8	8.0	11.4	10.2	23.9	8.0	13.1	13.6	6.5	29.3	9.2	8.7	20.3	11.9	202.8	15.1	11.9	14.8	7.6	15.7	14.1	13.0	7.1	14.4	13.5	101.6	14.0	10.2	6.3	14.8	11.2	17.7	18.0	18.7	19.1	18.3	19.3	18.9	18.6	18.0	17.9	19.1	17.9	4.4	3.2	1.1	2.6	8.8	1.9	3.8	3.5	1.8	4.5	5.2	3.4	3.3	5.7	4.4	3.7	0.0	62.0	15.5	4.7	3.9	7.8	0.5	1.8	2.9	6.8	1.8	2.1	2.2	11.4	15.8	6.1	5.6	2.4	1.3	5.2	8.6	5.6	14.0	3.3	2.2	6.1	2.0	6.6	3.7	0.9	3.4	8.0	1.8	1.0	21.1	14.0	16.5	3.5	5.5	7.2	2.8	3.8	14.0	5.1	7.2	4.5	1.7	1.3	6.6	5.1	4.0	0.6	7.8	2.2	3.0	22.4	9.1	4.4	5.2	4.1
YIPF1	"DJ167A19.1, FinGER1"	ENSG00000058799	"Yip1 domain family member 1"	Q9Y548	1	53851719-53889798	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.0;Syncytiotrophoblasts: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014716, HPA073931"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA014716: AB_1847686, HPA073931: "	"unprognostic (4.94e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.96e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.39e-3)"	"unprognostic (6.35e-1)"	7.1	9.2	5.3	6.2	5.6	5.7	8.5	5.8	15.2	6.7	6.9	7.9	6.9	4.1	7.6	9.0	6.3	5.5	6.6	5.9	6.3	11.1	13.5	7.7	7.1	6.7	5.8	7.0	6.8	7.0	6.2	9.7	6.8	11.3	9.2	7.2	11.7	4.8	14.6	9.4	6.9	6.0	6.2	8.2	8.7	7.2	6.0	8.8	22.1	10.4	10.7	7.7	7.1	6.4	11.0	6.4	10.1	7.1	11.9	13.1	9.0	7.7	12.0	14.0	18.3	7.1	3.3	3.8	12.9	9.2	21.6	13.2	12.9	17.0	14.4	27.4	10.3	8.9	6.4	11.6	15.9	10.0	8.1	13.3	15.8	11.3	13.5	12.0	15.0	13.2	9.6	10.0	14.0	9.2	10.8	14.2	7.7	12.7	10.4	6.6	9.3	15.4	11.5	5.8	4.5	5.6	7.4	13.8	35.4	31.0	21.4	11.1	7.1	5.7	5.8	10.4	6.8	20.1	24.7	7.0	9.3	8.1	5.0	19.1	18.4	20.2	11.8	16.5	11.0	10.4	10.0	12.1	16.6	13.8	9.5	9.2	38.3	11.0	23.3	11.5	24.3	16.5	5.3	5.6	5.8	15.2	5.9	6.3	6.7	5.8	6.8	6.2	6.0	6.4	11.6	6.4	12.6	9.8	9.0	8.5	17.6	19.2	9.6	6.6	20.0	12.4	9.6	24.3	24.0	9.2	0.0	80.0	8.5	14.6	11.7	28.3	30.5	11.4	10.9	10.9	9.6	12.2	9.8	32.6	28.4	9.9	9.7	14.7	9.5	6.3	11.7	20.8	39.7	10.1	8.2	27.5	30.5	19.4	7.7	54.9	5.9	18.9	10.6	11.2	20.2	16.5	21.6	8.5	11.5	32.5	10.8	9.4	28.1	33.2	12.3	17.7	19.7	6.5	0.0	5.6	17.7	22.2	20.9	12.3	10.9	129.6	10.8	17.7	10.8	29.0
ZBTB45	"FLJ14486, ZNF499"	ENSG00000119574	"Zinc finger and BTB domain containing 45"	Q96K62	19	58513530-58538911	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035754, HPA075485"	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	"Nuclear bodies"	"HPA035754: AB_10603461, HPA075485: "	"unprognostic (1.38e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.38e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.40e-1)"	7.9	8.5	6.5	5.1	6.7	4.9	8.6	5.2	11.4	9.9	1.9	10.3	6.1	12.0	1.1	10.1	9.5	3.1	9.1	7.1	4.9	7.7	6.9	6.1	4.2	8.9	6.4	9.3	8.2	4.2	7.1	3.1	8.3	9.5	1.6	2.1	9.0	4.1	10.3	12.7	7.6	2.4	4.5	8.0	8.3	4.9	6.7	3.3	8.3	3.0	2.3	10.5	9.0	7.4	21.3	29.7	7.6	11.7	7.7	6.6	9.6	11.8	4.8	3.0	2.9	5.8	13.4	31.9	15.6	6.6	8.4	13.2	4.2	10.7	1.1	21.4	55.3	17.3	15.1	7.1	4.9	11.1	11.1	6.3	7.4	4.7	3.9	5.6	6.2	32.1	16.0	1.8	4.6	14.2	17.4	11.6	10.6	12.5	26.1	13.8	4.7	19.4	6.2	19.4	23.4	16.7	8.7	22.5	6.1	4.6	33.4	7.6	13.1	12.9	5.6	4.3	11.7	34.8	27.2	15.9	14.7	4.6	8.4	5.8	5.0	10.2	5.7	7.6	6.8	4.4	3.9	5.3	5.3	5.0	4.6	3.4	4.4	5.5	9.1	6.4	3.7	4.7	6.5	6.7	5.2	11.4	7.1	4.9	8.9	6.4	8.3	4.5	6.7	7.4	3.3	9.6	0.5	2.9	5.6	1.7	3.7	5.5	2.2	4.2	4.5	4.6	3.3	1.5	4.0	12.9	0.0	8.9	5.1	6.3	5.9	10.6	0.6	3.4	4.6	5.0	10.3	7.4	1.9	8.9	8.0	3.9	8.6	3.8	0.0	5.6	8.6	4.5	6.6	6.7	2.0	4.6	8.2	6.8	2.4	1.3	5.9	3.7	7.2	0.0	12.3	3.7	7.2	1.5	1.6	8.8	2.6	9.8	3.6	3.8	5.9	5.6	3.8	3.0	13.1	2.5	5.1	5.2	5.9	3.5	2.7	5.6	3.1	4.8	6.0	2.6
ZFYVE19	"ANCHR, FLJ14840"	ENSG00000166140	"Zinc finger FYVE-type containing 19"	Q96K21	15	40807086-40815084	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040283, HPA041946"	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA040283: AB_10673369, HPA041946: AB_2677762"	"unprognostic (3.59e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-1)"	8.8	8.9	14.2	7.9	16.5	8.6	10.2	19.6	17.2	11.1	12.5	12.0	12.3	8.9	10.7	15.4	9.1	6.6	11.5	13.5	16.9	10.4	19.3	9.1	10.0	19.8	17.4	10.5	8.3	14.1	9.5	9.0	19.1	12.4	8.1	6.6	13.7	8.1	13.5	11.6	12.5	8.8	16.9	13.7	9.6	8.1	18.0	10.9	8.9	13.5	10.5	10.8	11.4	17.5	10.0	12.3	8.8	13.3	13.9	13.9	13.4	15.0	19.4	19.9	20.7	8.9	23.5	9.2	16.5	14.7	17.5	18.0	12.7	17.4	12.1	28.6	12.4	16.6	21.5	11.2	12.5	12.0	24.1	13.5	18.3	13.0	12.6	18.0	19.6	15.2	12.9	11.9	12.7	10.7	15.2	14.8	5.5	22.4	17.6	18.8	5.1	11.4	12.1	19.7	16.0	9.7	13.7	34.6	4.8	6.7	16.4	19.8	9.6	12.4	13.8	9.2	9.9	10.3	14.3	9.8	11.8	22.9	12.4	9.0	5.8	5.2	5.3	9.4	6.2	5.2	5.5	5.2	6.5	3.7	6.0	5.5	3.1	8.9	6.2	5.5	6.1	4.7	14.2	16.5	19.6	17.2	13.5	16.9	19.8	17.4	19.1	16.9	18.0	17.5	11.4	6.4	5.6	6.2	6.6	6.4	13.3	19.7	8.0	11.1	14.8	12.2	9.3	15.7	18.0	12.9	12.5	74.7	5.7	22.6	19.6	24.4	5.3	12.4	8.0	9.7	3.5	5.2	7.6	17.6	16.8	9.6	12.2	12.5	12.7	12.7	10.4	21.8	22.4	3.3	9.4	15.5	22.4	9.9	6.8	10.9	12.8	9.7	7.2	7.5	14.3	9.8	8.2	7.1	15.7	19.3	20.7	9.4	4.2	9.1	50.3	27.4	17.9	10.7	13.1	7.3	9.6	18.6	19.4	7.9	7.7	55.1	9.3	8.9	15.5	15.1
ZNF443	ZK1	ENSG00000180855	"Zinc finger protein 443"	Q9Y2A4	19	12429706-12441021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.3"									"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (5.64e-3)"	"unprognostic (1.51e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.38e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.74e-7)"	"unprognostic (3.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (3.91e-4)"	1.4	1.7	3.2	1.4	3.3	0.6	4.2	3.6	3.8	2.9	2.5	2.8	2.0	2.7	3.1	2.6	2.6	2.1	1.8	2.9	3.1	3.8	3.2	1.6	1.8	3.2	3.3	2.3	2.6	2.8	1.9	3.2	3.0	3.1	3.3	3.3	2.9	3.2	1.1	3.8	2.2	1.8	3.1	1.6	2.4	1.8	3.4	4.0	2.4	1.7	2.2	2.8	2.8	2.9	3.1	1.4	5.4	4.9	1.6	1.3	7.4	2.2	1.6	3.0	2.8	3.0	0.9	3.7	3.9	1.8	1.2	1.8	3.6	2.3	2.5	0.0	1.8	1.5	1.9	7.0	0.4	3.5	4.1	1.2	1.4	1.5	0.7	2.0	1.7	4.5	2.6	0.0	3.3	3.8	13.3	4.8	4.6	3.1	4.6	1.5	5.7	4.5	3.6	11.6	2.6	4.2	3.7	2.0	0.5	3.0	0.0	4.3	1.2	5.9	2.4	3.2	2.2	2.2	3.6	2.3	0.8	3.5	1.2	2.5	0.6	0.9	1.0	0.3	3.7	2.1	2.2	2.2	1.1	1.7	1.9	1.4	0.4	1.6	0.2	0.6	1.8	1.0	3.2	3.3	3.6	3.8	2.9	3.1	3.2	3.3	3.0	3.1	3.4	2.9	3.5	0.0	0.5	10.7	2.4	1.0	1.5	1.2	2.2	1.2	2.8	2.3	2.3	2.8	1.4	0.0	4.2	7.7	2.6	1.8	1.9	2.7	6.3	2.9	1.2	2.8	3.0	1.7	8.9	1.2	1.2	1.4	1.1	3.4	0.0	3.7	1.4	1.6	1.3	1.7	8.1	2.1	2.0	0.9	1.5	2.7	0.6	1.0	0.0	3.7	0.1	3.0	5.2	8.5	5.0	1.1	2.8	2.2	0.6	0.6	1.7	2.2	2.3	2.2	0.0	1.0	1.7	5.0	6.6	3.0	2.6	1.6	2.1	1.2	2.6	0.7
ZNF799	"HIT-40, MGC71805, ZNF842"	ENSG00000196466	"Zinc finger protein 799"	Q96GE5	19	12390016-12401271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (2.96e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.02e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.47e-5)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-3)"	2.9	3.0	2.4	1.5	2.5	1.6	3.8	3.5	2.6	3.4	2.3	2.5	2.1	2.9	2.0	1.8	3.9	2.1	2.0	2.5	2.3	3.4	3.8	2.9	2.6	2.7	2.4	4.4	2.2	2.4	1.1	4.7	2.5	2.6	2.6	1.6	2.2	2.2	1.8	2.4	2.5	2.4	2.4	2.9	2.0	2.7	2.8	3.1	2.0	2.3	2.3	2.7	2.6	2.9	3.0	2.4	3.0	7.2	1.6	1.5	6.0	1.6	2.2	3.9	3.7	4.6	1.2	3.8	2.8	1.9	1.9	2.1	2.4	2.8	3.7	0.0	2.2	3.0	2.0	7.5	0.5	2.3	5.3	1.8	1.7	2.8	2.2	1.2	1.9	3.6	3.1	0.0	2.5	4.2	4.8	3.3	1.6	3.9	6.1	0.5	4.5	3.9	4.0	7.2	1.9	2.2	2.9	0.7	0.9	2.2	3.2	4.2	1.8	4.0	2.3	4.8	1.8	2.6	4.4	3.0	0.4	2.4	1.7	3.1	2.6	2.9	3.9	2.6	4.5	4.7	3.6	5.7	2.1	4.4	3.4	2.7	2.5	2.8	1.6	2.7	4.5	2.3	2.4	2.5	3.5	2.6	2.5	2.3	2.7	2.4	2.5	2.4	2.8	2.9	7.5	6.4	1.5	5.2	3.8	2.4	3.1	1.4	4.6	1.8	5.6	4.3	5.4	1.5	2.0	3.7	0.0	15.2	3.0	3.2	5.9	4.6	8.6	8.0	2.4	7.3	4.2	0.8	5.4	1.3	2.9	2.9	2.6	8.5	3.8	2.9	3.3	1.4	4.4	0.0	4.0	5.7	6.1	1.2	2.6	2.3	2.5	2.2	0.0	10.3	2.1	1.3	6.2	8.0	4.7	2.5	2.3	1.2	2.0	2.1	3.6	2.9	4.7	3.1	13.1	2.8	4.6	4.5	5.6	4.0	1.4	4.5	3.7	1.9	4.0	2.6
ZNF816-ZNF321P	ZNF816-ZNF321	ENSG00000221874	"ZNF816-ZNF321P readthrough"		19	52928475-52962823	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 9.8;Syncytiotrophoblasts: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RT4: 9.0"									HPA051271	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA051271: AB_2681415"												"unprognostic (4.18e-2)"						0.2	0.1	0.0	0.3	0.0	0.4	0.8	0.0	0.2	0.7	0.0	0.9	0.0	0.5	0.0	0.2	0.8	0.3	0.2	0.0	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.5	0.3	0.2	0.2	0.8	0.0	1.7	1.5	0.0	0.4	0.7	0.0	0.2	0.2	0.0	0.0	0.3	1.0	0.1	0.0	0.2	0.2	0.0	0.4	0.6	0.4	0.0	0.3	0.0	0.8	0.2	0.5	0.1	0.5	0.0	0.3	0.5	0.5	0.0	0.3	0.9	0.3	0.4	0.8	0.1	0.8	0.1	0.0	0.5	1.1	0.4	0.1	1.1	0.6	0.0	0.2	0.5	0.0	0.8	0.0	0.3	0.4	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.3	0.1	0.0	0.2	9.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.6	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	0.8	0.0	3.8	0.0	3.4	0.0	1.5	2.4	0.6	4.3	0.0	0.0	0.0	9.8	1.2	4.4	3.9	3.6	1.9	7.3	1.9	1.0	0.0	3.0	0.7	3.6	5.7	1.1	6.6	7.4	4.5	1.5	1.4	0.3	3.7	0.0	0.3	3.6	0.0	1.6	0.0	1.1	0.3	1.8	0.0	1.0	2.9	0.0	4.1	1.0	0.6	3.5	2.5	0.7	1.0	2.7	1.9	1.1	0.0	0.0	0.0	1.3	1.1	1.3	1.6	2.0	0.0	11.2	1.6	1.0	3.0	5.9
ZNF823	HSZFP36	ENSG00000197933	"Zinc finger protein 823"	P16415	19	11721265-11739009	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 18.6;Syncytiotrophoblasts: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (2.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.76e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.50e-1)"	"unprognostic (2.36e-2)"	"prognostic favorable (4.49e-4)"	"prognostic favorable (5.05e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.47e-3)"	3.5	1.9	1.9	2.0	3.1	1.9	7.4	11.8	2.7	4.9	0.0	5.9	3.6	4.0	3.5	8.3	4.0	3.1	2.7	2.0	1.9	6.6	6.1	3.3	2.3	2.2	2.2	4.6	4.3	6.0	1.1	5.0	2.5	3.3	5.8	1.9	5.0	3.8	2.0	4.3	3.7	2.7	1.9	2.5	4.3	1.4	2.7	3.9	2.8	2.8	3.2	4.2	4.9	3.0	6.3	3.2	5.0	5.9	3.1	1.1	9.6	6.8	5.6	9.0	8.5	10.8	2.0	7.4	7.3	5.6	2.8	5.2	5.4	4.2	8.9	0.0	3.5	5.6	2.2	9.6	1.2	2.6	7.7	1.9	4.4	5.9	4.4	3.4	4.3	5.8	4.0	0.1	8.6	4.1	7.4	2.1	3.3	5.1	6.8	3.2	8.9	2.0	8.9	16.5	3.2	4.2	6.6	6.9	2.4	9.1	5.2	7.0	4.7	8.6	3.0	12.8	4.8	4.7	12.7	3.8	2.0	0.0	1.5	2.2	1.4	10.3	2.6	1.7	4.2	2.4	3.4	2.8	1.9	1.6	5.9	4.3	0.8	5.3	1.0	3.3	1.2	1.9	1.9	3.1	11.8	2.7	2.0	1.9	2.2	2.2	2.5	1.9	2.7	3.0	4.3	3.2	1.7	6.5	1.5	5.2	3.7	2.7	9.1	1.3	6.1	4.6	3.3	7.2	4.0	1.8	0.0	18.6	5.7	10.0	9.8	5.9	0.4	5.1	2.8	3.1	0.0	2.5	6.5	4.5	14.9	2.3	6.6	6.9	1.3	3.6	5.7	3.2	4.6	0.0	5.6	7.3	0.0	2.6	5.1	0.8	2.8	1.9	3.6	9.4	2.4	1.2	3.1	4.5	7.1	4.0	9.0	2.2	2.0	2.9	6.3	3.9	2.2	1.5	0.0	1.8	3.7	4.3	4.0	10.3	4.0	21.5	4.3	0.9	7.0	6.1